data_2cq4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cq4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.05 149.56 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.504 ' CE1' ' HB ' ' A' ' 193' ' ' ILE . 14.8 t80 -110.66 124.1 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.4 ' C ' ' HG3' ' A' ' 155' ' ' MET . 41.9 m -113.79 161.16 17.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.4 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 33.9 mtm -155.03 179.52 9.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.418 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.1 tt0 55.98 46.07 22.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.06 159.56 27.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.0 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.43 174.18 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.82 -38.26 38.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -118.39 50.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.96 156.8 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.04 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -131.51 155.06 81.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.02 -47.2 14.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -52.92 -53.92 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -39.73 -45.73 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.89 -46.84 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -45.1 -65.61 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.19 -46.31 88.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -54.17 -28.77 42.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.42 -8.56 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -70.24 -5.9 30.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.21 -23.6 47.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.5 -31.86 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.48 158.57 31.52 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -78.29 136.44 37.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.9 140.74 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -36.26 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.451 ' CG ' ' OE1' ' A' ' 197' ' ' GLU . 0.5 OUTLIER -151.49 152.34 32.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.3 t -141.19 109.3 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -96.53 106.71 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.3 mt -96.05 131.42 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.7 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 179.801 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.504 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 29.0 pt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.92 157.88 44.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.18 134.85 54.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.08 128.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.451 ' OE1' ' CG ' ' A' ' 178' ' ' ASP . 41.5 mt-10 -94.84 129.99 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -103.08 159.66 15.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.0 p -58.58 -32.21 68.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -148.01 164.91 32.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.0 tt -78.53 -20.72 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.407 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.1 mm-40 -73.53 -12.35 60.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 38.0 t -92.42 -14.41 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.5 t -63.8 -43.32 76.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.7 Cg_exo -47.92 -47.96 17.5 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.5 -45.0 95.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 222' ' ' VAL . . . -57.5 -43.2 83.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.7 mt -52.21 -47.53 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -55.47 -43.99 85.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.458 HD22 ' NE2' ' A' ' 213' ' ' GLN . 86.6 mt -40.32 -28.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 210' ' ' LEU . 53.2 m -35.52 102.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.12 4.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.458 ' NE2' HD22 ' A' ' 210' ' ' LEU . 17.9 mt-30 -98.28 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -46.75 107.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.24 108.51 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 mt 66.35 27.37 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.42 -15.52 63.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.24 118.99 25.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.616 0.722 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.4 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 76.0 Cg_exo -49.07 152.27 5.11 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.8 tt -115.5 149.29 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.3 mm -108.87 141.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.409 HG13 ' C ' ' A' ' 207' ' ' ALA . 2.8 t -138.03 127.33 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -150.55 151.3 32.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.6 p -119.8 146.19 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -98.15 127.76 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.41 ' C ' ' HG3' ' A' ' 155' ' ' MET . 64.7 m -115.54 149.61 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 22.9 mtm -149.37 -179.94 7.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.445 ' NE2' HD13 ' A' ' 221' ' ' ILE . 4.6 tt0 55.44 50.38 14.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.5 mt -79.24 163.21 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.67 171.72 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.67 -30.5 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -126.88 33.67 4.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.7 tt -71.57 150.88 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -128.83 150.35 74.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.576 0.703 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.33 -36.12 12.44 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.42 -59.62 4.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -38.54 -36.86 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.8 -50.89 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -39.17 -60.83 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.77 -44.98 84.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -52.21 -32.55 37.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -92.64 -16.17 25.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.3 m -66.5 -10.05 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.35 60.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.75 -28.14 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.39 151.84 14.41 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -62.75 137.11 58.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.77 126.14 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -87.04 -60.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -138.73 149.5 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.84 105.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.54 104.3 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.34 107.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.29 143.91 30.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.043 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.11 147.06 27.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 50.9 t -139.64 130.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -105.23 124.86 50.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.01 155.19 17.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -24.85 68.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -141.19 152.14 44.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.9 tt -76.78 -28.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.414 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 13.6 mm100 -67.73 -7.2 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.424 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 66.7 m -92.77 -25.49 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.87 -43.65 98.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.8 Cg_exo -47.95 -58.63 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.635 2.223 . . . . 0.0 112.411 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.4 mt -52.83 -44.68 66.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.42 ' C ' HG11 ' A' ' 222' ' ' VAL . . . -57.68 -38.26 74.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.24 -44.01 94.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.34 85.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 211' ' ' THR . 39.0 mt -56.4 -24.9 47.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 210' ' ' LEU . 12.5 m -36.76 118.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.23 6.25 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -102.51 110.41 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -47.49 104.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.57 108.02 18.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.3 mt 66.47 25.03 10.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.32 59.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.2 t -123.35 115.72 28.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 149.6 14.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.712 2.275 . . . . 0.0 112.356 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.4 tt -113.34 158.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.445 HD13 ' NE2' ' A' ' 156' ' ' GLN . 6.1 mm -119.22 133.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.42 HG11 ' C ' ' A' ' 207' ' ' ALA . 15.8 t -129.87 119.03 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -138.59 156.03 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.796 0.331 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.5 149.02 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 14.0 t80 -102.48 117.19 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.4 m -107.74 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.0 mtm -151.26 177.3 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.431 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.4 tt0 59.31 50.81 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.22 150.18 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.35 168.63 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.82 23.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -98.28 42.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.1 tt -88.04 157.95 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -127.26 143.65 47.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.95 -29.49 8.46 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.759 2.306 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 165' ' ' ASP . 18.7 mmt85 -66.47 -58.45 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 164' ' ' ARG . 43.3 m-20 -34.99 -45.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.79 -46.26 69.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 164' ' ' ARG . 29.9 mt-10 -47.11 -68.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.54 -50.26 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -49.39 -31.64 9.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -95.87 -11.54 26.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -66.51 -5.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.16 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 m -121.01 -30.74 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.57 153.72 24.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -77.0 134.23 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 179' ' ' VAL . 88.0 t -94.29 128.21 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.22 -41.27 8.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.6 154.78 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 176' ' ' VAL . 25.4 t -143.76 107.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -92.87 105.08 17.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 95.0 mt -96.72 123.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.821 0.343 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.25 157.65 43.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.072 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 98.8 m-85 -114.64 125.44 53.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 82.6 t -109.46 122.66 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -94.11 106.37 18.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 207' ' ' ALA . 38.4 m-85 -78.29 166.25 22.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 45.9 t -71.73 -35.75 70.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -133.93 165.78 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.65 -24.48 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -75.06 -9.76 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 -11.89 27.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.6 t -64.73 -43.75 70.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.4 Cg_exo -48.02 -54.2 5.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.607 2.205 . . . . 0.0 112.326 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.64 -33.37 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . . . -69.92 -34.85 74.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.17 -38.63 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 -40.32 98.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.455 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 95.7 mt -42.26 -32.17 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 210' ' ' LEU . 57.3 m -35.79 98.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 126.29 7.42 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.83 116.73 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 110.922 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -53.11 108.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 117.08 29.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.6 mt 61.64 24.96 14.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.23 -29.23 12.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.2 t -117.64 124.98 28.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.565 0.698 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.32 153.84 6.65 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.356 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.1 tt -116.48 154.28 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.431 HG12 ' CB ' ' A' ' 156' ' ' GLN . 8.5 mm -110.12 142.35 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.82 118.39 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.47 148.9 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.08 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 7.6 p -114.19 152.42 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.7 t80 -109.01 122.58 47.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 60.9 m -111.32 152.37 27.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.22 175.5 10.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.1 tt0 56.52 54.37 7.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.96 156.91 17.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.28 169.56 17.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.78 -44.49 23.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.0 mtm105 -98.57 46.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.71 148.86 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -121.2 143.16 36.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.01 -30.51 7.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.377 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -68.43 -55.83 10.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' ARG . 2.1 m-20 -35.23 -44.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.69 -52.56 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -38.5 -68.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 171' ' ' SER . 0.8 OUTLIER -56.9 -56.13 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -44.17 -29.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.448 ' CE2' HG21 ' A' ' 196' ' ' VAL . 23.8 m-85 -95.34 -21.8 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 168' ' ' ASP . 4.2 t -58.67 -14.16 7.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.84 -29.47 68.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 m -110.08 -30.9 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.53 150.99 16.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.08 138.13 55.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.05 134.66 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -92.77 -56.98 2.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -136.8 161.21 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.0 t -140.86 106.58 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -93.19 103.95 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -94.1 119.99 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.451 ' CG1' HG13 ' A' ' 193' ' ' ILE . 14.9 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.451 HG13 ' CG1' ' A' ' 182' ' ' ILE . 24.6 pt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -153.8 153.76 32.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.52 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 96.0 m-85 -109.04 135.34 50.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.921 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 87.2 t -118.88 133.45 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.89 112.81 24.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 207' ' ' ALA . 39.1 m-85 -89.0 162.13 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 10.9 t -64.87 -43.38 93.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.04 162.45 33.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.8 tt -73.51 -22.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -74.09 -6.46 47.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 66.1 m -97.83 -18.04 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.2 t -61.68 -43.49 88.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.646 0.736 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.2 Cg_exo -48.02 -55.28 4.17 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.2 -35.7 72.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.968 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . . . -67.5 -34.89 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.079 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.94 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.27 -33.87 87.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.4 mt -50.42 -27.6 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 19.8 m -38.01 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 125.38 9.88 4.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.486 ' N ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.04 117.91 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.0 110.977 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -54.51 109.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -113.21 112.73 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.1 mt 61.39 25.4 15.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.0 -30.63 9.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -114.74 121.34 35.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.712 0.768 . . . . 0.0 111.074 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.76 154.15 7.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 16.2 tt -116.77 152.73 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.3 mm -109.63 148.72 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.16 126.33 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -149.63 151.21 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.769 0.319 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.498 HG12 ' CE2' ' A' ' 198' ' ' PHE . 11.4 p -99.04 148.86 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 152' ' ' VAL . 7.4 t80 -106.04 141.58 37.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.402 ' C ' ' HG3' ' A' ' 155' ' ' MET . 82.0 m -133.34 150.7 51.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.402 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 32.3 mtm -148.76 -179.44 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.466 ' NE2' HD11 ' A' ' 221' ' ' ILE . 5.9 tt0 61.13 46.5 8.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.411 HD12 ' CB ' ' A' ' 194' ' ' ALA . 70.1 mt -86.3 154.25 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.21 171.87 9.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.047 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.87 -43.29 36.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 51.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.37 147.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -117.97 144.34 34.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -40.65 19.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 165' ' ' ASP . 26.4 mmt180 -54.97 -57.81 10.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 164' ' ' ARG . 14.2 m-20 -35.52 -47.0 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.17 -47.6 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -43.82 -62.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.45 -48.89 71.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -47.05 -35.78 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -91.98 -15.66 27.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -65.82 -6.53 12.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.26 55.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 174' ' ' GLY . 5.5 m -122.9 -32.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 173' ' ' VAL . . . -162.79 154.85 25.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.461 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 139.75 42.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.61 127.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -92.48 -49.44 6.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -142.69 145.7 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.76 115.4 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -103.0 108.56 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.67 112.67 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.9 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.4 pt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 157' ' ' LEU . . . -141.73 140.0 33.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -101.38 127.15 48.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 78.8 t -116.56 119.38 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.59 115.59 28.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 152' ' ' VAL . 38.4 m-85 -90.07 155.49 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.8 m -63.23 -39.97 96.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -126.77 165.05 20.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 tt -84.4 -29.5 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -71.8 -7.03 45.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -95.37 -17.38 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -63.07 -43.47 81.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.625 0.726 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.3 Cg_exo -47.98 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.97 -41.13 70.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 198' ' ' PHE . . . -61.26 -35.14 76.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.54 -38.95 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.11 -38.38 96.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 88.3 mt -45.01 -28.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' LEU . 41.7 m -35.41 107.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 119.29 5.75 11.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.47 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.506 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -84.51 119.54 25.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -59.49 100.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.46 112.26 24.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.9 mt 61.83 25.27 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.11 -23.14 36.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.464 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -116.68 117.99 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.69 149.6 13.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.445 HG12 ' N ' ' A' ' 221' ' ' ILE . 13.5 tt -113.49 159.49 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.466 HD11 ' NE2' ' A' ' 156' ' ' GLN . 3.6 mm -118.65 148.71 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 207' ' ' ALA . 21.7 t -147.0 138.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -152.67 -177.75 6.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.874 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.865 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.2 p -105.04 154.91 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.88 121.48 45.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.2 m -108.43 157.07 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 63.6 mtm -151.6 171.74 17.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.447 ' NE2' HD13 ' A' ' 221' ' ' ILE . 5.6 tt0 65.62 53.89 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.415 HD11 ' CB ' ' A' ' 194' ' ' ALA . 66.6 mt -91.63 152.23 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.63 179.57 3.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.47 -33.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -113.93 46.54 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.8 tt -91.76 150.03 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -125.37 148.76 62.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.497 0.665 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.6 -40.4 18.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.35 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -54.42 -52.93 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -41.22 -47.79 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.34 -41.5 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.11 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.14 -47.73 84.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 6.8 t80 -52.34 -33.4 42.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -96.9 -14.75 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 t -67.21 -5.62 14.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.2 -26.93 38.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.47 -33.75 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -163.81 150.08 18.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -70.6 135.68 48.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.831 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' A' ' 179' ' ' VAL . 93.1 t -95.72 131.15 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -103.94 -42.47 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -136.68 143.79 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.1 t -134.25 110.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -102.33 113.42 26.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.55 115.5 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.4 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.129 179.875 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 pt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.809 0.338 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -150.9 141.88 22.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -101.34 133.37 46.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 92.3 t -120.85 119.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.96 111.97 20.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.37 150.09 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.4 p -52.26 -36.06 51.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.74 176.94 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.2 tt -87.59 -29.28 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -65.24 -7.33 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 45.2 t -97.26 -17.2 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -61.02 -43.35 90.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.612 0.72 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 63.1 Cg_exo -47.93 -54.47 5.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.667 2.245 . . . . 0.0 112.392 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.33 -45.65 84.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.63 77.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 90.9 mt -56.67 -40.87 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.48 98.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 211' ' ' THR . 80.0 mt -55.3 -26.3 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' LEU . 93.3 m -35.68 104.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.7 26.64 2.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.475 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 44.8 mt-30 -101.71 106.07 17.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 110.947 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -41.47 104.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.06 109.99 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.6 mt 63.21 26.44 15.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.43 -25.37 28.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.6 t -115.24 118.31 40.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.02 150.53 9.98 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.277 . . . . 0.0 112.322 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 tt -110.98 149.44 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.447 HD13 ' NE2' ' A' ' 156' ' ' GLN . 5.2 mm -112.21 142.66 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.07 124.82 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -148.02 148.25 30.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.7 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.532 HG13 ' CE2' ' A' ' 198' ' ' PHE . 10.3 p -104.75 145.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 10.8 t80 -103.23 120.2 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . 0.413 ' C ' ' HG3' ' A' ' 155' ' ' MET . 0.6 OUTLIER -109.7 144.19 38.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.866 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.413 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 12.4 mtm -144.46 178.29 8.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.416 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 3.0 tt0 57.0 51.88 9.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.4 mt -102.6 129.49 49.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.12 169.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.068 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.3 -35.91 40.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -99.45 45.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.8 tt -93.51 148.32 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -120.71 147.4 45.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.66 -41.98 19.07 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.32 -51.68 67.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -39.59 -44.93 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -76.84 -48.41 18.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -40.82 -68.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.65 -54.94 38.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -47.83 -29.99 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.14 -20.57 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.3 t -65.57 -7.01 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.38 -23.68 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.96 -29.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.98 156.49 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 135.53 46.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.05 128.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -82.76 -56.8 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.86 154.15 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.93 121.35 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -110.13 107.41 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.67 121.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -150.77 170.6 18.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 97.2 m-85 -129.33 137.23 50.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 94.2 t -130.63 127.01 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.73 123.9 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.532 ' CE2' HG13 ' A' ' 152' ' ' VAL . 36.9 m-85 -94.66 162.56 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.42 -30.33 71.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -147.23 174.96 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 202' ' ' GLN . 10.6 tt -84.89 -35.9 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 201' ' ' ILE . 77.6 mt-30 -63.99 -6.71 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.6 t -95.18 -17.42 21.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.64 -43.37 83.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.62 0.724 . . . . 0.0 111.154 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.6 Cg_exo -47.99 -56.88 2.71 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.56 -49.03 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.419 ' C ' HG13 ' A' ' 222' ' ' VAL . . . -52.52 -39.92 61.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.57 -46.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.39 -43.5 84.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 211' ' ' THR . 97.5 mt -43.0 -28.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 210' ' ' LEU . 86.7 m -35.65 120.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.22 26.45 6.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -105.5 111.79 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -50.01 105.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.1 tp -112.09 112.47 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.2 mt 62.78 25.24 14.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.54 -27.55 19.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.36 121.07 32.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.64 148.44 15.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 221' ' ' ILE . 11.9 tt -106.79 154.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.083 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.42 ' N ' HG12 ' A' ' 220' ' ' ILE . 5.5 mm -112.92 140.61 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 207' ' ' ALA . 10.4 t -138.69 125.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -147.53 163.04 37.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.3 p -110.76 152.92 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -105.43 133.8 49.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 81.9 m -121.34 143.6 49.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.0 mtm -144.51 177.4 8.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' NE2' HD12 ' A' ' 221' ' ' ILE . 4.6 tt0 58.63 51.99 7.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.4 mt -82.28 162.55 22.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.63 174.91 11.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.124 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.69 -33.76 27.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -115.86 41.99 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.401 ' CG1' ' N ' ' A' ' 162' ' ' ARG . 13.4 tt -86.16 158.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 13.9 mtt85 -136.66 146.72 56.63 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.47 -33.11 8.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.346 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -66.6 -42.62 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -50.95 -34.88 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.1 mt -80.54 -50.64 9.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -38.83 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -52.2 65.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 213' ' ' GLN . 7.0 t80 -47.76 -27.59 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 196' ' ' VAL . 17.0 m-85 -96.96 -18.6 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -59.88 -12.18 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.19 -27.29 63.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.422 HG21 ' N ' ' A' ' 174' ' ' GLY . 5.3 m -109.58 -32.98 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.138 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . 0.422 ' N ' HG21 ' A' ' 173' ' ' VAL . . . -172.24 161.0 32.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 138.44 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.79 125.38 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -88.03 -50.01 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -149.92 151.12 32.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.95 114.87 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -106.77 106.39 16.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 90.6 mt -96.78 115.29 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.843 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--O 1.23 0.03 0 CA-C-O 120.888 0.375 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.13 152.14 36.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.32 148.39 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 91.7 t -139.2 133.96 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 196' ' ' VAL . 5.2 tm-20 -106.81 119.29 38.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -94.31 154.17 17.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -48.03 -43.17 29.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.27 175.24 9.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.5 tt -84.2 -30.0 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -66.11 -6.44 13.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.0 m -95.39 -21.75 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -57.93 -43.51 98.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.655 0.74 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.99 -55.59 3.88 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 41.4 mt -56.08 -43.28 77.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.46 77.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.1 -47.19 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.157 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.32 91.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 31.5 mt -43.19 -24.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.967 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 18.7 m -36.39 110.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.86 19.37 8.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 42.2 mt-30 -92.01 110.96 22.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -50.21 105.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 169' ' ' PHE . 15.7 tp -105.77 104.56 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.1 mt 64.06 25.01 13.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.53 29.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.488 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.23 114.21 48.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.38 148.53 14.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.662 2.242 . . . . 0.0 112.352 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.0 tt -113.68 153.32 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.452 HD12 ' NE2' ' A' ' 156' ' ' GLN . 5.7 mm -112.5 137.74 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.8 t -134.84 115.92 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -133.63 167.83 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.79 0.329 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.469 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.1 p -108.27 148.98 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.126 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -106.83 120.78 42.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 47.2 m -105.79 146.27 30.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.7 mtm -143.28 -179.3 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.441 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.7 tt0 53.52 51.54 15.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 99.1 mt -81.5 156.96 25.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.72 172.05 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.48 -35.07 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -124.37 42.36 3.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.488 ' CG1' ' N ' ' A' ' 162' ' ' ARG . 15.9 tt -74.3 164.19 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 44.0 mtt-85 -128.12 158.71 70.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.573 0.702 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.455 ' CA ' HD13 ' A' ' 181' ' ' ILE . 56.6 Cg_endo -71.06 -9.4 25.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 0.0 112.303 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -90.47 -41.84 11.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -49.64 -36.48 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.12 -40.3 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -48.46 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -57.13 -40.17 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.434 ' CZ ' HG22 ' A' ' 220' ' ' ILE . 24.3 t80 -61.38 -30.7 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.72 -16.12 23.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -67.48 -4.04 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.68 51.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.08 -27.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.34 154.49 24.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -77.83 137.77 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.8 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.67 138.94 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -99.38 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -152.88 145.87 24.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.75 120.35 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -109.48 104.38 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.455 HD13 ' CA ' ' A' ' 163' ' ' PRO . 45.3 mt -93.37 103.44 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.8 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.11 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -146.82 143.29 28.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.042 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -103.85 143.19 33.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 78.9 t -131.6 122.18 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -87.13 124.34 33.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -104.51 153.89 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.88 -44.71 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -130.93 168.91 16.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.34 -28.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.403 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 68.3 mm-40 -64.59 -9.87 22.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 14.8 m -93.21 -15.77 25.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -63.52 -43.42 78.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.667 0.746 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.9 Cg_exo -47.97 -52.02 8.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.9 mt -60.46 -44.21 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.42 ' C ' HG12 ' A' ' 222' ' ' VAL . . . -59.28 -37.56 77.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.63 -46.06 90.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.96 -39.41 94.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 211' ' ' THR . 19.5 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.6 m -34.48 112.11 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 114.47 19.26 6.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.16 112.0 24.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -49.92 106.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.2 tp -113.33 113.32 25.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.18 25.85 15.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.11 17.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.9 t -115.76 121.57 34.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.591 0.71 . . . . 0.0 111.213 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.07 154.0 5.91 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.434 HG22 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 tt -112.91 152.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.3 mm -111.97 123.76 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 207' ' ' ALA . 4.0 t -121.04 112.74 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -138.32 143.07 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.827 0.346 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.9 p -118.66 147.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.09 124.36 42.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.8 m -115.01 155.28 27.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 mtm -154.03 175.85 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.429 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.5 tt0 63.59 54.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 148.38 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.04 176.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.02 -43.33 22.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -107.39 46.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.5 tt -86.59 150.71 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -121.06 144.63 39.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.538 0.685 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.46 -43.85 17.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 165' ' ' ASP . 3.6 tmt_? -56.91 -55.28 36.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 164' ' ' ARG . 7.8 m-20 -36.54 -40.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 215' ' ' LEU . 21.0 mt -77.96 -48.19 16.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -47.53 -68.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.34 -55.39 10.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -48.92 -42.89 38.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -78.56 -20.61 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.1 t -63.57 -11.26 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.43 -27.79 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.74 -32.92 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.37 152.98 22.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -68.71 142.54 54.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.63 128.71 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -87.51 -53.61 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.53 152.79 41.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.54 113.1 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -101.88 109.09 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.3 mt -99.58 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.0 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.82 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.876 0.369 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.67 168.69 19.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -129.55 128.57 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 85.5 t -116.74 121.07 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -94.89 111.24 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.05 152.05 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 m -60.07 -35.24 74.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -135.82 151.33 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.93 -27.32 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -69.56 -6.36 30.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.9 m -95.34 -25.03 16.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.38 -43.72 97.98 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.0 111.186 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -47.93 -58.7 1.59 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.746 2.298 . . . . 0.0 112.306 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.86 -31.05 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' A' ' 222' ' ' VAL . . . -72.74 -31.83 65.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.44 -41.78 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -61.5 -44.42 98.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.485 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.472 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 90.3 mt -37.45 -31.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.3 m -34.45 103.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.32 9.47 5.5 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.477 ' CA ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.93 118.99 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.876 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -56.42 109.9 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.446 ' CD2' HD22 ' A' ' 166' ' ' LEU . 17.6 tp -115.36 115.65 26.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.0 mt 60.22 25.04 14.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.21 -32.08 7.93 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.46 124.13 31.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.612 0.72 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.02 154.02 5.79 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.4 tt -111.91 152.04 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.104 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.429 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.1 mm -110.47 132.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 207' ' ' ALA . 12.4 t -133.38 121.53 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -146.67 145.19 29.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.962 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.846 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.823 0.344 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.2 p -103.53 151.08 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.8 t80 -107.04 134.3 50.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.2 m -119.46 154.9 33.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.6 mtm -151.75 174.58 13.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.437 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 60.28 48.46 8.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.446 HD13 ' CB ' ' A' ' 194' ' ' ALA . 94.7 mt -77.74 156.67 30.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 173.03 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.45 -38.05 50.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -119.7 40.54 3.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -76.26 154.45 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -129.7 149.06 71.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.689 0.757 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.72 -43.66 18.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 165' ' ' ASP . 1.8 mpt_? -53.7 -59.48 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 164' ' ' ARG . 4.4 m-20 -36.51 -41.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.74 -51.64 13.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.39 -67.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.49 -45.19 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 210' ' ' LEU . 19.9 t80 -53.03 -32.24 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 196' ' ' VAL . 44.4 m-85 -95.96 -11.0 27.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -4.64 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.06 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 m -111.04 -28.56 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.04 166.88 35.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -74.99 136.58 41.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.17 123.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -77.12 -52.86 8.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -149.53 152.36 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.69 103.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -93.18 106.25 18.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.4 mt -95.39 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.811 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 46.0 pt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 157' ' ' LEU . . . -135.89 163.43 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 87.5 m-85 -127.15 137.86 53.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 170' ' ' PHE . 53.4 t -128.04 130.94 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -99.95 114.84 28.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.78 149.94 22.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.34 -35.83 65.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -137.25 168.19 20.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 6.7 tt -85.57 -30.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.407 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 44.8 mt-30 -67.97 -6.85 24.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -93.38 -19.65 21.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -58.71 -43.16 97.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.684 0.754 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.07 -45.37 25.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.35 -36.82 82.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.87 89.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 76.0 mt -55.18 -46.32 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.71 -42.62 91.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.453 HD21 ' NE2' ' A' ' 213' ' ' GLN . 34.1 mt -41.84 -30.48 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.947 0.403 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 210' ' ' LEU . 99.7 m -35.72 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.145 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 120.21 11.24 6.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.445 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.453 ' NE2' HD21 ' A' ' 210' ' ' LEU . 9.0 mt-30 -89.87 108.49 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -49.31 106.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.45 113.82 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.2 mt 61.73 26.62 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.36 -26.94 22.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.44 120.69 34.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.111 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.6 151.46 10.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.304 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.7 tt -113.48 144.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.0 mm -100.74 134.27 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.86 116.35 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -143.5 145.75 32.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.995 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.138 179.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.94 154.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.09 134.4 47.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.1 m -122.52 149.64 43.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.1 mtm -148.93 169.42 20.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.463 ' NE2' HD12 ' A' ' 221' ' ' ILE . 4.5 tt0 68.51 52.43 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.26 157.86 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.97 166.24 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.63 67.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 54.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.445 ' CG1' ' N ' ' A' ' 162' ' ' ARG . 16.3 tt -93.01 162.82 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.445 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 17.3 mtt85 -136.69 146.38 55.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.19 -25.31 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 165' ' ' ASP . 11.3 tpt85 -72.84 -60.53 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 164' ' ' ARG . 25.3 m-20 -35.67 -36.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.87 -45.61 16.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 164' ' ' ARG . 56.5 mt-10 -48.34 -66.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -56.12 -50.77 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 1.5 t80 -50.26 -29.57 9.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -96.58 -17.81 20.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.4 p -65.52 -7.78 16.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.36 -29.68 53.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.09 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.8 m -107.04 -31.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.13 161.58 34.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.579 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -75.62 139.39 42.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.4 ' CG1' HG21 ' A' ' 179' ' ' VAL . 82.8 t -97.2 123.29 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -84.23 -44.37 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -153.57 148.4 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.4 HG21 ' CG1' ' A' ' 176' ' ' VAL . 96.7 t -132.6 104.5 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -93.14 113.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.7 mt -100.62 111.19 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.862 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.4 pt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.37 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.08 155.07 41.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -109.58 137.22 47.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.87 126.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.01 115.05 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.828 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 207' ' ' ALA . 34.8 m-85 -90.44 155.04 19.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.8 -38.46 72.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.7 173.71 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.0 tt -84.82 -29.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -68.49 -6.55 25.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.3 m -96.91 -16.56 20.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -62.4 -43.33 84.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.649 0.737 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.9 Cg_exo -47.97 -52.19 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.681 2.254 . . . . 0.0 112.312 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -40.2 83.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.41 ' HB1' ' CZ ' ' A' ' 198' ' ' PHE . . . -65.0 -31.78 73.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.72 -36.56 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.55 -39.44 90.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.44 -24.99 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.07 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 122.41 15.56 4.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 33.0 mt-30 -91.45 109.41 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -48.13 103.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -104.07 107.33 18.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.1 mt 64.9 25.03 12.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.84 -22.72 37.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.6 t -116.66 115.95 39.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.45 153.56 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.683 2.255 . . . . 0.0 112.328 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.4 HG12 ' N ' ' A' ' 221' ' ' ILE . 18.6 tt -115.35 159.97 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.463 HD12 ' NE2' ' A' ' 156' ' ' GLN . 4.7 mm -118.84 139.94 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.407 HG13 ' C ' ' A' ' 207' ' ' ALA . 21.9 t -138.9 131.58 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 147.66 15.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.824 0.345 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.93 150.95 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 t80 -106.48 133.06 51.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 21.2 m -121.71 159.83 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 37.9 mtm -153.4 175.32 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.434 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 63.21 53.16 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.66 142.02 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.77 175.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.61 -46.81 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -103.43 48.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.1 tt -90.27 155.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -129.16 147.55 65.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.5 0.667 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.47 -47.35 13.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -46.96 -58.23 4.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.55 -55.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 215' ' ' LEU . 18.3 mt -64.3 -47.16 80.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -46.45 -66.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -59.96 -43.19 95.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.423 ' CE2' HG23 ' A' ' 220' ' ' ILE . 30.1 t80 -54.81 -35.65 64.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -92.64 -12.64 31.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.5 t -65.98 -7.22 15.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.84 58.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.03 -28.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.82 154.45 20.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -71.29 139.51 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.326 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.51 136.12 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -93.8 -50.94 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -142.18 157.27 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.92 108.03 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -95.95 112.54 24.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.65 107.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.854 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.4 pt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.832 0.348 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -151.25 166.85 29.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.474 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 88.6 m-85 -122.63 127.92 49.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -117.38 123.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.118 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.04 133.68 35.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.86 157.33 19.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 28.8 p -60.57 -40.09 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -135.82 163.25 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.8 tt -74.23 -29.25 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.198 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . 0.409 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 41.6 mt-30 -69.44 -5.95 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.7 m -94.12 -18.17 22.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -64.18 -43.32 73.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.64 0.733 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.6 Cg_exo -47.96 -53.38 6.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.77 -34.29 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.85 76.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.01 -40.5 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.93 92.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 84.6 mt -49.97 -28.24 6.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 210' ' ' LEU . 98.0 m -36.93 98.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.99 7.9 5.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.501 ' N ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -88.68 119.24 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.898 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.79 108.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.432 ' CD2' HD22 ' A' ' 166' ' ' LEU . 14.0 tp -116.36 118.22 32.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 52.3 mt 61.37 25.61 15.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.92 -29.04 13.33 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.523 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.91 126.88 26.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.07 153.96 3.76 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.423 HG23 ' CE2' ' A' ' 169' ' ' PHE . 16.1 tt -114.39 151.06 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.8 mm -109.94 139.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.58 134.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -157.56 142.88 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.913 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.4 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.848 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.62 157.9 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -114.63 149.33 36.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.6 mtm -144.34 177.8 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.434 ' CB ' HG12 ' A' ' 221' ' ' ILE . 5.9 tt0 56.77 47.69 17.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.54 154.44 28.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.53 169.63 17.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.37 31.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.34 38.0 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.5 tt -88.56 155.14 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -131.54 147.43 66.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -25.87 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.73 2.287 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -73.05 -52.89 12.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -40.77 -37.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.46 -41.94 26.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -50.09 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -58.94 -48.14 82.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CZ ' ' NE2' ' A' ' 213' ' ' GLN . 81.8 t80 -54.37 -29.84 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -96.54 -12.35 24.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.9 p -71.63 -5.13 31.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -22.09 45.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.79 -32.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.19 159.0 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -76.54 133.06 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.54 121.71 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -80.7 -60.9 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -135.4 145.8 47.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -126.69 104.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -102.42 104.95 15.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.39 119.55 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 7.0 mm . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.852 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.4 pt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.76 0.315 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -151.86 152.25 32.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.77 145.7 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.58 114.06 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.88 116.85 25.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -92.55 162.63 14.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.15 -16.14 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -145.67 148.91 33.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.87 -23.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -73.52 -6.49 46.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.8 m -95.91 -16.83 21.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.69 -43.22 82.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.645 0.736 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.1 Cg_exo -47.91 -49.47 13.74 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.64 2.227 . . . . 0.0 112.355 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.04 -38.91 90.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.412 ' C ' HG13 ' A' ' 222' ' ' VAL . . . -64.05 -35.7 81.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.11 -47.45 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.187 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -57.63 -32.7 65.52 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.52 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 211' ' ' THR . 24.7 mt -52.07 -28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 210' ' ' LEU . 76.3 m -35.86 105.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.59 14.07 6.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.426 ' NE2' ' CZ ' ' A' ' 169' ' ' PHE . 6.1 mt-30 -91.68 116.59 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.926 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -57.79 106.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.34 112.49 24.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.8 mt 64.08 25.87 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.55 -20.93 48.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.96 119.29 29.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.659 0.742 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.72 152.63 9.23 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -113.88 144.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.5 mm -103.25 133.17 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 207' ' ' ALA . 2.6 t -128.94 128.63 67.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -151.91 150.52 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.755 0.312 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.0 p -102.06 158.18 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.153 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 193' ' ' ILE . 17.1 t80 -109.27 141.27 41.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 58.9 m -126.85 156.66 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 35.8 mtm -152.98 176.48 11.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.446 ' NE2' HD12 ' A' ' 221' ' ' ILE . 4.8 tt0 58.95 46.96 12.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' ' 194' ' ' ALA . 96.1 mt -77.02 168.3 20.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.42 -178.84 6.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.093 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.49 -37.6 22.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 37.39 4.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.3 tt -73.22 154.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -128.78 146.58 60.94 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.63 -35.28 12.63 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -54.94 -51.94 64.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -48.13 -40.2 22.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.11 -42.9 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -43.12 -65.3 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.64 -48.83 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 23.8 t80 -49.25 -30.31 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 196' ' ' VAL . 24.3 m-85 -96.99 -15.46 21.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.9 t -68.0 -8.85 40.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.95 -23.16 55.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.37 -33.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.26 151.73 21.12 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 134.13 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 86.8 t -90.18 123.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -88.7 -61.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.51 144.32 51.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.03 104.04 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -100.49 105.81 17.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.34 105.73 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 48.4 pt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' CB ' HD12 ' A' ' 157' ' ' LEU . . . -139.81 158.29 44.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.094 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -124.4 127.53 47.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.42 HG23 ' CE2' ' A' ' 170' ' ' PHE . 61.8 t -121.5 120.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.18 111.64 23.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.0 148.63 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 m -56.8 -33.01 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.21 166.11 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 16.4 tt -85.98 -33.08 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -64.29 -6.49 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 m -94.65 -19.31 20.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -61.49 -43.23 88.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 111.179 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.3 Cg_exo -48.01 -52.96 7.35 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.06 -36.93 83.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.99 76.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.54 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.74 -40.44 79.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.537 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 211' ' ' THR . 67.3 mt -44.21 -26.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.3 m -35.61 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 116.65 23.58 3.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.557 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.553 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 28.4 mt-30 -100.13 108.9 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -47.93 110.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 169' ' ' PHE . 16.9 tp -116.52 112.31 21.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 62.2 mt 62.16 25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.64 -25.47 27.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.29 119.02 35.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.1 152.03 11.23 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.7 tt -111.99 151.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.446 HD12 ' NE2' ' A' ' 156' ' ' GLN . 5.0 mm -112.72 122.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.07 128.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -155.45 150.35 26.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.2 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.814 0.34 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.465 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 13.0 p -99.04 146.48 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 10.6 t80 -101.22 126.91 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 83.7 m -116.78 150.7 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 42.7 mtm -149.75 178.05 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 219' ' ' PRO . 4.5 tt0 58.54 52.68 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.9 mt -92.31 137.12 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.26 177.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.89 -42.65 13.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 53.9 mtm-85 -97.81 39.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.5 tt -85.05 158.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -135.63 147.13 60.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.566 0.698 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.06 -33.99 8.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.237 . . . . 0.0 112.423 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -66.79 -49.63 65.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -41.39 -36.69 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -83.79 -39.99 19.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.24 -64.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -53.65 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -45.42 -46.04 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 196' ' ' VAL . 21.4 m-85 -80.03 -19.93 46.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.4 t -63.39 -7.73 7.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.834 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.12 -24.01 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.05 -31.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.27 150.62 19.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.5 133.93 47.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.444 HG13 ' CG2' ' A' ' 179' ' ' VAL . 54.9 t -90.3 132.18 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -97.11 -52.87 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.38 145.67 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.444 ' CG2' HG13 ' A' ' 176' ' ' VAL . 94.4 t -130.76 108.49 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -96.47 111.01 23.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.95 106.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 mm . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.18 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -151.19 154.77 37.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 77.5 m-85 -116.82 139.34 50.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.536 HG21 ' CE2' ' A' ' 170' ' ' PHE . 99.0 t -120.82 128.09 76.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -96.81 104.37 16.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.432 ' CZ ' ' HB1' ' A' ' 207' ' ' ALA . 35.4 m-85 -79.42 157.17 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 11.5 t -58.89 -37.44 76.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -140.38 167.19 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.7 tt -77.42 -33.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -64.94 -6.1 7.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.1 m -95.85 -20.26 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -59.85 -43.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.97 -59.85 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.278 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.6 -45.67 63.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 198' ' ' PHE . . . -58.13 -30.4 66.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.48 -44.65 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.133 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.94 -30.84 70.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.9 mt -58.9 -17.83 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.34 114.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . 0.401 ' C ' ' OE1' ' A' ' 213' ' ' GLN . . . 113.33 15.55 8.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.5 ' CA ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.36 115.12 27.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -55.42 110.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -114.58 113.16 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 33.5 mt 61.56 25.02 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.12 -30.14 10.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.97 122.17 32.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.705 0.764 . . . . 0.0 111.093 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 74.5 Cg_exo -50.44 152.52 8.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.381 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.1 tt -108.06 154.17 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.96 124.2 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.17 125.11 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.082 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -156.0 152.7 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 179.93 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 4.1 p -102.95 151.95 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 9.7 t80 -109.09 137.12 47.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 25.2 m -126.62 152.64 46.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' MET . . . . . 0.427 ' CE ' ' OE1' ' A' ' 223' ' ' GLN . 42.8 mtm -152.5 172.85 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.41 ' NE2' HD13 ' A' ' 221' ' ' ILE . 4.4 tt0 65.38 41.51 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 62.1 mt -76.49 161.36 28.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.49 171.15 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.068 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.35 -29.03 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -114.73 42.92 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 tt -91.36 148.35 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -127.6 149.35 70.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 -35.6 13.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.679 2.252 . . . . 0.0 112.377 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -61.78 -53.12 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -41.95 -48.28 4.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.05 -49.3 58.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -43.13 -69.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.83 -48.29 81.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -51.57 -31.16 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -94.95 -10.41 31.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.6 t -69.92 -4.39 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.55 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.9 m -114.31 -28.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.07 154.57 20.9 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -69.65 137.08 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 81.1 t -93.51 136.2 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -101.06 -54.28 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.9 t -131.89 121.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -115.1 104.21 11.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.61 115.59 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.826 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.429 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 17.4 pt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.92 145.95 30.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.023 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.624 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 88.4 m-85 -110.98 139.02 46.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.461 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 90.9 t -128.04 128.29 68.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.47 127.42 36.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -105.39 150.59 25.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 49.1 t -48.07 -42.29 28.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -139.47 173.5 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.4 tt -86.08 -25.64 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -10.6 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 18.1 m -95.2 -13.65 24.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -64.04 -43.44 74.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.647 0.737 . . . . 0.0 111.191 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.6 Cg_exo -48.02 -47.52 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.268 . . . . 0.0 112.29 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.36 -40.2 95.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.24 95.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 92.3 mt -55.39 -44.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.06 98.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 44.9 mt -44.54 -27.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 49.0 m -36.74 116.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 108.3 13.03 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.414 ' NE2' HD21 ' A' ' 210' ' ' LEU . 8.7 mt-30 -92.19 114.37 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -48.81 109.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.39 113.18 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 42.2 mt 62.36 25.12 14.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.97 22.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.8 t -116.52 122.24 32.11 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 111.139 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.1 153.73 3.98 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.83 153.87 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.417 ' C ' HG22 ' A' ' 222' ' ' VAL . 5.1 mm -114.18 143.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 221' ' ' ILE . 67.7 t -140.14 120.19 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.185 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . 0.427 ' OE1' ' CE ' ' A' ' 155' ' ' MET . 0.3 OUTLIER -132.52 166.98 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.825 0.345 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.3 p -104.43 149.5 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -100.29 125.94 46.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.7 m -116.2 154.09 30.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.2 mtm -153.58 178.09 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 59.97 51.46 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.19 142.54 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.89 -175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.72 -43.38 11.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -109.68 32.84 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.76 153.39 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -127.0 146.89 59.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -48.63 11.49 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.64 2.226 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -47.44 -56.88 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -37.94 -55.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.35 -44.43 95.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -53.4 -68.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.78 -45.07 70.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -55.24 -42.31 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.423 ' CE2' HG23 ' A' ' 196' ' ' VAL . 37.1 m-85 -83.83 -19.26 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.8 t -58.41 -11.71 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.3 -26.32 64.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.98 -30.97 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.17 156.31 23.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.416 ' HA ' ' CE ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -70.24 133.49 47.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.27 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.124 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -86.1 -56.43 3.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 179' ' ' VAL . 9.7 t70 -137.59 159.08 42.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 21.2 t -138.73 119.63 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -110.8 117.45 33.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.78 113.94 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.822 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 pt . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.89 0.376 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -149.86 168.0 24.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.065 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.22 133.08 45.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 50.2 t -118.77 120.2 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.17 104.37 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -78.78 159.77 27.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.6 t -61.79 -33.31 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -140.06 152.36 46.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.5 tt -68.85 -31.68 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -64.33 -10.33 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 t -92.83 -18.07 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -60.28 -43.24 92.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.595 0.712 . . . . 0.0 111.129 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.01 -52.13 8.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.632 2.222 . . . . 0.0 112.328 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.85 -37.93 83.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' A' ' 222' ' ' VAL . . . -64.95 -32.57 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.084 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.7 -43.33 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.36 -42.0 99.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.47 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 77.1 mt -41.23 -28.72 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 75.8 m -36.85 107.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.86 11.59 7.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.457 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.495 ' CA ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.25 119.13 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.959 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -56.5 108.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.14 112.97 24.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.9 mt 61.18 26.51 16.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.19 -30.24 10.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.46 121.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.529 0.681 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.05 153.87 6.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -112.08 153.23 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.19 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mm -112.38 132.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 207' ' ' ALA . 11.7 t -131.97 120.61 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -151.36 142.37 23.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.928 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.57 149.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.148 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -100.83 137.92 38.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 91.4 m -127.62 149.82 50.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.6 mtm -151.84 -179.3 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.439 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.8 tt0 54.67 47.05 23.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.4 mt -75.81 165.37 25.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.72 175.76 10.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.87 -34.21 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -118.14 47.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.3 153.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -136.47 152.52 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.55 0.691 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -45.41 16.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.663 2.242 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -48.74 64.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -47.41 -63.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 -45.81 74.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -47.03 -68.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.27 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.427 ' CE1' ' OE1' ' A' ' 213' ' ' GLN . 44.4 t80 -54.68 -29.56 53.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . 23.0 m-85 -95.29 -12.34 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.5 p -67.71 -4.21 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.54 -21.36 41.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.22 -27.56 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.71 159.67 29.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.448 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -74.67 134.98 41.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 80.0 t -95.76 116.48 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.05 -43.49 43.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -153.32 158.0 40.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.07 141.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.38 120.03 30.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.68 114.39 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.841 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.83 0.348 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -146.09 137.01 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -103.4 112.73 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 197' ' ' GLU . 56.2 t -109.54 141.93 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 196' ' ' VAL . 2.9 pt-20 -118.42 153.21 34.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 170' ' ' PHE . 63.2 m-85 -123.05 -177.32 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 51.3 m -85.49 -21.73 28.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.49 144.39 29.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.86 -27.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -65.27 -9.61 25.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -94.89 -18.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -59.28 -43.56 96.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.0 Cg_exo -47.9 -51.59 9.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.371 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.11 -43.57 95.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.36 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.77 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.12 -32.88 85.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 211' ' ' THR . 71.2 mt -55.78 -20.47 15.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.955 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.9 m -36.75 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.93 14.09 6.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.427 ' OE1' ' CE1' ' A' ' 169' ' ' PHE . 27.0 mt-30 -88.65 106.29 18.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -45.9 106.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.43 107.06 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.2 mt 65.82 27.08 11.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.66 -18.15 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.24 115.21 31.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.695 0.759 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.69 149.79 13.36 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.2 tt -115.04 149.74 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.439 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.0 mm -109.0 125.62 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 17.3 t -120.51 124.2 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -143.62 165.79 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 179.871 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -113.92 149.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.65 120.72 40.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.4 m -106.29 154.48 20.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 54.2 mtm -155.54 176.68 12.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.457 ' NE2' HD13 ' A' ' 221' ' ' ILE . 5.4 tt0 57.69 52.05 8.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.45 166.78 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -90.68 174.17 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.05 -40.4 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -108.29 43.67 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.4 tt -92.94 153.71 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.81 153.92 79.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.578 0.704 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.5 -39.32 17.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.608 2.205 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 165' ' ' ASP . 12.0 mtt-85 -57.93 -59.74 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 164' ' ' ARG . 15.0 m-20 -34.43 -41.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.48 -43.78 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' ARG . 50.6 mt-10 -42.7 -66.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 171' ' ' SER . 33.4 t70 -62.15 -53.46 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 169' ' ' PHE . 1.5 t80 -45.46 -30.05 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -95.25 -20.92 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 168' ' ' ASP . 20.5 t -61.51 -9.49 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.86 62.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.33 -33.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.63 152.5 22.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -73.72 142.8 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 177' ' ' ARG . 92.0 t -103.18 136.55 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.462 ' N ' HG11 ' A' ' 176' ' ' VAL . 13.4 ptm180 -113.06 -39.07 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -141.11 134.58 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.441 ' CG2' ' CG1' ' A' ' 176' ' ' VAL . 59.6 t -134.94 102.89 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 -96.04 107.81 20.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 94.4 mt -98.08 117.57 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.4 pt . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -144.96 148.01 33.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -110.33 135.64 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.448 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 86.6 t -129.01 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.13 103.79 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.85 161.51 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.98 -33.55 74.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.26 170.33 15.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -84.27 -28.93 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.6 -6.8 27.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 t -95.34 -22.26 17.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.0 t -57.09 -43.72 99.44 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.579 0.704 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.92 -60.15 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.719 2.279 . . . . 0.0 112.415 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 72.6 mt -52.3 -42.42 63.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ALA . . . . . 0.414 ' C ' HG12 ' A' ' 222' ' ' VAL . . . -59.73 -39.76 85.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.25 -43.68 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.8 99.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.491 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 211' ' ' THR . 49.0 mt -42.33 -29.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 210' ' ' LEU . 51.5 m -33.97 123.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 101.24 17.7 21.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 39.2 mt-30 -93.7 109.82 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -51.49 99.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.46 105.63 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.1 mt 65.83 25.39 11.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.62 -19.75 51.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.0 114.33 37.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.719 0.771 . . . . 0.0 111.058 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.6 149.27 13.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.603 2.202 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -111.49 156.17 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.175 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.457 HD13 ' NE2' ' A' ' 156' ' ' GLN . 4.6 mm -119.55 135.44 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 207' ' ' ALA . 45.6 t -134.02 122.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -145.48 143.13 29.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.4 p -172.19 143.71 1.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 86.5 p -163.65 164.26 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.843 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.33 136.33 5.15 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.3 p -171.95 167.43 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.364 . . . . 0.0 110.835 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 m -129.9 137.57 50.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.31 -172.63 43.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.45 157.89 45.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.7 p -107.55 95.33 13.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.681 0.753 . . . . 0.0 110.841 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.92 159.45 41.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.704 2.269 . . . . 0.0 112.266 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.48 -28.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.112 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -131.17 143.97 51.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.57 143.7 49.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.649 0.738 . . . . 0.0 110.806 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.51 -173.04 1.64 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.669 2.246 . . . . 0.0 112.377 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.6 m -86.06 41.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -98.58 165.17 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -61.06 156.93 16.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 tp -46.13 141.81 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -103.33 147.16 33.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.672 0.749 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.78 -19.01 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.65 2.233 . . . . 0.0 112.348 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -96.49 -45.3 6.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -55.08 -35.04 64.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.929 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.512 ' CG ' ' N ' ' A' ' 148' ' ' ASP . 14.6 ptt180 -47.83 -48.92 30.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 147' ' ' ARG . 33.1 t70 -61.39 -44.9 96.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -46.69 -51.39 16.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.94 43.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.1 m -130.67 131.96 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.2 p -110.05 149.56 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.504 ' CE1' ' HB ' ' A' ' 193' ' ' ILE . 14.8 t80 -110.66 124.1 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.4 ' C ' ' HG3' ' A' ' 155' ' ' MET . 41.9 m -113.79 161.16 17.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.4 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 33.9 mtm -155.03 179.52 9.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.418 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.1 tt0 55.98 46.07 22.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.06 159.56 27.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.0 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -69.43 174.18 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.82 -38.26 38.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -118.39 50.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.7 tt -89.96 156.8 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.04 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -131.51 155.06 81.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.02 -47.2 14.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -52.92 -53.92 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.433 ' N ' ' OD1' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -39.73 -45.73 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.89 -46.84 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -45.1 -65.61 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.19 -46.31 88.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -54.17 -28.77 42.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.42 -8.56 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -70.24 -5.9 30.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.21 -23.6 47.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.5 -31.86 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.48 158.57 31.52 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -78.29 136.44 37.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 65.8 t -97.9 140.74 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -36.26 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.451 ' CG ' ' OE1' ' A' ' 197' ' ' GLU . 0.5 OUTLIER -151.49 152.34 32.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.3 t -141.19 109.3 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -96.53 106.71 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.3 mt -96.05 131.42 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.7 mm -96.3 120.78 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.0 t -111.56 -32.16 6.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.94 117.82 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -61.62 110.74 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -92.87 -46.47 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.1 m -118.54 147.42 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -39.02 -55.62 1.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -44.77 123.8 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.0 t -77.95 83.49 4.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -124.92 153.01 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.86 104.85 1.18 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.457 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.504 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 29.0 pt -98.71 143.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -141.92 157.88 44.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.18 134.85 54.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.08 128.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.112 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.451 ' OE1' ' CG ' ' A' ' 178' ' ' ASP . 41.5 mt-10 -94.84 129.99 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -103.08 159.66 15.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.0 p -58.58 -32.21 68.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -148.01 164.91 32.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.0 tt -78.53 -20.72 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.407 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.1 mm-40 -73.53 -12.35 60.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 38.0 t -92.42 -14.41 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.5 t -63.8 -43.32 76.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.7 Cg_exo -47.92 -47.96 17.5 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.5 -45.0 95.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.409 ' C ' HG13 ' A' ' 222' ' ' VAL . . . -57.5 -43.2 83.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.7 mt -52.21 -47.53 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -55.47 -43.99 85.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.458 HD22 ' NE2' ' A' ' 213' ' ' GLN . 86.6 mt -40.32 -28.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 210' ' ' LEU . 53.2 m -35.52 102.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.12 4.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.458 ' NE2' HD22 ' A' ' 210' ' ' LEU . 17.9 mt-30 -98.28 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -46.75 107.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.24 108.51 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 mt 66.35 27.37 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.42 -15.52 63.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.24 118.99 25.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.616 0.722 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.4 ' HB2' ' NE2' ' A' ' 156' ' ' GLN . 76.0 Cg_exo -49.07 152.27 5.11 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.284 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.8 tt -115.5 149.29 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.3 mm -108.87 141.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.409 HG13 ' C ' ' A' ' 207' ' ' ALA . 2.8 t -138.03 127.33 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -150.55 151.3 32.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -60.34 113.63 2.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.4 p -56.41 -32.18 64.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 229' ' ' LYS . 15.0 pt20 -70.74 -41.39 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -42.7 -55.5 3.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.86 -21.9 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 226' ' ' GLN . 25.7 tptp -79.89 -62.35 1.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -38.74 -39.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -58.27 8.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.825 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.0 tt -41.5 -50.84 3.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -74.99 160.85 30.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -61.09 157.62 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.238 . . . . 0.0 112.335 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 6.0 m -80.36 174.6 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.816 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 7.9 t -43.14 159.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.472 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -139.23 128.98 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.1 m -43.07 112.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -132.4 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 t -92.43 -48.59 6.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.3 m 43.31 42.49 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 135.07 110.15 1.08 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -53.68 141.92 24.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.1 m -55.74 143.52 59.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.701 0.762 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.17 110.01 2.8 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.658 2.239 . . . . 0.0 112.342 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.9 t -125.27 105.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -138.6 111.23 7.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.11 138.17 26.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.43 172.85 13.93 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.8 m -79.72 167.58 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -161.67 122.64 2.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.86 164.85 3.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.19 94.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -100.13 158.72 31.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.748 . . . . 0.0 110.818 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.04 -19.42 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 0.0 112.362 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -89.61 -39.55 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -59.86 -35.73 75.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -50.65 -48.96 58.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.63 -53.67 55.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -40.01 -44.48 1.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 199' ' ' CYS . 2.5 mtp-105 -83.35 37.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m -133.28 141.62 48.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.6 p -119.8 146.19 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -98.15 127.76 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.41 ' C ' ' HG3' ' A' ' 155' ' ' MET . 64.7 m -115.54 149.61 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.41 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 22.9 mtm -149.37 -179.94 7.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.445 ' NE2' HD13 ' A' ' 221' ' ' ILE . 4.6 tt0 55.44 50.38 14.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 79.5 mt -79.24 163.21 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.67 171.72 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.67 -30.5 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -126.88 33.67 4.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.7 tt -71.57 150.88 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -128.83 150.35 74.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.576 0.703 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.33 -36.12 12.44 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.42 -59.62 4.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -38.54 -36.86 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.9 mt -80.8 -50.89 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -39.17 -60.83 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.77 -44.98 84.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -52.21 -32.55 37.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -92.64 -16.17 25.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.3 m -66.5 -10.05 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.35 60.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.75 -28.14 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.39 151.84 14.41 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -62.75 137.11 58.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.77 126.14 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.407 ' C ' ' HD3' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -87.04 -60.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -138.73 149.5 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.1 t -136.84 105.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.54 104.3 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.34 107.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.48 106.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.8 p -102.96 150.57 23.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.23 178.63 6.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -92.08 -53.7 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.819 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -121.95 135.61 54.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.43 140.67 46.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -120.93 -59.89 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -129.84 -51.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.9 p -51.53 135.23 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 192' ' ' GLY . 23.4 mmmt -95.88 133.73 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . -34.78 111.41 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt -97.82 148.83 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.29 143.91 30.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.043 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.11 147.06 27.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 50.9 t -139.64 130.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -105.23 124.86 50.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.01 155.19 17.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.448 ' O ' ' NH2' ' A' ' 150' ' ' ARG . 26.7 p -63.21 -24.85 68.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -141.19 152.14 44.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.9 tt -76.78 -28.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.414 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 13.6 mm100 -67.73 -7.2 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.424 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 66.7 m -92.77 -25.49 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.87 -43.65 98.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.8 Cg_exo -47.95 -58.63 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.635 2.223 . . . . 0.0 112.411 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.4 mt -52.83 -44.68 66.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.42 ' C ' HG11 ' A' ' 222' ' ' VAL . . . -57.68 -38.26 74.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.24 -44.01 94.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.34 85.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 211' ' ' THR . 39.0 mt -56.4 -24.9 47.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 210' ' ' LEU . 12.5 m -36.76 118.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.23 6.25 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -102.51 110.41 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -47.49 104.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 29.6 tp -109.57 108.02 18.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.3 mt 66.47 25.03 10.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.32 59.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.2 t -123.35 115.72 28.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 149.6 14.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.712 2.275 . . . . 0.0 112.356 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.4 tt -113.34 158.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.445 HD13 ' NE2' ' A' ' 156' ' ' GLN . 6.1 mm -119.22 133.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.42 HG11 ' C ' ' A' ' 207' ' ' ALA . 15.8 t -129.87 119.03 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -138.59 156.03 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -65.57 139.39 58.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.7 m -88.57 42.57 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.441 ' HG3' ' N ' ' A' ' 227' ' ' ALA . 12.5 pt20 -94.47 -42.04 9.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.441 ' N ' ' HG3' ' A' ' 226' ' ' GLN . . . -70.71 -55.53 8.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -39.86 -41.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -69.7 -53.97 16.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.72 -57.24 5.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -50.78 -42.64 58.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 tp -53.83 142.73 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.2 p -78.17 143.5 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 94.68 73.22 1.19 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.438 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.01 -18.61 14.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.288 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 26.6 t -87.43 134.89 33.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.3 m -73.59 127.29 32.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.471 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.0 m -113.89 163.39 15.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.7 t -148.35 143.95 27.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.27 98.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 t -146.87 120.04 8.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.7 p -93.17 155.95 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 129.26 109.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.04 151.83 42.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 m -140.91 141.38 24.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.65 0.738 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.23 172.07 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.58 116.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 137' ' ' GLU . 20.8 mtp85 -149.54 173.33 13.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 136' ' ' ARG . 5.9 mm-40 -37.26 154.73 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.671 0.748 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.11 126.66 8.76 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.599 2.199 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.92 174.04 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.74 -51.29 61.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -40.94 149.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -40.15 117.61 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.465 ' N ' HD11 ' A' ' 142' ' ' LEU . 3.7 p -125.69 160.29 56.86 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.65 0.738 . . . . 0.0 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.19 -19.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.723 2.282 . . . . 0.0 112.291 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.03 -41.24 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.22 -39.98 67.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -46.84 -42.85 17.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.19 -54.98 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.17 -39.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.7 43.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.9 m -136.9 126.11 24.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.3 p -102.5 149.02 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 14.0 t80 -102.48 117.19 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.4 m -107.74 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.0 mtm -151.26 177.3 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.431 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.4 tt0 59.31 50.81 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 58.3 mt -95.22 150.18 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.35 168.63 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.82 23.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -98.28 42.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.1 tt -88.04 157.95 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -127.26 143.65 47.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.95 -29.49 8.46 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.759 2.306 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 165' ' ' ASP . 18.7 mmt85 -66.47 -58.45 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 164' ' ' ARG . 43.3 m-20 -34.99 -45.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 29.4 mt -68.79 -46.26 69.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 164' ' ' ARG . 29.9 mt-10 -47.11 -68.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.54 -50.26 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -49.39 -31.64 9.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -95.87 -11.54 26.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -66.51 -5.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.16 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 m -121.01 -30.74 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.57 153.72 24.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -77.0 134.23 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 179' ' ' VAL . 88.0 t -94.29 128.21 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.22 -41.27 8.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.6 154.78 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.465 ' CG2' HG12 ' A' ' 176' ' ' VAL . 25.4 t -143.76 107.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -92.87 105.08 17.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 95.0 mt -96.72 123.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.96 119.04 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.0 t -127.38 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.443 ' OD2' ' NH1' ' A' ' 185' ' ' ARG . 24.8 t0 -126.99 -59.18 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' OD2' ' A' ' 184' ' ' ASP . 0.7 OUTLIER -110.79 39.52 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -50.69 -27.07 6.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m -101.98 -60.32 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.0 tpt85 -43.74 -31.07 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -109.6 -10.65 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.0 m 46.95 36.85 4.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -134.01 -177.88 4.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.94 113.04 0.55 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 41.4 pt -118.4 141.6 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.126 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.25 157.65 43.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.072 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 98.8 m-85 -114.64 125.44 53.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 82.6 t -109.46 122.66 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.103 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -94.11 106.37 18.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 207' ' ' ALA . 38.4 m-85 -78.29 166.25 22.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 45.9 t -71.73 -35.75 70.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -133.93 165.78 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.65 -24.48 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -75.06 -9.76 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 -11.89 27.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.6 t -64.73 -43.75 70.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.4 Cg_exo -48.02 -54.2 5.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.607 2.205 . . . . 0.0 112.326 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.64 -33.37 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.478 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . . . -69.92 -34.85 74.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.17 -38.63 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 -40.32 98.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.455 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 95.7 mt -42.26 -32.17 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 210' ' ' LEU . 57.3 m -35.79 98.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 126.29 7.42 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' N ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.83 116.73 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 110.922 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -53.11 108.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 117.08 29.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.6 mt 61.64 24.96 14.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.23 -29.23 12.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.2 t -117.64 124.98 28.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.565 0.698 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.32 153.84 6.65 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.356 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.1 tt -116.48 154.28 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.431 HG12 ' CB ' ' A' ' 156' ' ' GLN . 8.5 mm -110.12 142.35 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 4.5 t -142.82 118.39 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.47 148.9 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -45.78 125.06 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.08 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 23.2 t -76.65 50.17 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -85.86 43.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.75 -36.46 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.01 -44.93 87.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.71 -40.79 61.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -61.54 -48.09 82.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 232' ' ' LEU . 23.8 ttm180 -60.04 -52.11 66.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -36.0 -54.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.944 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.88 -43.75 71.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 149.64 145.8 4.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.18 42.1 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.4 t -56.03 123.51 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -42.83 -45.89 5.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.851 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 p -140.3 148.46 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.3 m -132.12 109.11 9.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.822 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.51 175.16 38.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.456 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.7 m -93.9 -55.18 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.839 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.2 m -73.33 152.89 40.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.27 -135.31 2.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 124.17 19.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.2 p -128.71 94.42 34.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.727 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.73 124.33 4.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.637 2.224 . . . . 0.0 112.389 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.61 150.04 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.8 171.72 19.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.38 155.68 51.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.674 0.75 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -45.22 122.38 4.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.254 . . . . 0.0 112.248 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.9 m -110.73 178.65 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.96 105.16 17.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 142' ' ' LEU . 31.7 m-20 -171.99 173.57 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.453 HD21 ' CB ' ' A' ' 146' ' ' GLU . 1.3 tm? -34.74 115.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 95.4 p -82.33 147.25 56.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.649 0.738 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.88 -16.05 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.723 2.282 . . . . 0.0 112.394 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -44.39 13.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.453 ' CB ' HD21 ' A' ' 142' ' ' LEU . 23.8 mt-10 -55.18 -42.31 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -58.72 -41.32 86.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -55.94 -48.61 75.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.42 -53.57 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.422 ' NH2' HD22 ' A' ' 142' ' ' LEU . 46.2 mtm180 -82.5 46.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 74.3 m -140.61 138.6 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 7.6 p -114.19 152.42 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.7 t80 -109.01 122.58 47.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 60.9 m -111.32 152.37 27.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.8 mtm -147.22 175.5 10.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.863 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.408 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.1 tt0 56.52 54.37 7.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 87.3 mt -91.96 156.91 17.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.28 169.56 17.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.78 -44.49 23.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.0 mtm105 -98.57 46.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.9 tt -91.71 148.86 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -121.2 143.16 36.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.01 -30.51 7.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.377 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -68.43 -55.83 10.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' ARG . 2.1 m-20 -35.23 -44.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 26.7 mt -71.69 -52.56 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -38.5 -68.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 171' ' ' SER . 0.8 OUTLIER -56.9 -56.13 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -44.17 -29.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.448 ' CE2' HG21 ' A' ' 196' ' ' VAL . 23.8 m-85 -95.34 -21.8 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 168' ' ' ASP . 4.2 t -58.67 -14.16 7.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.84 -29.47 68.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 m -110.08 -30.9 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.53 150.99 16.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.08 138.13 55.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.05 134.66 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -92.77 -56.98 2.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -136.8 161.21 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 99.0 t -140.86 106.58 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -93.19 103.95 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -94.1 119.99 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.451 ' CG1' HG13 ' A' ' 193' ' ' ILE . 14.9 mm -67.99 145.96 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.1 t 75.02 40.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -104.9 -32.22 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 186' ' ' ASN . 0.3 OUTLIER -116.57 77.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' ARG . 7.0 p-10 37.81 40.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.3 m -94.85 166.27 12.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -38.59 155.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -109.41 132.96 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 9.1 t -172.82 176.35 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 190' ' ' SER . 0.0 OUTLIER -35.38 126.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.836 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.77 89.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.451 HG13 ' CG1' ' A' ' 182' ' ' ILE . 24.6 pt -111.5 146.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.14 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -153.8 153.76 32.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.52 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 96.0 m-85 -109.04 135.34 50.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.921 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 87.2 t -118.88 133.45 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.89 112.81 24.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 207' ' ' ALA . 39.1 m-85 -89.0 162.13 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 10.9 t -64.87 -43.38 93.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.04 162.45 33.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.8 tt -73.51 -22.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -74.09 -6.46 47.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 66.1 m -97.83 -18.04 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.2 t -61.68 -43.49 88.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.646 0.736 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.2 Cg_exo -48.02 -55.28 4.17 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.2 -35.7 72.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.968 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . . . -67.5 -34.89 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.079 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.94 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.27 -33.87 87.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.4 mt -50.42 -27.6 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 19.8 m -38.01 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 125.38 9.88 4.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.04 117.91 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.0 110.977 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -54.51 109.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -113.21 112.73 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.1 mt 61.39 25.4 15.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.0 -30.63 9.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -114.74 121.34 35.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.712 0.768 . . . . 0.0 111.074 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.76 154.15 7.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 16.2 tt -116.77 152.73 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.3 mm -109.63 148.72 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.16 126.33 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -149.63 151.21 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.09 107.53 0.55 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.2 t -49.37 -36.93 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -94.7 41.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -67.15 -45.5 76.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.009 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -58.46 -56.53 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.29 -57.83 7.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.55 -41.66 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 42.5 mtt85 -92.31 56.68 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 15.0 tp -129.41 -49.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 135.61 42.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.88 145.2 48.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.35 98.78 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.676 2.251 . . . . 0.0 112.335 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 t -59.31 106.01 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 13.3 m -128.02 -55.99 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.42 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -121.62 109.87 15.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.4 t -136.4 130.34 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 129' ' ' SER . . . 123.51 -92.87 0.46 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 128' ' ' GLY . 69.8 m 34.36 52.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 0.0 110.817 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.7 m -119.51 42.9 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' LYS . . . 119.78 -107.35 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' GLY . 14.2 ptpt 34.42 45.39 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.8 p -99.65 139.11 20.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.39 137.92 13.56 Favored 'Trans proline' 0 N--CA 1.466 -0.118 0 C-N-CA 122.738 2.292 . . . . 0.0 112.366 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.26 173.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -48.56 114.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -136.84 148.79 64.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.738 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 176.1 10.52 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.9 35.9 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.35 -55.41 5.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -106.71 156.25 18.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.83 167.98 16.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -164.89 160.9 15.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.4 -17.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -106.11 -49.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -57.65 -38.49 75.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -46.23 -44.83 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.44 -47.77 63.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -41.95 -46.65 4.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.056 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -82.29 39.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.814 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m -137.2 120.9 17.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.498 HG12 ' CE2' ' A' ' 198' ' ' PHE . 11.4 p -99.04 148.86 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.421 ' N ' HG21 ' A' ' 152' ' ' VAL . 7.4 t80 -106.04 141.58 37.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.402 ' C ' ' HG3' ' A' ' 155' ' ' MET . 82.0 m -133.34 150.7 51.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.402 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 32.3 mtm -148.76 -179.44 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.466 ' NE2' HD11 ' A' ' 221' ' ' ILE . 5.9 tt0 61.13 46.5 8.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.411 HD12 ' CB ' ' A' ' 194' ' ' ALA . 70.1 mt -86.3 154.25 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.21 171.87 9.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.047 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.87 -43.29 36.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 51.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 15.7 tt -87.37 147.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -117.97 144.34 34.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -40.65 19.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 165' ' ' ASP . 26.4 mmt180 -54.97 -57.81 10.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 164' ' ' ARG . 14.2 m-20 -35.52 -47.0 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.17 -47.6 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -43.82 -62.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.45 -48.89 71.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -47.05 -35.78 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -91.98 -15.66 27.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -65.82 -6.53 12.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.26 55.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.417 HG23 ' N ' ' A' ' 174' ' ' GLY . 5.5 m -122.9 -32.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.417 ' N ' HG23 ' A' ' 173' ' ' VAL . . . -162.79 154.85 25.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.461 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 139.75 42.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 87.0 t -95.61 127.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -92.48 -49.44 6.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -142.69 145.7 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 93.2 t -127.76 115.4 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -103.0 108.56 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.67 112.67 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.83 111.69 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -106.35 77.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -154.85 164.87 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -119.49 117.97 29.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -133.32 -43.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 m -84.55 177.96 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -82.14 -61.04 2.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -115.64 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.7 m -169.28 130.39 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm -75.61 -51.39 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 164.3 129.66 1.06 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.3 140.75 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 111.13 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.411 ' CB ' HD12 ' A' ' 157' ' ' LEU . . . -141.73 140.0 33.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -101.38 127.15 48.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 78.8 t -116.56 119.38 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.59 115.59 28.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.498 ' CE2' HG12 ' A' ' 152' ' ' VAL . 38.4 m-85 -90.07 155.49 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.8 m -63.23 -39.97 96.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -126.77 165.05 20.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 tt -84.4 -29.5 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -71.8 -7.03 45.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -95.37 -17.38 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -63.07 -43.47 81.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.625 0.726 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.3 Cg_exo -47.98 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.97 -41.13 70.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 198' ' ' PHE . . . -61.26 -35.14 76.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.54 -38.95 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.11 -38.38 96.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 88.3 mt -45.01 -28.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' LEU . 41.7 m -35.41 107.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 119.29 5.75 11.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.47 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.506 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -84.51 119.54 25.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -59.49 100.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.46 112.26 24.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.9 mt 61.83 25.27 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.11 -23.14 36.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.464 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -116.68 117.99 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.69 149.6 13.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.445 HG12 ' N ' ' A' ' 221' ' ' ILE . 13.5 tt -113.49 159.49 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.466 HD11 ' NE2' ' A' ' 156' ' ' GLN . 3.6 mm -118.65 148.71 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 207' ' ' ALA . 21.7 t -147.0 138.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 12.9 mp0 -152.67 -177.75 6.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.84 115.82 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -75.71 57.82 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -100.55 35.11 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -95.53 -40.69 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.32 -47.52 73.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -45.88 -22.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -93.24 -40.21 10.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -108.14 62.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.0 tp -138.97 116.33 11.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -51.37 132.42 29.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 165.41 95.83 0.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.6 145.71 33.48 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 27.9 p -111.37 141.72 44.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 23.3 t -88.22 -45.3 10.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.49 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 p -53.94 170.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.92 0.391 . . . . 0.0 110.888 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.0 t 61.66 45.22 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.91 123.36 2.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.45 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.2 m -107.91 157.72 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -121.24 112.26 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.16 43.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -111.76 98.1 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.4 t -107.33 93.41 9.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.668 0.747 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.18 142.9 27.88 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.27 144.5 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . 4.6 ptp180 -121.62 43.02 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.21 141.81 10.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.27 154.3 24.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.374 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.79 145.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.201 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.69 -57.74 3.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' LEU . 39.6 p-10 -126.15 147.82 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' ASN . 13.4 mt -35.83 131.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 p -76.44 155.53 83.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.679 0.752 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.72 -40.6 19.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.299 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -74.73 -53.79 8.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -49.37 -42.13 41.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -58.05 -66.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -40.71 -47.19 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -45.43 -62.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.134 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -43.83 -25.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.7 m -96.0 133.9 39.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.453 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.2 p -105.04 154.91 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.88 121.48 45.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.2 m -108.43 157.07 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 63.6 mtm -151.6 171.74 17.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.447 ' NE2' HD13 ' A' ' 221' ' ' ILE . 5.6 tt0 65.62 53.89 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.415 HD11 ' CB ' ' A' ' 194' ' ' ALA . 66.6 mt -91.63 152.23 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.63 179.57 3.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.47 -33.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -113.93 46.54 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 11.8 tt -91.76 150.03 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -125.37 148.76 62.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.497 0.665 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.6 -40.4 18.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.35 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -54.42 -52.93 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -41.22 -47.79 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.34 -41.5 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.11 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.14 -47.73 84.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 6.8 t80 -52.34 -33.4 42.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -96.9 -14.75 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 t -67.21 -5.62 14.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.2 -26.93 38.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.47 -33.75 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -163.81 150.08 18.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -70.6 135.68 48.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.831 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' A' ' 179' ' ' VAL . 93.1 t -95.72 131.15 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -103.94 -42.47 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -136.68 143.79 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.1 t -134.25 110.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -102.33 113.42 26.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.55 115.5 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.52 108.75 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.129 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.6 t -94.01 74.24 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.25 151.44 34.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -153.76 138.0 16.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -90.09 -42.21 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.7 t -127.35 165.0 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -49.16 -62.54 1.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -80.56 90.21 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -109.96 141.21 43.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.28 120.19 6.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 pt -96.89 146.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.156 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.415 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -150.9 141.88 22.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -101.34 133.37 46.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.453 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 92.3 t -120.85 119.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.96 111.97 20.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -90.37 150.09 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.4 p -52.26 -36.06 51.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.74 176.94 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.2 tt -87.59 -29.28 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -65.24 -7.33 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 45.2 t -97.26 -17.2 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -61.02 -43.35 90.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.612 0.72 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 63.1 Cg_exo -47.93 -54.47 5.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.667 2.245 . . . . 0.0 112.392 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.33 -45.65 84.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.63 77.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 90.9 mt -56.67 -40.87 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.48 98.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.418 ' O ' ' C ' ' A' ' 211' ' ' THR . 80.0 mt -55.3 -26.3 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 210' ' ' LEU . 93.3 m -35.68 104.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.7 26.64 2.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.475 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 44.8 mt-30 -101.71 106.07 17.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 110.947 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -41.47 104.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.2 tp -110.06 109.99 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.6 mt 63.21 26.44 15.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.43 -25.37 28.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.6 t -115.24 118.31 40.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.02 150.53 9.98 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.277 . . . . 0.0 112.322 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 tt -110.98 149.44 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.447 HD13 ' NE2' ' A' ' 156' ' ' GLN . 5.2 mm -112.21 142.66 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.07 124.82 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -148.02 148.25 30.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.0 7.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.6 t -61.93 -39.92 93.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -1.39 15.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -101.48 9.27 41.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -109.5 -35.84 6.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 230' ' ' ASN . 14.3 mmmt -87.66 -46.93 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 p-10 -34.72 -48.32 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -64.08 -62.01 1.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.888 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.07 121.5 1.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.94 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.9 t -84.49 101.65 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -99.44 162.0 19.76 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.24 97.09 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.683 2.256 . . . . 0.0 112.353 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 7.8 t -52.01 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 77.8 p -100.24 139.63 35.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.842 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.487 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.0 p -112.32 161.33 16.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.844 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.2 m -102.95 138.85 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.63 177.51 21.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -147.67 159.09 44.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.399 . . . . 0.0 110.771 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -143.89 138.89 28.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.84 159.99 1.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.549 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -109.26 86.97 2.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.742 0.306 . . . . 0.0 110.837 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.9 m -151.76 145.18 17.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 110.847 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.57 109.24 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 0.0 112.37 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.4 m -120.24 163.66 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -100.85 104.92 16.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -121.99 156.17 59.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.26 -168.54 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.725 2.283 . . . . 0.0 112.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 m -80.94 52.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.135 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -119.08 87.4 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -165.68 165.67 18.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.425 HD22 ' CG ' ' A' ' 147' ' ' ARG . 8.4 tp -64.06 149.53 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.0 m -67.67 143.58 96.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.731 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.98 -40.76 25.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.34 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.17 -52.32 12.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -42.36 -45.94 4.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.425 ' CG ' HD22 ' A' ' 142' ' ' LEU . 12.3 mtp180 -47.5 -58.28 4.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.27 -49.5 73.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.13 -43.77 21.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -83.97 38.73 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.7 m -139.48 138.83 36.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.532 HG13 ' CE2' ' A' ' 198' ' ' PHE . 10.3 p -104.75 145.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 10.8 t80 -103.23 120.2 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . 0.413 ' C ' ' HG3' ' A' ' 155' ' ' MET . 0.6 OUTLIER -109.7 144.19 38.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.866 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.413 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 12.4 mtm -144.46 178.29 8.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.416 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 3.0 tt0 57.0 51.88 9.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 28.4 mt -102.6 129.49 49.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.12 169.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.068 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.3 -35.91 40.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -99.45 45.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.8 tt -93.51 148.32 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -120.71 147.4 45.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.66 -41.98 19.07 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.32 -51.68 67.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -39.59 -44.93 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -76.84 -48.41 18.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -40.82 -68.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.65 -54.94 38.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -47.83 -29.99 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.14 -20.57 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.3 t -65.57 -7.01 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.38 -23.68 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.96 -29.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.98 156.49 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 135.53 46.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.05 128.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -82.76 -56.8 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.86 154.15 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 76.9 t -133.93 121.35 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -110.13 107.41 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.67 121.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.2 mm -78.25 104.53 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 t -99.63 44.11 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.76 144.57 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -111.54 41.81 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -47.79 -49.88 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.0 m -102.24 160.11 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -82.36 44.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -114.2 170.72 8.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.0 t -109.69 21.73 16.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.449 ' N ' ' HE3' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -73.34 170.21 15.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.54 98.45 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.3 pt -94.09 148.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -150.77 170.6 18.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 97.2 m-85 -129.33 137.23 50.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 94.2 t -130.63 127.01 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.73 123.9 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.532 ' CE2' HG13 ' A' ' 152' ' ' VAL . 36.9 m-85 -94.66 162.56 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.42 -30.33 71.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -147.23 174.96 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.4 HG22 ' N ' ' A' ' 202' ' ' GLN . 10.6 tt -84.89 -35.9 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.4 ' N ' HG22 ' A' ' 201' ' ' ILE . 77.6 mt-30 -63.99 -6.71 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.6 t -95.18 -17.42 21.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.64 -43.37 83.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.62 0.724 . . . . 0.0 111.154 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.6 Cg_exo -47.99 -56.88 2.71 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.56 -49.03 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.419 ' C ' HG13 ' A' ' 222' ' ' VAL . . . -52.52 -39.92 61.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.57 -46.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.39 -43.5 84.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 211' ' ' THR . 97.5 mt -43.0 -28.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 210' ' ' LEU . 86.7 m -35.65 120.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.22 26.45 6.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -105.5 111.79 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -50.01 105.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.1 tp -112.09 112.47 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.2 mt 62.78 25.24 14.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.54 -27.55 19.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.36 121.07 32.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.64 148.44 15.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 221' ' ' ILE . 11.9 tt -106.79 154.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.083 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.42 ' N ' HG12 ' A' ' 220' ' ' ILE . 5.5 mm -112.92 140.61 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.419 HG13 ' C ' ' A' ' 207' ' ' ALA . 10.4 t -138.69 125.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -147.53 163.04 37.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -68.33 130.51 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -89.6 53.1 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 230' ' ' ASN . 21.3 pt20 -129.94 33.99 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.49 -57.62 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.14 -57.06 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -63.3 -49.65 73.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 226' ' ' GLN . 25.2 t-20 -48.13 -55.96 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.438 ' NE ' ' HA ' ' A' ' 231' ' ' ARG . 2.2 tpm_? -63.77 -60.58 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.5 tp -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -148.35 137.44 21.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -116.13 176.29 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.03 -179.8 5.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.266 . . . . 0.0 112.369 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.0 t -167.08 151.09 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.3 t -61.36 109.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.435 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.3 m -114.49 165.66 12.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -121.75 -53.65 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.08 -113.82 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.535 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.4 m 57.05 42.7 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.898 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 p -51.46 142.49 13.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.77 159.85 52.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -74.76 168.31 20.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 91.9 p -72.97 143.41 84.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.74 86.06 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.729 2.286 . . . . 0.0 112.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.22 165.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -96.41 140.76 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -106.48 142.29 24.6 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.62 0.724 . . . . 0.0 110.853 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -47.04 153.09 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.293 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -51.28 148.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -173.35 165.98 4.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -53.47 179.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.413 HD11 ' N ' ' A' ' 147' ' ' ARG . 4.7 tp -39.18 107.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.2 m -68.7 144.17 95.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.697 0.761 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.63 -22.34 1.11 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.344 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -88.76 -32.2 18.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -65.7 -35.86 81.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.413 ' N ' HD11 ' A' ' 142' ' ' LEU . 4.7 ptp180 -59.32 -34.96 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' THR . 4.9 t0 -65.14 -49.89 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.4 -39.93 2.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 -91.61 37.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 148' ' ' ASP . 76.9 m -137.92 135.01 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.442 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.3 p -110.76 152.92 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -105.43 133.8 49.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 81.9 m -121.34 143.6 49.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.0 mtm -144.51 177.4 8.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' NE2' HD12 ' A' ' 221' ' ' ILE . 4.6 tt0 58.63 51.99 7.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 49.4 mt -82.28 162.55 22.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.63 174.91 11.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.124 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.69 -33.76 27.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -115.86 41.99 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.401 ' CG1' ' N ' ' A' ' 162' ' ' ARG . 13.4 tt -86.16 158.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 13.9 mtt85 -136.66 146.72 56.63 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.47 -33.11 8.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.346 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -66.6 -42.62 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -50.95 -34.88 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.1 mt -80.54 -50.64 9.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -38.83 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -52.2 65.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.55 ' CZ ' ' OE1' ' A' ' 213' ' ' GLN . 7.0 t80 -47.76 -27.59 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 196' ' ' VAL . 17.0 m-85 -96.96 -18.6 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -59.88 -12.18 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.19 -27.29 63.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.422 HG21 ' N ' ' A' ' 174' ' ' GLY . 5.3 m -109.58 -32.98 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.138 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.422 ' N ' HG21 ' A' ' 173' ' ' VAL . . . -172.24 161.0 32.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 138.44 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 72.8 t -90.79 125.38 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -88.03 -50.01 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -149.92 151.12 32.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.4 t -137.95 114.87 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -106.77 106.39 16.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 90.6 mt -96.78 115.29 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 41.2 mm -74.35 114.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 t -125.74 119.35 27.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -129.7 -48.0 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.881 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -106.46 116.17 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.79 97.22 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.0 m -140.54 158.3 44.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -84.49 156.96 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.812 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 42.68 47.75 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.7 t -119.63 147.97 43.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -71.4 176.08 4.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.96 151.82 13.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.9 pt -114.14 143.79 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.13 152.14 36.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.32 148.39 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 91.7 t -139.2 133.96 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 196' ' ' VAL . 5.2 tm-20 -106.81 119.29 38.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -94.31 154.17 17.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -48.03 -43.17 29.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.27 175.24 9.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.5 tt -84.2 -30.0 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -66.11 -6.44 13.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.0 m -95.39 -21.75 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -57.93 -43.51 98.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.655 0.74 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.99 -55.59 3.88 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 41.4 mt -56.08 -43.28 77.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.46 77.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.1 -47.19 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.157 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.32 91.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 31.5 mt -43.19 -24.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.967 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 18.7 m -36.39 110.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.86 19.37 8.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 42.2 mt-30 -92.01 110.96 22.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -50.21 105.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.42 ' CD1' ' CD2' ' A' ' 169' ' ' PHE . 15.7 tp -105.77 104.56 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.1 mt 64.06 25.01 13.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.53 29.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.488 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.23 114.21 48.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.38 148.53 14.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.662 2.242 . . . . 0.0 112.352 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.0 tt -113.68 153.32 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.452 HD12 ' NE2' ' A' ' 156' ' ' GLN . 5.7 mm -112.5 137.74 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.8 t -134.84 115.92 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -133.63 167.83 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -72.92 109.5 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' GLN . 1.7 t -62.6 -55.61 25.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 225' ' ' SER . 21.0 pt20 -36.62 -44.5 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.96 49.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -41.69 -56.66 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 230' ' ' ASN . 0.0 OUTLIER -56.72 -71.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 229' ' ' LYS . 5.3 t-20 -34.28 -58.15 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 232' ' ' LEU . 31.5 mmt180 -56.65 -60.16 3.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -36.54 125.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.413 ' N ' HD12 ' A' ' 232' ' ' LEU . 95.8 p -77.72 130.87 37.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.69 79.98 0.3 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.17 112.15 3.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.337 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 39.7 t -174.42 128.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.7 p -93.18 127.21 38.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.86 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.537 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -109.94 113.45 26.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.5 t -140.05 113.08 8.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.783 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.56 115.43 0.67 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.6 p -117.9 166.69 12.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.9 t -123.23 139.59 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.22 35.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.425 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.81 177.69 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.1 m -109.59 91.41 10.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.694 0.759 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.09 119.62 5.41 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.6 m -51.74 158.7 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -118.46 158.38 25.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -107.89 152.68 41.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.653 0.74 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.94 150.02 29.66 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.721 2.28 . . . . 0.0 112.359 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.78 174.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.23 -41.99 90.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 142' ' ' LEU . 30.4 t30 -40.54 155.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.443 ' CD2' ' HG3' ' A' ' 147' ' ' ARG . 14.4 tp -35.58 136.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 m -68.42 161.7 67.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.67 -27.17 18.72 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.686 2.257 . . . . 0.0 112.305 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.44 -38.89 29.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -51.72 -29.74 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.443 ' HG3' ' CD2' ' A' ' 142' ' ' LEU . 47.6 mtt180 -78.73 -41.57 30.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.838 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 149' ' ' ALA . 0.2 OUTLIER -61.8 -47.89 83.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 148' ' ' ASP . . . -45.45 -36.4 4.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -95.95 48.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.814 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.3 m -143.23 134.08 25.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.469 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.1 p -108.27 148.98 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.126 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -106.83 120.78 42.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 47.2 m -105.79 146.27 30.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.7 mtm -143.28 -179.3 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.441 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.7 tt0 53.52 51.54 15.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 99.1 mt -81.5 156.96 25.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.72 172.05 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.48 -35.07 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -124.37 42.36 3.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.488 ' CG1' ' N ' ' A' ' 162' ' ' ARG . 15.9 tt -74.3 164.19 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 44.0 mtt-85 -128.12 158.71 70.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.573 0.702 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.455 ' CA ' HD13 ' A' ' 181' ' ' ILE . 56.6 Cg_endo -71.06 -9.4 25.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 0.0 112.303 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -90.47 -41.84 11.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -49.64 -36.48 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.12 -40.3 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -48.46 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -57.13 -40.17 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.434 ' CZ ' HG22 ' A' ' 220' ' ' ILE . 24.3 t80 -61.38 -30.7 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.72 -16.12 23.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -67.48 -4.04 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.68 51.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.08 -27.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.34 154.49 24.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -77.83 137.77 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.8 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 69.6 t -93.67 138.94 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -99.38 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -152.88 145.87 24.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.75 120.35 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -109.48 104.38 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.455 HD13 ' CA ' ' A' ' 163' ' ' PRO . 45.3 mt -93.37 103.44 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.89 112.12 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.11 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.3 m -136.08 130.65 33.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.45 108.08 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -64.6 99.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -159.4 170.53 21.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -93.04 40.75 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -113.26 128.63 56.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.66 111.81 16.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 96.5 p -152.79 169.03 23.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.84 174.93 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.28 118.65 4.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.54 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.8 pt -109.61 142.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -146.82 143.29 28.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.042 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -103.85 143.19 33.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.469 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 78.9 t -131.6 122.18 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -87.13 124.34 33.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -104.51 153.89 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.88 -44.71 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -130.93 168.91 16.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.1 tt -87.34 -28.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.125 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.403 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 68.3 mm-40 -64.59 -9.87 22.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 14.8 m -93.21 -15.77 25.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -63.52 -43.42 78.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.667 0.746 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.9 Cg_exo -47.97 -52.02 8.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.9 mt -60.46 -44.21 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.42 ' C ' HG12 ' A' ' 222' ' ' VAL . . . -59.28 -37.56 77.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.63 -46.06 90.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.96 -39.41 94.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 211' ' ' THR . 19.5 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.6 m -34.48 112.11 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 114.47 19.26 6.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -98.16 112.0 24.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -49.92 106.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.2 tp -113.33 113.32 25.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.18 25.85 15.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.11 17.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.9 t -115.76 121.57 34.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.591 0.71 . . . . 0.0 111.213 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.07 154.0 5.91 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.434 HG22 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 tt -112.91 152.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.441 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.3 mm -111.97 123.76 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 207' ' ' ALA . 4.0 t -121.04 112.74 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -138.32 143.07 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -43.31 139.3 2.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.3 t -98.81 51.94 0.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -121.75 -39.27 2.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -46.94 -52.25 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 227' ' ' ALA . 9.3 tp10 -35.79 -45.95 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -65.2 -50.69 64.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -45.79 -61.68 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -50.47 -56.16 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -42.46 -59.99 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t 65.63 48.92 1.86 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.05 32.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.79 -8.93 18.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 37.0 t -64.67 113.17 3.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 8.5 t -76.51 172.38 13.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.2 p -150.23 163.52 38.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 t -173.15 140.05 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -97.07 -127.79 5.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.9 p -135.38 133.19 38.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 0.0 110.855 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.4 t -144.13 126.35 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 133.7 178.93 15.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.465 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.6 tptt 61.01 54.69 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.5 p -86.91 139.17 32.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.27 149.66 3.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.66 111.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -130.88 168.41 17.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -43.28 148.86 0.6 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.683 0.754 . . . . 0.0 110.839 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.66 121.49 5.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.1 m -85.76 165.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.125 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -66.52 -48.83 68.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -40.91 144.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.39 119.81 7.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 t -95.45 154.6 39.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.71 -28.91 7.16 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -70.27 -55.3 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -43.98 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -43.57 -39.81 3.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.06 -56.28 22.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -40.51 -48.96 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -87.68 48.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 m -144.55 140.77 29.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.9 p -118.66 147.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.09 124.36 42.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 84.8 m -115.01 155.28 27.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 64.2 mtm -154.03 175.85 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.429 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.5 tt0 63.59 54.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.0 mt -93.41 148.38 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.04 176.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.02 -43.33 22.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -107.39 46.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.5 tt -86.59 150.71 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -121.06 144.63 39.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.538 0.685 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.46 -43.85 17.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 165' ' ' ASP . 3.6 tmt_? -56.91 -55.28 36.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 164' ' ' ARG . 7.8 m-20 -36.54 -40.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.446 HD22 ' CD2' ' A' ' 215' ' ' LEU . 21.0 mt -77.96 -48.19 16.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -47.53 -68.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.34 -55.39 10.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -48.92 -42.89 38.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -78.56 -20.61 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.1 t -63.57 -11.26 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.43 -27.79 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.74 -32.92 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.37 152.98 22.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -68.71 142.54 54.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.9 t -98.63 128.71 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -87.51 -53.61 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.53 152.79 41.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.54 113.1 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -101.88 109.09 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.3 mt -99.58 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.5 102.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -118.41 99.83 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -120.51 -38.47 2.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? 54.24 54.78 9.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.43 -40.9 93.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.2 p -109.8 176.52 5.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -63.41 -53.67 48.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -119.7 101.11 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.1 t -121.53 169.64 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 134.31 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.66 100.55 2.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.8 pt -93.27 145.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.67 168.69 19.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -129.55 128.57 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 85.5 t -116.74 121.07 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -94.89 111.24 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -85.05 152.05 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 m -60.07 -35.24 74.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -135.82 151.33 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.93 -27.32 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -69.56 -6.36 30.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' SER . . . . . 0.425 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.9 m -95.34 -25.03 16.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.38 -43.72 97.98 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.0 111.186 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -47.93 -58.7 1.59 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.746 2.298 . . . . 0.0 112.306 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.86 -31.05 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.406 ' O ' ' CG1' ' A' ' 222' ' ' VAL . . . -72.74 -31.83 65.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 82.5 mt -64.44 -41.78 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -61.5 -44.42 98.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.485 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.472 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 90.3 mt -37.45 -31.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.3 m -34.45 103.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.32 9.47 5.5 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.477 ' CA ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.93 118.99 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.876 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -56.42 109.9 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.446 ' CD2' HD22 ' A' ' 166' ' ' LEU . 17.6 tp -115.36 115.65 26.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.0 mt 60.22 25.04 14.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.21 -32.08 7.93 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.46 124.13 31.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.612 0.72 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.02 154.02 5.79 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 9.4 tt -111.91 152.04 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.104 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.429 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.1 mm -110.47 132.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 207' ' ' ALA . 12.4 t -133.38 121.53 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -146.67 145.19 29.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.962 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -51.36 133.63 29.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 7.6 t -89.35 36.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.837 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -84.35 33.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 230' ' ' ASN . . . -77.12 -57.38 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -43.08 -30.84 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -67.36 -39.18 85.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.47 ' OD1' ' C ' ' A' ' 230' ' ' ASN . 0.7 OUTLIER -67.83 -39.19 83.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' N ' ' OD1' ' A' ' 230' ' ' ASN . 8.5 tpt180 -91.13 44.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.2 tp -118.38 -56.51 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 28.2 t -88.5 92.0 9.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.05 169.26 26.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.502 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.72 15.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.618 2.212 . . . . 0.0 112.35 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 m -53.0 169.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 9.5 t -149.28 144.14 26.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t 54.76 42.43 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.79 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.2 p -94.19 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.6 160.33 26.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.5 p -136.34 153.35 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -167.25 133.88 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -141.15 173.65 23.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.505 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -67.82 80.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.956 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 p -173.04 154.25 2.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.64 0.733 . . . . 0.0 110.915 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.65 141.93 7.72 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.751 2.301 . . . . 0.0 112.306 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.11 138.34 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -106.85 53.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.822 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -122.21 161.16 44.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.9 120.03 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.7 m -95.14 170.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.01 164.91 27.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -148.7 119.13 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 tp -68.13 123.57 21.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.07 150.12 51.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.72 0.771 . . . . 0.0 110.793 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -44.93 -20.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.727 2.285 . . . . 0.0 112.299 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.74 -48.45 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -52.1 -37.75 55.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -52.78 -41.26 63.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -80.65 -43.96 19.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -50.05 -54.26 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -47.9 -24.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m -91.36 134.28 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.2 p -103.53 151.08 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.8 t80 -107.04 134.3 50.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.2 m -119.46 154.9 33.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.6 mtm -151.75 174.58 13.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.437 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 60.28 48.46 8.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.446 HD13 ' CB ' ' A' ' 194' ' ' ALA . 94.7 mt -77.74 156.67 30.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.44 173.03 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.45 -38.05 50.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -119.7 40.54 3.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 17.4 tt -76.26 154.45 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -129.7 149.06 71.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.689 0.757 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.72 -43.66 18.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 165' ' ' ASP . 1.8 mpt_? -53.7 -59.48 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 164' ' ' ARG . 4.4 m-20 -36.51 -41.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.74 -51.64 13.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.39 -67.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.49 -45.19 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.442 ' CZ ' HD12 ' A' ' 210' ' ' LEU . 19.9 t80 -53.03 -32.24 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.461 ' CE2' HG23 ' A' ' 196' ' ' VAL . 44.4 m-85 -95.96 -11.0 27.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -4.64 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.06 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 m -111.04 -28.56 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.04 166.88 35.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -74.99 136.58 41.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 55.7 t -93.17 123.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.167 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -77.12 -52.86 8.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -149.53 152.36 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 60.7 t -130.69 103.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -93.18 106.25 18.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.4 mt -95.39 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.36 104.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -119.41 84.02 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -112.74 171.62 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -90.44 98.8 11.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 187' ' ' SER . 17.4 m-20 -114.37 176.11 5.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 188' ' ' ARG . 14.2 t -37.99 155.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 187' ' ' SER . 10.6 mtt85 -36.16 -56.26 0.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -82.83 116.5 22.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 12.8 m -154.03 130.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -83.45 -73.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 129.61 112.01 1.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.414 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 46.0 pt -95.76 144.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.446 ' CB ' HD13 ' A' ' 157' ' ' LEU . . . -135.89 163.43 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 87.5 m-85 -127.15 137.86 53.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 170' ' ' PHE . 53.4 t -128.04 130.94 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -99.95 114.84 28.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.78 149.94 22.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.34 -35.83 65.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -137.25 168.19 20.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 6.7 tt -85.57 -30.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.407 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 44.8 mt-30 -67.97 -6.85 24.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -93.38 -19.65 21.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -58.71 -43.16 97.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.684 0.754 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.07 -45.37 25.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.35 -36.82 82.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.87 89.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 76.0 mt -55.18 -46.32 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.71 -42.62 91.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.453 HD21 ' NE2' ' A' ' 213' ' ' GLN . 34.1 mt -41.84 -30.48 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.947 0.403 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 210' ' ' LEU . 99.7 m -35.72 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.145 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 120.21 11.24 6.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.445 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.453 ' NE2' HD21 ' A' ' 210' ' ' LEU . 9.0 mt-30 -89.87 108.49 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -49.31 106.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.45 113.82 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.2 mt 61.73 26.62 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.36 -26.94 22.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.44 120.69 34.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.111 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.6 151.46 10.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.304 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.7 tt -113.48 144.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.0 mm -100.74 134.27 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.86 116.35 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -143.5 145.75 32.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.995 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -60.54 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.138 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 44.1 t -42.5 -25.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.845 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.32 48.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.46 -67.73 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -51.61 -59.81 3.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -43.21 -40.54 3.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.22 -55.87 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -42.09 -61.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.8 tp -42.43 126.66 3.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 m -74.52 -52.17 12.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.86 -145.97 47.53 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.508 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.05 121.65 3.76 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.613 2.209 . . . . 0.0 112.434 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 83.9 p -62.71 -47.02 85.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 2.7 m -78.36 141.34 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 t -140.7 145.48 36.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.3 p -164.8 170.08 15.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.73 71.14 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.541 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -74.55 159.66 31.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -65.51 154.34 38.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.809 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 170.29 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -134.51 148.6 50.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.5 p -114.03 82.72 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.661 0.743 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.28 124.62 7.28 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.633 2.222 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.21 171.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -151.14 109.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -112.26 144.92 31.79 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.675 0.75 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.67 -176.76 3.31 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.37 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.37 143.06 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.17 160.5 6.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -38.23 129.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.426 ' HG ' ' N ' ' A' ' 143' ' ' SER . 6.5 tp -91.58 149.06 21.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.426 ' N ' ' HG ' ' A' ' 142' ' ' LEU . 2.2 m -73.52 160.9 81.22 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.724 0.773 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.42 -18.93 19.89 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.657 2.238 . . . . 0.0 112.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.12 -19.67 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -85.94 -32.42 21.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -60.36 -34.42 73.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -75.66 -32.01 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 201' ' ' ILE . . . -61.9 -57.87 10.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.053 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.5 mtp85 -46.74 -29.1 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.3 m -89.57 136.37 33.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 p -107.94 154.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.09 134.4 47.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.1 m -122.52 149.64 43.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.1 mtm -148.93 169.42 20.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.463 ' NE2' HD12 ' A' ' 221' ' ' ILE . 4.5 tt0 68.51 52.43 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 86.2 mt -86.26 157.86 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.97 166.24 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.63 67.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 54.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.445 ' CG1' ' N ' ' A' ' 162' ' ' ARG . 16.3 tt -93.01 162.82 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.445 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 17.3 mtt85 -136.69 146.38 55.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.19 -25.31 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 165' ' ' ASP . 11.3 tpt85 -72.84 -60.53 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 164' ' ' ARG . 25.3 m-20 -35.67 -36.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.87 -45.61 16.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 164' ' ' ARG . 56.5 mt-10 -48.34 -66.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -56.12 -50.77 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 1.5 t80 -50.26 -29.57 9.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -96.58 -17.81 20.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.4 p -65.52 -7.78 16.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.36 -29.68 53.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.09 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.8 m -107.04 -31.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.13 161.58 34.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.579 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -75.62 139.39 42.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.4 ' CG1' HG21 ' A' ' 179' ' ' VAL . 82.8 t -97.2 123.29 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -84.23 -44.37 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -153.57 148.4 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.4 HG21 ' CG1' ' A' ' 176' ' ' VAL . 96.7 t -132.6 104.5 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -93.14 113.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.7 mt -100.62 111.19 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.9 mm -70.08 138.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.4 t -158.7 126.18 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -74.31 -63.37 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -148.42 130.15 15.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -45.44 101.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 t -165.59 137.2 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -44.02 133.86 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -151.79 169.56 21.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.1 p -118.46 2.44 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -132.01 171.31 13.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.0 144.03 3.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.519 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 44.4 pt -124.14 141.49 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.127 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.08 155.07 41.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -109.58 137.22 47.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.3 t -121.87 126.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.01 115.05 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.828 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.41 ' CZ ' ' HB1' ' A' ' 207' ' ' ALA . 34.8 m-85 -90.44 155.04 19.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.8 -38.46 72.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.7 173.71 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . 0.456 ' CD1' ' HB2' ' A' ' 149' ' ' ALA . 15.0 tt -84.82 -29.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -68.49 -6.55 25.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.3 m -96.91 -16.56 20.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -62.4 -43.33 84.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.649 0.737 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.9 Cg_exo -47.97 -52.19 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.681 2.254 . . . . 0.0 112.312 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -40.2 83.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.41 ' HB1' ' CZ ' ' A' ' 198' ' ' PHE . . . -65.0 -31.78 73.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.72 -36.56 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.55 -39.44 90.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.44 -24.99 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.07 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 122.41 15.56 4.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 33.0 mt-30 -91.45 109.41 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -48.13 103.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -104.07 107.33 18.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.1 mt 64.9 25.03 12.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.84 -22.72 37.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.6 t -116.66 115.95 39.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.45 153.56 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.683 2.255 . . . . 0.0 112.328 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.4 HG12 ' N ' ' A' ' 221' ' ' ILE . 18.6 tt -115.35 159.97 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.463 HD12 ' NE2' ' A' ' 156' ' ' GLN . 4.7 mm -118.84 139.94 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.407 HG13 ' C ' ' A' ' 207' ' ' ALA . 21.9 t -138.9 131.58 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 147.66 15.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.55 121.75 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.0 t -54.29 -18.14 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 226' ' ' GLN . 0.0 OUTLIER -94.98 40.66 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.0 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.015 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -54.83 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.25 -54.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.83 -62.77 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.426 ' HB2' ' NH1' ' A' ' 231' ' ' ARG . 0.2 OUTLIER -61.04 -65.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 231' ' ' ARG . 8.9 tp -37.11 131.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.2 m -66.6 139.27 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -107.84 177.63 21.21 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.91 152.1 31.8 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.692 2.262 . . . . 0.0 112.346 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 t -78.42 143.5 36.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 10.1 t -119.08 -55.44 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.6 t -100.91 -56.55 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -50.02 60.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 105.51 130.19 6.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -95.66 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.4 t -108.89 154.05 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 147.33 97.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 44.1 tttp -124.71 3.49 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -54.22 -44.91 99.2 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.801 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 133' ' ' SER . 61.1 Cg_endo -80.42 92.87 1.06 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.653 2.236 . . . . 0.0 112.364 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 29.0 m -117.63 -24.63 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -167.86 169.11 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -128.35 140.33 38.06 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.672 0.749 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.86 163.4 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.357 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.36 37.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.2 157.46 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -41.83 149.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -45.54 120.07 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 19.8 m -110.87 155.03 43.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.682 0.753 . . . . 0.0 110.84 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.85 -19.13 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.745 2.297 . . . . 0.0 112.305 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.28 -33.62 19.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -29.51 70.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -59.98 -45.02 94.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -64.32 -38.37 90.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.25 -60.12 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 150' ' ' ARG . 20.7 mtm105 -49.44 -22.99 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.4 m -96.79 138.5 34.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 9.9 p -111.93 150.95 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 t80 -106.48 133.06 51.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 21.2 m -121.71 159.83 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 37.9 mtm -153.4 175.32 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.434 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 63.21 53.16 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 29.5 mt -93.66 142.02 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.77 175.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.61 -46.81 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -103.43 48.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 10.1 tt -90.27 155.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -129.16 147.55 65.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.5 0.667 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.47 -47.35 13.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -46.96 -58.23 4.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -37.55 -55.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.432 HD22 ' CD2' ' A' ' 215' ' ' LEU . 18.3 mt -64.3 -47.16 80.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -46.45 -66.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -59.96 -43.19 95.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.423 ' CE2' HG23 ' A' ' 220' ' ' ILE . 30.1 t80 -54.81 -35.65 64.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -92.64 -12.64 31.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.5 t -65.98 -7.22 15.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.84 58.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.03 -28.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.82 154.45 20.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -71.29 139.51 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.326 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.8 t -98.51 136.12 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -93.8 -50.94 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -142.18 157.27 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 84.5 t -142.92 108.03 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -95.95 112.54 24.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.65 107.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.18 121.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 t -116.06 90.11 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -97.34 160.38 14.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -53.73 115.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -49.42 128.38 17.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -132.2 166.75 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -46.19 -53.02 11.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.4 92.62 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.3 t -146.34 157.23 43.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 39.6 mmtm -141.35 124.53 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.59 105.39 0.73 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.4 pt -101.28 148.46 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.348 . . . . 0.0 111.068 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -151.25 166.85 29.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.474 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 88.6 m-85 -122.63 127.92 49.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 23.6 t -117.38 123.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.118 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.04 133.68 35.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -109.86 157.33 19.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 28.8 p -60.57 -40.09 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -135.82 163.25 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.8 tt -74.23 -29.25 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.198 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . 0.409 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 41.6 mt-30 -69.44 -5.95 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.7 m -94.12 -18.17 22.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -64.18 -43.32 73.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.64 0.733 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.6 Cg_exo -47.96 -53.38 6.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.77 -34.29 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.85 76.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.5 mt -63.01 -40.5 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.93 92.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 84.6 mt -49.97 -28.24 6.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 210' ' ' LEU . 98.0 m -36.93 98.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.99 7.9 5.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.501 ' N ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -88.68 119.24 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.898 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.79 108.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.432 ' CD2' HD22 ' A' ' 166' ' ' LEU . 14.0 tp -116.36 118.22 32.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 52.3 mt 61.37 25.61 15.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.92 -29.04 13.33 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.523 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.91 126.88 26.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.07 153.96 3.76 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.423 HG23 ' CE2' ' A' ' 169' ' ' PHE . 16.1 tt -114.39 151.06 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.8 mm -109.94 139.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.58 134.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -157.56 142.88 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.68 118.37 6.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 21.2 t -57.23 -44.89 84.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -50.46 -40.55 51.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -41.44 -62.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.45 -39.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.946 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -61.59 -70.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 230' ' ' ASN . 0.2 OUTLIER -49.29 -51.23 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.96 58.91 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -144.81 142.66 30.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.972 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -68.93 90.62 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.816 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.0 89.58 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.456 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.57 -43.59 17.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.754 2.303 . . . . 0.0 112.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 75.7 m -120.11 158.0 27.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 99.5 p -113.13 119.68 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.439 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.6 t -68.79 95.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.2 m -92.39 99.08 11.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.15 160.29 15.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 m -162.65 160.5 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.776 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.42 162.99 13.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.844 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.8 -172.14 0.59 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -150.92 122.07 7.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.37 143.53 36.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.648 0.737 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.71 57.7 6.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -91.89 178.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -127.9 138.81 52.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.17 151.99 94.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.647 0.737 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.95 173.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.253 . . . . 0.0 112.358 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -116.7 45.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.12 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 141' ' ' ASN . 1.0 OUTLIER -128.01 175.76 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 140' ' ' ASP . 6.6 m120 -36.96 151.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.516 ' CD1' ' C ' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -70.98 131.65 44.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 146' ' ' GLU . 3.4 m -89.88 157.85 45.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.66 0.743 . . . . 0.0 110.859 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.25 -22.59 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.715 2.277 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -91.54 -27.08 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 143' ' ' SER . 38.8 mt-10 -75.17 -28.58 60.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -57.99 -35.7 71.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.39 -44.52 97.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.32 13.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -89.88 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.4 m -128.23 127.75 43.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.62 157.9 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -114.63 149.33 36.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 60.6 mtm -144.34 177.8 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.434 ' CB ' HG12 ' A' ' 221' ' ' ILE . 5.9 tt0 56.77 47.69 17.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 93.4 mt -79.54 154.44 28.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.53 169.63 17.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.37 31.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.34 38.0 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.5 tt -88.56 155.14 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -131.54 147.43 66.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -25.87 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.73 2.287 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -73.05 -52.89 12.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -40.77 -37.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.46 -41.94 26.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -50.09 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -58.94 -48.14 82.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CZ ' ' NE2' ' A' ' 213' ' ' GLN . 81.8 t80 -54.37 -29.84 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -96.54 -12.35 24.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.9 p -71.63 -5.13 31.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -22.09 45.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.79 -32.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.19 159.0 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -76.54 133.06 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 39.4 t -91.54 121.71 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -80.7 -60.9 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -135.4 145.8 47.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 42.9 t -126.69 104.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -102.42 104.95 15.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.39 119.55 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 7.0 mm -94.37 130.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 29.9 t -113.0 44.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.782 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -112.11 86.71 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.832 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -91.51 95.32 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.828 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.74 88.88 2.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.6 m 58.58 40.39 23.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -104.81 138.13 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -67.41 -44.71 78.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.4 p -60.48 163.12 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -83.21 -53.88 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -147.72 142.41 10.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.505 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 22.4 pt -117.04 144.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.315 . . . . 0.0 111.169 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -151.86 152.25 32.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.77 145.7 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.58 114.06 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.88 116.85 25.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -92.55 162.63 14.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.15 -16.14 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -145.67 148.91 33.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.87 -23.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -73.52 -6.49 46.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.8 m -95.91 -16.83 21.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.69 -43.22 82.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.645 0.736 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.1 Cg_exo -47.91 -49.47 13.74 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.64 2.227 . . . . 0.0 112.355 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.04 -38.91 90.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.412 ' C ' HG13 ' A' ' 222' ' ' VAL . . . -64.05 -35.7 81.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.11 -47.45 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.187 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -57.63 -32.7 65.52 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.52 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 211' ' ' THR . 24.7 mt -52.07 -28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 210' ' ' LEU . 76.3 m -35.86 105.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.59 14.07 6.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.426 ' NE2' ' CZ ' ' A' ' 169' ' ' PHE . 6.1 mt-30 -91.68 116.59 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.926 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -57.79 106.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.34 112.49 24.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.8 mt 64.08 25.87 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.55 -20.93 48.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.96 119.29 29.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.659 0.742 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.72 152.63 9.23 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -113.88 144.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.434 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.5 mm -103.25 133.17 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 207' ' ' ALA . 2.6 t -128.94 128.63 67.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -151.91 150.52 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.34 115.46 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 227' ' ' ALA . 5.6 t -63.29 -54.19 41.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.836 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -61.48 76.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 225' ' ' SER . . . -125.28 -50.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -78.67 -61.31 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 230' ' ' ASN . 10.6 mmtp -55.07 -57.74 10.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 229' ' ' LYS . 57.5 t-20 -37.54 -48.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -51.05 -58.29 6.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.41 -53.23 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 46.3 t -53.99 134.96 43.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.3 67.75 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.99 99.15 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.354 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 58.2 m -47.76 -44.48 28.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.5 p -135.7 176.34 8.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.527 -179.945 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p 45.18 41.96 6.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 110.941 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.6 t -85.75 134.4 33.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 145.66 157.25 7.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.1 p -58.3 155.89 10.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 95.9 p -81.65 112.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 156.15 121.89 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -41.71 130.6 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 89.9 p -132.19 145.27 56.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.713 0.768 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.36 143.61 5.32 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.745 2.297 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 135' ' ' VAL . 7.1 p -131.19 91.45 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -126.93 161.71 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -160.37 138.83 7.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.92 163.2 23.39 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.95 142.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -172.5 157.97 4.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 142' ' ' LEU . 9.1 t-20 -53.83 160.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 141' ' ' ASN . 4.4 tp -36.57 128.04 0.82 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.23 149.04 36.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.602 0.715 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.37 -35.49 5.67 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -67.76 -53.27 28.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -44.69 -42.86 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -44.07 -57.45 3.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.49 -51.99 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.964 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.13 -60.47 1.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -48.85 -27.95 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.3 m -89.06 126.41 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.0 p -102.06 158.18 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.153 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.473 ' CZ ' ' HB ' ' A' ' 193' ' ' ILE . 17.1 t80 -109.27 141.27 41.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 58.9 m -126.85 156.66 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.839 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 35.8 mtm -152.98 176.48 11.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.446 ' NE2' HD12 ' A' ' 221' ' ' ILE . 4.8 tt0 58.95 46.96 12.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.421 HD12 ' CB ' ' A' ' 194' ' ' ALA . 96.1 mt -77.02 168.3 20.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -79.42 -178.84 6.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.093 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.49 -37.6 22.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 37.39 4.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 13.3 tt -73.22 154.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -128.78 146.58 60.94 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.63 -35.28 12.63 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -54.94 -51.94 64.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -48.13 -40.2 22.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.11 -42.9 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -43.12 -65.3 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.64 -48.83 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 23.8 t80 -49.25 -30.31 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.42 ' CE2' HG23 ' A' ' 196' ' ' VAL . 24.3 m-85 -96.99 -15.46 21.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.9 t -68.0 -8.85 40.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.95 -23.16 55.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.37 -33.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.26 151.73 21.12 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 134.13 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 86.8 t -90.18 123.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -88.7 -61.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.51 144.32 51.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.03 104.04 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -100.49 105.81 17.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.34 105.73 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.8 mm -71.29 128.36 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 p -126.55 107.36 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -103.68 97.51 7.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -34.48 77.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -53.09 -46.67 68.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.4 m -131.23 103.62 6.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -86.57 -12.17 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.58 -38.35 89.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 m -54.54 177.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -99.62 127.59 45.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.05 110.29 2.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.473 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 48.4 pt -100.0 143.03 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' CB ' HD12 ' A' ' 157' ' ' LEU . . . -139.81 158.29 44.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.094 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -124.4 127.53 47.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.42 HG23 ' CE2' ' A' ' 170' ' ' PHE . 61.8 t -121.5 120.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.18 111.64 23.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.0 148.63 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 m -56.8 -33.01 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.21 166.11 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 16.4 tt -85.98 -33.08 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -64.29 -6.49 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 m -94.65 -19.31 20.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -61.49 -43.23 88.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 111.179 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.3 Cg_exo -48.01 -52.96 7.35 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.06 -36.93 83.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.99 76.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.54 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.74 -40.44 79.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.537 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 211' ' ' THR . 67.3 mt -44.21 -26.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.3 m -35.61 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 116.65 23.58 3.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.557 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.553 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 28.4 mt-30 -100.13 108.9 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -47.93 110.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . 0.532 HD13 ' CD2' ' A' ' 169' ' ' PHE . 16.9 tp -116.52 112.31 21.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 62.2 mt 62.16 25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.64 -25.47 27.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.29 119.02 35.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.1 152.03 11.23 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.7 tt -111.99 151.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.446 HD12 ' NE2' ' A' ' 156' ' ' GLN . 5.0 mm -112.72 122.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 18.1 t -118.07 128.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -155.45 150.35 26.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -57.96 126.35 27.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.8 t -64.35 -38.47 91.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -86.03 35.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.0 69.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.52 -62.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -58.55 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -39.76 -54.7 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -47.07 -57.36 5.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.5 tp -39.83 -61.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.4 m -39.5 -59.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.08 145.15 14.15 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.24 106.4 2.14 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.674 2.25 . . . . 0.0 112.356 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 53.7 p -141.98 117.97 10.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.7 t -154.66 153.02 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.482 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -121.35 176.92 5.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.822 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.8 m -130.66 140.32 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.866 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 118.93 -112.23 2.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m 41.27 40.26 1.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.871 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 98.1 p -109.43 154.63 22.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.821 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.86 35.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -83.46 144.82 29.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.743 0.306 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 81.1 p -110.44 105.15 56.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.83 119.82 2.08 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.727 2.285 . . . . 0.0 112.339 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.3 t -44.61 125.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.56 152.37 32.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -41.25 144.55 0.68 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.672 0.748 . . . . 0.0 110.838 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.73 150.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -103.22 166.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -51.31 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.6 169.93 4.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 18.0 mt -54.05 177.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 51.5 p -126.83 151.15 73.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.97 -18.81 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -93.73 -57.64 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -45.09 -42.81 9.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -50.19 -39.57 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.12 -50.33 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -46.96 -46.41 21.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mtp-105 -83.67 38.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.2 m -137.36 122.02 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.465 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 13.0 p -99.04 146.48 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 10.6 t80 -101.22 126.91 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 83.7 m -116.78 150.7 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 42.7 mtm -149.75 178.05 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 219' ' ' PRO . 4.5 tt0 58.54 52.68 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 60.9 mt -92.31 137.12 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.26 177.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.89 -42.65 13.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 53.9 mtm-85 -97.81 39.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.5 tt -85.05 158.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -135.63 147.13 60.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.566 0.698 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.06 -33.99 8.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.237 . . . . 0.0 112.423 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -66.79 -49.63 65.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -41.39 -36.69 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -83.79 -39.99 19.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.24 -64.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -53.65 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -45.42 -46.04 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.536 ' CE2' HG21 ' A' ' 196' ' ' VAL . 21.4 m-85 -80.03 -19.93 46.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.4 t -63.39 -7.73 7.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.834 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.12 -24.01 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.05 -31.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.27 150.62 19.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.5 133.93 47.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.444 HG13 ' CG2' ' A' ' 179' ' ' VAL . 54.9 t -90.3 132.18 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -97.11 -52.87 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.38 145.67 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.444 ' CG2' HG13 ' A' ' 176' ' ' VAL . 94.4 t -130.76 108.49 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -96.47 111.01 23.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.95 106.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 mm -73.66 111.72 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.18 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.5 t -105.83 39.8 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.58 99.08 9.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -39.91 136.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -116.02 175.67 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.3 t -127.36 -54.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.818 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -100.22 -46.44 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -96.53 74.78 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 39.0 t -80.61 112.86 18.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.0 108.86 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.56 102.58 0.76 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.64 147.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -151.19 154.77 37.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 77.5 m-85 -116.82 139.34 50.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.536 HG21 ' CE2' ' A' ' 170' ' ' PHE . 99.0 t -120.82 128.09 76.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -96.81 104.37 16.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.432 ' CZ ' ' HB1' ' A' ' 207' ' ' ALA . 35.4 m-85 -79.42 157.17 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 11.5 t -58.89 -37.44 76.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -140.38 167.19 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.7 tt -77.42 -33.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -64.94 -6.1 7.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.1 m -95.85 -20.26 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -59.85 -43.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.97 -59.85 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.278 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.6 -45.67 63.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.432 ' HB1' ' CZ ' ' A' ' 198' ' ' PHE . . . -58.13 -30.4 66.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.48 -44.65 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.133 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.94 -30.84 70.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.463 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.9 mt -58.9 -17.83 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.34 114.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . 0.401 ' C ' ' OE1' ' A' ' 213' ' ' GLN . . . 113.33 15.55 8.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.5 ' CA ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.36 115.12 27.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -55.42 110.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -114.58 113.16 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 33.5 mt 61.56 25.02 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.12 -30.14 10.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.97 122.17 32.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.705 0.764 . . . . 0.0 111.093 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 74.5 Cg_exo -50.44 152.52 8.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.381 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.1 tt -108.06 154.17 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 7.4 mm -110.96 124.2 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.7 t -122.17 125.11 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.082 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -156.0 152.7 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.33 129.69 43.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 11.6 t -74.61 -44.7 49.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.83 -26.61 58.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.72 81.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.05 -47.32 78.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 230' ' ' ASN . 6.8 mmpt? -66.01 -62.1 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 229' ' ' LYS . 4.4 m120 -34.39 -39.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.3 75.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.59 116.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 t -135.87 113.55 10.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 176.25 145.33 5.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.51 -15.94 13.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 79.4 p -64.0 149.27 47.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 32.3 t -124.59 41.98 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.7 p -83.75 136.15 34.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -165.05 152.1 10.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.94 145.4 16.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 62.5 p -42.75 136.54 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.2 m -100.6 92.13 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.04 -83.39 0.7 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.437 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.08 108.05 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -152.08 144.13 16.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.685 0.755 . . . . 0.0 110.843 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.419 ' C ' HG22 ' A' ' 135' ' ' VAL . 63.0 Cg_endo -78.57 146.94 21.91 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.419 HG22 ' C ' ' A' ' 134' ' ' PRO . 19.9 t -138.7 106.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.63 153.06 21.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.875 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -93.52 155.1 41.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.709 0.766 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.08 155.4 38.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.709 2.272 . . . . 0.0 112.308 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.61 49.92 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.79 144.71 25.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -82.32 166.36 19.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 5.8 tp -89.31 147.7 23.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.3 p -75.32 153.82 86.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.672 0.749 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.0 -17.89 36.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.359 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.47 -25.2 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.44 -38.92 71.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -49.05 -44.26 41.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.1 -47.94 53.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -52.35 -28.26 18.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.413 ' NH1' ' HB2' ' A' ' 150' ' ' ARG . 9.1 mtp-105 -90.19 34.94 0.86 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.6 m -123.47 127.08 47.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.461 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 4.1 p -102.95 151.95 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 9.7 t80 -109.09 137.12 47.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 25.2 m -126.62 152.64 46.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' MET . . . . . 0.427 ' CE ' ' OE1' ' A' ' 223' ' ' GLN . 42.8 mtm -152.5 172.85 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.41 ' NE2' HD13 ' A' ' 221' ' ' ILE . 4.4 tt0 65.38 41.51 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 62.1 mt -76.49 161.36 28.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.49 171.15 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.068 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.35 -29.03 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -114.73 42.92 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 tt -91.36 148.35 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -127.6 149.35 70.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 -35.6 13.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.679 2.252 . . . . 0.0 112.377 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -61.78 -53.12 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -41.95 -48.28 4.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.05 -49.3 58.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -43.13 -69.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.797 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.83 -48.29 81.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -51.57 -31.16 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -94.95 -10.41 31.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.6 t -69.92 -4.39 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.55 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.9 m -114.31 -28.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.07 154.57 20.9 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -69.65 137.08 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 81.1 t -93.51 136.2 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -101.06 -54.28 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 2.9 t -131.89 121.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -115.1 104.21 11.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.61 115.59 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.18 119.73 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 p -113.57 121.28 43.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.81 125.78 52.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -89.13 140.22 29.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 43.15 50.37 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.4 p -91.0 143.6 26.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.816 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 189' ' ' ARG . 3.3 mpt_? -63.33 170.74 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 188' ' ' ARG . 49.8 ttt180 -35.41 99.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.908 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 t -159.42 172.36 18.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.03 163.16 16.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.71 117.48 4.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.429 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 17.4 pt -101.9 144.17 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -145.92 145.95 30.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.023 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.624 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 88.4 m-85 -110.98 139.02 46.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.461 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 90.9 t -128.04 128.29 68.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.47 127.42 36.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -105.39 150.59 25.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 49.1 t -48.07 -42.29 28.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -139.47 173.5 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.4 tt -86.08 -25.64 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -10.6 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 18.1 m -95.2 -13.65 24.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -64.04 -43.44 74.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.647 0.737 . . . . 0.0 111.191 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.6 Cg_exo -48.02 -47.52 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.268 . . . . 0.0 112.29 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.36 -40.2 95.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.24 95.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 92.3 mt -55.39 -44.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.06 98.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 44.9 mt -44.54 -27.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 49.0 m -36.74 116.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 108.3 13.03 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.414 ' NE2' HD21 ' A' ' 210' ' ' LEU . 8.7 mt-30 -92.19 114.37 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -48.81 109.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 16.6 tp -115.39 113.18 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 42.2 mt 62.36 25.12 14.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.97 22.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.8 t -116.52 122.24 32.11 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 111.139 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.1 153.73 3.98 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.83 153.87 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.417 ' C ' HG22 ' A' ' 222' ' ' VAL . 5.1 mm -114.18 143.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 221' ' ' ILE . 67.7 t -140.14 120.19 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.185 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . 0.427 ' OE1' ' CE ' ' A' ' 155' ' ' MET . 0.3 OUTLIER -132.52 166.98 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.56 107.32 15.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.4 t -57.48 -38.6 74.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -45.11 -42.39 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -41.9 -45.17 3.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 232' ' ' LEU . 30.5 tp10 -57.02 -38.03 72.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -72.93 -18.22 61.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -17.96 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -127.91 9.42 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 228' ' ' GLU . 1.1 pt? -47.26 -20.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 8.8 m -140.34 118.95 12.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -153.35 -94.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.487 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.31 148.04 26.45 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 m -117.87 -51.3 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.2 t -39.8 116.57 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -151.26 162.47 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.3 m -153.27 158.47 41.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.49 144.7 16.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -78.25 118.29 20.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.806 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -171.92 141.4 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.29 98.1 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.09 133.99 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -54.38 108.77 1.23 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.636 0.732 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -44.64 163.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 0.0 112.353 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.4 t -81.7 -17.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.171 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -126.68 175.37 8.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -36.01 141.84 0.32 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.06 -172.81 1.64 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 0.0 112.321 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.0 m -61.7 145.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 141' ' ' ASN . 0.5 OUTLIER -153.59 175.85 12.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.805 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 140' ' ' ASP . 16.9 t-20 -36.83 111.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 tp -51.16 149.13 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.3 m -79.9 161.33 66.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.822 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.09 -20.09 17.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -88.08 -20.06 26.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -75.87 -36.67 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -50.26 -26.76 5.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -72.73 -47.13 49.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.77 -44.81 4.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.04 42.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.6 m -142.51 128.28 19.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.3 p -104.43 149.5 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -100.29 125.94 46.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.7 m -116.2 154.09 30.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.2 mtm -153.58 178.09 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 59.97 51.46 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.854 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 82.0 mt -89.19 142.54 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.89 -175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.72 -43.38 11.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -109.68 32.84 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.5 tt -67.76 153.39 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -127.0 146.89 59.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -48.63 11.49 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.64 2.226 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -47.44 -56.88 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -37.94 -55.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.35 -44.43 95.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -53.4 -68.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.78 -45.07 70.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -55.24 -42.31 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.423 ' CE2' HG23 ' A' ' 196' ' ' VAL . 37.1 m-85 -83.83 -19.26 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.8 t -58.41 -11.71 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.3 -26.32 64.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.98 -30.97 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.17 156.31 23.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.416 ' HA ' ' CE ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -70.24 133.49 47.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.27 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.124 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -86.1 -56.43 3.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 179' ' ' VAL . 9.7 t70 -137.59 159.08 42.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 21.2 t -138.73 119.63 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -110.8 117.45 33.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.78 113.94 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mm -78.74 104.89 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -102.62 95.89 6.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -159.83 141.67 13.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -110.19 96.89 6.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -82.43 -49.81 9.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 188' ' ' ARG . 68.3 p -131.07 127.8 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 187' ' ' SER . 15.0 ptm180 -34.46 133.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 69.58 44.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.0 t -84.8 167.41 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.58 165.08 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.07 107.74 2.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 pt -96.04 148.15 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 111.109 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -149.86 168.0 24.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.065 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.22 133.08 45.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 50.2 t -118.77 120.2 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.17 104.37 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -78.78 159.77 27.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.6 t -61.79 -33.31 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -140.06 152.36 46.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.5 tt -68.85 -31.68 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -64.33 -10.33 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 t -92.83 -18.07 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -60.28 -43.24 92.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.595 0.712 . . . . 0.0 111.129 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.01 -52.13 8.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.632 2.222 . . . . 0.0 112.328 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.85 -37.93 83.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.415 ' O ' ' CG1' ' A' ' 222' ' ' VAL . . . -64.95 -32.57 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.084 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.7 -43.33 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.36 -42.0 99.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.47 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 77.1 mt -41.23 -28.72 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 75.8 m -36.85 107.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.86 11.59 7.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.457 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.495 ' CA ' ' OE1' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.25 119.13 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.959 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -56.5 108.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.14 112.97 24.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.9 mt 61.18 26.51 16.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.19 -30.24 10.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.46 121.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.529 0.681 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.05 153.87 6.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -112.08 153.23 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.19 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.9 mm -112.38 132.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.415 ' CG1' ' O ' ' A' ' 207' ' ' ALA . 11.7 t -131.97 120.61 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -151.36 142.37 23.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -48.84 133.41 17.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 42.4 t -74.24 -43.42 57.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -91.3 44.41 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.74 65.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.25 -42.62 20.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -59.66 -56.52 20.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -42.54 -41.47 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -106.83 77.94 1.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -157.35 110.02 2.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -128.49 131.85 48.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 146.05 82.62 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.24 38.46 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.73 2.287 . . . . 0.0 112.402 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 76.6 p -167.27 138.48 3.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.6 p -59.17 118.04 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.812 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -86.05 167.28 15.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.7 t -99.2 -43.95 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.41 169.85 12.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.1 m -135.92 152.11 50.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.1 p -173.72 164.46 4.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.41 73.01 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -172.68 170.37 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -123.62 87.52 52.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.98 170.92 18.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.368 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.89 129.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -164.24 160.57 21.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -43.33 143.25 1.47 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.669 0.747 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.33 112.24 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.228 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.5 m -81.39 139.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -138.22 148.17 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -135.48 144.52 46.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.534 ' C ' ' CD2' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -49.16 178.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.001 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.0 p -85.11 149.83 53.73 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.89 -34.2 8.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 0.0 112.348 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -72.32 -41.85 66.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -55.92 -33.89 65.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.24 -51.28 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -72.63 -26.78 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.77 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.77 84.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 48.9 mtt180 -85.92 33.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 m -125.9 137.38 53.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 12.0 p -116.57 149.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.148 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -100.83 137.92 38.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 91.4 m -127.62 149.82 50.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.6 mtm -151.84 -179.3 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.439 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.8 tt0 54.67 47.05 23.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 72.4 mt -75.81 165.37 25.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.72 175.76 10.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.87 -34.21 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -118.14 47.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.3 tt -90.3 153.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -136.47 152.52 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.55 0.691 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -45.41 16.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.663 2.242 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -48.74 64.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -47.41 -63.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 -45.81 74.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -47.03 -68.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.27 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.427 ' CE1' ' OE1' ' A' ' 213' ' ' GLN . 44.4 t80 -54.68 -29.56 53.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . 23.0 m-85 -95.29 -12.34 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.5 p -67.71 -4.21 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.54 -21.36 41.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.22 -27.56 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.71 159.67 29.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.448 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -74.67 134.98 41.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 80.0 t -95.76 116.48 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.05 -43.49 43.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -153.32 158.0 40.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 86.7 t -137.07 141.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.38 120.03 30.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.68 114.39 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.74 150.45 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.4 p -157.19 160.4 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -150.79 175.37 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -47.65 -53.26 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -125.45 107.68 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.8 p -100.84 41.95 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -102.23 -53.41 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -80.5 43.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 95.3 p -174.82 171.62 3.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -104.58 133.96 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.94 109.12 2.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt -95.09 145.34 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -146.09 137.01 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -103.4 112.73 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 197' ' ' GLU . 56.2 t -109.54 141.93 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 196' ' ' VAL . 2.9 pt-20 -118.42 153.21 34.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.482 ' CZ ' ' HB3' ' A' ' 170' ' ' PHE . 63.2 m-85 -123.05 -177.32 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 51.3 m -85.49 -21.73 28.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.49 144.39 29.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.7 tt -70.86 -27.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -65.27 -9.61 25.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -94.89 -18.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -59.28 -43.56 96.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.0 Cg_exo -47.9 -51.59 9.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.371 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.11 -43.57 95.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.36 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.77 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.12 -32.88 85.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 211' ' ' THR . 71.2 mt -55.78 -20.47 15.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.955 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.9 m -36.75 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.93 14.09 6.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.427 ' OE1' ' CE1' ' A' ' 169' ' ' PHE . 27.0 mt-30 -88.65 106.29 18.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -45.9 106.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.2 tp -108.43 107.06 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.2 mt 65.82 27.08 11.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.66 -18.15 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.24 115.21 31.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.695 0.759 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.69 149.79 13.36 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.2 tt -115.04 149.74 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.439 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.0 mm -109.0 125.62 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 17.3 t -120.51 124.2 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -143.62 165.79 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -74.91 124.41 26.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 90.1 p -75.69 -5.86 47.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.833 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.43 40.44 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -96.03 -32.19 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -81.32 -43.35 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -60.51 -16.39 36.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -88.8 -47.7 8.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -89.97 34.96 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.2 tp -116.13 140.39 49.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.0 p -69.84 163.39 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 167.81 145.7 4.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.01 88.11 1.46 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 7.8 t -123.88 161.64 24.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -85.19 -57.95 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.58 -0.208 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -154.57 171.68 19.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.933 0.397 . . . . 0.0 110.837 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.8 p -163.63 152.95 14.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.23 138.48 3.53 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.538 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.5 p -145.68 106.85 4.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.8 p -118.31 153.92 33.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 114.08 -130.72 9.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -147.44 120.11 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.5 m -145.57 156.74 52.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.705 0.764 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.7 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.708 2.272 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.4 p -96.7 119.43 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.59 89.25 7.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -150.37 153.8 35.14 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.899 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.0 133.27 14.95 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.17 143.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -84.8 96.1 9.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.04 160.09 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.475 ' C ' ' CD1' ' A' ' 142' ' ' LEU . 0.4 OUTLIER -81.6 125.83 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.1 p -82.96 154.35 67.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.73 0.776 . . . . 0.0 110.813 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.2 -20.17 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.634 2.223 . . . . 0.0 112.288 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -83.99 -33.03 24.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.23 -38.57 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 1.9 ptm180 -58.72 -33.99 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 6.8 t0 -82.43 -38.51 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.86 -41.42 77.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -86.73 39.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.1 m -133.06 138.52 46.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.448 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -113.92 149.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.65 120.72 40.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.4 m -106.29 154.48 20.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 54.2 mtm -155.54 176.68 12.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.457 ' NE2' HD13 ' A' ' 221' ' ' ILE . 5.4 tt0 57.69 52.05 8.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 81.4 mt -81.45 166.78 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -90.68 174.17 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.05 -40.4 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -108.29 43.67 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 14.4 tt -92.94 153.71 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.81 153.92 79.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.578 0.704 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.5 -39.32 17.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.608 2.205 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 165' ' ' ASP . 12.0 mtt-85 -57.93 -59.74 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 164' ' ' ARG . 15.0 m-20 -34.43 -41.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.48 -43.78 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' ARG . 50.6 mt-10 -42.7 -66.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 171' ' ' SER . 33.4 t70 -62.15 -53.46 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.519 ' CD1' ' C ' ' A' ' 169' ' ' PHE . 1.5 t80 -45.46 -30.05 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -95.25 -20.92 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 168' ' ' ASP . 20.5 t -61.51 -9.49 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.86 62.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.33 -33.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.63 152.5 22.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -73.72 142.8 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 177' ' ' ARG . 92.0 t -103.18 136.55 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.462 ' N ' HG11 ' A' ' 176' ' ' VAL . 13.4 ptm180 -113.06 -39.07 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -141.11 134.58 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.441 ' CG2' ' CG1' ' A' ' 176' ' ' VAL . 59.6 t -134.94 102.89 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 -96.04 107.81 20.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 94.4 mt -98.08 117.57 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.59 115.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -125.68 102.04 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.46 148.6 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.816 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -93.1 -50.2 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -107.71 96.25 6.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 99.2 p -144.09 146.05 32.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.9 -54.26 9.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.81 127.14 13.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 p -166.07 121.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -69.9 -46.34 65.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 131.18 103.46 0.95 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.485 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.4 pt -98.59 144.02 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -144.96 148.01 33.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -110.33 135.64 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.448 ' HB ' ' CG1' ' A' ' 152' ' ' VAL . 86.6 t -129.01 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.13 103.79 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -73.85 161.51 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.98 -33.55 74.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.26 170.33 15.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -84.27 -28.93 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.6 -6.8 27.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 t -95.34 -22.26 17.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.0 t -57.09 -43.72 99.44 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.579 0.704 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.92 -60.15 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.719 2.279 . . . . 0.0 112.415 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 72.6 mt -52.3 -42.42 63.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ALA . . . . . 0.414 ' C ' HG12 ' A' ' 222' ' ' VAL . . . -59.73 -39.76 85.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.25 -43.68 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.8 99.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.491 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 211' ' ' THR . 49.0 mt -42.33 -29.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 210' ' ' LEU . 51.5 m -33.97 123.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 101.24 17.7 21.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 39.2 mt-30 -93.7 109.82 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -51.49 99.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.46 105.63 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.1 mt 65.83 25.39 11.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.62 -19.75 51.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.0 114.33 37.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.719 0.771 . . . . 0.0 111.058 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.6 149.27 13.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.603 2.202 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -111.49 156.17 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.175 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.457 HD13 ' NE2' ' A' ' 156' ' ' GLN . 4.6 mm -119.55 135.44 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' VAL . . . . . 0.414 HG12 ' C ' ' A' ' 207' ' ' ALA . 45.6 t -134.02 122.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -145.48 143.13 29.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -43.33 153.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 89.6 p -86.29 51.23 2.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.5 pt20 -105.41 44.1 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.95 -58.7 3.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 229' ' ' LYS . 1.0 OUTLIER -63.86 -59.79 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 228' ' ' GLU . 19.6 ttmt -36.08 -64.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -38.82 -55.84 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.75 -55.03 22.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 tp -48.64 111.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 m -61.68 125.15 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -125.74 88.88 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.63 -47.43 13.52 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.636 2.224 . . . . 0.0 112.353 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.9 p -55.59 126.23 24.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.5 t -55.94 -51.15 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.506 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.2 p -110.05 149.56 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 193' ' ' ILE . 14.8 t80 -110.66 124.1 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG3' ' A' ' 155' ' ' MET . 41.9 m -113.79 161.16 17.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.414 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 33.9 mtm -155.03 179.52 9.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.435 ' CB ' HG12 ' A' ' 221' ' ' ILE . 16.2 tt0 55.98 46.07 22.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 161' ' ' ILE . 62.5 mt -79.06 159.56 27.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.0 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -69.43 174.18 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.82 -38.26 38.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -118.39 50.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 157' ' ' LEU . 14.7 tt -89.96 156.8 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.04 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -131.51 155.06 81.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.02 -47.2 14.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -52.92 -53.92 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -39.73 -45.73 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.89 -46.84 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -45.1 -65.61 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.19 -46.31 88.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -54.17 -28.77 42.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.42 -8.56 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -70.24 -5.9 30.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.21 -23.6 47.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.5 -31.86 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.48 158.57 31.52 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -78.29 136.44 37.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.406 HG11 ' CG2' ' A' ' 179' ' ' VAL . 65.8 t -97.9 140.74 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -36.26 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.451 ' CG ' ' OE1' ' A' ' 197' ' ' GLU . 0.5 OUTLIER -151.49 152.34 32.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.406 ' CG2' HG11 ' A' ' 176' ' ' VAL . 99.3 t -141.19 109.3 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -96.53 106.71 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.3 mt -96.05 131.42 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.7 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 179.801 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 29.0 pt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.641 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -141.92 157.88 44.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.18 134.85 54.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 152' ' ' VAL . 60.6 t -131.08 128.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLU . . . . . 0.451 ' OE1' ' CG ' ' A' ' 178' ' ' ASP . 41.5 mt-10 -94.84 129.99 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -103.08 159.66 15.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.0 p -58.58 -32.21 68.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -148.01 164.91 32.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.0 tt -78.53 -20.72 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.421 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.1 mm-40 -73.53 -12.35 60.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 38.0 t -92.42 -14.41 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.5 t -63.8 -43.32 76.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.7 Cg_exo -47.92 -47.96 17.5 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.5 -45.0 95.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.2 83.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.7 mt -52.21 -47.53 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -55.47 -43.99 85.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.58 HD22 ' NE2' ' A' ' 213' ' ' GLN . 86.6 mt -40.32 -28.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 210' ' ' LEU . 53.2 m -35.52 102.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.12 4.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 210' ' ' LEU . 17.9 mt-30 -98.28 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -46.75 107.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.24 108.51 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 mt 66.35 27.37 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.42 -15.52 63.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.24 118.99 25.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.616 0.722 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.07 152.27 5.11 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.284 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.8 tt -115.5 149.29 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.435 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.3 mm -108.87 141.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.03 127.33 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -150.55 151.3 32.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.6 p -119.8 146.19 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -98.15 127.76 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.423 ' C ' ' HG3' ' A' ' 155' ' ' MET . 64.7 m -115.54 149.61 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 22.9 mtm -149.37 -179.94 7.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' CB ' HG12 ' A' ' 221' ' ' ILE . 14.9 tt0 55.44 50.38 14.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.675 ' HB3' HG21 ' A' ' 161' ' ' ILE . 79.5 mt -79.24 163.21 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.67 171.72 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.67 -30.5 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -126.88 33.67 4.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.7 tt -71.57 150.88 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -128.83 150.35 74.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.576 0.703 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.33 -36.12 12.44 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.42 -59.62 4.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -38.54 -36.86 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 161' ' ' ILE . 23.9 mt -80.8 -50.89 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -39.17 -60.83 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.77 -44.98 84.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 215' ' ' LEU . 23.3 t80 -52.21 -32.55 37.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -92.64 -16.17 25.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.3 m -66.5 -10.05 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.35 60.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.75 -28.14 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.39 151.84 14.41 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -62.75 137.11 58.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.77 126.14 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -87.04 -60.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -138.73 149.5 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 196' ' ' VAL . 60.1 t -136.84 105.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.54 104.3 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.34 107.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -145.29 143.91 30.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.043 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.11 147.06 27.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 179' ' ' VAL . 50.9 t -139.64 130.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -105.23 124.86 50.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.01 155.19 17.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -24.85 68.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -141.19 152.14 44.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.9 tt -76.78 -28.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.428 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 13.6 mm100 -67.73 -7.2 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.435 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 66.7 m -92.77 -25.49 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.87 -43.65 98.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.8 Cg_exo -47.95 -58.63 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.635 2.223 . . . . 0.0 112.411 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.4 mt -52.83 -44.68 66.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.26 74.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.24 -44.01 94.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.34 85.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 211' ' ' THR . 39.0 mt -56.4 -24.9 47.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 210' ' ' LEU . 12.5 m -36.76 118.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.23 6.25 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -102.51 110.41 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -47.49 104.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 169' ' ' PHE . 29.6 tp -109.57 108.02 18.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.3 mt 66.47 25.03 10.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.32 59.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.2 t -123.35 115.72 28.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 149.6 14.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.712 2.275 . . . . 0.0 112.356 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.4 tt -113.34 158.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.452 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.1 mm -119.22 133.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 15.8 t -129.87 119.03 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -138.59 156.03 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.796 0.331 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' CG1' ' A' ' 222' ' ' VAL . 7.3 p -102.5 149.02 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 14.0 t80 -102.48 117.19 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.4 m -107.74 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.0 mtm -151.26 177.3 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.447 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.4 tt0 59.31 50.81 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 166' ' ' LEU . 58.3 mt -95.22 150.18 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.35 168.63 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.82 23.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -98.28 42.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.1 tt -88.04 157.95 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -127.26 143.65 47.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.95 -29.49 8.46 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.759 2.306 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 165' ' ' ASP . 18.7 mmt85 -66.47 -58.45 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 216' ' ' LEU . 43.3 m-20 -34.99 -45.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 157' ' ' LEU . 29.4 mt -68.79 -46.26 69.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.474 ' HA ' HG21 ' A' ' 176' ' ' VAL . 29.9 mt-10 -47.11 -68.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.54 -50.26 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.65 ' CE2' HG21 ' A' ' 220' ' ' ILE . 22.1 t80 -49.39 -31.64 9.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 196' ' ' VAL . 27.1 m-85 -95.87 -11.54 26.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -66.51 -5.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.16 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 m -121.01 -30.74 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.57 153.72 24.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -77.0 134.23 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 167' ' ' GLU . 88.0 t -94.29 128.21 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.22 -41.27 8.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.6 154.78 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.459 ' CG2' HG11 ' A' ' 176' ' ' VAL . 25.4 t -143.76 107.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -92.87 105.08 17.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 95.0 mt -96.72 123.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.821 0.343 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.25 157.65 43.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.072 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 98.8 m-85 -114.64 125.44 53.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 170' ' ' PHE . 82.6 t -109.46 122.66 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.103 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -94.11 106.37 18.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.29 166.25 22.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 45.9 t -71.73 -35.75 70.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -133.93 165.78 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.65 -24.48 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -75.06 -9.76 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 -11.89 27.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.6 t -64.73 -43.75 70.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.4 Cg_exo -48.02 -54.2 5.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.607 2.205 . . . . 0.0 112.326 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.64 -33.37 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -69.92 -34.85 74.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.17 -38.63 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 -40.32 98.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.467 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 95.7 mt -42.26 -32.17 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 210' ' ' LEU . 57.3 m -35.79 98.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 126.29 7.42 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.83 116.73 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 110.922 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -53.11 108.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 117.08 29.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.48 HD11 ' OD2' ' A' ' 165' ' ' ASP . 46.6 mt 61.64 24.96 14.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.23 -29.23 12.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.2 t -117.64 124.98 28.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.565 0.698 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.32 153.84 6.65 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.356 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 169' ' ' PHE . 14.1 tt -116.48 154.28 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.447 HG12 ' CB ' ' A' ' 156' ' ' GLN . 8.5 mm -110.12 142.35 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.5 t -142.82 118.39 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.47 148.9 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.08 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 7.6 p -114.19 152.42 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.7 t80 -109.01 122.58 47.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 60.9 m -111.32 152.37 27.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.8 mtm -147.22 175.5 10.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.863 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.424 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.1 tt0 56.52 54.37 7.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 161' ' ' ILE . 87.3 mt -91.96 156.91 17.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.28 169.56 17.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.78 -44.49 23.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.0 mtm105 -98.57 46.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.539 HD13 HD22 ' A' ' 157' ' ' LEU . 17.9 tt -91.71 148.86 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -121.2 143.16 36.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.01 -30.51 7.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.377 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -68.43 -55.83 10.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' ARG . 2.1 m-20 -35.23 -44.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 179' ' ' VAL . 26.7 mt -71.69 -52.56 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -38.5 -68.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 171' ' ' SER . 0.8 OUTLIER -56.9 -56.13 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 220' ' ' ILE . 38.7 t80 -44.17 -29.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 196' ' ' VAL . 23.8 m-85 -95.34 -21.8 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 168' ' ' ASP . 4.2 t -58.67 -14.16 7.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.84 -29.47 68.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 m -110.08 -30.9 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.53 150.99 16.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.08 138.13 55.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.05 134.66 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -92.77 -56.98 2.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -136.8 161.21 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 166' ' ' LEU . 99.0 t -140.86 106.58 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -93.19 103.95 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -94.1 119.99 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.448 ' CG1' HG13 ' A' ' 193' ' ' ILE . 14.9 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.464 HG22 ' HG2' ' A' ' 155' ' ' MET . 24.6 pt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -153.8 153.76 32.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.52 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 96.0 m-85 -109.04 135.34 50.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.921 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' A' ' 170' ' ' PHE . 87.2 t -118.88 133.45 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.89 112.81 24.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.463 ' HE2' HG11 ' A' ' 152' ' ' VAL . 39.1 m-85 -89.0 162.13 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 10.9 t -64.87 -43.38 93.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.04 162.45 33.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.8 tt -73.51 -22.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -74.09 -6.46 47.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 66.1 m -97.83 -18.04 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.2 t -61.68 -43.49 88.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.646 0.736 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.2 Cg_exo -48.02 -55.28 4.17 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.2 -35.7 72.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.968 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.89 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.94 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.27 -33.87 87.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.4 mt -50.42 -27.6 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 19.8 m -38.01 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 125.38 9.88 4.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.04 117.91 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.0 110.977 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -54.51 109.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -113.21 112.73 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.1 mt 61.39 25.4 15.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.0 -30.63 9.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -114.74 121.34 35.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.712 0.768 . . . . 0.0 111.074 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.76 154.15 7.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.2 tt -116.77 152.73 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.3 mm -109.63 148.72 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.16 126.33 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -149.63 151.21 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.769 0.319 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 196' ' ' VAL . 11.4 p -99.04 148.86 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -106.04 141.58 37.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.424 ' C ' ' HG3' ' A' ' 155' ' ' MET . 82.0 m -133.34 150.7 51.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.424 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 32.3 mtm -148.76 -179.44 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 21.6 tt0 61.13 46.5 8.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.573 HD11 ' CB ' ' A' ' 194' ' ' ALA . 70.1 mt -86.3 154.25 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.21 171.87 9.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.047 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.87 -43.29 36.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 51.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.469 HD13 HD22 ' A' ' 157' ' ' LEU . 15.7 tt -87.37 147.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -117.97 144.34 34.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -40.65 19.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 165' ' ' ASP . 26.4 mmt180 -54.97 -57.81 10.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 164' ' ' ARG . 14.2 m-20 -35.52 -47.0 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.17 -47.6 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -43.82 -62.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.45 -48.89 71.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 220' ' ' ILE . 17.4 t80 -47.05 -35.78 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 196' ' ' VAL . 38.0 m-85 -91.98 -15.66 27.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -65.82 -6.53 12.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.26 55.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.9 -32.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.79 154.85 25.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 139.75 42.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.44 HG11 ' CG2' ' A' ' 179' ' ' VAL . 87.0 t -95.61 127.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -92.48 -49.44 6.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -142.69 145.7 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.44 ' CG2' HG11 ' A' ' 176' ' ' VAL . 93.2 t -127.76 115.4 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -103.0 108.56 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.67 112.67 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.9 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.4 pt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.573 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -141.73 140.0 33.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -101.38 127.15 48.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.812 ' O ' HG12 ' A' ' 152' ' ' VAL . 78.8 t -116.56 119.38 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.59 115.59 28.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.653 ' HE2' HG11 ' A' ' 152' ' ' VAL . 38.4 m-85 -90.07 155.49 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.8 m -63.23 -39.97 96.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -126.77 165.05 20.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 tt -84.4 -29.5 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -71.8 -7.03 45.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -95.37 -17.38 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -63.07 -43.47 81.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.625 0.726 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.3 Cg_exo -47.98 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.97 -41.13 70.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.14 76.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.54 -38.95 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.11 -38.38 96.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 88.3 mt -45.01 -28.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' LEU . 41.7 m -35.41 107.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 119.29 5.75 11.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.47 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.506 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -84.51 119.54 25.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -59.49 100.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.46 112.26 24.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.9 mt 61.83 25.27 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.11 -23.14 36.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.464 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -116.68 117.99 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.69 149.6 13.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.47 HG12 ' N ' ' A' ' 221' ' ' ILE . 13.5 tt -113.49 159.49 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 220' ' ' ILE . 3.6 mm -118.65 148.71 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 t -147.0 138.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 221' ' ' ILE . 12.9 mp0 -152.67 -177.75 6.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.874 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.865 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.56 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.2 p -105.04 154.91 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.88 121.48 45.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.2 m -108.43 157.07 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 193' ' ' ILE . 63.6 mtm -151.6 171.74 17.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.461 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 16.3 tt0 65.62 53.89 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 161' ' ' ILE . 66.6 mt -91.63 152.23 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.63 179.57 3.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.47 -33.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -113.93 46.54 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.748 HD13 HD22 ' A' ' 157' ' ' LEU . 11.8 tt -91.76 150.03 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -125.37 148.76 62.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.497 0.665 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.6 -40.4 18.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.35 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -54.42 -52.93 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -41.22 -47.79 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.34 -41.5 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.11 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.14 -47.73 84.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 6.8 t80 -52.34 -33.4 42.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 196' ' ' VAL . 35.3 m-85 -96.9 -14.75 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 t -67.21 -5.62 14.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.2 -26.93 38.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.47 -33.75 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -163.81 150.08 18.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -70.6 135.68 48.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.831 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.472 HG11 ' CG2' ' A' ' 179' ' ' VAL . 93.1 t -95.72 131.15 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -103.94 -42.47 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -136.68 143.79 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.1 t -134.25 110.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -102.33 113.42 26.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.55 115.5 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.4 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.129 179.875 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.757 HG22 ' HG2' ' A' ' 155' ' ' MET . 32.7 pt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.809 0.338 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -150.9 141.88 22.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -101.34 133.37 46.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 152' ' ' VAL . 92.3 t -120.85 119.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.96 111.97 20.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.56 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.37 150.09 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.4 p -52.26 -36.06 51.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.74 176.94 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.2 tt -87.59 -29.28 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -65.24 -7.33 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 45.2 t -97.26 -17.2 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -61.02 -43.35 90.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.612 0.72 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 63.1 Cg_exo -47.93 -54.47 5.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.667 2.245 . . . . 0.0 112.392 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.33 -45.65 84.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.63 77.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 90.9 mt -56.67 -40.87 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.48 98.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 213' ' ' GLN . 80.0 mt -55.3 -26.3 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' ' 221' ' ' ILE . 93.3 m -35.68 104.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.7 26.64 2.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 210' ' ' LEU . 44.8 mt-30 -101.71 106.07 17.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 110.947 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -41.47 104.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.2 tp -110.06 109.99 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.6 mt 63.21 26.44 15.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.43 -25.37 28.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.6 t -115.24 118.31 40.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.02 150.53 9.98 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.277 . . . . 0.0 112.322 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 tt -110.98 149.44 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.519 ' HA ' HG23 ' A' ' 211' ' ' THR . 5.2 mm -112.21 142.66 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.07 124.82 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -148.02 148.25 30.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.7 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.75 145.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 10.8 t80 -103.23 120.2 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.492 ' HG ' ' C ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -109.7 144.19 38.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.866 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 12.4 mtm -144.46 178.29 8.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.466 ' OE1' HD11 ' A' ' 221' ' ' ILE . 3.0 tt0 57.0 51.88 9.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.46 HD22 HD21 ' A' ' 166' ' ' LEU . 28.4 mt -102.6 129.49 49.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.12 169.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.068 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.3 -35.91 40.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -99.45 45.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.8 tt -93.51 148.32 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -120.71 147.4 45.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.66 -41.98 19.07 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.32 -51.68 67.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -39.59 -44.93 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.46 HD21 HD22 ' A' ' 157' ' ' LEU . 68.1 mt -76.84 -48.41 18.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -40.82 -68.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.65 -54.94 38.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -47.83 -29.99 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.14 -20.57 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.3 t -65.57 -7.01 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.38 -23.68 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.96 -29.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.98 156.49 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 135.53 46.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.05 128.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -82.76 -56.8 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.86 154.15 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 196' ' ' VAL . 76.9 t -133.93 121.35 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -110.13 107.41 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.67 121.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.492 ' C ' ' HG ' ' A' ' 154' ' ' CYS . . . -150.77 170.6 18.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 97.2 m-85 -129.33 137.23 50.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 152' ' ' VAL . 94.2 t -130.63 127.01 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.73 123.9 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 152' ' ' VAL . 36.9 m-85 -94.66 162.56 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.42 -30.33 71.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -147.23 174.96 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.6 tt -84.89 -35.9 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.99 -6.71 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.6 t -95.18 -17.42 21.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.64 -43.37 83.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.62 0.724 . . . . 0.0 111.154 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.6 Cg_exo -47.99 -56.88 2.71 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.56 -49.03 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.52 -39.92 61.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.57 -46.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.39 -43.5 84.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 211' ' ' THR . 97.5 mt -43.0 -28.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 210' ' ' LEU . 86.7 m -35.65 120.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.22 26.45 6.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -105.5 111.79 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -50.01 105.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.1 tp -112.09 112.47 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.2 mt 62.78 25.24 14.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.54 -27.55 19.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.36 121.07 32.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.64 148.44 15.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.445 HG12 ' N ' ' A' ' 221' ' ' ILE . 11.9 tt -106.79 154.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.083 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.466 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.5 mm -112.92 140.61 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 152' ' ' VAL . 10.4 t -138.69 125.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -147.53 163.04 37.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.451 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.3 p -110.76 152.92 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -105.43 133.8 49.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 81.9 m -121.34 143.6 49.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.0 mtm -144.51 177.4 8.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.45 ' CB ' HG12 ' A' ' 221' ' ' ILE . 16.0 tt0 58.63 51.99 7.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 161' ' ' ILE . 49.4 mt -82.28 162.55 22.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.63 174.91 11.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.124 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.69 -33.76 27.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -115.86 41.99 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.603 HD13 HD22 ' A' ' 157' ' ' LEU . 13.4 tt -86.16 158.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 13.9 mtt85 -136.66 146.72 56.63 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.47 -33.11 8.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.346 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -66.6 -42.62 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -50.95 -34.88 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.1 mt -80.54 -50.64 9.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.686 ' HA ' HG21 ' A' ' 176' ' ' VAL . 21.5 mt-10 -38.83 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -52.2 65.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.718 ' CD2' HD13 ' A' ' 215' ' ' LEU . 7.0 t80 -47.76 -27.59 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 196' ' ' VAL . 17.0 m-85 -96.96 -18.6 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -59.88 -12.18 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.19 -27.29 63.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.58 -32.98 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.24 161.0 32.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 138.44 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 167' ' ' GLU . 72.8 t -90.79 125.38 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -88.03 -50.01 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -149.92 151.12 32.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 46.4 t -137.95 114.87 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -106.77 106.39 16.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 90.6 mt -96.78 115.29 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.843 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--O 1.23 0.03 0 CA-C-O 120.888 0.375 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -148.13 152.14 36.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.32 148.39 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 170' ' ' PHE . 91.7 t -139.2 133.96 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -106.81 119.29 38.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -94.31 154.17 17.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -48.03 -43.17 29.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.27 175.24 9.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 14.5 tt -84.2 -30.0 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -66.11 -6.44 13.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.0 m -95.39 -21.75 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -57.93 -43.51 98.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.655 0.74 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.99 -55.59 3.88 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 41.4 mt -56.08 -43.28 77.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.46 77.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.1 -47.19 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.157 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.32 91.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 31.5 mt -43.19 -24.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.967 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 18.7 m -36.39 110.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.86 19.37 8.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 42.2 mt-30 -92.01 110.96 22.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -50.21 105.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.718 HD13 ' CD2' ' A' ' 169' ' ' PHE . 15.7 tp -105.77 104.56 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.1 mt 64.06 25.01 13.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.53 29.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.488 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.23 114.21 48.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.38 148.53 14.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.662 2.242 . . . . 0.0 112.352 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.0 tt -113.68 153.32 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.45 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.7 mm -112.5 137.74 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.8 t -134.84 115.92 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -133.63 167.83 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.79 0.329 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.478 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.1 p -108.27 148.98 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.126 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -106.83 120.78 42.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 47.2 m -105.79 146.27 30.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.7 mtm -143.28 -179.3 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.463 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.7 tt0 53.52 51.54 15.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.896 HD22 HD13 ' A' ' 161' ' ' ILE . 99.1 mt -81.5 156.96 25.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.72 172.05 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.48 -35.07 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -124.37 42.36 3.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.896 HD13 HD22 ' A' ' 157' ' ' LEU . 15.9 tt -74.3 164.19 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 44.0 mtt-85 -128.12 158.71 70.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.573 0.702 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.487 ' CA ' HD11 ' A' ' 181' ' ' ILE . 56.6 Cg_endo -71.06 -9.4 25.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 0.0 112.303 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -90.47 -41.84 11.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -49.64 -36.48 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.12 -40.3 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -48.46 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -57.13 -40.17 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 220' ' ' ILE . 24.3 t80 -61.38 -30.7 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.72 -16.12 23.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -67.48 -4.04 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.68 51.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.08 -27.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.34 154.49 24.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -77.83 137.77 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.8 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 196' ' ' VAL . 69.6 t -93.67 138.94 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -99.38 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -152.88 145.87 24.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.75 120.35 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -109.48 104.38 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.487 HD11 ' CA ' ' A' ' 163' ' ' PRO . 45.3 mt -93.37 103.44 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.8 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.11 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.82 143.29 28.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.042 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -103.85 143.19 33.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 176' ' ' VAL . 78.9 t -131.6 122.18 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -87.13 124.34 33.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.44 ' HE2' HG11 ' A' ' 152' ' ' VAL . 31.4 m-85 -104.51 153.89 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.88 -44.71 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -130.93 168.91 16.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 20.1 tt -87.34 -28.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.417 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 68.3 mm-40 -64.59 -9.87 22.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 14.8 m -93.21 -15.77 25.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -63.52 -43.42 78.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.667 0.746 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.9 Cg_exo -47.97 -52.02 8.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.9 mt -60.46 -44.21 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.454 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -59.28 -37.56 77.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.63 -46.06 90.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.96 -39.41 94.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 211' ' ' THR . 19.5 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.6 m -34.48 112.11 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 114.47 19.26 6.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -98.16 112.0 24.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -49.92 106.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.2 tp -113.33 113.32 25.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.18 25.85 15.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.11 17.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.9 t -115.76 121.57 34.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.591 0.71 . . . . 0.0 111.213 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.07 154.0 5.91 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 tt -112.91 152.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.463 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.3 mm -111.97 123.76 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.0 t -121.04 112.74 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -138.32 143.07 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.827 0.346 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.486 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.9 p -118.66 147.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.09 124.36 42.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.404 ' C ' ' HG3' ' A' ' 155' ' ' MET . 84.8 m -115.01 155.28 27.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.404 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 64.2 mtm -154.03 175.85 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.5 tt0 63.59 54.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 161' ' ' ILE . 72.0 mt -93.41 148.38 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.04 176.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.02 -43.33 22.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -107.39 46.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 157' ' ' LEU . 16.5 tt -86.59 150.71 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -121.06 144.63 39.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.538 0.685 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.46 -43.85 17.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 165' ' ' ASP . 3.6 tmt_? -56.91 -55.28 36.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 164' ' ' ARG . 7.8 m-20 -36.54 -40.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.96 -48.19 16.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 176' ' ' VAL . 23.6 mt-10 -47.53 -68.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.34 -55.39 10.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -48.92 -42.89 38.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 196' ' ' VAL . 19.0 m-85 -78.56 -20.61 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.1 t -63.57 -11.26 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.43 -27.79 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.74 -32.92 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.37 152.98 22.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -68.71 142.54 54.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 167' ' ' GLU . 90.9 t -98.63 128.71 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -87.51 -53.61 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.53 152.79 41.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.54 113.1 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -101.88 109.09 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.3 mt -99.58 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.0 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.82 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.876 0.369 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.67 168.69 19.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -129.55 128.57 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.606 HG21 ' CE2' ' A' ' 170' ' ' PHE . 85.5 t -116.74 121.07 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -94.89 111.24 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.486 ' HE2' HG11 ' A' ' 152' ' ' VAL . 49.3 m-85 -85.05 152.05 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 m -60.07 -35.24 74.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -135.82 151.33 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.93 -27.32 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -69.56 -6.36 30.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' SER . . . . . 0.436 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.9 m -95.34 -25.03 16.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.38 -43.72 97.98 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.0 111.186 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -47.93 -58.7 1.59 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.746 2.298 . . . . 0.0 112.306 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.86 -31.05 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.574 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -72.74 -31.83 65.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 224' ' ' ALA . 82.5 mt -64.44 -41.78 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.105 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -61.5 -44.42 98.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.485 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 90.3 mt -37.45 -31.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.3 m -34.45 103.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.32 9.47 5.5 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -90.93 118.99 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.876 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -56.42 109.9 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.6 tp -115.36 115.65 26.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.0 mt 60.22 25.04 14.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.21 -32.08 7.93 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.46 124.13 31.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.612 0.72 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.02 154.02 5.79 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.424 HG12 ' N ' ' A' ' 221' ' ' ILE . 9.4 tt -111.91 152.04 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.104 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.449 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.1 mm -110.47 132.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 207' ' ' ALA . 12.4 t -133.38 121.53 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -146.67 145.19 29.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.962 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.823 0.344 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.2 p -103.53 151.08 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.8 t80 -107.04 134.3 50.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.2 m -119.46 154.9 33.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.6 mtm -151.75 174.58 13.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 60.28 48.46 8.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.736 HD22 HD13 ' A' ' 161' ' ' ILE . 94.7 mt -77.74 156.67 30.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.44 173.03 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.45 -38.05 50.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -119.7 40.54 3.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.736 HD13 HD22 ' A' ' 157' ' ' LEU . 17.4 tt -76.26 154.45 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -129.7 149.06 71.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.689 0.757 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.72 -43.66 18.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 165' ' ' ASP . 1.8 mpt_? -53.7 -59.48 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 164' ' ' ARG . 4.4 m-20 -36.51 -41.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.74 -51.64 13.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.39 -67.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.49 -45.19 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.03 -32.24 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.47 ' CE2' HG21 ' A' ' 196' ' ' VAL . 44.4 m-85 -95.96 -11.0 27.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -4.64 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.06 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 m -111.04 -28.56 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.04 166.88 35.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -74.99 136.58 41.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 179' ' ' VAL . 55.7 t -93.17 123.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -77.12 -52.86 8.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -149.53 152.36 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 176' ' ' VAL . 60.7 t -130.69 103.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -93.18 106.25 18.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.4 mt -95.39 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.811 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 46.0 pt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.735 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -135.89 163.43 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 87.5 m-85 -127.15 137.86 53.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 170' ' ' PHE . 53.4 t -128.04 130.94 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -99.95 114.84 28.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.78 149.94 22.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.34 -35.83 65.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -137.25 168.19 20.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 6.7 tt -85.57 -30.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.42 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 44.8 mt-30 -67.97 -6.85 24.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -93.38 -19.65 21.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -58.71 -43.16 97.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.684 0.754 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.07 -45.37 25.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.35 -36.82 82.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.87 89.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 224' ' ' ALA . 76.0 mt -55.18 -46.32 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.71 -42.62 91.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 213' ' ' GLN . 34.1 mt -41.84 -30.48 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.947 0.403 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 210' ' ' LEU . 99.7 m -35.72 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.145 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 120.21 11.24 6.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.445 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 210' ' ' LEU . 9.0 mt-30 -89.87 108.49 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -49.31 106.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.45 113.82 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.2 mt 61.73 26.62 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.36 -26.94 22.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.44 120.69 34.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.111 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.6 151.46 10.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.304 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.7 tt -113.48 144.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.0 mm -100.74 134.27 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.86 116.35 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -143.5 145.75 32.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.995 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.138 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.626 HG11 ' HE2' ' A' ' 198' ' ' PHE . 11.6 p -107.94 154.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.09 134.4 47.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.1 m -122.52 149.64 43.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.527 ' HG2' HG22 ' A' ' 193' ' ' ILE . 34.1 mtm -148.93 169.42 20.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.442 ' CB ' HG12 ' A' ' 221' ' ' ILE . 15.1 tt0 68.51 52.43 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 161' ' ' ILE . 86.2 mt -86.26 157.86 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.97 166.24 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.63 67.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 54.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 157' ' ' LEU . 16.3 tt -93.01 162.82 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.445 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 17.3 mtt85 -136.69 146.38 55.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.19 -25.31 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 165' ' ' ASP . 11.3 tpt85 -72.84 -60.53 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 164' ' ' ARG . 25.3 m-20 -35.67 -36.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.87 -45.61 16.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 164' ' ' ARG . 56.5 mt-10 -48.34 -66.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -56.12 -50.77 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 1.5 t80 -50.26 -29.57 9.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 196' ' ' VAL . 30.3 m-85 -96.58 -17.81 20.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.4 p -65.52 -7.78 16.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.36 -29.68 53.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.09 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.8 m -107.04 -31.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.13 161.58 34.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.579 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -75.62 139.39 42.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 179' ' ' VAL . 82.8 t -97.2 123.29 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -84.23 -44.37 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -153.57 148.4 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.599 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.7 t -132.6 104.5 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -93.14 113.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.7 mt -100.62 111.19 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.862 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.527 HG22 ' HG2' ' A' ' 155' ' ' MET . 44.4 pt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.37 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.08 155.07 41.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -109.58 137.22 47.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 170' ' ' PHE . 98.3 t -121.87 126.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.01 115.05 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.828 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.626 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.44 155.04 19.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.8 -38.46 72.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.7 173.71 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.0 tt -84.82 -29.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -68.49 -6.55 25.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.3 m -96.91 -16.56 20.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -62.4 -43.33 84.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.649 0.737 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.9 Cg_exo -47.97 -52.19 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.681 2.254 . . . . 0.0 112.312 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -40.2 83.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -65.0 -31.78 73.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.72 -36.56 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.55 -39.44 90.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.44 -24.99 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.07 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 122.41 15.56 4.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 33.0 mt-30 -91.45 109.41 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -48.13 103.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -104.07 107.33 18.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.1 mt 64.9 25.03 12.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.84 -22.72 37.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.6 t -116.66 115.95 39.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.45 153.56 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.683 2.255 . . . . 0.0 112.328 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 221' ' ' ILE . 18.6 tt -115.35 159.97 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 156' ' ' GLN . 4.7 mm -118.84 139.94 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 207' ' ' ALA . 21.9 t -138.9 131.58 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 147.66 15.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.824 0.345 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 196' ' ' VAL . 9.9 p -111.93 150.95 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 t80 -106.48 133.06 51.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 21.2 m -121.71 159.83 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.471 ' HG2' HG22 ' A' ' 193' ' ' ILE . 37.9 mtm -153.4 175.32 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 63.21 53.16 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 194' ' ' ALA . 29.5 mt -93.66 142.02 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.77 175.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.61 -46.81 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -103.43 48.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 216' ' ' LEU . 10.1 tt -90.27 155.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -129.16 147.55 65.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.5 0.667 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.47 -47.35 13.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -46.96 -58.23 4.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 216' ' ' LEU . 3.5 m-20 -37.55 -55.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.3 mt -64.3 -47.16 80.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -46.45 -66.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -59.96 -43.19 95.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 220' ' ' ILE . 30.1 t80 -54.81 -35.65 64.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.6 m-85 -92.64 -12.64 31.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.5 t -65.98 -7.22 15.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.84 58.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.03 -28.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.82 154.45 20.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -71.29 139.51 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.326 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 ' CG2' ' A' ' 179' ' ' VAL . 98.8 t -98.51 136.12 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -93.8 -50.94 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -142.18 157.27 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 84.5 t -142.92 108.03 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -95.95 112.54 24.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.65 107.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.854 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.471 HG22 ' HG2' ' A' ' 155' ' ' MET . 36.4 pt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.832 0.348 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.25 166.85 29.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.474 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 88.6 m-85 -122.63 127.92 49.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 152' ' ' VAL . 23.6 t -117.38 123.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.04 133.68 35.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.52 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.8 m-85 -109.86 157.33 19.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 28.8 p -60.57 -40.09 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -135.82 163.25 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.8 tt -74.23 -29.25 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.198 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.423 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 41.6 mt-30 -69.44 -5.95 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.7 m -94.12 -18.17 22.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -64.18 -43.32 73.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.64 0.733 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.6 Cg_exo -47.96 -53.38 6.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.77 -34.29 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.85 76.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 224' ' ' ALA . 71.5 mt -63.01 -40.5 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.93 92.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 84.6 mt -49.97 -28.24 6.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 210' ' ' LEU . 98.0 m -36.93 98.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.99 7.9 5.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -88.68 119.24 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.898 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.79 108.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.36 118.22 32.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.584 HD21 ' OD2' ' A' ' 165' ' ' ASP . 52.3 mt 61.37 25.61 15.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.92 -29.04 13.33 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.523 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.91 126.88 26.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.07 153.96 3.76 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.1 tt -114.39 151.06 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.449 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.8 mm -109.94 139.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.58 134.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -157.56 142.88 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.4 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.848 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.62 157.9 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -114.63 149.33 36.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.813 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.6 mtm -144.34 177.8 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.451 ' CB ' HG12 ' A' ' 221' ' ' ILE . 5.9 tt0 56.77 47.69 17.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD13 ' A' ' 161' ' ' ILE . 93.4 mt -79.54 154.44 28.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.53 169.63 17.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.37 31.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.34 38.0 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.656 HD13 HD22 ' A' ' 157' ' ' LEU . 14.5 tt -88.56 155.14 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -131.54 147.43 66.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -25.87 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.73 2.287 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -73.05 -52.89 12.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -40.77 -37.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.46 -41.94 26.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -50.09 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -58.94 -48.14 82.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -54.37 -29.84 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -96.54 -12.35 24.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.9 p -71.63 -5.13 31.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -22.09 45.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.79 -32.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.19 159.0 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -76.54 133.06 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 179' ' ' VAL . 39.4 t -91.54 121.71 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -80.7 -60.9 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -135.4 145.8 47.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 176' ' ' VAL . 42.9 t -126.69 104.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -102.42 104.95 15.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.39 119.55 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 7.0 mm . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.852 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.813 HG22 ' HG2' ' A' ' 155' ' ' MET . 22.4 pt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.76 0.315 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.58 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.86 152.25 32.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.77 145.7 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.58 114.06 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.88 116.85 25.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -92.55 162.63 14.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.15 -16.14 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -145.67 148.91 33.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.87 -23.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -73.52 -6.49 46.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.8 m -95.91 -16.83 21.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.69 -43.22 82.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.645 0.736 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.1 Cg_exo -47.91 -49.47 13.74 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.64 2.227 . . . . 0.0 112.355 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.04 -38.91 90.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.7 81.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.11 -47.45 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.187 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -57.63 -32.7 65.52 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.52 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.451 HD22 ' OE1' ' A' ' 213' ' ' GLN . 24.7 mt -52.07 -28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 210' ' ' LEU . 76.3 m -35.86 105.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.59 14.07 6.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.451 ' OE1' HD22 ' A' ' 210' ' ' LEU . 10.9 mt-30 -91.68 116.59 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.926 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -57.79 106.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.34 112.49 24.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.8 mt 64.08 25.87 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.55 -20.93 48.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.96 119.29 29.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.659 0.742 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.72 152.63 9.23 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -113.88 144.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.5 mm -103.25 133.17 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.94 128.63 67.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -151.91 150.52 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.755 0.312 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.422 HG12 ' HB ' ' A' ' 196' ' ' VAL . 4.0 p -102.06 158.18 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.153 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CZ ' ' HB ' ' A' ' 193' ' ' ILE . 17.1 t80 -109.27 141.27 41.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 194' ' ' ALA . 58.9 m -126.85 156.66 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 35.8 mtm -152.98 176.48 11.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 58.95 46.96 12.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 194' ' ' ALA . 96.1 mt -77.02 168.3 20.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.798 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.42 -178.84 6.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.093 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.49 -37.6 22.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 37.39 4.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.798 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.3 tt -73.22 154.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -128.78 146.58 60.94 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.63 -35.28 12.63 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -54.94 -51.94 64.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' OD2' HD21 ' A' ' 216' ' ' LEU . 9.0 m-20 -48.13 -40.2 22.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.11 -42.9 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -43.12 -65.3 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.64 -48.83 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 23.8 t80 -49.25 -30.31 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 196' ' ' VAL . 24.3 m-85 -96.99 -15.46 21.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.9 t -68.0 -8.85 40.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.95 -23.16 55.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.37 -33.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.26 151.73 21.12 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 134.13 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 196' ' ' VAL . 86.8 t -90.18 123.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -88.7 -61.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.51 144.32 51.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.03 104.04 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -100.49 105.81 17.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.34 105.73 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.479 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 48.4 pt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.89 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -139.81 158.29 44.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.094 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -124.4 127.53 47.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 176' ' ' VAL . 61.8 t -121.5 120.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.18 111.64 23.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.0 148.63 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 m -56.8 -33.01 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.21 166.11 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 16.4 tt -85.98 -33.08 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -64.29 -6.49 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 m -94.65 -19.31 20.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -61.49 -43.23 88.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 111.179 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.3 Cg_exo -48.01 -52.96 7.35 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.06 -36.93 83.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.489 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -66.35 -33.99 76.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.54 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.74 -40.44 79.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.537 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 211' ' ' THR . 67.3 mt -44.21 -26.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.3 m -35.61 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 116.65 23.58 3.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.557 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.553 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 28.4 mt-30 -100.13 108.9 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -47.93 110.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 169' ' ' PHE . 16.9 tp -116.52 112.31 21.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.432 HD21 ' OD2' ' A' ' 165' ' ' ASP . 62.2 mt 62.16 25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.64 -25.47 27.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.29 119.02 35.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.1 152.03 11.23 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.7 tt -111.99 151.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.0 mm -112.72 122.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.489 HG11 ' O ' ' A' ' 207' ' ' ALA . 18.1 t -118.07 128.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -155.45 150.35 26.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.2 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.814 0.34 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 196' ' ' VAL . 13.0 p -99.04 146.48 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 10.6 t80 -101.22 126.91 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 83.7 m -116.78 150.7 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 42.7 mtm -149.75 178.05 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 219' ' ' PRO . 4.5 tt0 58.54 52.68 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.431 HD22 HD13 ' A' ' 161' ' ' ILE . 60.9 mt -92.31 137.12 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.26 177.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.89 -42.65 13.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 53.9 mtm-85 -97.81 39.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 157' ' ' LEU . 19.5 tt -85.05 158.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -135.63 147.13 60.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.566 0.698 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.06 -33.99 8.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.237 . . . . 0.0 112.423 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -66.79 -49.63 65.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.508 ' OD2' HD11 ' A' ' 216' ' ' LEU . 72.0 m-20 -41.39 -36.69 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -83.79 -39.99 19.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.24 -64.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -53.65 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 220' ' ' ILE . 29.0 t80 -45.42 -46.04 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 196' ' ' VAL . 21.4 m-85 -80.03 -19.93 46.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.4 t -63.39 -7.73 7.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.834 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.12 -24.01 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.05 -31.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.27 150.62 19.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.5 133.93 47.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 179' ' ' VAL . 54.9 t -90.3 132.18 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -97.11 -52.87 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.38 145.67 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 176' ' ' VAL . 94.4 t -130.76 108.49 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -96.47 111.01 23.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.95 106.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 mm . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.18 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -151.19 154.77 37.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 77.5 m-85 -116.82 139.34 50.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 170' ' ' PHE . 99.0 t -120.82 128.09 76.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -96.81 104.37 16.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.42 157.17 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 11.5 t -58.89 -37.44 76.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -140.38 167.19 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 18.7 tt -77.42 -33.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -64.94 -6.1 7.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.1 m -95.85 -20.26 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -59.85 -43.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.97 -59.85 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.278 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.6 -45.67 63.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.59 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -58.13 -30.4 66.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.48 -44.65 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.133 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.94 -30.84 70.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.473 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.9 mt -58.9 -17.83 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.34 114.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.401 ' C ' ' OE1' ' A' ' 213' ' ' GLN . . . 113.33 15.55 8.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.5 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.36 115.12 27.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -55.42 110.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -114.58 113.16 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.508 HD11 ' OD2' ' A' ' 165' ' ' ASP . 33.5 mt 61.56 25.02 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.12 -30.14 10.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.97 122.17 32.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.705 0.764 . . . . 0.0 111.093 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 74.5 Cg_exo -50.44 152.52 8.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.381 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 169' ' ' PHE . 20.1 tt -108.06 154.17 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.4 mm -110.96 124.2 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.59 HG11 ' O ' ' A' ' 207' ' ' ALA . 16.7 t -122.17 125.11 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -156.0 152.7 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 179.93 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.1 p -102.95 151.95 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 9.7 t80 -109.09 137.12 47.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 25.2 m -126.62 152.64 46.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' MET . . . . . 0.577 ' CE ' ' NE2' ' A' ' 223' ' ' GLN . 42.8 mtm -152.5 172.85 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.414 ' CB ' HG12 ' A' ' 221' ' ' ILE . 14.7 tt0 65.38 41.51 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.519 HD11 ' CB ' ' A' ' 194' ' ' ALA . 62.1 mt -76.49 161.36 28.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.49 171.15 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.068 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.35 -29.03 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -114.73 42.92 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 tt -91.36 148.35 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -127.6 149.35 70.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 -35.6 13.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.679 2.252 . . . . 0.0 112.377 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -61.78 -53.12 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -41.95 -48.28 4.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.05 -49.3 58.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 176' ' ' VAL . 38.3 mt-10 -43.13 -69.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.797 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.83 -48.29 81.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.575 ' CD1' HD13 ' A' ' 215' ' ' LEU . 36.2 t80 -51.57 -31.16 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -94.95 -10.41 31.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.6 t -69.92 -4.39 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.55 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.9 m -114.31 -28.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.07 154.57 20.9 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -69.65 137.08 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 167' ' ' GLU . 81.1 t -93.51 136.2 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -101.06 -54.28 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 196' ' ' VAL . 2.9 t -131.89 121.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -115.1 104.21 11.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.61 115.59 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.826 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 17.4 pt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -145.92 145.95 30.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.023 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.624 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 88.4 m-85 -110.98 139.02 46.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 152' ' ' VAL . 90.9 t -128.04 128.29 68.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.47 127.42 36.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -105.39 150.59 25.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 49.1 t -48.07 -42.29 28.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -139.47 173.5 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.4 tt -86.08 -25.64 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -10.6 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 18.1 m -95.2 -13.65 24.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -64.04 -43.44 74.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.647 0.737 . . . . 0.0 111.191 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.6 Cg_exo -48.02 -47.52 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.268 . . . . 0.0 112.29 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.36 -40.2 95.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.24 95.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 92.3 mt -55.39 -44.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.06 98.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.443 HD22 ' NE2' ' A' ' 213' ' ' GLN . 44.9 mt -44.54 -27.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 49.0 m -36.74 116.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 108.3 13.03 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' ' 210' ' ' LEU . 8.7 mt-30 -92.19 114.37 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -48.81 109.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 169' ' ' PHE . 16.6 tp -115.39 113.18 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 42.2 mt 62.36 25.12 14.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.97 22.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.8 t -116.52 122.24 32.11 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 111.139 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.1 153.73 3.98 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.83 153.87 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.414 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.1 mm -114.18 143.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.7 t -140.14 120.19 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLN . . . . . 0.577 ' NE2' ' CE ' ' A' ' 155' ' ' MET . 0.0 OUTLIER -132.52 166.98 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.825 0.345 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.43 149.5 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -100.29 125.94 46.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.7 m -116.2 154.09 30.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.2 mtm -153.58 178.09 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.418 ' OE1' HD11 ' A' ' 221' ' ' ILE . 4.7 tt0 59.97 51.46 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 161' ' ' ILE . 82.0 mt -89.19 142.54 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -52.89 -175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.72 -43.38 11.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -109.68 32.84 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 157' ' ' LEU . 18.5 tt -67.76 153.39 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -127.0 146.89 59.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -48.63 11.49 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.64 2.226 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -47.44 -56.88 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -37.94 -55.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.35 -44.43 95.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -53.4 -68.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.78 -45.07 70.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 220' ' ' ILE . 16.5 t80 -55.24 -42.31 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.1 m-85 -83.83 -19.26 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.8 t -58.41 -11.71 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.3 -26.32 64.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.98 -30.97 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.17 156.31 23.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.421 ' HA ' ' CE ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -70.24 133.49 47.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.27 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.124 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -86.1 -56.43 3.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 179' ' ' VAL . 9.7 t70 -137.59 159.08 42.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 21.2 t -138.73 119.63 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -110.8 117.45 33.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.78 113.94 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.822 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 pt . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.89 0.376 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -149.86 168.0 24.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.22 133.08 45.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 152' ' ' VAL . 50.2 t -118.77 120.2 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.17 104.37 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -78.78 159.77 27.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.6 t -61.79 -33.31 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -140.06 152.36 46.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.5 tt -68.85 -31.68 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 27.4 mt-30 -64.33 -10.33 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 t -92.83 -18.07 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -60.28 -43.24 92.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.595 0.712 . . . . 0.0 111.129 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.01 -52.13 8.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.632 2.222 . . . . 0.0 112.328 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.85 -37.93 83.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ALA . . . . . 0.605 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -64.95 -32.57 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.084 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.7 -43.33 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.36 -42.0 99.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 77.1 mt -41.23 -28.72 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 75.8 m -36.85 107.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.86 11.59 7.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.457 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.495 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.25 119.13 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.959 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -56.5 108.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.14 112.97 24.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.9 mt 61.18 26.51 16.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.19 -30.24 10.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.46 121.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.529 0.681 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.05 153.87 6.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 169' ' ' PHE . 19.8 tt -112.08 153.23 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.418 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.9 mm -112.38 132.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 207' ' ' ALA . 11.7 t -131.97 120.61 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -151.36 142.37 23.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.928 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 196' ' ' VAL . 12.0 p -116.57 149.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.148 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -100.83 137.92 38.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 91.4 m -127.62 149.82 50.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.6 mtm -151.84 -179.3 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' CB ' HG12 ' A' ' 221' ' ' ILE . 14.8 tt0 54.67 47.05 23.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 194' ' ' ALA . 72.4 mt -75.81 165.37 25.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -81.72 175.76 10.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.87 -34.21 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -118.14 47.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.646 HD13 HD22 ' A' ' 157' ' ' LEU . 14.3 tt -90.3 153.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -136.47 152.52 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.55 0.691 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -45.41 16.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.663 2.242 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -48.74 64.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -47.41 -63.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 -45.81 74.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -47.03 -68.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.27 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 215' ' ' LEU . 44.4 t80 -54.68 -29.56 53.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PHE . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . 23.0 m-85 -95.29 -12.34 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.5 p -67.71 -4.21 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.54 -21.36 41.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.22 -27.56 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.71 159.67 29.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.448 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -74.67 134.98 41.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 179' ' ' VAL . 80.0 t -95.76 116.48 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.05 -43.49 43.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -153.32 158.0 40.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 196' ' ' VAL . 86.7 t -137.07 141.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.38 120.03 30.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.68 114.39 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.841 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.83 0.348 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.683 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.09 137.01 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -103.4 112.73 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 152' ' ' VAL . 56.2 t -109.54 141.93 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -118.42 153.21 34.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 170' ' ' PHE . 63.2 m-85 -123.05 -177.32 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 51.3 m -85.49 -21.73 28.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.49 144.39 29.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ILE . . . . . 0.403 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 14.7 tt -70.86 -27.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -65.27 -9.61 25.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -94.89 -18.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -59.28 -43.56 96.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.0 Cg_exo -47.9 -51.59 9.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.371 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.11 -43.57 95.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.36 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.77 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.12 -32.88 85.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 211' ' ' THR . 71.2 mt -55.78 -20.47 15.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.955 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.9 m -36.75 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.93 14.09 6.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.567 ' NE2' ' CE1' ' A' ' 169' ' ' PHE . 9.4 mt-30 -88.65 106.29 18.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -45.9 106.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 169' ' ' PHE . 21.2 tp -108.43 107.06 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.2 mt 65.82 27.08 11.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.66 -18.15 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.24 115.21 31.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.695 0.759 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.69 149.79 13.36 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.2 tt -115.04 149.74 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.0 mm -109.0 125.62 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 17.3 t -120.51 124.2 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -143.62 165.79 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 179.871 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.1 p -113.92 149.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.65 120.72 40.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.4 m -106.29 154.48 20.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 54.2 mtm -155.54 176.68 12.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.47 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 17.8 tt0 57.69 52.05 8.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 194' ' ' ALA . 81.4 mt -81.45 166.78 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -90.68 174.17 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.05 -40.4 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -108.29 43.67 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 14.4 tt -92.94 153.71 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.81 153.92 79.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.578 0.704 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.5 -39.32 17.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.608 2.205 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 165' ' ' ASP . 12.0 mtt-85 -57.93 -59.74 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 164' ' ' ARG . 15.0 m-20 -34.43 -41.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.48 -43.78 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' ARG . 50.6 mt-10 -42.7 -66.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 171' ' ' SER . 33.4 t70 -62.15 -53.46 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.641 ' CD2' HD13 ' A' ' 215' ' ' LEU . 1.5 t80 -45.46 -30.05 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -95.25 -20.92 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 168' ' ' ASP . 20.5 t -61.51 -9.49 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.86 62.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.33 -33.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.63 152.5 22.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -73.72 142.8 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.674 HG11 ' CG2' ' A' ' 179' ' ' VAL . 92.0 t -103.18 136.55 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -113.06 -39.07 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -141.11 134.58 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.674 ' CG2' HG11 ' A' ' 176' ' ' VAL . 59.6 t -134.94 102.89 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 -96.04 107.81 20.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 94.4 mt -98.08 117.57 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.4 pt . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -144.96 148.01 33.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -110.33 135.64 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.6 t -129.01 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.13 103.79 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' PHE . . . . . 0.443 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.3 m-85 -73.85 161.51 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.98 -33.55 74.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.26 170.33 15.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -84.27 -28.93 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.6 -6.8 27.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 t -95.34 -22.26 17.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.0 t -57.09 -43.72 99.44 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.579 0.704 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.92 -60.15 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.719 2.279 . . . . 0.0 112.415 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 72.6 mt -52.3 -42.42 63.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.76 85.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.25 -43.68 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.8 99.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.491 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 211' ' ' THR . 49.0 mt -42.33 -29.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 210' ' ' LEU . 51.5 m -33.97 123.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 101.24 17.7 21.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLN . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 39.2 mt-30 -93.7 109.82 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -51.49 99.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . 0.641 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.7 tp -101.46 105.63 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.1 mt 65.83 25.39 11.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.62 -19.75 51.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.0 114.33 37.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.719 0.771 . . . . 0.0 111.058 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.6 149.27 13.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.603 2.202 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -111.49 156.17 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.175 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 4.6 mm -119.55 135.44 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.02 122.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -145.48 143.13 29.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.4 p -172.19 143.71 1.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 86.5 p -163.65 164.26 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.843 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.33 136.33 5.15 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.3 p -171.95 167.43 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.364 . . . . 0.0 110.835 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 m -129.9 137.57 50.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.31 -172.63 43.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.45 157.89 45.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.7 p -107.55 95.33 13.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.681 0.753 . . . . 0.0 110.841 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.92 159.45 41.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.704 2.269 . . . . 0.0 112.266 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.48 -28.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.112 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -131.17 143.97 51.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.57 143.7 49.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.649 0.738 . . . . 0.0 110.806 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.51 -173.04 1.64 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.669 2.246 . . . . 0.0 112.377 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.6 m -86.06 41.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -98.58 165.17 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -61.06 156.93 16.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 tp -46.13 141.81 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -103.33 147.16 33.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.672 0.749 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.78 -19.01 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.65 2.233 . . . . 0.0 112.348 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -96.49 -45.3 6.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -55.08 -35.04 64.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.929 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.512 ' CG ' ' N ' ' A' ' 148' ' ' ASP . 14.6 ptt180 -47.83 -48.92 30.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 147' ' ' ARG . 33.1 t70 -61.39 -44.9 96.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -46.69 -51.39 16.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.94 43.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.1 m -130.67 131.96 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.2 p -110.05 149.56 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 193' ' ' ILE . 14.8 t80 -110.66 124.1 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG3' ' A' ' 155' ' ' MET . 41.9 m -113.79 161.16 17.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.414 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 33.9 mtm -155.03 179.52 9.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.435 ' CB ' HG12 ' A' ' 221' ' ' ILE . 16.2 tt0 55.98 46.07 22.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 161' ' ' ILE . 62.5 mt -79.06 159.56 27.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.0 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -69.43 174.18 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.82 -38.26 38.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -118.39 50.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 157' ' ' LEU . 14.7 tt -89.96 156.8 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.04 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -131.51 155.06 81.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.02 -47.2 14.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -52.92 -53.92 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -39.73 -45.73 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.89 -46.84 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -45.1 -65.61 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.19 -46.31 88.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -54.17 -28.77 42.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.42 -8.56 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -70.24 -5.9 30.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.21 -23.6 47.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.5 -31.86 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.48 158.57 31.52 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -78.29 136.44 37.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.406 HG11 ' CG2' ' A' ' 179' ' ' VAL . 65.8 t -97.9 140.74 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -36.26 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.451 ' CG ' ' OE1' ' A' ' 197' ' ' GLU . 0.5 OUTLIER -151.49 152.34 32.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.406 ' CG2' HG11 ' A' ' 176' ' ' VAL . 99.3 t -141.19 109.3 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -96.53 106.71 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.3 mt -96.05 131.42 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.7 mm -96.3 120.78 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.0 t -111.56 -32.16 6.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.94 117.82 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -61.62 110.74 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -92.87 -46.47 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.1 m -118.54 147.42 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -39.02 -55.62 1.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -44.77 123.8 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.0 t -77.95 83.49 4.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -124.92 153.01 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.86 104.85 1.18 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.457 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 29.0 pt -98.71 143.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.641 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -141.92 157.88 44.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.18 134.85 54.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 152' ' ' VAL . 60.6 t -131.08 128.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLU . . . . . 0.451 ' OE1' ' CG ' ' A' ' 178' ' ' ASP . 41.5 mt-10 -94.84 129.99 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -103.08 159.66 15.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.0 p -58.58 -32.21 68.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -148.01 164.91 32.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.0 tt -78.53 -20.72 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.421 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.1 mm-40 -73.53 -12.35 60.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 38.0 t -92.42 -14.41 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.5 t -63.8 -43.32 76.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.7 Cg_exo -47.92 -47.96 17.5 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.5 -45.0 95.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.2 83.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.7 mt -52.21 -47.53 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -55.47 -43.99 85.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.58 HD22 ' NE2' ' A' ' 213' ' ' GLN . 86.6 mt -40.32 -28.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 210' ' ' LEU . 53.2 m -35.52 102.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.12 4.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 210' ' ' LEU . 17.9 mt-30 -98.28 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -46.75 107.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.24 108.51 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 mt 66.35 27.37 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.42 -15.52 63.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.24 118.99 25.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.616 0.722 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.07 152.27 5.11 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.284 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.8 tt -115.5 149.29 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.435 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.3 mm -108.87 141.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.03 127.33 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -150.55 151.3 32.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -60.34 113.63 2.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.4 p -56.41 -32.18 64.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 229' ' ' LYS . 15.0 pt20 -70.74 -41.39 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -42.7 -55.5 3.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.86 -21.9 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 226' ' ' GLN . 25.7 tptp -79.89 -62.35 1.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -38.74 -39.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -58.27 8.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.825 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.0 tt -41.5 -50.84 3.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -74.99 160.85 30.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -61.09 157.62 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.238 . . . . 0.0 112.335 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 6.0 m -80.36 174.6 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.816 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 7.9 t -43.14 159.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.472 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -139.23 128.98 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.1 m -43.07 112.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -132.4 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 t -92.43 -48.59 6.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.3 m 43.31 42.49 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 135.07 110.15 1.08 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -53.68 141.92 24.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.1 m -55.74 143.52 59.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.701 0.762 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.17 110.01 2.8 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.658 2.239 . . . . 0.0 112.342 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.9 t -125.27 105.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -138.6 111.23 7.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.11 138.17 26.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.43 172.85 13.93 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.8 m -79.72 167.58 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -161.67 122.64 2.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.86 164.85 3.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.19 94.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -100.13 158.72 31.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.748 . . . . 0.0 110.818 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.04 -19.42 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 0.0 112.362 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -89.61 -39.55 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -59.86 -35.73 75.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -50.65 -48.96 58.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.63 -53.67 55.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -40.01 -44.48 1.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 199' ' ' CYS . 2.5 mtp-105 -83.35 37.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m -133.28 141.62 48.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.6 p -119.8 146.19 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -98.15 127.76 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.423 ' C ' ' HG3' ' A' ' 155' ' ' MET . 64.7 m -115.54 149.61 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 22.9 mtm -149.37 -179.94 7.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' CB ' HG12 ' A' ' 221' ' ' ILE . 14.9 tt0 55.44 50.38 14.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.675 ' HB3' HG21 ' A' ' 161' ' ' ILE . 79.5 mt -79.24 163.21 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.67 171.72 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.67 -30.5 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -126.88 33.67 4.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.7 tt -71.57 150.88 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -128.83 150.35 74.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.576 0.703 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.33 -36.12 12.44 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.42 -59.62 4.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -38.54 -36.86 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 161' ' ' ILE . 23.9 mt -80.8 -50.89 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -39.17 -60.83 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.77 -44.98 84.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 215' ' ' LEU . 23.3 t80 -52.21 -32.55 37.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -92.64 -16.17 25.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.3 m -66.5 -10.05 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.35 60.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.75 -28.14 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.39 151.84 14.41 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -62.75 137.11 58.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.77 126.14 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -87.04 -60.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -138.73 149.5 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 196' ' ' VAL . 60.1 t -136.84 105.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.54 104.3 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.34 107.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.48 106.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.8 p -102.96 150.57 23.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.23 178.63 6.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -92.08 -53.7 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.819 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -121.95 135.61 54.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.43 140.67 46.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -120.93 -59.89 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -129.84 -51.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.9 p -51.53 135.23 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 192' ' ' GLY . 23.4 mmmt -95.88 133.73 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . -34.78 111.41 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt -97.82 148.83 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -145.29 143.91 30.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.043 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.11 147.06 27.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 179' ' ' VAL . 50.9 t -139.64 130.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -105.23 124.86 50.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.01 155.19 17.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.448 ' O ' ' NH2' ' A' ' 150' ' ' ARG . 26.7 p -63.21 -24.85 68.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -141.19 152.14 44.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.45 HD12 ' HB1' ' A' ' 149' ' ' ALA . 15.9 tt -76.78 -28.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.428 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 13.6 mm100 -67.73 -7.2 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.435 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 66.7 m -92.77 -25.49 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.87 -43.65 98.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.8 Cg_exo -47.95 -58.63 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.635 2.223 . . . . 0.0 112.411 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.4 mt -52.83 -44.68 66.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.26 74.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.24 -44.01 94.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.34 85.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 211' ' ' THR . 39.0 mt -56.4 -24.9 47.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 210' ' ' LEU . 12.5 m -36.76 118.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.23 6.25 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -102.51 110.41 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -47.49 104.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 169' ' ' PHE . 29.6 tp -109.57 108.02 18.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.3 mt 66.47 25.03 10.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.32 59.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.2 t -123.35 115.72 28.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 149.6 14.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.712 2.275 . . . . 0.0 112.356 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.4 tt -113.34 158.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.452 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.1 mm -119.22 133.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 15.8 t -129.87 119.03 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -138.59 156.03 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -65.57 139.39 58.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.7 m -88.57 42.57 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.456 ' HG3' ' N ' ' A' ' 227' ' ' ALA . 12.5 pt20 -94.47 -42.04 9.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 226' ' ' GLN . . . -70.71 -55.53 8.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -39.86 -41.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -69.7 -53.97 16.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.72 -57.24 5.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -50.78 -42.64 58.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 tp -53.83 142.73 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.2 p -78.17 143.5 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 94.68 73.22 1.19 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.438 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.01 -18.61 14.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.288 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 26.6 t -87.43 134.89 33.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.3 m -73.59 127.29 32.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.471 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.0 m -113.89 163.39 15.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.7 t -148.35 143.95 27.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.27 98.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 t -146.87 120.04 8.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.7 p -93.17 155.95 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 129.26 109.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.04 151.83 42.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 m -140.91 141.38 24.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.65 0.738 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.23 172.07 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.58 116.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 137' ' ' GLU . 20.8 mtp85 -149.54 173.33 13.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 136' ' ' ARG . 5.9 mm-40 -37.26 154.73 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.671 0.748 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.11 126.66 8.76 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.599 2.199 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.92 174.04 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.74 -51.29 61.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -40.94 149.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 143' ' ' SER . 0.2 OUTLIER -40.15 117.61 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.609 ' N ' HD13 ' A' ' 142' ' ' LEU . 3.7 p -125.69 160.29 56.86 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.65 0.738 . . . . 0.0 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.19 -19.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.723 2.282 . . . . 0.0 112.291 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.03 -41.24 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.22 -39.98 67.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -46.84 -42.85 17.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.19 -54.98 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.554 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -42.17 -39.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.7 43.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.9 m -136.9 126.11 24.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' CG1' ' A' ' 222' ' ' VAL . 7.3 p -102.5 149.02 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 14.0 t80 -102.48 117.19 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.4 m -107.74 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.0 mtm -151.26 177.3 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.447 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.4 tt0 59.31 50.81 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 166' ' ' LEU . 58.3 mt -95.22 150.18 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.35 168.63 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.82 23.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -98.28 42.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.1 tt -88.04 157.95 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -127.26 143.65 47.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.95 -29.49 8.46 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.759 2.306 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 165' ' ' ASP . 18.7 mmt85 -66.47 -58.45 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 216' ' ' LEU . 43.3 m-20 -34.99 -45.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 157' ' ' LEU . 29.4 mt -68.79 -46.26 69.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.474 ' HA ' HG21 ' A' ' 176' ' ' VAL . 29.9 mt-10 -47.11 -68.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.54 -50.26 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.65 ' CE2' HG21 ' A' ' 220' ' ' ILE . 22.1 t80 -49.39 -31.64 9.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 196' ' ' VAL . 27.1 m-85 -95.87 -11.54 26.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -66.51 -5.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.16 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 m -121.01 -30.74 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.57 153.72 24.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -77.0 134.23 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 167' ' ' GLU . 88.0 t -94.29 128.21 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.22 -41.27 8.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.6 154.78 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.459 ' CG2' HG11 ' A' ' 176' ' ' VAL . 25.4 t -143.76 107.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -92.87 105.08 17.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 95.0 mt -96.72 123.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.96 119.04 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.0 t -127.38 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.443 ' OD2' ' NH1' ' A' ' 185' ' ' ARG . 24.8 t0 -126.99 -59.18 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' OD2' ' A' ' 184' ' ' ASP . 0.7 OUTLIER -110.79 39.52 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -50.69 -27.07 6.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m -101.98 -60.32 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.0 tpt85 -43.74 -31.07 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -109.6 -10.65 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.0 m 46.95 36.85 4.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -134.01 -177.88 4.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.94 113.04 0.55 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 41.4 pt -118.4 141.6 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.126 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.25 157.65 43.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.072 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 98.8 m-85 -114.64 125.44 53.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 170' ' ' PHE . 82.6 t -109.46 122.66 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.103 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -94.11 106.37 18.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.29 166.25 22.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 45.9 t -71.73 -35.75 70.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -133.93 165.78 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.554 HD12 ' HB1' ' A' ' 149' ' ' ALA . 20.8 tt -84.65 -24.48 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -75.06 -9.76 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 -11.89 27.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.6 t -64.73 -43.75 70.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.4 Cg_exo -48.02 -54.2 5.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.607 2.205 . . . . 0.0 112.326 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.64 -33.37 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -69.92 -34.85 74.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.17 -38.63 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 -40.32 98.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.467 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 95.7 mt -42.26 -32.17 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 210' ' ' LEU . 57.3 m -35.79 98.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 126.29 7.42 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.83 116.73 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 110.922 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -53.11 108.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 117.08 29.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.48 HD11 ' OD2' ' A' ' 165' ' ' ASP . 46.6 mt 61.64 24.96 14.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.23 -29.23 12.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.2 t -117.64 124.98 28.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.565 0.698 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.32 153.84 6.65 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.356 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 169' ' ' PHE . 14.1 tt -116.48 154.28 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.447 HG12 ' CB ' ' A' ' 156' ' ' GLN . 8.5 mm -110.12 142.35 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.5 t -142.82 118.39 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.47 148.9 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -45.78 125.06 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.08 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 153' ' ' PHE . 23.2 t -76.65 50.17 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -85.86 43.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.75 -36.46 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.01 -44.93 87.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.71 -40.79 61.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -61.54 -48.09 82.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 232' ' ' LEU . 23.8 ttm180 -60.04 -52.11 66.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -36.0 -54.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.944 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.88 -43.75 71.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 149.64 145.8 4.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.18 42.1 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.4 t -56.03 123.51 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -42.83 -45.89 5.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.851 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 p -140.3 148.46 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.3 m -132.12 109.11 9.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.822 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.51 175.16 38.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.456 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.7 m -93.9 -55.18 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.839 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.2 m -73.33 152.89 40.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.27 -135.31 2.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 124.17 19.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.2 p -128.71 94.42 34.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.727 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.73 124.33 4.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.637 2.224 . . . . 0.0 112.389 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.61 150.04 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.8 171.72 19.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.38 155.68 51.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.674 0.75 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -45.22 122.38 4.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.254 . . . . 0.0 112.248 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.9 m -110.73 178.65 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.96 105.16 17.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 142' ' ' LEU . 31.7 m-20 -171.99 173.57 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.52 HD21 ' NH2' ' A' ' 150' ' ' ARG . 1.3 tm? -34.74 115.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 95.4 p -82.33 147.25 56.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.649 0.738 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.88 -16.05 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.723 2.282 . . . . 0.0 112.394 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -44.39 13.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -55.18 -42.31 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -58.72 -41.32 86.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -55.94 -48.61 75.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.42 -53.57 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.52 ' NH2' HD21 ' A' ' 142' ' ' LEU . 46.2 mtm180 -82.5 46.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 74.3 m -140.61 138.6 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 7.6 p -114.19 152.42 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.7 t80 -109.01 122.58 47.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 60.9 m -111.32 152.37 27.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.8 mtm -147.22 175.5 10.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.863 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.424 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.1 tt0 56.52 54.37 7.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 161' ' ' ILE . 87.3 mt -91.96 156.91 17.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.28 169.56 17.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.78 -44.49 23.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.0 mtm105 -98.57 46.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.539 HD13 HD22 ' A' ' 157' ' ' LEU . 17.9 tt -91.71 148.86 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -121.2 143.16 36.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.01 -30.51 7.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.377 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -68.43 -55.83 10.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' ARG . 2.1 m-20 -35.23 -44.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 179' ' ' VAL . 26.7 mt -71.69 -52.56 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -38.5 -68.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 171' ' ' SER . 0.8 OUTLIER -56.9 -56.13 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 220' ' ' ILE . 38.7 t80 -44.17 -29.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 196' ' ' VAL . 23.8 m-85 -95.34 -21.8 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 168' ' ' ASP . 4.2 t -58.67 -14.16 7.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.84 -29.47 68.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 m -110.08 -30.9 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.53 150.99 16.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.08 138.13 55.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.05 134.66 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -92.77 -56.98 2.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -136.8 161.21 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 166' ' ' LEU . 99.0 t -140.86 106.58 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -93.19 103.95 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -94.1 119.99 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.448 ' CG1' HG13 ' A' ' 193' ' ' ILE . 14.9 mm -67.99 145.96 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.1 t 75.02 40.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -104.9 -32.22 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 186' ' ' ASN . 0.3 OUTLIER -116.57 77.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' ARG . 7.0 p-10 37.81 40.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.3 m -94.85 166.27 12.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -38.59 155.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -109.41 132.96 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 9.1 t -172.82 176.35 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -35.38 126.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.836 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.77 89.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 191' ' ' LYS . 24.6 pt -111.5 146.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.14 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -153.8 153.76 32.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.52 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 96.0 m-85 -109.04 135.34 50.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.921 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' A' ' 170' ' ' PHE . 87.2 t -118.88 133.45 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.89 112.81 24.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.463 ' HE2' HG11 ' A' ' 152' ' ' VAL . 39.1 m-85 -89.0 162.13 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 10.9 t -64.87 -43.38 93.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.04 162.45 33.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.8 tt -73.51 -22.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -74.09 -6.46 47.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 66.1 m -97.83 -18.04 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.2 t -61.68 -43.49 88.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.646 0.736 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.2 Cg_exo -48.02 -55.28 4.17 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.2 -35.7 72.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.968 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.89 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.94 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.27 -33.87 87.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.4 mt -50.42 -27.6 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 19.8 m -38.01 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 125.38 9.88 4.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.04 117.91 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.0 110.977 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -54.51 109.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -113.21 112.73 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.1 mt 61.39 25.4 15.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.0 -30.63 9.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -114.74 121.34 35.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.712 0.768 . . . . 0.0 111.074 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.76 154.15 7.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.2 tt -116.77 152.73 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.3 mm -109.63 148.72 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.16 126.33 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -149.63 151.21 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.09 107.53 0.55 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.2 t -49.37 -36.93 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -94.7 41.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.407 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . -67.15 -45.5 76.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.009 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.503 ' OE2' HD13 ' A' ' 232' ' ' LEU . 2.4 tm-20 -58.46 -56.53 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.29 -57.83 7.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.55 -41.66 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.407 ' NH1' ' HB1' ' A' ' 227' ' ' ALA . 42.5 mtt85 -92.31 56.68 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.503 HD13 ' OE2' ' A' ' 228' ' ' GLU . 15.0 tp -129.41 -49.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 135.61 42.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.88 145.2 48.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.35 98.78 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.676 2.251 . . . . 0.0 112.335 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 t -59.31 106.01 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 13.3 m -128.02 -55.99 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.42 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -121.62 109.87 15.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.4 t -136.4 130.34 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 129' ' ' SER . . . 123.51 -92.87 0.46 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 128' ' ' GLY . 69.8 m 34.36 52.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 0.0 110.817 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.7 m -119.51 42.9 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' LYS . . . 119.78 -107.35 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' GLY . 14.2 ptpt 34.42 45.39 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.8 p -99.65 139.11 20.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.39 137.92 13.56 Favored 'Trans proline' 0 N--CA 1.466 -0.118 0 C-N-CA 122.738 2.292 . . . . 0.0 112.366 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.26 173.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -48.56 114.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -136.84 148.79 64.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.738 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 176.1 10.52 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.9 35.9 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.35 -55.41 5.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -106.71 156.25 18.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.83 167.98 16.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -164.89 160.9 15.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.4 -17.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -106.11 -49.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -57.65 -38.49 75.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -46.23 -44.83 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.44 -47.77 63.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -41.95 -46.65 4.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.056 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -82.29 39.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.814 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m -137.2 120.9 17.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 196' ' ' VAL . 11.4 p -99.04 148.86 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -106.04 141.58 37.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.424 ' C ' ' HG3' ' A' ' 155' ' ' MET . 82.0 m -133.34 150.7 51.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.424 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 32.3 mtm -148.76 -179.44 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 21.6 tt0 61.13 46.5 8.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.573 HD11 ' CB ' ' A' ' 194' ' ' ALA . 70.1 mt -86.3 154.25 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.21 171.87 9.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.047 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.87 -43.29 36.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 51.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.469 HD13 HD22 ' A' ' 157' ' ' LEU . 15.7 tt -87.37 147.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -117.97 144.34 34.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -40.65 19.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 165' ' ' ASP . 26.4 mmt180 -54.97 -57.81 10.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 164' ' ' ARG . 14.2 m-20 -35.52 -47.0 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.17 -47.6 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -43.82 -62.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.45 -48.89 71.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 220' ' ' ILE . 17.4 t80 -47.05 -35.78 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 196' ' ' VAL . 38.0 m-85 -91.98 -15.66 27.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -65.82 -6.53 12.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.26 55.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.9 -32.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.79 154.85 25.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 139.75 42.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.44 HG11 ' CG2' ' A' ' 179' ' ' VAL . 87.0 t -95.61 127.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -92.48 -49.44 6.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -142.69 145.7 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.44 ' CG2' HG11 ' A' ' 176' ' ' VAL . 93.2 t -127.76 115.4 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -103.0 108.56 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.67 112.67 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.83 111.69 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -106.35 77.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -154.85 164.87 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -119.49 117.97 29.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -133.32 -43.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 m -84.55 177.96 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -82.14 -61.04 2.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -115.64 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.7 m -169.28 130.39 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm -75.61 -51.39 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 164.3 129.66 1.06 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.3 140.75 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 111.13 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.573 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -141.73 140.0 33.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -101.38 127.15 48.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.812 ' O ' HG12 ' A' ' 152' ' ' VAL . 78.8 t -116.56 119.38 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.59 115.59 28.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.653 ' HE2' HG11 ' A' ' 152' ' ' VAL . 38.4 m-85 -90.07 155.49 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.8 m -63.23 -39.97 96.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -126.77 165.05 20.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 tt -84.4 -29.5 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -71.8 -7.03 45.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -95.37 -17.38 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -63.07 -43.47 81.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.625 0.726 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.3 Cg_exo -47.98 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.97 -41.13 70.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.14 76.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.54 -38.95 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.11 -38.38 96.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 88.3 mt -45.01 -28.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' LEU . 41.7 m -35.41 107.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 119.29 5.75 11.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.47 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.506 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -84.51 119.54 25.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -59.49 100.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.46 112.26 24.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.9 mt 61.83 25.27 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.11 -23.14 36.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.464 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -116.68 117.99 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.69 149.6 13.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.47 HG12 ' N ' ' A' ' 221' ' ' ILE . 13.5 tt -113.49 159.49 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 220' ' ' ILE . 3.6 mm -118.65 148.71 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 t -147.0 138.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 221' ' ' ILE . 12.9 mp0 -152.67 -177.75 6.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.84 115.82 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -75.71 57.82 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -100.55 35.11 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -95.53 -40.69 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.32 -47.52 73.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -45.88 -22.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -93.24 -40.21 10.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -108.14 62.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.0 tp -138.97 116.33 11.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -51.37 132.42 29.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 165.41 95.83 0.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.6 145.71 33.48 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 27.9 p -111.37 141.72 44.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 23.3 t -88.22 -45.3 10.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.49 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 p -53.94 170.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.92 0.391 . . . . 0.0 110.888 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.0 t 61.66 45.22 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.91 123.36 2.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.45 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.2 m -107.91 157.72 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -121.24 112.26 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.16 43.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -111.76 98.1 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.4 t -107.33 93.41 9.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.668 0.747 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.18 142.9 27.88 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.27 144.5 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 136' ' ' ARG . 4.6 ptp180 -121.62 43.02 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.21 141.81 10.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.27 154.3 24.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.374 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.79 145.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.201 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.69 -57.74 3.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' LEU . 39.6 p-10 -126.15 147.82 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' ASN . 13.4 mt -35.83 131.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 p -76.44 155.53 83.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.679 0.752 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.72 -40.6 19.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.299 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -74.73 -53.79 8.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -49.37 -42.13 41.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -58.05 -66.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -40.71 -47.19 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.595 ' HB1' ' CD1' ' A' ' 201' ' ' ILE . . . -45.43 -62.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -43.83 -25.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.7 m -96.0 133.9 39.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.56 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.2 p -105.04 154.91 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.88 121.48 45.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.2 m -108.43 157.07 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 193' ' ' ILE . 63.6 mtm -151.6 171.74 17.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.461 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 16.3 tt0 65.62 53.89 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 161' ' ' ILE . 66.6 mt -91.63 152.23 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.63 179.57 3.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.47 -33.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -113.93 46.54 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.748 HD13 HD22 ' A' ' 157' ' ' LEU . 11.8 tt -91.76 150.03 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -125.37 148.76 62.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.497 0.665 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.6 -40.4 18.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.35 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -54.42 -52.93 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -41.22 -47.79 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.34 -41.5 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.11 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.14 -47.73 84.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 6.8 t80 -52.34 -33.4 42.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 196' ' ' VAL . 35.3 m-85 -96.9 -14.75 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 t -67.21 -5.62 14.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.2 -26.93 38.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.47 -33.75 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -163.81 150.08 18.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -70.6 135.68 48.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.831 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.472 HG11 ' CG2' ' A' ' 179' ' ' VAL . 93.1 t -95.72 131.15 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -103.94 -42.47 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -136.68 143.79 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.1 t -134.25 110.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -102.33 113.42 26.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.55 115.5 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.52 108.75 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.129 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.6 t -94.01 74.24 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.25 151.44 34.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -153.76 138.0 16.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -90.09 -42.21 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.7 t -127.35 165.0 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -49.16 -62.54 1.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -80.56 90.21 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -109.96 141.21 43.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.28 120.19 6.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.757 HG22 ' HG2' ' A' ' 155' ' ' MET . 32.7 pt -96.89 146.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.156 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -150.9 141.88 22.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -101.34 133.37 46.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 152' ' ' VAL . 92.3 t -120.85 119.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.96 111.97 20.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.56 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.37 150.09 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.4 p -52.26 -36.06 51.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.74 176.94 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.595 ' CD1' ' HB1' ' A' ' 149' ' ' ALA . 7.2 tt -87.59 -29.28 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -65.24 -7.33 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 45.2 t -97.26 -17.2 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -61.02 -43.35 90.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.612 0.72 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 63.1 Cg_exo -47.93 -54.47 5.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.667 2.245 . . . . 0.0 112.392 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.33 -45.65 84.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.63 77.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 90.9 mt -56.67 -40.87 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.48 98.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 213' ' ' GLN . 80.0 mt -55.3 -26.3 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' ' 221' ' ' ILE . 93.3 m -35.68 104.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.7 26.64 2.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 210' ' ' LEU . 44.8 mt-30 -101.71 106.07 17.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 110.947 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -41.47 104.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.2 tp -110.06 109.99 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.6 mt 63.21 26.44 15.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.43 -25.37 28.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.6 t -115.24 118.31 40.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.02 150.53 9.98 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.277 . . . . 0.0 112.322 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 tt -110.98 149.44 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.519 ' HA ' HG23 ' A' ' 211' ' ' THR . 5.2 mm -112.21 142.66 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.07 124.82 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -148.02 148.25 30.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.0 7.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.6 t -61.93 -39.92 93.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -1.39 15.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -101.48 9.27 41.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -109.5 -35.84 6.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 230' ' ' ASN . 14.3 mmmt -87.66 -46.93 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 p-10 -34.72 -48.32 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -64.08 -62.01 1.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.888 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -41.07 121.5 1.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.94 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.9 t -84.49 101.65 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -99.44 162.0 19.76 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.24 97.09 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.683 2.256 . . . . 0.0 112.353 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 7.8 t -52.01 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 77.8 p -100.24 139.63 35.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.842 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.487 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.0 p -112.32 161.33 16.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.844 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.2 m -102.95 138.85 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.63 177.51 21.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -147.67 159.09 44.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.399 . . . . 0.0 110.771 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -143.89 138.89 28.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.84 159.99 1.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.549 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -109.26 86.97 2.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.742 0.306 . . . . 0.0 110.837 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.612 ' O ' HG13 ' A' ' 135' ' ' VAL . 32.9 m -151.76 145.18 17.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.57 109.24 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 0.0 112.37 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 133' ' ' SER . 21.4 m -120.24 163.66 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -100.85 104.92 16.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -121.99 156.17 59.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.26 -168.54 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.725 2.283 . . . . 0.0 112.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 139' ' ' VAL . 21.5 m -80.94 52.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -119.08 87.4 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -165.68 165.67 18.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.412 HD23 ' CG ' ' A' ' 147' ' ' ARG . 8.4 tp -64.06 149.53 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.0 m -67.67 143.58 96.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.731 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.98 -40.76 25.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.34 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.17 -52.32 12.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -42.36 -45.94 4.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.412 ' CG ' HD23 ' A' ' 142' ' ' LEU . 12.3 mtp180 -47.5 -58.28 4.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.27 -49.5 73.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.13 -43.77 21.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -83.97 38.73 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.7 m -139.48 138.83 36.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.75 145.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 10.8 t80 -103.23 120.2 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.492 ' HG ' ' C ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -109.7 144.19 38.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.866 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 12.4 mtm -144.46 178.29 8.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.466 ' OE1' HD11 ' A' ' 221' ' ' ILE . 3.0 tt0 57.0 51.88 9.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.46 HD22 HD21 ' A' ' 166' ' ' LEU . 28.4 mt -102.6 129.49 49.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.12 169.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.068 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.3 -35.91 40.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -99.45 45.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.8 tt -93.51 148.32 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -120.71 147.4 45.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.66 -41.98 19.07 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.32 -51.68 67.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -39.59 -44.93 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.46 HD21 HD22 ' A' ' 157' ' ' LEU . 68.1 mt -76.84 -48.41 18.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -40.82 -68.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.65 -54.94 38.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -47.83 -29.99 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.14 -20.57 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.3 t -65.57 -7.01 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.38 -23.68 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.96 -29.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.98 156.49 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 135.53 46.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.05 128.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -82.76 -56.8 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.86 154.15 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 196' ' ' VAL . 76.9 t -133.93 121.35 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -110.13 107.41 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.67 121.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.2 mm -78.25 104.53 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 t -99.63 44.11 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.76 144.57 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -111.54 41.81 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -47.79 -49.88 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.0 m -102.24 160.11 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -82.36 44.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -114.2 170.72 8.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.0 t -109.69 21.73 16.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.443 ' HE3' ' N ' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -73.34 170.21 15.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.54 98.45 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.3 pt -94.09 148.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.492 ' C ' ' HG ' ' A' ' 154' ' ' CYS . . . -150.77 170.6 18.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 97.2 m-85 -129.33 137.23 50.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 152' ' ' VAL . 94.2 t -130.63 127.01 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.73 123.9 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 152' ' ' VAL . 36.9 m-85 -94.66 162.56 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.42 -30.33 71.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -147.23 174.96 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.6 tt -84.89 -35.9 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.99 -6.71 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.6 t -95.18 -17.42 21.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.64 -43.37 83.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.62 0.724 . . . . 0.0 111.154 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.6 Cg_exo -47.99 -56.88 2.71 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.56 -49.03 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.52 -39.92 61.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.57 -46.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.39 -43.5 84.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 211' ' ' THR . 97.5 mt -43.0 -28.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 210' ' ' LEU . 86.7 m -35.65 120.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.22 26.45 6.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -105.5 111.79 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -50.01 105.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.1 tp -112.09 112.47 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.2 mt 62.78 25.24 14.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.54 -27.55 19.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.36 121.07 32.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.64 148.44 15.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.445 HG12 ' N ' ' A' ' 221' ' ' ILE . 11.9 tt -106.79 154.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.083 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.466 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.5 mm -112.92 140.61 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 152' ' ' VAL . 10.4 t -138.69 125.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -147.53 163.04 37.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -68.33 130.51 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -89.6 53.1 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 230' ' ' ASN . 21.3 pt20 -129.94 33.99 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.49 -57.62 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.14 -57.06 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -63.3 -49.65 73.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 226' ' ' GLN . 25.2 t-20 -48.13 -55.96 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 231' ' ' ARG . 2.2 tpm_? -63.77 -60.58 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.5 tp -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -148.35 137.44 21.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -116.13 176.29 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.03 -179.8 5.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.266 . . . . 0.0 112.369 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.0 t -167.08 151.09 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.3 t -61.36 109.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.435 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.3 m -114.49 165.66 12.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -121.75 -53.65 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.08 -113.82 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.535 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.4 m 57.05 42.7 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.898 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 p -51.46 142.49 13.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.77 159.85 52.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -74.76 168.31 20.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 91.9 p -72.97 143.41 84.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.74 86.06 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.729 2.286 . . . . 0.0 112.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.22 165.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -96.41 140.76 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -106.48 142.29 24.6 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.62 0.724 . . . . 0.0 110.853 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -47.04 153.09 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.293 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -51.28 148.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -173.35 165.98 4.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -53.47 179.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 146' ' ' GLU . 4.7 tp -39.18 107.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.2 m -68.7 144.17 95.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.697 0.761 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.63 -22.34 1.11 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.344 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -88.76 -32.2 18.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HB3' HD12 ' A' ' 142' ' ' LEU . 22.5 mt-10 -65.7 -35.86 81.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -59.32 -34.96 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' THR . 4.9 t0 -65.14 -49.89 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.4 -39.93 2.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 -91.61 37.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 148' ' ' ASP . 76.9 m -137.92 135.01 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.451 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.3 p -110.76 152.92 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -105.43 133.8 49.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 81.9 m -121.34 143.6 49.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.0 mtm -144.51 177.4 8.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.45 ' CB ' HG12 ' A' ' 221' ' ' ILE . 16.0 tt0 58.63 51.99 7.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 161' ' ' ILE . 49.4 mt -82.28 162.55 22.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.63 174.91 11.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.124 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.69 -33.76 27.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -115.86 41.99 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.603 HD13 HD22 ' A' ' 157' ' ' LEU . 13.4 tt -86.16 158.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 13.9 mtt85 -136.66 146.72 56.63 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.47 -33.11 8.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.346 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -66.6 -42.62 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -50.95 -34.88 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.1 mt -80.54 -50.64 9.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.686 ' HA ' HG21 ' A' ' 176' ' ' VAL . 21.5 mt-10 -38.83 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -52.2 65.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.718 ' CD2' HD13 ' A' ' 215' ' ' LEU . 7.0 t80 -47.76 -27.59 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 196' ' ' VAL . 17.0 m-85 -96.96 -18.6 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -59.88 -12.18 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.19 -27.29 63.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.58 -32.98 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.24 161.0 32.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 138.44 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 167' ' ' GLU . 72.8 t -90.79 125.38 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -88.03 -50.01 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -149.92 151.12 32.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 46.4 t -137.95 114.87 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -106.77 106.39 16.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 90.6 mt -96.78 115.29 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 41.2 mm -74.35 114.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 t -125.74 119.35 27.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -129.7 -48.0 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.881 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -106.46 116.17 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.79 97.22 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.0 m -140.54 158.3 44.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -84.49 156.96 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.812 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 42.68 47.75 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.7 t -119.63 147.97 43.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -71.4 176.08 4.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.96 151.82 13.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.9 pt -114.14 143.79 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -148.13 152.14 36.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.32 148.39 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 170' ' ' PHE . 91.7 t -139.2 133.96 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -106.81 119.29 38.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -94.31 154.17 17.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -48.03 -43.17 29.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.27 175.24 9.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 14.5 tt -84.2 -30.0 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -66.11 -6.44 13.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.0 m -95.39 -21.75 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -57.93 -43.51 98.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.655 0.74 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.99 -55.59 3.88 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 41.4 mt -56.08 -43.28 77.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.46 77.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.1 -47.19 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.157 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.32 91.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 31.5 mt -43.19 -24.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.967 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 18.7 m -36.39 110.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.86 19.37 8.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 42.2 mt-30 -92.01 110.96 22.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -50.21 105.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.718 HD13 ' CD2' ' A' ' 169' ' ' PHE . 15.7 tp -105.77 104.56 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.1 mt 64.06 25.01 13.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.53 29.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.488 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.23 114.21 48.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.38 148.53 14.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.662 2.242 . . . . 0.0 112.352 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.0 tt -113.68 153.32 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.45 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.7 mm -112.5 137.74 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.8 t -134.84 115.92 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -133.63 167.83 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -72.92 109.5 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' GLN . 1.7 t -62.6 -55.61 25.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 225' ' ' SER . 21.0 pt20 -36.62 -44.5 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.96 49.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -41.69 -56.66 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 230' ' ' ASN . 0.0 OUTLIER -56.72 -71.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 229' ' ' LYS . 5.3 t-20 -34.28 -58.15 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 232' ' ' LEU . 31.5 mmt180 -56.65 -60.16 3.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -36.54 125.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.8 p -77.72 130.87 37.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.69 79.98 0.3 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.17 112.15 3.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.337 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 39.7 t -174.42 128.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.7 p -93.18 127.21 38.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.86 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.537 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -109.94 113.45 26.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.5 t -140.05 113.08 8.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.783 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.56 115.43 0.67 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.6 p -117.9 166.69 12.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.9 t -123.23 139.59 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.22 35.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.425 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.81 177.69 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.1 m -109.59 91.41 10.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.694 0.759 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.09 119.62 5.41 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.6 m -51.74 158.7 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -118.46 158.38 25.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -107.89 152.68 41.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.653 0.74 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.94 150.02 29.66 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.721 2.28 . . . . 0.0 112.359 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.78 174.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.23 -41.99 90.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 142' ' ' LEU . 30.4 t30 -40.54 155.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 146' ' ' GLU . 14.4 tp -35.58 136.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 m -68.42 161.7 67.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.67 -27.17 18.72 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.686 2.257 . . . . 0.0 112.305 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.44 -38.89 29.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.479 ' HB3' HD11 ' A' ' 142' ' ' LEU . 20.6 mt-10 -51.72 -29.74 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 142' ' ' LEU . 47.6 mtt180 -78.73 -41.57 30.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.838 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 149' ' ' ALA . 0.2 OUTLIER -61.8 -47.89 83.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.833 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -45.45 -36.4 4.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -95.95 48.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.814 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.3 m -143.23 134.08 25.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.478 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.1 p -108.27 148.98 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.126 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -106.83 120.78 42.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 47.2 m -105.79 146.27 30.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.7 mtm -143.28 -179.3 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.463 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.7 tt0 53.52 51.54 15.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.896 HD22 HD13 ' A' ' 161' ' ' ILE . 99.1 mt -81.5 156.96 25.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.72 172.05 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.48 -35.07 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -124.37 42.36 3.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.896 HD13 HD22 ' A' ' 157' ' ' LEU . 15.9 tt -74.3 164.19 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 44.0 mtt-85 -128.12 158.71 70.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.573 0.702 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.487 ' CA ' HD11 ' A' ' 181' ' ' ILE . 56.6 Cg_endo -71.06 -9.4 25.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 0.0 112.303 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -90.47 -41.84 11.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -49.64 -36.48 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.12 -40.3 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -48.46 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -57.13 -40.17 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 220' ' ' ILE . 24.3 t80 -61.38 -30.7 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.72 -16.12 23.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -67.48 -4.04 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.68 51.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.08 -27.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.34 154.49 24.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -77.83 137.77 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.8 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 196' ' ' VAL . 69.6 t -93.67 138.94 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -99.38 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -152.88 145.87 24.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.75 120.35 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -109.48 104.38 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.487 HD11 ' CA ' ' A' ' 163' ' ' PRO . 45.3 mt -93.37 103.44 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.89 112.12 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.11 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.3 m -136.08 130.65 33.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.45 108.08 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -64.6 99.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -159.4 170.53 21.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -93.04 40.75 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -113.26 128.63 56.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.66 111.81 16.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 96.5 p -152.79 169.03 23.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.84 174.93 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.28 118.65 4.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.54 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.8 pt -109.61 142.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.82 143.29 28.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.042 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -103.85 143.19 33.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 176' ' ' VAL . 78.9 t -131.6 122.18 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -87.13 124.34 33.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.44 ' HE2' HG11 ' A' ' 152' ' ' VAL . 31.4 m-85 -104.51 153.89 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.88 -44.71 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -130.93 168.91 16.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.833 HD12 ' HB1' ' A' ' 149' ' ' ALA . 20.1 tt -87.34 -28.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.417 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 68.3 mm-40 -64.59 -9.87 22.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 14.8 m -93.21 -15.77 25.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -63.52 -43.42 78.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.667 0.746 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.9 Cg_exo -47.97 -52.02 8.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.9 mt -60.46 -44.21 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.454 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -59.28 -37.56 77.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.63 -46.06 90.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.96 -39.41 94.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 211' ' ' THR . 19.5 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.6 m -34.48 112.11 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 114.47 19.26 6.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -98.16 112.0 24.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -49.92 106.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.2 tp -113.33 113.32 25.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.18 25.85 15.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.11 17.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.9 t -115.76 121.57 34.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.591 0.71 . . . . 0.0 111.213 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.07 154.0 5.91 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 tt -112.91 152.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.463 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.3 mm -111.97 123.76 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.0 t -121.04 112.74 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -138.32 143.07 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -43.31 139.3 2.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.3 t -98.81 51.94 0.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -121.75 -39.27 2.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -46.94 -52.25 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 227' ' ' ALA . 9.3 tp10 -35.79 -45.95 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -65.2 -50.69 64.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -45.79 -61.68 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -50.47 -56.16 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 236' ' ' SER . 0.3 OUTLIER -42.46 -59.99 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t 65.63 48.92 1.86 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.05 32.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.79 -8.93 18.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' SER . . . . . 0.496 ' O ' HD11 ' A' ' 232' ' ' LEU . 37.0 t -64.67 113.17 3.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 8.5 t -76.51 172.38 13.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.2 p -150.23 163.52 38.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 t -173.15 140.05 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -97.07 -127.79 5.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.9 p -135.38 133.19 38.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 0.0 110.855 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.4 t -144.13 126.35 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 133.7 178.93 15.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.465 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.6 tptt 61.01 54.69 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.5 p -86.91 139.17 32.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.27 149.66 3.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.66 111.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -130.88 168.41 17.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -43.28 148.86 0.6 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.683 0.754 . . . . 0.0 110.839 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.66 121.49 5.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.1 m -85.76 165.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.125 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -66.52 -48.83 68.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -40.91 144.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -58.39 119.81 7.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 t -95.45 154.6 39.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.71 -28.91 7.16 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -70.27 -55.3 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -43.98 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -43.57 -39.81 3.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.06 -56.28 22.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -40.51 -48.96 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -87.68 48.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 m -144.55 140.77 29.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.486 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.9 p -118.66 147.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.09 124.36 42.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.404 ' C ' ' HG3' ' A' ' 155' ' ' MET . 84.8 m -115.01 155.28 27.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.404 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 64.2 mtm -154.03 175.85 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.5 tt0 63.59 54.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 161' ' ' ILE . 72.0 mt -93.41 148.38 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.04 176.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.02 -43.33 22.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -107.39 46.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 157' ' ' LEU . 16.5 tt -86.59 150.71 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -121.06 144.63 39.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.538 0.685 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.46 -43.85 17.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 165' ' ' ASP . 3.6 tmt_? -56.91 -55.28 36.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 164' ' ' ARG . 7.8 m-20 -36.54 -40.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.96 -48.19 16.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 176' ' ' VAL . 23.6 mt-10 -47.53 -68.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.34 -55.39 10.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -48.92 -42.89 38.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 196' ' ' VAL . 19.0 m-85 -78.56 -20.61 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.1 t -63.57 -11.26 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.43 -27.79 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.74 -32.92 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.37 152.98 22.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -68.71 142.54 54.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 167' ' ' GLU . 90.9 t -98.63 128.71 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -87.51 -53.61 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.53 152.79 41.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.54 113.1 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -101.88 109.09 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.3 mt -99.58 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.5 102.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -118.41 99.83 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -120.51 -38.47 2.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? 54.24 54.78 9.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.43 -40.9 93.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.2 p -109.8 176.52 5.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -63.41 -53.67 48.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -119.7 101.11 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.1 t -121.53 169.64 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 134.31 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.66 100.55 2.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.8 pt -93.27 145.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.67 168.69 19.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -129.55 128.57 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.606 HG21 ' CE2' ' A' ' 170' ' ' PHE . 85.5 t -116.74 121.07 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -94.89 111.24 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.486 ' HE2' HG11 ' A' ' 152' ' ' VAL . 49.3 m-85 -85.05 152.05 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 m -60.07 -35.24 74.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -135.82 151.33 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.421 HD12 ' HB1' ' A' ' 149' ' ' ALA . 20.4 tt -70.93 -27.32 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -69.56 -6.36 30.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' SER . . . . . 0.436 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.9 m -95.34 -25.03 16.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.38 -43.72 97.98 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.0 111.186 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -47.93 -58.7 1.59 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.746 2.298 . . . . 0.0 112.306 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.86 -31.05 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.574 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -72.74 -31.83 65.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 224' ' ' ALA . 82.5 mt -64.44 -41.78 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.105 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -61.5 -44.42 98.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.485 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 90.3 mt -37.45 -31.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.3 m -34.45 103.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.32 9.47 5.5 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -90.93 118.99 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.876 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -56.42 109.9 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.6 tp -115.36 115.65 26.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.0 mt 60.22 25.04 14.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.21 -32.08 7.93 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.46 124.13 31.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.612 0.72 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.02 154.02 5.79 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.424 HG12 ' N ' ' A' ' 221' ' ' ILE . 9.4 tt -111.91 152.04 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.104 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.449 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.1 mm -110.47 132.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 207' ' ' ALA . 12.4 t -133.38 121.53 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -146.67 145.19 29.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.962 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . -51.36 133.63 29.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 7.6 t -89.35 36.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.837 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -84.35 33.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 230' ' ' ASN . . . -77.12 -57.38 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -43.08 -30.84 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -67.36 -39.18 85.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.47 ' OD1' ' C ' ' A' ' 230' ' ' ASN . 0.7 OUTLIER -67.83 -39.19 83.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' N ' ' OD1' ' A' ' 230' ' ' ASN . 8.5 tpt180 -91.13 44.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.2 tp -118.38 -56.51 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 28.2 t -88.5 92.0 9.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.05 169.26 26.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.502 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.72 15.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.618 2.212 . . . . 0.0 112.35 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 m -53.0 169.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 9.5 t -149.28 144.14 26.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t 54.76 42.43 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.79 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.2 p -94.19 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.6 160.33 26.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.5 p -136.34 153.35 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -167.25 133.88 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -141.15 173.65 23.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.505 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -67.82 80.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.956 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 p -173.04 154.25 2.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.64 0.733 . . . . 0.0 110.915 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.65 141.93 7.72 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.751 2.301 . . . . 0.0 112.306 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.11 138.34 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -106.85 53.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.822 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -122.21 161.16 44.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.9 120.03 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.7 m -95.14 170.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.01 164.91 27.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -148.7 119.13 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 tp -68.13 123.57 21.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.402 ' OG ' ' HD2' ' A' ' 144' ' ' PRO . 0.4 OUTLIER -86.07 150.12 51.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.72 0.771 . . . . 0.0 110.793 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 143' ' ' SER . 74.8 Cg_exo -44.93 -20.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.727 2.285 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.74 -48.45 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -52.1 -37.75 55.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -52.78 -41.26 63.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -80.65 -43.96 19.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 201' ' ' ILE . . . -50.05 -54.26 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -47.9 -24.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m -91.36 134.28 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.2 p -103.53 151.08 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.8 t80 -107.04 134.3 50.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.2 m -119.46 154.9 33.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.6 mtm -151.75 174.58 13.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 60.28 48.46 8.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.736 HD22 HD13 ' A' ' 161' ' ' ILE . 94.7 mt -77.74 156.67 30.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.44 173.03 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.45 -38.05 50.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -119.7 40.54 3.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.736 HD13 HD22 ' A' ' 157' ' ' LEU . 17.4 tt -76.26 154.45 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -129.7 149.06 71.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.689 0.757 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.72 -43.66 18.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 165' ' ' ASP . 1.8 mpt_? -53.7 -59.48 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 164' ' ' ARG . 4.4 m-20 -36.51 -41.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.74 -51.64 13.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.39 -67.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.49 -45.19 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.03 -32.24 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.47 ' CE2' HG21 ' A' ' 196' ' ' VAL . 44.4 m-85 -95.96 -11.0 27.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -4.64 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.06 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 m -111.04 -28.56 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.04 166.88 35.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -74.99 136.58 41.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 179' ' ' VAL . 55.7 t -93.17 123.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -77.12 -52.86 8.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -149.53 152.36 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 176' ' ' VAL . 60.7 t -130.69 103.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -93.18 106.25 18.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.4 mt -95.39 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.36 104.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -119.41 84.02 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -112.74 171.62 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -90.44 98.8 11.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 187' ' ' SER . 17.4 m-20 -114.37 176.11 5.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 188' ' ' ARG . 14.2 t -37.99 155.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 187' ' ' SER . 10.6 mtt85 -36.16 -56.26 0.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -82.83 116.5 22.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 12.8 m -154.03 130.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -83.45 -73.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 129.61 112.01 1.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 46.0 pt -95.76 144.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.735 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -135.89 163.43 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 87.5 m-85 -127.15 137.86 53.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 170' ' ' PHE . 53.4 t -128.04 130.94 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -99.95 114.84 28.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.78 149.94 22.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.34 -35.83 65.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -137.25 168.19 20.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.496 HD11 ' HB1' ' A' ' 149' ' ' ALA . 6.7 tt -85.57 -30.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.42 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 44.8 mt-30 -67.97 -6.85 24.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -93.38 -19.65 21.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -58.71 -43.16 97.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.684 0.754 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.07 -45.37 25.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.35 -36.82 82.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.87 89.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 224' ' ' ALA . 76.0 mt -55.18 -46.32 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.71 -42.62 91.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 213' ' ' GLN . 34.1 mt -41.84 -30.48 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.947 0.403 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 210' ' ' LEU . 99.7 m -35.72 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.145 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 120.21 11.24 6.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.445 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 210' ' ' LEU . 9.0 mt-30 -89.87 108.49 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -49.31 106.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.45 113.82 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.2 mt 61.73 26.62 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.36 -26.94 22.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.44 120.69 34.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.111 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.6 151.46 10.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.304 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.7 tt -113.48 144.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.0 mm -100.74 134.27 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.86 116.35 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -143.5 145.75 32.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.995 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . -60.54 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 44.1 t -42.5 -25.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.845 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.32 48.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.46 -67.73 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -51.61 -59.81 3.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -43.21 -40.54 3.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -67.22 -55.87 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -42.09 -61.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.8 tp -42.43 126.66 3.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 m -74.52 -52.17 12.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.86 -145.97 47.53 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.508 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.05 121.65 3.76 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.613 2.209 . . . . 0.0 112.434 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 83.9 p -62.71 -47.02 85.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 2.7 m -78.36 141.34 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 t -140.7 145.48 36.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.3 p -164.8 170.08 15.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.73 71.14 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.541 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -74.55 159.66 31.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -65.51 154.34 38.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.809 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 170.29 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -134.51 148.6 50.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.5 p -114.03 82.72 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.661 0.743 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.28 124.62 7.28 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.633 2.222 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.21 171.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -151.14 109.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -112.26 144.92 31.79 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.675 0.75 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.67 -176.76 3.31 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.37 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.37 143.06 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.17 160.5 6.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -38.23 129.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 146' ' ' GLU . 6.5 tp -91.58 149.06 21.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 142' ' ' LEU . 2.2 m -73.52 160.9 81.22 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.724 0.773 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.42 -18.93 19.89 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.657 2.238 . . . . 0.0 112.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.12 -19.67 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' A' ' 142' ' ' LEU . 27.1 mm-40 -85.94 -32.42 21.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -60.36 -34.42 73.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -75.66 -32.01 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.9 -57.87 10.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.053 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.5 mtp85 -46.74 -29.1 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.3 m -89.57 136.37 33.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.626 HG11 ' HE2' ' A' ' 198' ' ' PHE . 11.6 p -107.94 154.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.09 134.4 47.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.1 m -122.52 149.64 43.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.527 ' HG2' HG22 ' A' ' 193' ' ' ILE . 34.1 mtm -148.93 169.42 20.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.442 ' CB ' HG12 ' A' ' 221' ' ' ILE . 15.1 tt0 68.51 52.43 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 161' ' ' ILE . 86.2 mt -86.26 157.86 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.97 166.24 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.63 67.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 54.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 157' ' ' LEU . 16.3 tt -93.01 162.82 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.445 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 17.3 mtt85 -136.69 146.38 55.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.19 -25.31 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 165' ' ' ASP . 11.3 tpt85 -72.84 -60.53 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 164' ' ' ARG . 25.3 m-20 -35.67 -36.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.87 -45.61 16.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 164' ' ' ARG . 56.5 mt-10 -48.34 -66.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -56.12 -50.77 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 1.5 t80 -50.26 -29.57 9.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 196' ' ' VAL . 30.3 m-85 -96.58 -17.81 20.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.4 p -65.52 -7.78 16.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.36 -29.68 53.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.09 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.8 m -107.04 -31.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.13 161.58 34.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.579 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -75.62 139.39 42.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 179' ' ' VAL . 82.8 t -97.2 123.29 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -84.23 -44.37 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -153.57 148.4 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.599 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.7 t -132.6 104.5 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -93.14 113.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.7 mt -100.62 111.19 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.9 mm -70.08 138.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.4 t -158.7 126.18 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -74.31 -63.37 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -148.42 130.15 15.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -45.44 101.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 t -165.59 137.2 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -44.02 133.86 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -151.79 169.56 21.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.1 p -118.46 2.44 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -132.01 171.31 13.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.0 144.03 3.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.519 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.527 HG22 ' HG2' ' A' ' 155' ' ' MET . 44.4 pt -124.14 141.49 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.08 155.07 41.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -109.58 137.22 47.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 170' ' ' PHE . 98.3 t -121.87 126.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.01 115.05 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.828 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.626 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.44 155.04 19.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.8 -38.46 72.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.7 173.71 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.0 tt -84.82 -29.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -68.49 -6.55 25.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.3 m -96.91 -16.56 20.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -62.4 -43.33 84.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.649 0.737 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.9 Cg_exo -47.97 -52.19 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.681 2.254 . . . . 0.0 112.312 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -40.2 83.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -65.0 -31.78 73.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.72 -36.56 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.55 -39.44 90.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.44 -24.99 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.07 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 122.41 15.56 4.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 33.0 mt-30 -91.45 109.41 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -48.13 103.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -104.07 107.33 18.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.1 mt 64.9 25.03 12.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.84 -22.72 37.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.6 t -116.66 115.95 39.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.45 153.56 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.683 2.255 . . . . 0.0 112.328 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 221' ' ' ILE . 18.6 tt -115.35 159.97 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 156' ' ' GLN . 4.7 mm -118.84 139.94 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 207' ' ' ALA . 21.9 t -138.9 131.58 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -160.7 147.66 15.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.55 121.75 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.0 t -54.29 -18.14 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 226' ' ' GLN . 4.2 pp0? -94.98 40.66 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.0 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.015 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -54.83 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.25 -54.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.83 -62.77 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -61.04 -65.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 231' ' ' ARG . 8.9 tp -37.11 131.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.2 m -66.6 139.27 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -107.84 177.63 21.21 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.91 152.1 31.8 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.692 2.262 . . . . 0.0 112.346 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 t -78.42 143.5 36.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 10.1 t -119.08 -55.44 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.6 t -100.91 -56.55 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -50.02 60.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 105.51 130.19 6.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -95.66 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.4 t -108.89 154.05 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 147.33 97.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 135' ' ' VAL . 44.1 tttp -124.71 3.49 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -54.22 -44.91 99.2 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.801 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 133' ' ' SER . 61.1 Cg_endo -80.42 92.87 1.06 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.653 2.236 . . . . 0.0 112.364 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 132' ' ' LYS . 29.0 m -117.63 -24.63 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -167.86 169.11 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -128.35 140.33 38.06 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.672 0.749 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.86 163.4 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.357 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.36 37.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.2 157.46 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -41.83 149.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 143' ' ' SER . 0.7 OUTLIER -45.54 120.07 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' HD13 ' A' ' 142' ' ' LEU . 19.8 m -110.87 155.03 43.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.682 0.753 . . . . 0.0 110.84 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.85 -19.13 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.745 2.297 . . . . 0.0 112.305 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.28 -33.62 19.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -29.51 70.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -59.98 -45.02 94.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -64.32 -38.37 90.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.25 -60.12 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ARG . 20.7 mtm105 -49.44 -22.99 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.4 m -96.79 138.5 34.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 196' ' ' VAL . 9.9 p -111.93 150.95 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 t80 -106.48 133.06 51.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 21.2 m -121.71 159.83 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.471 ' HG2' HG22 ' A' ' 193' ' ' ILE . 37.9 mtm -153.4 175.32 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 63.21 53.16 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 194' ' ' ALA . 29.5 mt -93.66 142.02 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.77 175.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.61 -46.81 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -103.43 48.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 216' ' ' LEU . 10.1 tt -90.27 155.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -129.16 147.55 65.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.5 0.667 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.47 -47.35 13.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -46.96 -58.23 4.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 216' ' ' LEU . 3.5 m-20 -37.55 -55.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.3 mt -64.3 -47.16 80.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -46.45 -66.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -59.96 -43.19 95.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 220' ' ' ILE . 30.1 t80 -54.81 -35.65 64.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.6 m-85 -92.64 -12.64 31.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.5 t -65.98 -7.22 15.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.84 58.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.03 -28.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.82 154.45 20.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -71.29 139.51 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.326 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 ' CG2' ' A' ' 179' ' ' VAL . 98.8 t -98.51 136.12 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -93.8 -50.94 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -142.18 157.27 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 84.5 t -142.92 108.03 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -95.95 112.54 24.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.65 107.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.18 121.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 t -116.06 90.11 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -97.34 160.38 14.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -53.73 115.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -49.42 128.38 17.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -132.2 166.75 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -46.19 -53.02 11.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.4 92.62 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.3 t -146.34 157.23 43.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 193' ' ' ILE . 39.6 mmtm -141.35 124.53 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.59 105.39 0.73 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.471 HG22 ' HG2' ' A' ' 155' ' ' MET . 36.4 pt -101.28 148.46 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.348 . . . . 0.0 111.068 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.25 166.85 29.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.474 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 88.6 m-85 -122.63 127.92 49.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 152' ' ' VAL . 23.6 t -117.38 123.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.04 133.68 35.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.52 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.8 m-85 -109.86 157.33 19.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 28.8 p -60.57 -40.09 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -135.82 163.25 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.8 tt -74.23 -29.25 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.198 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.423 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 41.6 mt-30 -69.44 -5.95 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.7 m -94.12 -18.17 22.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -64.18 -43.32 73.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.64 0.733 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.6 Cg_exo -47.96 -53.38 6.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.77 -34.29 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.85 76.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 224' ' ' ALA . 71.5 mt -63.01 -40.5 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.93 92.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 84.6 mt -49.97 -28.24 6.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 210' ' ' LEU . 98.0 m -36.93 98.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.99 7.9 5.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -88.68 119.24 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.898 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.79 108.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.36 118.22 32.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.584 HD21 ' OD2' ' A' ' 165' ' ' ASP . 52.3 mt 61.37 25.61 15.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.92 -29.04 13.33 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.523 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.91 126.88 26.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.07 153.96 3.76 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.1 tt -114.39 151.06 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.449 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.8 mm -109.94 139.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.58 134.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -157.56 142.88 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . -59.68 118.37 6.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 21.2 t -57.23 -44.89 84.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -50.46 -40.55 51.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.405 ' HA ' ' OD1' ' A' ' 230' ' ' ASN . . . -41.44 -62.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.45 -39.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.946 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -61.59 -70.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.533 ' H ' ' ND2' ' A' ' 230' ' ' ASN . 0.2 OUTLIER -49.29 -51.23 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.96 58.91 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -144.81 142.66 30.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.972 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -68.93 90.62 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.816 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.0 89.58 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.456 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.57 -43.59 17.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.754 2.303 . . . . 0.0 112.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 75.7 m -120.11 158.0 27.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 99.5 p -113.13 119.68 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.439 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.6 t -68.79 95.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.2 m -92.39 99.08 11.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.15 160.29 15.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 m -162.65 160.5 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.776 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.42 162.99 13.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.844 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.8 -172.14 0.59 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -150.92 122.07 7.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.37 143.53 36.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.648 0.737 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.71 57.7 6.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -91.89 178.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -127.9 138.81 52.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.17 151.99 94.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.647 0.737 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.95 173.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.253 . . . . 0.0 112.358 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 139' ' ' VAL . 33.9 m -116.7 45.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 141' ' ' ASN . 1.0 OUTLIER -128.01 175.76 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 140' ' ' ASP . 6.6 m120 -36.96 151.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.762 ' C ' HD12 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -70.98 131.65 44.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 146' ' ' GLU . 3.4 m -89.88 157.85 45.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.66 0.743 . . . . 0.0 110.859 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.25 -22.59 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.715 2.277 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -91.54 -27.08 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 143' ' ' SER . 38.8 mt-10 -75.17 -28.58 60.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -57.99 -35.7 71.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.39 -44.52 97.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.32 13.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -89.88 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.4 m -128.23 127.75 43.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.62 157.9 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -114.63 149.33 36.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.813 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.6 mtm -144.34 177.8 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.451 ' CB ' HG12 ' A' ' 221' ' ' ILE . 5.9 tt0 56.77 47.69 17.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD13 ' A' ' 161' ' ' ILE . 93.4 mt -79.54 154.44 28.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.53 169.63 17.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.37 31.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.34 38.0 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.656 HD13 HD22 ' A' ' 157' ' ' LEU . 14.5 tt -88.56 155.14 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -131.54 147.43 66.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -25.87 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.73 2.287 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -73.05 -52.89 12.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -40.77 -37.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.46 -41.94 26.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -50.09 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -58.94 -48.14 82.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -54.37 -29.84 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -96.54 -12.35 24.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.9 p -71.63 -5.13 31.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -22.09 45.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.79 -32.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.19 159.0 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -76.54 133.06 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 179' ' ' VAL . 39.4 t -91.54 121.71 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -80.7 -60.9 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -135.4 145.8 47.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 176' ' ' VAL . 42.9 t -126.69 104.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -102.42 104.95 15.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.39 119.55 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 7.0 mm -94.37 130.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 29.9 t -113.0 44.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.782 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -112.11 86.71 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.832 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -91.51 95.32 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.828 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.74 88.88 2.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.6 m 58.58 40.39 23.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -104.81 138.13 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -67.41 -44.71 78.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.4 p -60.48 163.12 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -83.21 -53.88 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -147.72 142.41 10.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.505 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.813 HG22 ' HG2' ' A' ' 155' ' ' MET . 22.4 pt -117.04 144.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.315 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.58 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.86 152.25 32.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.77 145.7 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.58 114.06 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.88 116.85 25.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -92.55 162.63 14.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.15 -16.14 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -145.67 148.91 33.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.87 -23.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -73.52 -6.49 46.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.8 m -95.91 -16.83 21.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.69 -43.22 82.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.645 0.736 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.1 Cg_exo -47.91 -49.47 13.74 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.64 2.227 . . . . 0.0 112.355 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.04 -38.91 90.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.7 81.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.11 -47.45 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.187 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -57.63 -32.7 65.52 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.52 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.451 HD22 ' OE1' ' A' ' 213' ' ' GLN . 24.7 mt -52.07 -28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 210' ' ' LEU . 76.3 m -35.86 105.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.59 14.07 6.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.451 ' OE1' HD22 ' A' ' 210' ' ' LEU . 10.9 mt-30 -91.68 116.59 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.926 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -57.79 106.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.34 112.49 24.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.8 mt 64.08 25.87 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.55 -20.93 48.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.96 119.29 29.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.659 0.742 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.72 152.63 9.23 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -113.88 144.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.5 mm -103.25 133.17 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.94 128.63 67.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -151.91 150.52 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.34 115.46 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 227' ' ' ALA . 5.6 t -63.29 -54.19 41.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.836 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.48 76.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 225' ' ' SER . . . -125.28 -50.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -78.67 -61.31 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 230' ' ' ASN . 10.6 mmtp -55.07 -57.74 10.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 229' ' ' LYS . 57.5 t-20 -37.54 -48.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -51.05 -58.29 6.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.41 -53.23 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 46.3 t -53.99 134.96 43.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.3 67.75 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.99 99.15 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.354 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 58.2 m -47.76 -44.48 28.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.5 p -135.7 176.34 8.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.527 -179.945 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p 45.18 41.96 6.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 110.941 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.6 t -85.75 134.4 33.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 145.66 157.25 7.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.1 p -58.3 155.89 10.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 95.9 p -81.65 112.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 156.15 121.89 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -41.71 130.6 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 89.9 p -132.19 145.27 56.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.713 0.768 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.36 143.61 5.32 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.745 2.297 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 135' ' ' VAL . 7.1 p -131.19 91.45 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -126.93 161.71 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -160.37 138.83 7.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.92 163.2 23.39 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.95 142.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -172.5 157.97 4.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 142' ' ' LEU . 9.1 t-20 -53.83 160.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 141' ' ' ASN . 4.4 tp -36.57 128.04 0.82 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.23 149.04 36.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.602 0.715 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.37 -35.49 5.67 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -67.76 -53.27 28.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -44.69 -42.86 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -44.07 -57.45 3.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.49 -51.99 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.964 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.702 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -42.13 -60.47 1.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -48.85 -27.95 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.3 m -89.06 126.41 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.422 HG12 ' HB ' ' A' ' 196' ' ' VAL . 4.0 p -102.06 158.18 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.153 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CZ ' ' HB ' ' A' ' 193' ' ' ILE . 17.1 t80 -109.27 141.27 41.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 194' ' ' ALA . 58.9 m -126.85 156.66 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 35.8 mtm -152.98 176.48 11.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 58.95 46.96 12.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 194' ' ' ALA . 96.1 mt -77.02 168.3 20.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.798 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.42 -178.84 6.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.093 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.49 -37.6 22.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 37.39 4.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.798 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.3 tt -73.22 154.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -128.78 146.58 60.94 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.63 -35.28 12.63 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -54.94 -51.94 64.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.432 ' OD2' HD21 ' A' ' 216' ' ' LEU . 9.0 m-20 -48.13 -40.2 22.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.11 -42.9 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -43.12 -65.3 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.64 -48.83 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 23.8 t80 -49.25 -30.31 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 196' ' ' VAL . 24.3 m-85 -96.99 -15.46 21.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.9 t -68.0 -8.85 40.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.95 -23.16 55.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.37 -33.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.26 151.73 21.12 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 134.13 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 196' ' ' VAL . 86.8 t -90.18 123.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -88.7 -61.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.51 144.32 51.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.03 104.04 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -100.49 105.81 17.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.34 105.73 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.8 mm -71.29 128.36 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 p -126.55 107.36 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -103.68 97.51 7.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -34.48 77.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -53.09 -46.67 68.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.4 m -131.23 103.62 6.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -86.57 -12.17 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.58 -38.35 89.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 m -54.54 177.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -99.62 127.59 45.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.05 110.29 2.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.479 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 48.4 pt -100.0 143.03 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.89 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -139.81 158.29 44.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.094 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -124.4 127.53 47.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 176' ' ' VAL . 61.8 t -121.5 120.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.18 111.64 23.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.0 148.63 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 m -56.8 -33.01 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.21 166.11 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.702 HD12 ' HB1' ' A' ' 149' ' ' ALA . 16.4 tt -85.98 -33.08 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -64.29 -6.49 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 m -94.65 -19.31 20.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -61.49 -43.23 88.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 111.179 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.3 Cg_exo -48.01 -52.96 7.35 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.06 -36.93 83.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.489 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -66.35 -33.99 76.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.54 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.74 -40.44 79.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.537 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 211' ' ' THR . 67.3 mt -44.21 -26.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.3 m -35.61 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 116.65 23.58 3.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.557 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.553 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 28.4 mt-30 -100.13 108.9 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -47.93 110.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 169' ' ' PHE . 16.9 tp -116.52 112.31 21.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.432 HD21 ' OD2' ' A' ' 165' ' ' ASP . 62.2 mt 62.16 25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.64 -25.47 27.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.29 119.02 35.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.1 152.03 11.23 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.7 tt -111.99 151.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.0 mm -112.72 122.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.489 HG11 ' O ' ' A' ' 207' ' ' ALA . 18.1 t -118.07 128.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -155.45 150.35 26.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -57.96 126.35 27.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.8 t -64.35 -38.47 91.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -86.03 35.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.0 69.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.52 -62.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -58.55 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -39.76 -54.7 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -47.07 -57.36 5.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.5 tp -39.83 -61.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.4 m -39.5 -59.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.08 145.15 14.15 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.24 106.4 2.14 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.674 2.25 . . . . 0.0 112.356 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 53.7 p -141.98 117.97 10.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.7 t -154.66 153.02 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.482 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -121.35 176.92 5.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.822 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.8 m -130.66 140.32 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.866 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 118.93 -112.23 2.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m 41.27 40.26 1.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.871 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 98.1 p -109.43 154.63 22.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.821 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.86 35.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -83.46 144.82 29.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.743 0.306 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 81.1 p -110.44 105.15 56.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.83 119.82 2.08 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.727 2.285 . . . . 0.0 112.339 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.3 t -44.61 125.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.56 152.37 32.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -41.25 144.55 0.68 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.672 0.748 . . . . 0.0 110.838 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.73 150.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -103.22 166.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -51.31 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.6 169.93 4.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 146' ' ' GLU . 18.0 mt -54.05 177.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 51.5 p -126.83 151.15 73.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.97 -18.81 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -93.73 -57.64 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.436 ' HB3' HD22 ' A' ' 142' ' ' LEU . 39.2 mm-40 -45.09 -42.81 9.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -50.19 -39.57 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.12 -50.33 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -46.96 -46.41 21.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mtp-105 -83.67 38.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.2 m -137.36 122.02 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 196' ' ' VAL . 13.0 p -99.04 146.48 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 10.6 t80 -101.22 126.91 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 83.7 m -116.78 150.7 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 42.7 mtm -149.75 178.05 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 219' ' ' PRO . 4.5 tt0 58.54 52.68 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.431 HD22 HD13 ' A' ' 161' ' ' ILE . 60.9 mt -92.31 137.12 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.26 177.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.89 -42.65 13.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 53.9 mtm-85 -97.81 39.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 157' ' ' LEU . 19.5 tt -85.05 158.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -135.63 147.13 60.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.566 0.698 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.06 -33.99 8.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.237 . . . . 0.0 112.423 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -66.79 -49.63 65.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.508 ' OD2' HD11 ' A' ' 216' ' ' LEU . 72.0 m-20 -41.39 -36.69 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -83.79 -39.99 19.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.24 -64.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -53.65 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 220' ' ' ILE . 29.0 t80 -45.42 -46.04 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 196' ' ' VAL . 21.4 m-85 -80.03 -19.93 46.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.4 t -63.39 -7.73 7.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.834 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.12 -24.01 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.05 -31.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.27 150.62 19.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.5 133.93 47.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 179' ' ' VAL . 54.9 t -90.3 132.18 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -97.11 -52.87 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.38 145.67 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 176' ' ' VAL . 94.4 t -130.76 108.49 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -96.47 111.01 23.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.95 106.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 mm -73.66 111.72 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.18 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.5 t -105.83 39.8 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.58 99.08 9.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -39.91 136.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -116.02 175.67 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.3 t -127.36 -54.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.818 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -100.22 -46.44 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -96.53 74.78 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 39.0 t -80.61 112.86 18.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.0 108.86 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.56 102.58 0.76 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.64 147.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -151.19 154.77 37.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 77.5 m-85 -116.82 139.34 50.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 170' ' ' PHE . 99.0 t -120.82 128.09 76.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -96.81 104.37 16.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.42 157.17 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 11.5 t -58.89 -37.44 76.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -140.38 167.19 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 18.7 tt -77.42 -33.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -64.94 -6.1 7.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.1 m -95.85 -20.26 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -59.85 -43.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.97 -59.85 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.278 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.6 -45.67 63.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.59 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -58.13 -30.4 66.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.48 -44.65 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.133 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.94 -30.84 70.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.473 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.9 mt -58.9 -17.83 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.34 114.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.401 ' C ' ' OE1' ' A' ' 213' ' ' GLN . . . 113.33 15.55 8.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.5 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.36 115.12 27.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -55.42 110.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -114.58 113.16 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.508 HD11 ' OD2' ' A' ' 165' ' ' ASP . 33.5 mt 61.56 25.02 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.12 -30.14 10.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.97 122.17 32.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.705 0.764 . . . . 0.0 111.093 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 74.5 Cg_exo -50.44 152.52 8.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.381 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 169' ' ' PHE . 20.1 tt -108.06 154.17 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.4 mm -110.96 124.2 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.59 HG11 ' O ' ' A' ' 207' ' ' ALA . 16.7 t -122.17 125.11 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -156.0 152.7 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.33 129.69 43.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 11.6 t -74.61 -44.7 49.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.83 -26.61 58.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.72 81.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.05 -47.32 78.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 230' ' ' ASN . 6.8 mmpt? -66.01 -62.1 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 229' ' ' LYS . 4.4 m120 -34.39 -39.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.3 75.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.59 116.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 t -135.87 113.55 10.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 176.25 145.33 5.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.51 -15.94 13.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 79.4 p -64.0 149.27 47.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 32.3 t -124.59 41.98 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.7 p -83.75 136.15 34.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -165.05 152.1 10.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.94 145.4 16.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 62.5 p -42.75 136.54 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.2 m -100.6 92.13 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.04 -83.39 0.7 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.437 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.08 108.05 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -152.08 144.13 16.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.685 0.755 . . . . 0.0 110.843 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.57 146.94 21.91 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.9 t -138.7 106.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.63 153.06 21.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.875 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -93.52 155.1 41.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.709 0.766 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.08 155.4 38.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.709 2.272 . . . . 0.0 112.308 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 139' ' ' VAL . 33.7 m -119.61 49.92 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.79 144.71 25.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -82.32 166.36 19.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 147' ' ' ARG . 5.8 tp -89.31 147.7 23.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.3 p -75.32 153.82 86.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.672 0.749 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.0 -17.89 36.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.359 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.47 -25.2 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.44 -38.92 71.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.551 ' HG3' HD23 ' A' ' 142' ' ' LEU . 72.0 mtm180 -49.05 -44.26 41.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.1 -47.94 53.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -52.35 -28.26 18.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.423 ' HB2' ' NH1' ' A' ' 150' ' ' ARG . 9.1 mtp-105 -90.19 34.94 0.86 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.6 m -123.47 127.08 47.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.1 p -102.95 151.95 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 9.7 t80 -109.09 137.12 47.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 25.2 m -126.62 152.64 46.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' MET . . . . . 0.577 ' CE ' ' NE2' ' A' ' 223' ' ' GLN . 42.8 mtm -152.5 172.85 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.414 ' CB ' HG12 ' A' ' 221' ' ' ILE . 14.7 tt0 65.38 41.51 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.519 HD11 ' CB ' ' A' ' 194' ' ' ALA . 62.1 mt -76.49 161.36 28.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.49 171.15 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.068 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.35 -29.03 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -114.73 42.92 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 tt -91.36 148.35 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -127.6 149.35 70.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 -35.6 13.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.679 2.252 . . . . 0.0 112.377 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -61.78 -53.12 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -41.95 -48.28 4.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.05 -49.3 58.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 176' ' ' VAL . 38.3 mt-10 -43.13 -69.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.797 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.83 -48.29 81.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.575 ' CD1' HD13 ' A' ' 215' ' ' LEU . 36.2 t80 -51.57 -31.16 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -94.95 -10.41 31.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.6 t -69.92 -4.39 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.55 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.9 m -114.31 -28.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.07 154.57 20.9 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -69.65 137.08 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 167' ' ' GLU . 81.1 t -93.51 136.2 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -101.06 -54.28 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 196' ' ' VAL . 2.9 t -131.89 121.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -115.1 104.21 11.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.61 115.59 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.18 119.73 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 p -113.57 121.28 43.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.81 125.78 52.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -89.13 140.22 29.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 43.15 50.37 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.4 p -91.0 143.6 26.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.816 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 189' ' ' ARG . 3.3 mpt_? -63.33 170.74 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 188' ' ' ARG . 49.8 ttt180 -35.41 99.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.908 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 t -159.42 172.36 18.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.03 163.16 16.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.71 117.48 4.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 17.4 pt -101.9 144.17 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -145.92 145.95 30.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.023 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.624 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 88.4 m-85 -110.98 139.02 46.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 152' ' ' VAL . 90.9 t -128.04 128.29 68.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.47 127.42 36.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -105.39 150.59 25.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 49.1 t -48.07 -42.29 28.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -139.47 173.5 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.481 HD12 ' HB1' ' A' ' 149' ' ' ALA . 19.4 tt -86.08 -25.64 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -10.6 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 18.1 m -95.2 -13.65 24.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -64.04 -43.44 74.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.647 0.737 . . . . 0.0 111.191 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.6 Cg_exo -48.02 -47.52 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.268 . . . . 0.0 112.29 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.36 -40.2 95.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.24 95.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 92.3 mt -55.39 -44.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.06 98.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.443 HD22 ' NE2' ' A' ' 213' ' ' GLN . 44.9 mt -44.54 -27.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 49.0 m -36.74 116.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 108.3 13.03 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' ' 210' ' ' LEU . 8.7 mt-30 -92.19 114.37 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -48.81 109.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 169' ' ' PHE . 16.6 tp -115.39 113.18 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 42.2 mt 62.36 25.12 14.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.97 22.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.8 t -116.52 122.24 32.11 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 111.139 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.1 153.73 3.98 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.83 153.87 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.414 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.1 mm -114.18 143.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 67.7 t -140.14 120.19 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.185 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLN . . . . . 0.577 ' NE2' ' CE ' ' A' ' 155' ' ' MET . 0.0 OUTLIER -132.52 166.98 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.56 107.32 15.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.4 t -57.48 -38.6 74.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -45.11 -42.39 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -41.9 -45.17 3.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 232' ' ' LEU . 30.5 tp10 -57.02 -38.03 72.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -72.93 -18.22 61.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -92.02 -17.96 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -127.91 9.42 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 233' ' ' SER . 1.1 pt? -47.26 -20.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.629 ' N ' HD23 ' A' ' 232' ' ' LEU . 8.8 m -140.34 118.95 12.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -153.35 -94.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.487 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.31 148.04 26.45 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 m -117.87 -51.3 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.2 t -39.8 116.57 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -151.26 162.47 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.3 m -153.27 158.47 41.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.49 144.7 16.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -78.25 118.29 20.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.806 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -171.92 141.4 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.29 98.1 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.09 133.99 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -54.38 108.77 1.23 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.636 0.732 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -44.64 163.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 0.0 112.353 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.4 t -81.7 -17.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.171 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -126.68 175.37 8.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -36.01 141.84 0.32 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.06 -172.81 1.64 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 0.0 112.321 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.0 m -61.7 145.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 141' ' ' ASN . 0.5 OUTLIER -153.59 175.85 12.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.805 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 140' ' ' ASP . 16.9 t-20 -36.83 111.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 tp -51.16 149.13 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.3 m -79.9 161.33 66.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.822 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.09 -20.09 17.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -88.08 -20.06 26.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -75.87 -36.67 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -50.26 -26.76 5.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -72.73 -47.13 49.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -42.77 -44.81 4.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.04 42.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.6 m -142.51 128.28 19.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.43 149.5 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -100.29 125.94 46.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.7 m -116.2 154.09 30.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.2 mtm -153.58 178.09 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.418 ' OE1' HD11 ' A' ' 221' ' ' ILE . 4.7 tt0 59.97 51.46 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 161' ' ' ILE . 82.0 mt -89.19 142.54 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -52.89 -175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.72 -43.38 11.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -109.68 32.84 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 157' ' ' LEU . 18.5 tt -67.76 153.39 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -127.0 146.89 59.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -48.63 11.49 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.64 2.226 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -47.44 -56.88 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -37.94 -55.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.35 -44.43 95.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -53.4 -68.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.78 -45.07 70.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 220' ' ' ILE . 16.5 t80 -55.24 -42.31 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.1 m-85 -83.83 -19.26 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.8 t -58.41 -11.71 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.3 -26.32 64.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.98 -30.97 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.17 156.31 23.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.421 ' HA ' ' CE ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -70.24 133.49 47.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.27 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.124 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -86.1 -56.43 3.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 179' ' ' VAL . 9.7 t70 -137.59 159.08 42.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 21.2 t -138.73 119.63 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -110.8 117.45 33.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.78 113.94 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mm -78.74 104.89 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -102.62 95.89 6.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -159.83 141.67 13.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -110.19 96.89 6.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -82.43 -49.81 9.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 188' ' ' ARG . 68.3 p -131.07 127.8 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 187' ' ' SER . 15.0 ptm180 -34.46 133.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 69.58 44.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.0 t -84.8 167.41 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.58 165.08 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.07 107.74 2.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 pt -96.04 148.15 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 111.109 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -149.86 168.0 24.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.22 133.08 45.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 152' ' ' VAL . 50.2 t -118.77 120.2 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.17 104.37 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -78.78 159.77 27.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.6 t -61.79 -33.31 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -140.06 152.36 46.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.53 HD12 ' HB1' ' A' ' 149' ' ' ALA . 17.5 tt -68.85 -31.68 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 27.4 mt-30 -64.33 -10.33 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 t -92.83 -18.07 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -60.28 -43.24 92.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.595 0.712 . . . . 0.0 111.129 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.01 -52.13 8.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.632 2.222 . . . . 0.0 112.328 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.85 -37.93 83.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ALA . . . . . 0.605 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -64.95 -32.57 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.084 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.7 -43.33 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.36 -42.0 99.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 77.1 mt -41.23 -28.72 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 75.8 m -36.85 107.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.86 11.59 7.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.457 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.495 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.25 119.13 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.959 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -56.5 108.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.14 112.97 24.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.9 mt 61.18 26.51 16.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.19 -30.24 10.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.46 121.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.529 0.681 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.05 153.87 6.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 169' ' ' PHE . 19.8 tt -112.08 153.23 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.418 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.9 mm -112.38 132.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 207' ' ' ALA . 11.7 t -131.97 120.61 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -151.36 142.37 23.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -48.84 133.41 17.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 42.4 t -74.24 -43.42 57.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -91.3 44.41 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.74 65.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.25 -42.62 20.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -59.66 -56.52 20.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -42.54 -41.47 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -106.83 77.94 1.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -157.35 110.02 2.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -128.49 131.85 48.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 146.05 82.62 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.24 38.46 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.73 2.287 . . . . 0.0 112.402 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 76.6 p -167.27 138.48 3.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.6 p -59.17 118.04 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.812 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -86.05 167.28 15.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.7 t -99.2 -43.95 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.41 169.85 12.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.1 m -135.92 152.11 50.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.1 p -173.72 164.46 4.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.41 73.01 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -172.68 170.37 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -123.62 87.52 52.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.98 170.92 18.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.368 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.89 129.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -164.24 160.57 21.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -43.33 143.25 1.47 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.669 0.747 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.33 112.24 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.228 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.5 m -81.39 139.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -138.22 148.17 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -135.48 144.52 46.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -49.16 178.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.001 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.0 p -85.11 149.83 53.73 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.89 -34.2 8.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 0.0 112.348 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 6.9 pt-20 -72.32 -41.85 66.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 30.3 mm-40 -55.92 -33.89 65.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.24 -51.28 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -72.63 -26.78 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.77 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.467 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -66.13 -36.77 84.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' NH1' HD12 ' A' ' 142' ' ' LEU . 48.9 mtt180 -85.92 33.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 m -125.9 137.38 53.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 196' ' ' VAL . 12.0 p -116.57 149.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.148 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -100.83 137.92 38.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 91.4 m -127.62 149.82 50.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.6 mtm -151.84 -179.3 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' CB ' HG12 ' A' ' 221' ' ' ILE . 14.8 tt0 54.67 47.05 23.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 194' ' ' ALA . 72.4 mt -75.81 165.37 25.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -81.72 175.76 10.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.87 -34.21 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -118.14 47.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.646 HD13 HD22 ' A' ' 157' ' ' LEU . 14.3 tt -90.3 153.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -136.47 152.52 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.55 0.691 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -45.41 16.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.663 2.242 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -48.74 64.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -47.41 -63.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 -45.81 74.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -47.03 -68.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.27 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 215' ' ' LEU . 44.4 t80 -54.68 -29.56 53.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PHE . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . 23.0 m-85 -95.29 -12.34 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.5 p -67.71 -4.21 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.54 -21.36 41.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.22 -27.56 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.71 159.67 29.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.448 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -74.67 134.98 41.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 179' ' ' VAL . 80.0 t -95.76 116.48 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.05 -43.49 43.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -153.32 158.0 40.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 196' ' ' VAL . 86.7 t -137.07 141.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.38 120.03 30.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.68 114.39 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.74 150.45 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.4 p -157.19 160.4 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -150.79 175.37 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -47.65 -53.26 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -125.45 107.68 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.8 p -100.84 41.95 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -102.23 -53.41 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -80.5 43.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 95.3 p -174.82 171.62 3.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -104.58 133.96 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.94 109.12 2.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt -95.09 145.34 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.683 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.09 137.01 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -103.4 112.73 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 152' ' ' VAL . 56.2 t -109.54 141.93 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -118.42 153.21 34.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 170' ' ' PHE . 63.2 m-85 -123.05 -177.32 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 51.3 m -85.49 -21.73 28.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.49 144.39 29.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ILE . . . . . 0.467 HD12 ' HB1' ' A' ' 149' ' ' ALA . 14.7 tt -70.86 -27.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -65.27 -9.61 25.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -94.89 -18.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -59.28 -43.56 96.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.0 Cg_exo -47.9 -51.59 9.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.371 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.11 -43.57 95.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.36 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.77 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.12 -32.88 85.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 211' ' ' THR . 71.2 mt -55.78 -20.47 15.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.955 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.9 m -36.75 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.93 14.09 6.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.567 ' NE2' ' CE1' ' A' ' 169' ' ' PHE . 9.4 mt-30 -88.65 106.29 18.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -45.9 106.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 169' ' ' PHE . 21.2 tp -108.43 107.06 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.2 mt 65.82 27.08 11.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.66 -18.15 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.24 115.21 31.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.695 0.759 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.69 149.79 13.36 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.2 tt -115.04 149.74 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.0 mm -109.0 125.62 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 17.3 t -120.51 124.2 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -143.62 165.79 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -74.91 124.41 26.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 90.1 p -75.69 -5.86 47.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.833 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.43 40.44 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -96.03 -32.19 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -81.32 -43.35 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -60.51 -16.39 36.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -88.8 -47.7 8.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -89.97 34.96 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.2 tp -116.13 140.39 49.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.0 p -69.84 163.39 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 167.81 145.7 4.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.01 88.11 1.46 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 7.8 t -123.88 161.64 24.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -85.19 -57.95 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.58 -0.208 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -154.57 171.68 19.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.933 0.397 . . . . 0.0 110.837 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.8 p -163.63 152.95 14.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.23 138.48 3.53 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.538 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.5 p -145.68 106.85 4.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.8 p -118.31 153.92 33.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 114.08 -130.72 9.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -147.44 120.11 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.5 m -145.57 156.74 52.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.705 0.764 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.7 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.708 2.272 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 135' ' ' VAL . 11.4 p -96.7 119.43 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.59 89.25 7.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -150.37 153.8 35.14 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.899 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.0 133.27 14.95 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.17 143.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -84.8 96.1 9.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.04 160.09 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.71 ' C ' HD12 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -81.6 125.83 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.1 p -82.96 154.35 67.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.73 0.776 . . . . 0.0 110.813 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.4 ' HA ' ' HD2' ' A' ' 147' ' ' ARG . 71.0 Cg_exo -46.2 -20.17 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.634 2.223 . . . . 0.0 112.288 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -83.99 -33.03 24.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.23 -38.57 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 1.9 ptm180 -58.72 -33.99 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.42 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 6.8 t0 -82.43 -38.51 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.86 -41.42 77.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -86.73 39.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.1 m -133.06 138.52 46.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.1 p -113.92 149.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.65 120.72 40.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.4 m -106.29 154.48 20.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 54.2 mtm -155.54 176.68 12.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.47 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 17.8 tt0 57.69 52.05 8.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 194' ' ' ALA . 81.4 mt -81.45 166.78 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -90.68 174.17 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.05 -40.4 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -108.29 43.67 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 14.4 tt -92.94 153.71 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.81 153.92 79.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.578 0.704 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.5 -39.32 17.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.608 2.205 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 165' ' ' ASP . 12.0 mtt-85 -57.93 -59.74 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 164' ' ' ARG . 15.0 m-20 -34.43 -41.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.48 -43.78 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' ARG . 50.6 mt-10 -42.7 -66.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 171' ' ' SER . 33.4 t70 -62.15 -53.46 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.641 ' CD2' HD13 ' A' ' 215' ' ' LEU . 1.5 t80 -45.46 -30.05 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -95.25 -20.92 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 168' ' ' ASP . 20.5 t -61.51 -9.49 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.86 62.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.33 -33.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.63 152.5 22.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -73.72 142.8 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.674 HG11 ' CG2' ' A' ' 179' ' ' VAL . 92.0 t -103.18 136.55 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -113.06 -39.07 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -141.11 134.58 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.674 ' CG2' HG11 ' A' ' 176' ' ' VAL . 59.6 t -134.94 102.89 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 -96.04 107.81 20.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 94.4 mt -98.08 117.57 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.59 115.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -125.68 102.04 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.46 148.6 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.816 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -93.1 -50.2 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -107.71 96.25 6.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 99.2 p -144.09 146.05 32.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.9 -54.26 9.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.81 127.14 13.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 p -166.07 121.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -69.9 -46.34 65.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 131.18 103.46 0.95 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.485 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.4 pt -98.59 144.02 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -144.96 148.01 33.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -110.33 135.64 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.6 t -129.01 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.13 103.79 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.443 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.3 m-85 -73.85 161.51 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.98 -33.55 74.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.26 170.33 15.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -84.27 -28.93 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.6 -6.8 27.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 t -95.34 -22.26 17.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.0 t -57.09 -43.72 99.44 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.579 0.704 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.92 -60.15 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.719 2.279 . . . . 0.0 112.415 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 72.6 mt -52.3 -42.42 63.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.76 85.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.25 -43.68 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.8 99.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.491 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 211' ' ' THR . 49.0 mt -42.33 -29.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 210' ' ' LEU . 51.5 m -33.97 123.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 101.24 17.7 21.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLN . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 39.2 mt-30 -93.7 109.82 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -51.49 99.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . 0.641 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.7 tp -101.46 105.63 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.1 mt 65.83 25.39 11.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.62 -19.75 51.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.0 114.33 37.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.719 0.771 . . . . 0.0 111.058 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.6 149.27 13.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.603 2.202 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -111.49 156.17 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.175 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 4.6 mm -119.55 135.44 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.02 122.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -145.48 143.13 29.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -43.33 153.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 89.6 p -86.29 51.23 2.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -105.41 44.1 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.95 -58.7 3.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 229' ' ' LYS . 1.0 OUTLIER -63.86 -59.79 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 228' ' ' GLU . 19.6 ttmt -36.08 -64.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -38.82 -55.84 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.75 -55.03 22.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 tp -48.64 111.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 m -61.68 125.15 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -125.74 88.88 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.63 -47.43 13.52 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.636 2.224 . . . . 0.0 112.353 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.9 p -55.59 126.23 24.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.5 t -55.94 -51.15 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.506 179.961 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.1 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.771 0.319 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.2 p -110.05 149.56 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 193' ' ' ILE . 14.8 t80 -110.66 124.1 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG3' ' A' ' 155' ' ' MET . 41.9 m -113.79 161.16 17.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.414 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 33.9 mtm -155.03 179.52 9.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.435 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.1 tt0 55.98 46.07 22.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 161' ' ' ILE . 62.5 mt -79.06 159.56 27.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.0 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -69.43 174.18 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.82 -38.26 38.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -118.39 50.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 157' ' ' LEU . 14.7 tt -89.96 156.8 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.04 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -131.51 155.06 81.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.02 -47.2 14.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -52.92 -53.92 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -39.73 -45.73 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.89 -46.84 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -45.1 -65.61 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.19 -46.31 88.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -54.17 -28.77 42.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.42 -8.56 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -70.24 -5.9 30.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.21 -23.6 47.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.5 -31.86 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.48 158.57 31.52 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -78.29 136.44 37.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.406 HG11 ' CG2' ' A' ' 179' ' ' VAL . 65.8 t -97.9 140.74 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -36.26 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.451 ' CG ' ' OE1' ' A' ' 197' ' ' GLU . 0.5 OUTLIER -151.49 152.34 32.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.406 ' CG2' HG11 ' A' ' 176' ' ' VAL . 99.3 t -141.19 109.3 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -96.53 106.71 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.3 mt -96.05 131.42 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.7 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 179.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 29.0 pt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.641 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -141.92 157.88 44.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.18 134.85 54.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 152' ' ' VAL . 60.6 t -131.08 128.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . 0.451 ' OE1' ' CG ' ' A' ' 178' ' ' ASP . 41.5 mt-10 -94.84 129.99 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -103.08 159.66 15.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.0 p -58.58 -32.21 68.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -148.01 164.91 32.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.0 tt -78.53 -20.72 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.421 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.1 mm-40 -73.53 -12.35 60.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 38.0 t -92.42 -14.41 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.5 t -63.8 -43.32 76.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.7 Cg_exo -47.92 -47.96 17.5 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.5 -45.0 95.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.2 83.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.7 mt -52.21 -47.53 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -55.47 -43.99 85.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.58 HD22 ' NE2' ' A' ' 213' ' ' GLN . 86.6 mt -40.32 -28.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 210' ' ' LEU . 53.2 m -35.52 102.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.12 4.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 210' ' ' LEU . 17.9 mt-30 -98.28 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -46.75 107.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.24 108.51 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 mt 66.35 27.37 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.42 -15.52 63.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.24 118.99 25.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.616 0.722 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.07 152.27 5.11 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.284 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.8 tt -115.5 149.29 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.435 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.3 mm -108.87 141.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.03 127.33 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -150.55 151.3 32.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.6 p -119.8 146.19 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -98.15 127.76 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.423 ' C ' ' HG3' ' A' ' 155' ' ' MET . 64.7 m -115.54 149.61 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 22.9 mtm -149.37 -179.94 7.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.6 tt0 55.44 50.38 14.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.675 ' HB3' HG21 ' A' ' 161' ' ' ILE . 79.5 mt -79.24 163.21 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.67 171.72 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.67 -30.5 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -126.88 33.67 4.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.7 tt -71.57 150.88 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -128.83 150.35 74.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.576 0.703 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.33 -36.12 12.44 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.42 -59.62 4.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -38.54 -36.86 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 161' ' ' ILE . 23.9 mt -80.8 -50.89 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -39.17 -60.83 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.77 -44.98 84.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 215' ' ' LEU . 23.3 t80 -52.21 -32.55 37.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -92.64 -16.17 25.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.3 m -66.5 -10.05 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.35 60.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.75 -28.14 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.39 151.84 14.41 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -62.75 137.11 58.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.77 126.14 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -87.04 -60.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -138.73 149.5 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 196' ' ' VAL . 60.1 t -136.84 105.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.54 104.3 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.34 107.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -145.29 143.91 30.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.043 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.11 147.06 27.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 179' ' ' VAL . 50.9 t -139.64 130.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -105.23 124.86 50.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.01 155.19 17.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 26.7 p -63.21 -24.85 68.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -141.19 152.14 44.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.9 tt -76.78 -28.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.428 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 13.6 mm100 -67.73 -7.2 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.435 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 66.7 m -92.77 -25.49 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.87 -43.65 98.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.8 Cg_exo -47.95 -58.63 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.635 2.223 . . . . 0.0 112.411 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.4 mt -52.83 -44.68 66.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.26 74.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.24 -44.01 94.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.34 85.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 211' ' ' THR . 39.0 mt -56.4 -24.9 47.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 210' ' ' LEU . 12.5 m -36.76 118.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.23 6.25 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -102.51 110.41 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -47.49 104.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 169' ' ' PHE . 29.6 tp -109.57 108.02 18.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.3 mt 66.47 25.03 10.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.32 59.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.2 t -123.35 115.72 28.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 149.6 14.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.712 2.275 . . . . 0.0 112.356 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.4 tt -113.34 158.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.452 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.1 mm -119.22 133.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 15.8 t -129.87 119.03 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -138.59 156.03 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.796 0.331 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' CG1' ' A' ' 222' ' ' VAL . 7.3 p -102.5 149.02 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 14.0 t80 -102.48 117.19 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.4 m -107.74 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.0 mtm -151.26 177.3 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.447 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.4 tt0 59.31 50.81 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 166' ' ' LEU . 58.3 mt -95.22 150.18 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.35 168.63 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.82 23.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -98.28 42.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.1 tt -88.04 157.95 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -127.26 143.65 47.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.95 -29.49 8.46 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.759 2.306 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 165' ' ' ASP . 18.7 mmt85 -66.47 -58.45 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 216' ' ' LEU . 43.3 m-20 -34.99 -45.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 157' ' ' LEU . 29.4 mt -68.79 -46.26 69.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.474 ' HA ' HG21 ' A' ' 176' ' ' VAL . 29.9 mt-10 -47.11 -68.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.54 -50.26 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.65 ' CE2' HG21 ' A' ' 220' ' ' ILE . 22.1 t80 -49.39 -31.64 9.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 196' ' ' VAL . 27.1 m-85 -95.87 -11.54 26.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -66.51 -5.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.16 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 m -121.01 -30.74 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.57 153.72 24.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -77.0 134.23 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 167' ' ' GLU . 88.0 t -94.29 128.21 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.22 -41.27 8.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.6 154.78 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.459 ' CG2' HG11 ' A' ' 176' ' ' VAL . 25.4 t -143.76 107.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -92.87 105.08 17.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 95.0 mt -96.72 123.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 38.5 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.843 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 41.4 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.821 0.343 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.25 157.65 43.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.072 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 98.8 m-85 -114.64 125.44 53.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 170' ' ' PHE . 82.6 t -109.46 122.66 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.103 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -94.11 106.37 18.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.29 166.25 22.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 45.9 t -71.73 -35.75 70.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -133.93 165.78 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.8 tt -84.65 -24.48 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -75.06 -9.76 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 -11.89 27.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.6 t -64.73 -43.75 70.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.4 Cg_exo -48.02 -54.2 5.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.607 2.205 . . . . 0.0 112.326 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.64 -33.37 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -69.92 -34.85 74.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.17 -38.63 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 -40.32 98.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.467 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 95.7 mt -42.26 -32.17 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 210' ' ' LEU . 57.3 m -35.79 98.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 126.29 7.42 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.83 116.73 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 110.922 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -53.11 108.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 117.08 29.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.48 HD11 ' OD2' ' A' ' 165' ' ' ASP . 46.6 mt 61.64 24.96 14.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.23 -29.23 12.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.2 t -117.64 124.98 28.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.565 0.698 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.32 153.84 6.65 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.356 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 169' ' ' PHE . 14.1 tt -116.48 154.28 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.447 HG12 ' CB ' ' A' ' 156' ' ' GLN . 8.5 mm -110.12 142.35 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.5 t -142.82 118.39 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.47 148.9 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.08 179.91 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 74.3 m . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 7.6 p -114.19 152.42 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.7 t80 -109.01 122.58 47.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 60.9 m -111.32 152.37 27.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.8 mtm -147.22 175.5 10.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.863 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.424 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.1 tt0 56.52 54.37 7.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 161' ' ' ILE . 87.3 mt -91.96 156.91 17.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.28 169.56 17.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.78 -44.49 23.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.0 mtm105 -98.57 46.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.539 HD13 HD22 ' A' ' 157' ' ' LEU . 17.9 tt -91.71 148.86 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -121.2 143.16 36.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.01 -30.51 7.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.377 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -68.43 -55.83 10.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' ARG . 2.1 m-20 -35.23 -44.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 179' ' ' VAL . 26.7 mt -71.69 -52.56 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -38.5 -68.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 171' ' ' SER . 0.8 OUTLIER -56.9 -56.13 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 220' ' ' ILE . 38.7 t80 -44.17 -29.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 196' ' ' VAL . 23.8 m-85 -95.34 -21.8 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 168' ' ' ASP . 4.2 t -58.67 -14.16 7.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.84 -29.47 68.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 m -110.08 -30.9 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.53 150.99 16.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.08 138.13 55.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.05 134.66 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -92.77 -56.98 2.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -136.8 161.21 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 166' ' ' LEU . 99.0 t -140.86 106.58 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -93.19 103.95 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -94.1 119.99 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.448 ' CG1' HG13 ' A' ' 193' ' ' ILE . 14.9 mm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.464 HG22 ' HG2' ' A' ' 155' ' ' MET . 24.6 pt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 120.814 0.34 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -153.8 153.76 32.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.52 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 96.0 m-85 -109.04 135.34 50.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.921 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' A' ' 170' ' ' PHE . 87.2 t -118.88 133.45 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.89 112.81 24.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.463 ' HE2' HG11 ' A' ' 152' ' ' VAL . 39.1 m-85 -89.0 162.13 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 10.9 t -64.87 -43.38 93.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.04 162.45 33.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.8 tt -73.51 -22.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -74.09 -6.46 47.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 66.1 m -97.83 -18.04 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.2 t -61.68 -43.49 88.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.646 0.736 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.2 Cg_exo -48.02 -55.28 4.17 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.2 -35.7 72.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.968 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.89 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.94 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.27 -33.87 87.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.4 mt -50.42 -27.6 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 19.8 m -38.01 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 125.38 9.88 4.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.04 117.91 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.0 110.977 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -54.51 109.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -113.21 112.73 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.1 mt 61.39 25.4 15.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.0 -30.63 9.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -114.74 121.34 35.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.712 0.768 . . . . 0.0 111.074 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.76 154.15 7.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.2 tt -116.77 152.73 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.3 mm -109.63 148.72 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.16 126.33 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -149.63 151.21 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.769 0.319 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 196' ' ' VAL . 11.4 p -99.04 148.86 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -106.04 141.58 37.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.424 ' C ' ' HG3' ' A' ' 155' ' ' MET . 82.0 m -133.34 150.7 51.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.424 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 32.3 mtm -148.76 -179.44 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.9 tt0 61.13 46.5 8.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.573 HD11 ' CB ' ' A' ' 194' ' ' ALA . 70.1 mt -86.3 154.25 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.21 171.87 9.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.047 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.87 -43.29 36.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 51.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.469 HD13 HD22 ' A' ' 157' ' ' LEU . 15.7 tt -87.37 147.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -117.97 144.34 34.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -40.65 19.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 165' ' ' ASP . 26.4 mmt180 -54.97 -57.81 10.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 164' ' ' ARG . 14.2 m-20 -35.52 -47.0 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.17 -47.6 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -43.82 -62.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.45 -48.89 71.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 220' ' ' ILE . 17.4 t80 -47.05 -35.78 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 196' ' ' VAL . 38.0 m-85 -91.98 -15.66 27.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -65.82 -6.53 12.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.26 55.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.9 -32.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.79 154.85 25.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 139.75 42.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.44 HG11 ' CG2' ' A' ' 179' ' ' VAL . 87.0 t -95.61 127.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -92.48 -49.44 6.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -142.69 145.7 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.44 ' CG2' HG11 ' A' ' 176' ' ' VAL . 93.2 t -127.76 115.4 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -103.0 108.56 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.67 112.67 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.9 mm . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.4 pt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.789 0.328 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.573 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -141.73 140.0 33.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -101.38 127.15 48.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.812 ' O ' HG12 ' A' ' 152' ' ' VAL . 78.8 t -116.56 119.38 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.59 115.59 28.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.653 ' HE2' HG11 ' A' ' 152' ' ' VAL . 38.4 m-85 -90.07 155.49 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.8 m -63.23 -39.97 96.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -126.77 165.05 20.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 tt -84.4 -29.5 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -71.8 -7.03 45.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -95.37 -17.38 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -63.07 -43.47 81.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.625 0.726 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.3 Cg_exo -47.98 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.97 -41.13 70.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.14 76.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.54 -38.95 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.11 -38.38 96.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 88.3 mt -45.01 -28.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' LEU . 41.7 m -35.41 107.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 119.29 5.75 11.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.47 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.506 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -84.51 119.54 25.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -59.49 100.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.46 112.26 24.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.9 mt 61.83 25.27 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.11 -23.14 36.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.464 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -116.68 117.99 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.69 149.6 13.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.47 HG12 ' N ' ' A' ' 221' ' ' ILE . 13.5 tt -113.49 159.49 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 220' ' ' ILE . 3.6 mm -118.65 148.71 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 t -147.0 138.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 221' ' ' ILE . 12.9 mp0 -152.67 -177.75 6.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.874 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.865 0.364 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.56 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.2 p -105.04 154.91 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.88 121.48 45.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.2 m -108.43 157.07 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 193' ' ' ILE . 63.6 mtm -151.6 171.74 17.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 221' ' ' ILE . 5.6 tt0 65.62 53.89 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 161' ' ' ILE . 66.6 mt -91.63 152.23 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.63 179.57 3.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.47 -33.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -113.93 46.54 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.748 HD13 HD22 ' A' ' 157' ' ' LEU . 11.8 tt -91.76 150.03 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -125.37 148.76 62.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.497 0.665 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.6 -40.4 18.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.35 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -54.42 -52.93 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -41.22 -47.79 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.34 -41.5 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.11 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.14 -47.73 84.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 6.8 t80 -52.34 -33.4 42.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 196' ' ' VAL . 35.3 m-85 -96.9 -14.75 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 t -67.21 -5.62 14.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.2 -26.93 38.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.47 -33.75 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -163.81 150.08 18.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -70.6 135.68 48.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.831 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.472 HG11 ' CG2' ' A' ' 179' ' ' VAL . 93.1 t -95.72 131.15 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -103.94 -42.47 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -136.68 143.79 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.1 t -134.25 110.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -102.33 113.42 26.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.55 115.5 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.4 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.129 179.875 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.757 HG22 ' HG2' ' A' ' 155' ' ' MET . 32.7 pt . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.809 0.338 . . . . 0.0 111.156 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -150.9 141.88 22.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -101.34 133.37 46.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 152' ' ' VAL . 92.3 t -120.85 119.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.96 111.97 20.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.56 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.37 150.09 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.4 p -52.26 -36.06 51.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.74 176.94 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 7.2 tt -87.59 -29.28 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -65.24 -7.33 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 45.2 t -97.26 -17.2 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -61.02 -43.35 90.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.612 0.72 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 63.1 Cg_exo -47.93 -54.47 5.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.667 2.245 . . . . 0.0 112.392 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.33 -45.65 84.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.63 77.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 90.9 mt -56.67 -40.87 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.48 98.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 213' ' ' GLN . 80.0 mt -55.3 -26.3 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' ' 221' ' ' ILE . 93.3 m -35.68 104.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.7 26.64 2.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 210' ' ' LEU . 44.8 mt-30 -101.71 106.07 17.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 110.947 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -41.47 104.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.2 tp -110.06 109.99 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.6 mt 63.21 26.44 15.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.43 -25.37 28.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.6 t -115.24 118.31 40.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.02 150.53 9.98 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.277 . . . . 0.0 112.322 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 tt -110.98 149.44 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.519 ' HA ' HG23 ' A' ' 211' ' ' THR . 5.2 mm -112.21 142.66 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.07 124.82 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -148.02 148.25 30.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 179.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.7 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.869 0.366 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.75 145.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 10.8 t80 -103.23 120.2 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.492 ' HG ' ' C ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -109.7 144.19 38.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.866 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 12.4 mtm -144.46 178.29 8.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.466 ' OE1' HD11 ' A' ' 221' ' ' ILE . 3.0 tt0 57.0 51.88 9.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.46 HD22 HD21 ' A' ' 166' ' ' LEU . 28.4 mt -102.6 129.49 49.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.12 169.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.068 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.3 -35.91 40.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -99.45 45.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.8 tt -93.51 148.32 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -120.71 147.4 45.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.66 -41.98 19.07 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.32 -51.68 67.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -39.59 -44.93 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.46 HD21 HD22 ' A' ' 157' ' ' LEU . 68.1 mt -76.84 -48.41 18.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -40.82 -68.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.65 -54.94 38.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -47.83 -29.99 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.14 -20.57 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.3 t -65.57 -7.01 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.38 -23.68 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.96 -29.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.98 156.49 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 135.53 46.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.05 128.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -82.76 -56.8 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.86 154.15 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 196' ' ' VAL . 76.9 t -133.93 121.35 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -110.13 107.41 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.67 121.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.839 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.3 pt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.492 ' C ' ' HG ' ' A' ' 154' ' ' CYS . . . -150.77 170.6 18.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 97.2 m-85 -129.33 137.23 50.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 152' ' ' VAL . 94.2 t -130.63 127.01 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.73 123.9 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 152' ' ' VAL . 36.9 m-85 -94.66 162.56 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.42 -30.33 71.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -147.23 174.96 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.6 tt -84.89 -35.9 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.99 -6.71 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.6 t -95.18 -17.42 21.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.64 -43.37 83.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.62 0.724 . . . . 0.0 111.154 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.6 Cg_exo -47.99 -56.88 2.71 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.56 -49.03 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.52 -39.92 61.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.57 -46.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.39 -43.5 84.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 211' ' ' THR . 97.5 mt -43.0 -28.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 210' ' ' LEU . 86.7 m -35.65 120.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.22 26.45 6.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -105.5 111.79 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -50.01 105.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.1 tp -112.09 112.47 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.2 mt 62.78 25.24 14.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.54 -27.55 19.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.36 121.07 32.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.64 148.44 15.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.445 HG12 ' N ' ' A' ' 221' ' ' ILE . 11.9 tt -106.79 154.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.083 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.466 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.5 mm -112.92 140.61 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 152' ' ' VAL . 10.4 t -138.69 125.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -147.53 163.04 37.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.871 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.77 0.319 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.451 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.3 p -110.76 152.92 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -105.43 133.8 49.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 81.9 m -121.34 143.6 49.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.0 mtm -144.51 177.4 8.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.45 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.6 tt0 58.63 51.99 7.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 161' ' ' ILE . 49.4 mt -82.28 162.55 22.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.63 174.91 11.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.124 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.69 -33.76 27.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -115.86 41.99 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.603 HD13 HD22 ' A' ' 157' ' ' LEU . 13.4 tt -86.16 158.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.401 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 13.9 mtt85 -136.66 146.72 56.63 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.47 -33.11 8.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.346 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -66.6 -42.62 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -50.95 -34.88 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.1 mt -80.54 -50.64 9.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.686 ' HA ' HG21 ' A' ' 176' ' ' VAL . 21.5 mt-10 -38.83 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -52.2 65.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.718 ' CD2' HD13 ' A' ' 215' ' ' LEU . 7.0 t80 -47.76 -27.59 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 196' ' ' VAL . 17.0 m-85 -96.96 -18.6 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -59.88 -12.18 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.19 -27.29 63.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.58 -32.98 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.24 161.0 32.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 138.44 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 167' ' ' GLU . 72.8 t -90.79 125.38 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -88.03 -50.01 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -149.92 151.12 32.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 46.4 t -137.95 114.87 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -106.77 106.39 16.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 90.6 mt -96.78 115.29 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.843 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.9 pt . . . . . 0 C--O 1.23 0.03 0 CA-C-O 120.888 0.375 . . . . 0.0 111.097 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -148.13 152.14 36.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.32 148.39 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 170' ' ' PHE . 91.7 t -139.2 133.96 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -106.81 119.29 38.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -94.31 154.17 17.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -48.03 -43.17 29.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.27 175.24 9.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 14.5 tt -84.2 -30.0 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -66.11 -6.44 13.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.0 m -95.39 -21.75 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -57.93 -43.51 98.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.655 0.74 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.99 -55.59 3.88 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 41.4 mt -56.08 -43.28 77.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.46 77.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.1 -47.19 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.157 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.32 91.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 31.5 mt -43.19 -24.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.967 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 18.7 m -36.39 110.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.86 19.37 8.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 42.2 mt-30 -92.01 110.96 22.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -50.21 105.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.718 HD13 ' CD2' ' A' ' 169' ' ' PHE . 15.7 tp -105.77 104.56 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.1 mt 64.06 25.01 13.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.53 29.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.488 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.23 114.21 48.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.38 148.53 14.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.662 2.242 . . . . 0.0 112.352 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.0 tt -113.68 153.32 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.45 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.7 mm -112.5 137.74 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.8 t -134.84 115.92 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -133.63 167.83 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.3 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.79 0.329 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.478 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.1 p -108.27 148.98 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.126 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -106.83 120.78 42.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 47.2 m -105.79 146.27 30.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.7 mtm -143.28 -179.3 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.463 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.7 tt0 53.52 51.54 15.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.896 HD22 HD13 ' A' ' 161' ' ' ILE . 99.1 mt -81.5 156.96 25.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.72 172.05 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.48 -35.07 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -124.37 42.36 3.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.896 HD13 HD22 ' A' ' 157' ' ' LEU . 15.9 tt -74.3 164.19 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 44.0 mtt-85 -128.12 158.71 70.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.573 0.702 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.487 ' CA ' HD11 ' A' ' 181' ' ' ILE . 56.6 Cg_endo -71.06 -9.4 25.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 0.0 112.303 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -90.47 -41.84 11.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -49.64 -36.48 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.12 -40.3 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -48.46 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -57.13 -40.17 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 220' ' ' ILE . 24.3 t80 -61.38 -30.7 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.72 -16.12 23.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -67.48 -4.04 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.68 51.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.08 -27.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.34 154.49 24.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -77.83 137.77 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.8 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 196' ' ' VAL . 69.6 t -93.67 138.94 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -99.38 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -152.88 145.87 24.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.75 120.35 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -109.48 104.38 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.487 HD11 ' CA ' ' A' ' 163' ' ' PRO . 45.3 mt -93.37 103.44 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.8 mm . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.11 179.878 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.8 pt . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.82 143.29 28.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.042 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -103.85 143.19 33.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 176' ' ' VAL . 78.9 t -131.6 122.18 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -87.13 124.34 33.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.44 ' HE2' HG11 ' A' ' 152' ' ' VAL . 31.4 m-85 -104.51 153.89 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.88 -44.71 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -130.93 168.91 16.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 20.1 tt -87.34 -28.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.417 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 68.3 mm-40 -64.59 -9.87 22.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 14.8 m -93.21 -15.77 25.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -63.52 -43.42 78.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.667 0.746 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.9 Cg_exo -47.97 -52.02 8.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.9 mt -60.46 -44.21 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.454 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -59.28 -37.56 77.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.63 -46.06 90.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.96 -39.41 94.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 211' ' ' THR . 19.5 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.6 m -34.48 112.11 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 114.47 19.26 6.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.411 ' NE2' HD22 ' A' ' 210' ' ' LEU . 6.8 mt-30 -98.16 112.0 24.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.0 110.948 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -49.92 106.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.2 tp -113.33 113.32 25.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.18 25.85 15.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.11 17.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.9 t -115.76 121.57 34.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.591 0.71 . . . . 0.0 111.213 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.07 154.0 5.91 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 tt -112.91 152.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.463 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.3 mm -111.97 123.76 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.0 t -121.04 112.74 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -138.32 143.07 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.827 0.346 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.486 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.9 p -118.66 147.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.09 124.36 42.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.404 ' C ' ' HG3' ' A' ' 155' ' ' MET . 84.8 m -115.01 155.28 27.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.404 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 64.2 mtm -154.03 175.85 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.5 tt0 63.59 54.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 161' ' ' ILE . 72.0 mt -93.41 148.38 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.04 176.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.02 -43.33 22.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -107.39 46.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 157' ' ' LEU . 16.5 tt -86.59 150.71 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -121.06 144.63 39.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.538 0.685 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.46 -43.85 17.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 165' ' ' ASP . 3.6 tmt_? -56.91 -55.28 36.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 164' ' ' ARG . 7.8 m-20 -36.54 -40.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.96 -48.19 16.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 176' ' ' VAL . 23.6 mt-10 -47.53 -68.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.34 -55.39 10.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -48.92 -42.89 38.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 196' ' ' VAL . 19.0 m-85 -78.56 -20.61 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.1 t -63.57 -11.26 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.43 -27.79 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.74 -32.92 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.37 152.98 22.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -68.71 142.54 54.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 167' ' ' GLU . 90.9 t -98.63 128.71 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -87.51 -53.61 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.53 152.79 41.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.54 113.1 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -101.88 109.09 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.3 mt -99.58 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.0 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.82 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.8 pt . . . . . 0 C--O 1.23 0.045 0 CA-C-O 120.876 0.369 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.67 168.69 19.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -129.55 128.57 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.606 HG21 ' CE2' ' A' ' 170' ' ' PHE . 85.5 t -116.74 121.07 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -94.89 111.24 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.486 ' HE2' HG11 ' A' ' 152' ' ' VAL . 49.3 m-85 -85.05 152.05 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 m -60.07 -35.24 74.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -135.82 151.33 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 20.4 tt -70.93 -27.32 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -69.56 -6.36 30.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . 0.436 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.9 m -95.34 -25.03 16.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.38 -43.72 97.98 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.0 111.186 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -47.93 -58.7 1.59 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.746 2.298 . . . . 0.0 112.306 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.86 -31.05 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.574 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -72.74 -31.83 65.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 224' ' ' ALA . 82.5 mt -64.44 -41.78 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.105 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -61.5 -44.42 98.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.485 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 90.3 mt -37.45 -31.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.3 m -34.45 103.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.32 9.47 5.5 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -90.93 118.99 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.876 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -56.42 109.9 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.6 tp -115.36 115.65 26.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.0 mt 60.22 25.04 14.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.21 -32.08 7.93 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.46 124.13 31.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.612 0.72 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.02 154.02 5.79 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.424 HG12 ' N ' ' A' ' 221' ' ' ILE . 9.4 tt -111.91 152.04 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.104 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.449 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.1 mm -110.47 132.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 207' ' ' ALA . 12.4 t -133.38 121.53 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -146.67 145.19 29.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.962 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.823 0.344 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.2 p -103.53 151.08 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.8 t80 -107.04 134.3 50.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.2 m -119.46 154.9 33.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.6 mtm -151.75 174.58 13.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 60.28 48.46 8.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.736 HD22 HD13 ' A' ' 161' ' ' ILE . 94.7 mt -77.74 156.67 30.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.44 173.03 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.45 -38.05 50.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -119.7 40.54 3.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.736 HD13 HD22 ' A' ' 157' ' ' LEU . 17.4 tt -76.26 154.45 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -129.7 149.06 71.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.689 0.757 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.72 -43.66 18.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 165' ' ' ASP . 1.8 mpt_? -53.7 -59.48 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 164' ' ' ARG . 4.4 m-20 -36.51 -41.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.74 -51.64 13.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.39 -67.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.49 -45.19 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.03 -32.24 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.47 ' CE2' HG21 ' A' ' 196' ' ' VAL . 44.4 m-85 -95.96 -11.0 27.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -4.64 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.06 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 m -111.04 -28.56 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.04 166.88 35.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -74.99 136.58 41.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 179' ' ' VAL . 55.7 t -93.17 123.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -77.12 -52.86 8.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -149.53 152.36 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 176' ' ' VAL . 60.7 t -130.69 103.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -93.18 106.25 18.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.4 mt -95.39 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 32.2 mm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.811 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 46.0 pt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.735 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -135.89 163.43 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 87.5 m-85 -127.15 137.86 53.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 170' ' ' PHE . 53.4 t -128.04 130.94 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -99.95 114.84 28.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.78 149.94 22.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.34 -35.83 65.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -137.25 168.19 20.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 6.7 tt -85.57 -30.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.42 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 44.8 mt-30 -67.97 -6.85 24.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -93.38 -19.65 21.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -58.71 -43.16 97.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.684 0.754 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.07 -45.37 25.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.35 -36.82 82.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.87 89.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 224' ' ' ALA . 76.0 mt -55.18 -46.32 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.71 -42.62 91.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 213' ' ' GLN . 34.1 mt -41.84 -30.48 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.947 0.403 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 210' ' ' LEU . 99.7 m -35.72 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.145 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 120.21 11.24 6.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.445 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 210' ' ' LEU . 9.0 mt-30 -89.87 108.49 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -49.31 106.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.45 113.82 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.2 mt 61.73 26.62 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.36 -26.94 22.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.44 120.69 34.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.111 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.6 151.46 10.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.304 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.7 tt -113.48 144.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.0 mm -100.74 134.27 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.86 116.35 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -143.5 145.75 32.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.995 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.138 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.827 0.346 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.626 HG11 ' HE2' ' A' ' 198' ' ' PHE . 11.6 p -107.94 154.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.09 134.4 47.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.1 m -122.52 149.64 43.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.527 ' HG2' HG22 ' A' ' 193' ' ' ILE . 34.1 mtm -148.93 169.42 20.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.442 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.5 tt0 68.51 52.43 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 161' ' ' ILE . 86.2 mt -86.26 157.86 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.97 166.24 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.63 67.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 54.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 157' ' ' LEU . 16.3 tt -93.01 162.82 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.445 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 17.3 mtt85 -136.69 146.38 55.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.19 -25.31 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 165' ' ' ASP . 11.3 tpt85 -72.84 -60.53 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 164' ' ' ARG . 25.3 m-20 -35.67 -36.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.87 -45.61 16.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 164' ' ' ARG . 56.5 mt-10 -48.34 -66.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -56.12 -50.77 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 1.5 t80 -50.26 -29.57 9.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 196' ' ' VAL . 30.3 m-85 -96.58 -17.81 20.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.4 p -65.52 -7.78 16.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.36 -29.68 53.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.09 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.8 m -107.04 -31.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.13 161.58 34.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.579 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -75.62 139.39 42.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 179' ' ' VAL . 82.8 t -97.2 123.29 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -84.23 -44.37 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -153.57 148.4 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.599 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.7 t -132.6 104.5 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -93.14 113.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.7 mt -100.62 111.19 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.9 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.862 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.527 HG22 ' HG2' ' A' ' 155' ' ' MET . 44.4 pt . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.37 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.08 155.07 41.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -109.58 137.22 47.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 170' ' ' PHE . 98.3 t -121.87 126.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.01 115.05 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.828 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.626 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.44 155.04 19.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.8 -38.46 72.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.7 173.71 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.0 tt -84.82 -29.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -68.49 -6.55 25.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.3 m -96.91 -16.56 20.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -62.4 -43.33 84.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.649 0.737 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.9 Cg_exo -47.97 -52.19 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.681 2.254 . . . . 0.0 112.312 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -40.2 83.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -65.0 -31.78 73.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.72 -36.56 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.55 -39.44 90.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.44 -24.99 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.07 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 122.41 15.56 4.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 33.0 mt-30 -91.45 109.41 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -48.13 103.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -104.07 107.33 18.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.1 mt 64.9 25.03 12.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.84 -22.72 37.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.6 t -116.66 115.95 39.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.45 153.56 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.683 2.255 . . . . 0.0 112.328 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 221' ' ' ILE . 18.6 tt -115.35 159.97 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 156' ' ' GLN . 4.7 mm -118.84 139.94 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 207' ' ' ALA . 21.9 t -138.9 131.58 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 147.66 15.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 179.935 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.824 0.345 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 196' ' ' VAL . 9.9 p -111.93 150.95 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 t80 -106.48 133.06 51.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 21.2 m -121.71 159.83 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.471 ' HG2' HG22 ' A' ' 193' ' ' ILE . 37.9 mtm -153.4 175.32 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.449 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 63.21 53.16 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 194' ' ' ALA . 29.5 mt -93.66 142.02 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.77 175.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.61 -46.81 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -103.43 48.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 216' ' ' LEU . 10.1 tt -90.27 155.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -129.16 147.55 65.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.5 0.667 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.47 -47.35 13.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -46.96 -58.23 4.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 216' ' ' LEU . 3.5 m-20 -37.55 -55.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.3 mt -64.3 -47.16 80.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -46.45 -66.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -59.96 -43.19 95.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 220' ' ' ILE . 30.1 t80 -54.81 -35.65 64.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.6 m-85 -92.64 -12.64 31.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.5 t -65.98 -7.22 15.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.84 58.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.03 -28.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.82 154.45 20.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -71.29 139.51 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.326 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 ' CG2' ' A' ' 179' ' ' VAL . 98.8 t -98.51 136.12 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -93.8 -50.94 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -142.18 157.27 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 84.5 t -142.92 108.03 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -95.95 112.54 24.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.65 107.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.3 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.854 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.471 HG22 ' HG2' ' A' ' 155' ' ' MET . 36.4 pt . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.832 0.348 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.25 166.85 29.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.474 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 88.6 m-85 -122.63 127.92 49.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 152' ' ' VAL . 23.6 t -117.38 123.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.04 133.68 35.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.52 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.8 m-85 -109.86 157.33 19.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 28.8 p -60.57 -40.09 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -135.82 163.25 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.8 tt -74.23 -29.25 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.198 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.423 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 41.6 mt-30 -69.44 -5.95 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.7 m -94.12 -18.17 22.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -64.18 -43.32 73.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.64 0.733 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.6 Cg_exo -47.96 -53.38 6.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.77 -34.29 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.85 76.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 224' ' ' ALA . 71.5 mt -63.01 -40.5 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.93 92.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 84.6 mt -49.97 -28.24 6.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 210' ' ' LEU . 98.0 m -36.93 98.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.99 7.9 5.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -88.68 119.24 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.898 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.79 108.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.36 118.22 32.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.584 HD21 ' OD2' ' A' ' 165' ' ' ASP . 52.3 mt 61.37 25.61 15.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.92 -29.04 13.33 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.523 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.91 126.88 26.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.07 153.96 3.76 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.1 tt -114.39 151.06 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.449 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.8 mm -109.94 139.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.58 134.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -157.56 142.88 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.4 m . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.848 0.356 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.62 157.9 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -114.63 149.33 36.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.813 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.6 mtm -144.34 177.8 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.451 ' CB ' HG12 ' A' ' 221' ' ' ILE . 5.9 tt0 56.77 47.69 17.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD13 ' A' ' 161' ' ' ILE . 93.4 mt -79.54 154.44 28.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.53 169.63 17.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.37 31.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.34 38.0 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.656 HD13 HD22 ' A' ' 157' ' ' LEU . 14.5 tt -88.56 155.14 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -131.54 147.43 66.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -25.87 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.73 2.287 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -73.05 -52.89 12.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -40.77 -37.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.46 -41.94 26.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -50.09 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -58.94 -48.14 82.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CZ ' ' NE2' ' A' ' 213' ' ' GLN . 81.8 t80 -54.37 -29.84 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -96.54 -12.35 24.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.9 p -71.63 -5.13 31.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -22.09 45.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.79 -32.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.19 159.0 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -76.54 133.06 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 179' ' ' VAL . 39.4 t -91.54 121.71 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -80.7 -60.9 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -135.4 145.8 47.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 176' ' ' VAL . 42.9 t -126.69 104.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -102.42 104.95 15.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.39 119.55 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 7.0 mm . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.852 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.813 HG22 ' HG2' ' A' ' 155' ' ' MET . 22.4 pt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.76 0.315 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.58 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.86 152.25 32.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.77 145.7 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.58 114.06 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.88 116.85 25.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -92.55 162.63 14.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.15 -16.14 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -145.67 148.91 33.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -81.87 -23.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -73.52 -6.49 46.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.8 m -95.91 -16.83 21.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.69 -43.22 82.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.645 0.736 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.1 Cg_exo -47.91 -49.47 13.74 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.64 2.227 . . . . 0.0 112.355 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.04 -38.91 90.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.7 81.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.11 -47.45 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.187 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -57.63 -32.7 65.52 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.52 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.603 HD22 ' NE2' ' A' ' 213' ' ' GLN . 24.7 mt -52.07 -28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 210' ' ' LEU . 76.3 m -35.86 105.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.59 14.07 6.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.603 ' NE2' HD22 ' A' ' 210' ' ' LEU . 6.1 mt-30 -91.68 116.59 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.926 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -57.79 106.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.34 112.49 24.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.8 mt 64.08 25.87 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.55 -20.93 48.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.96 119.29 29.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.659 0.742 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.72 152.63 9.23 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -113.88 144.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.5 mm -103.25 133.17 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.94 128.63 67.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -151.91 150.52 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.892 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.3 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.755 0.312 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.422 HG12 ' HB ' ' A' ' 196' ' ' VAL . 4.0 p -102.06 158.18 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.153 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CZ ' ' HB ' ' A' ' 193' ' ' ILE . 17.1 t80 -109.27 141.27 41.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 194' ' ' ALA . 58.9 m -126.85 156.66 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 35.8 mtm -152.98 176.48 11.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 58.95 46.96 12.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 194' ' ' ALA . 96.1 mt -77.02 168.3 20.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.798 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.42 -178.84 6.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.093 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.49 -37.6 22.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 37.39 4.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.798 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.3 tt -73.22 154.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -128.78 146.58 60.94 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.63 -35.28 12.63 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -54.94 -51.94 64.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.432 ' OD2' HD21 ' A' ' 216' ' ' LEU . 9.0 m-20 -48.13 -40.2 22.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.11 -42.9 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -43.12 -65.3 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.64 -48.83 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 23.8 t80 -49.25 -30.31 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 196' ' ' VAL . 24.3 m-85 -96.99 -15.46 21.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.9 t -68.0 -8.85 40.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.95 -23.16 55.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.37 -33.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.26 151.73 21.12 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 134.13 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 196' ' ' VAL . 86.8 t -90.18 123.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -88.7 -61.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.51 144.32 51.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.03 104.04 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -100.49 105.81 17.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.34 105.73 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.8 mm . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.479 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 48.4 pt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.89 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -139.81 158.29 44.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.094 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -124.4 127.53 47.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 176' ' ' VAL . 61.8 t -121.5 120.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.18 111.64 23.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.0 148.63 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 m -56.8 -33.01 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.21 166.11 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 16.4 tt -85.98 -33.08 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -64.29 -6.49 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 m -94.65 -19.31 20.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -61.49 -43.23 88.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 111.179 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.3 Cg_exo -48.01 -52.96 7.35 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.06 -36.93 83.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.489 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -66.35 -33.99 76.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.54 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.74 -40.44 79.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.537 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 211' ' ' THR . 67.3 mt -44.21 -26.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.3 m -35.61 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 116.65 23.58 3.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.557 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.553 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 28.4 mt-30 -100.13 108.9 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -47.93 110.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 169' ' ' PHE . 16.9 tp -116.52 112.31 21.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.432 HD21 ' OD2' ' A' ' 165' ' ' ASP . 62.2 mt 62.16 25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.64 -25.47 27.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.29 119.02 35.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.1 152.03 11.23 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.7 tt -111.99 151.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.0 mm -112.72 122.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.489 HG11 ' O ' ' A' ' 207' ' ' ALA . 18.1 t -118.07 128.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -155.45 150.35 26.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.854 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.2 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.814 0.34 . . . . 0.0 111.148 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 196' ' ' VAL . 13.0 p -99.04 146.48 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 10.6 t80 -101.22 126.91 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 83.7 m -116.78 150.7 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 42.7 mtm -149.75 178.05 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 219' ' ' PRO . 4.5 tt0 58.54 52.68 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.431 HD22 HD13 ' A' ' 161' ' ' ILE . 60.9 mt -92.31 137.12 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.26 177.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.89 -42.65 13.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 53.9 mtm-85 -97.81 39.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 157' ' ' LEU . 19.5 tt -85.05 158.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -135.63 147.13 60.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.566 0.698 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.06 -33.99 8.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.237 . . . . 0.0 112.423 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -66.79 -49.63 65.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.508 ' OD2' HD11 ' A' ' 216' ' ' LEU . 72.0 m-20 -41.39 -36.69 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -83.79 -39.99 19.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.24 -64.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -53.65 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 220' ' ' ILE . 29.0 t80 -45.42 -46.04 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 196' ' ' VAL . 21.4 m-85 -80.03 -19.93 46.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.4 t -63.39 -7.73 7.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.834 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.12 -24.01 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.05 -31.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.27 150.62 19.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.5 133.93 47.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 179' ' ' VAL . 54.9 t -90.3 132.18 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -97.11 -52.87 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.38 145.67 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 176' ' ' VAL . 94.4 t -130.76 108.49 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -96.47 111.01 23.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.95 106.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 mm . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.18 179.84 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -151.19 154.77 37.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 77.5 m-85 -116.82 139.34 50.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 170' ' ' PHE . 99.0 t -120.82 128.09 76.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -96.81 104.37 16.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.42 157.17 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 11.5 t -58.89 -37.44 76.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -140.38 167.19 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 18.7 tt -77.42 -33.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -64.94 -6.1 7.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.1 m -95.85 -20.26 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -59.85 -43.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.97 -59.85 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.278 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.6 -45.67 63.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.59 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -58.13 -30.4 66.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.48 -44.65 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.133 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.94 -30.84 70.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.473 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.9 mt -58.9 -17.83 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.34 114.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.401 ' C ' ' OE1' ' A' ' 213' ' ' GLN . . . 113.33 15.55 8.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.5 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.36 115.12 27.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -55.42 110.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -114.58 113.16 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.508 HD11 ' OD2' ' A' ' 165' ' ' ASP . 33.5 mt 61.56 25.02 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.12 -30.14 10.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.97 122.17 32.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.705 0.764 . . . . 0.0 111.093 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 74.5 Cg_exo -50.44 152.52 8.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.381 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 169' ' ' PHE . 20.1 tt -108.06 154.17 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.4 mm -110.96 124.2 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.59 HG11 ' O ' ' A' ' 207' ' ' ALA . 16.7 t -122.17 125.11 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -156.0 152.7 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 179.93 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.795 0.331 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.1 p -102.95 151.95 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 9.7 t80 -109.09 137.12 47.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 25.2 m -126.62 152.64 46.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . 0.427 ' CE ' ' OE1' ' A' ' 223' ' ' GLN . 42.8 mtm -152.5 172.85 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.414 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.4 tt0 65.38 41.51 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.519 HD11 ' CB ' ' A' ' 194' ' ' ALA . 62.1 mt -76.49 161.36 28.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.49 171.15 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.068 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.35 -29.03 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -114.73 42.92 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 tt -91.36 148.35 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -127.6 149.35 70.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 -35.6 13.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.679 2.252 . . . . 0.0 112.377 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -61.78 -53.12 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -41.95 -48.28 4.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.05 -49.3 58.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 176' ' ' VAL . 38.3 mt-10 -43.13 -69.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.797 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.83 -48.29 81.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.575 ' CD1' HD13 ' A' ' 215' ' ' LEU . 36.2 t80 -51.57 -31.16 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -94.95 -10.41 31.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.6 t -69.92 -4.39 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.55 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.9 m -114.31 -28.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.07 154.57 20.9 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -69.65 137.08 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 167' ' ' GLU . 81.1 t -93.51 136.2 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -101.06 -54.28 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 196' ' ' VAL . 2.9 t -131.89 121.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -115.1 104.21 11.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.61 115.59 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.0 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.826 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 17.4 pt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -145.92 145.95 30.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.023 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.624 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 88.4 m-85 -110.98 139.02 46.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 152' ' ' VAL . 90.9 t -128.04 128.29 68.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.47 127.42 36.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -105.39 150.59 25.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 49.1 t -48.07 -42.29 28.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -139.47 173.5 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 19.4 tt -86.08 -25.64 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -10.6 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 18.1 m -95.2 -13.65 24.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -64.04 -43.44 74.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.647 0.737 . . . . 0.0 111.191 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.6 Cg_exo -48.02 -47.52 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.268 . . . . 0.0 112.29 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.36 -40.2 95.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.24 95.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 92.3 mt -55.39 -44.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.06 98.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.443 HD22 ' NE2' ' A' ' 213' ' ' GLN . 44.9 mt -44.54 -27.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 49.0 m -36.74 116.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 108.3 13.03 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' ' 210' ' ' LEU . 8.7 mt-30 -92.19 114.37 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -48.81 109.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 169' ' ' PHE . 16.6 tp -115.39 113.18 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 42.2 mt 62.36 25.12 14.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.97 22.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.8 t -116.52 122.24 32.11 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 111.139 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.1 153.73 3.98 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.83 153.87 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.414 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.1 mm -114.18 143.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.443 ' N ' HE21 ' A' ' 223' ' ' GLN . 67.7 t -140.14 120.19 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.185 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . 0.443 HE21 ' N ' ' A' ' 222' ' ' VAL . 0.3 OUTLIER -132.52 166.98 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.942 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.6 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.825 0.345 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.43 149.5 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -100.29 125.94 46.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.7 m -116.2 154.09 30.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.2 mtm -153.58 178.09 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.418 ' OE1' HD11 ' A' ' 221' ' ' ILE . 4.7 tt0 59.97 51.46 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 161' ' ' ILE . 82.0 mt -89.19 142.54 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -52.89 -175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.72 -43.38 11.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -109.68 32.84 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 157' ' ' LEU . 18.5 tt -67.76 153.39 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -127.0 146.89 59.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -48.63 11.49 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.64 2.226 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -47.44 -56.88 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -37.94 -55.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.35 -44.43 95.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -53.4 -68.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.78 -45.07 70.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 220' ' ' ILE . 16.5 t80 -55.24 -42.31 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.1 m-85 -83.83 -19.26 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.8 t -58.41 -11.71 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.3 -26.32 64.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.98 -30.97 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.17 156.31 23.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.421 ' HA ' ' CE ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -70.24 133.49 47.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.27 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.124 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -86.1 -56.43 3.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 179' ' ' VAL . 9.7 t70 -137.59 159.08 42.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 21.2 t -138.73 119.63 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -110.8 117.45 33.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.78 113.94 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.822 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 pt . . . . . 0 N--CA 1.458 -0.052 0 CA-C-O 120.89 0.376 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -149.86 168.0 24.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.22 133.08 45.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 152' ' ' VAL . 50.2 t -118.77 120.2 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.17 104.37 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -78.78 159.77 27.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.6 t -61.79 -33.31 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -140.06 152.36 46.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 17.5 tt -68.85 -31.68 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . 0.41 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 27.4 mt-30 -64.33 -10.33 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 t -92.83 -18.07 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -60.28 -43.24 92.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.595 0.712 . . . . 0.0 111.129 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.01 -52.13 8.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.632 2.222 . . . . 0.0 112.328 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.85 -37.93 83.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . 0.605 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -64.95 -32.57 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.084 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.7 -43.33 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.36 -42.0 99.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 77.1 mt -41.23 -28.72 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 75.8 m -36.85 107.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.86 11.59 7.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.457 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.495 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.25 119.13 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.959 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -56.5 108.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.14 112.97 24.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.9 mt 61.18 26.51 16.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.19 -30.24 10.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.46 121.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.529 0.681 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.05 153.87 6.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 169' ' ' PHE . 19.8 tt -112.08 153.23 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.418 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.9 mm -112.38 132.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 207' ' ' ALA . 11.7 t -131.97 120.61 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -151.36 142.37 23.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.928 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 C--O 1.232 0.164 0 CA-C-O 120.845 0.355 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 196' ' ' VAL . 12.0 p -116.57 149.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.148 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -100.83 137.92 38.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 91.4 m -127.62 149.82 50.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.6 mtm -151.84 -179.3 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.459 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.8 tt0 54.67 47.05 23.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 194' ' ' ALA . 72.4 mt -75.81 165.37 25.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -81.72 175.76 10.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.87 -34.21 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -118.14 47.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.646 HD13 HD22 ' A' ' 157' ' ' LEU . 14.3 tt -90.3 153.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -136.47 152.52 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.55 0.691 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -45.41 16.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.663 2.242 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -48.74 64.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -47.41 -63.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 -45.81 74.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -47.03 -68.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.27 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 215' ' ' LEU . 44.4 t80 -54.68 -29.56 53.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . 23.0 m-85 -95.29 -12.34 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.5 p -67.71 -4.21 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.54 -21.36 41.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.22 -27.56 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.71 159.67 29.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.448 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -74.67 134.98 41.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 179' ' ' VAL . 80.0 t -95.76 116.48 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.05 -43.49 43.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -153.32 158.0 40.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 196' ' ' VAL . 86.7 t -137.07 141.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.38 120.03 30.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.68 114.39 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 28.2 mm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.841 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.83 0.348 . . . . 0.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.683 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.09 137.01 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -103.4 112.73 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 152' ' ' VAL . 56.2 t -109.54 141.93 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -118.42 153.21 34.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 170' ' ' PHE . 63.2 m-85 -123.05 -177.32 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 51.3 m -85.49 -21.73 28.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.49 144.39 29.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . 0.403 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 14.7 tt -70.86 -27.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -65.27 -9.61 25.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -94.89 -18.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -59.28 -43.56 96.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.0 Cg_exo -47.9 -51.59 9.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.371 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.11 -43.57 95.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.36 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.77 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.12 -32.88 85.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.535 HD22 ' NE2' ' A' ' 213' ' ' GLN . 71.2 mt -55.78 -20.47 15.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.955 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.9 m -36.75 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.93 14.09 6.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.535 ' NE2' HD22 ' A' ' 210' ' ' LEU . 27.0 mt-30 -88.65 106.29 18.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -45.9 106.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 169' ' ' PHE . 21.2 tp -108.43 107.06 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.2 mt 65.82 27.08 11.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.66 -18.15 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.24 115.21 31.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.695 0.759 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.69 149.79 13.36 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.2 tt -115.04 149.74 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.0 mm -109.0 125.62 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 17.3 t -120.51 124.2 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -143.62 165.79 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 179.871 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.1 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.802 0.334 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.1 p -113.92 149.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.65 120.72 40.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.4 m -106.29 154.48 20.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 54.2 mtm -155.54 176.68 12.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.47 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.4 tt0 57.69 52.05 8.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 194' ' ' ALA . 81.4 mt -81.45 166.78 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -90.68 174.17 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.05 -40.4 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -108.29 43.67 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 14.4 tt -92.94 153.71 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.81 153.92 79.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.578 0.704 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.5 -39.32 17.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.608 2.205 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 165' ' ' ASP . 12.0 mtt-85 -57.93 -59.74 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 164' ' ' ARG . 15.0 m-20 -34.43 -41.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.48 -43.78 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' ARG . 50.6 mt-10 -42.7 -66.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 171' ' ' SER . 33.4 t70 -62.15 -53.46 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.641 ' CD2' HD13 ' A' ' 215' ' ' LEU . 1.5 t80 -45.46 -30.05 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -95.25 -20.92 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 168' ' ' ASP . 20.5 t -61.51 -9.49 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.86 62.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.33 -33.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.63 152.5 22.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -73.72 142.8 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.674 HG11 ' CG2' ' A' ' 179' ' ' VAL . 92.0 t -103.18 136.55 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -113.06 -39.07 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -141.11 134.58 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.674 ' CG2' HG11 ' A' ' 176' ' ' VAL . 59.6 t -134.94 102.89 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 -96.04 107.81 20.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 94.4 mt -98.08 117.57 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.911 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.4 pt . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -144.96 148.01 33.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -110.33 135.64 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.6 t -129.01 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.13 103.79 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' PHE . . . . . 0.443 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.3 m-85 -73.85 161.51 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.98 -33.55 74.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.26 170.33 15.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -84.27 -28.93 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.6 -6.8 27.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 t -95.34 -22.26 17.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.0 t -57.09 -43.72 99.44 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.579 0.704 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.92 -60.15 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.719 2.279 . . . . 0.0 112.415 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 72.6 mt -52.3 -42.42 63.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.76 85.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.25 -43.68 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.8 99.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.491 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 211' ' ' THR . 49.0 mt -42.33 -29.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 210' ' ' LEU . 51.5 m -33.97 123.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 101.24 17.7 21.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 39.2 mt-30 -93.7 109.82 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -51.49 99.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . 0.641 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.7 tp -101.46 105.63 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.1 mt 65.83 25.39 11.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.62 -19.75 51.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.0 114.33 37.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.719 0.771 . . . . 0.0 111.058 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.6 149.27 13.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.603 2.202 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -111.49 156.17 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.175 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 4.6 mm -119.55 135.44 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.02 122.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -145.48 143.13 29.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 53.4 p -172.19 143.71 1.53 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.9 0.381 . . . . 0.0 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 86.5 p -163.65 164.26 24.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.843 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 120.33 136.33 5.15 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.491 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.3 p -171.95 167.43 6.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.863 0.364 . . . . 0.0 110.835 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 13.1 m -129.9 137.57 50.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 169.31 -172.63 43.53 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.532 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.45 157.89 45.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.801 0.334 . . . . 0.0 110.843 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.7 p -107.55 95.33 13.71 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.681 0.753 . . . . 0.0 110.841 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -74.92 159.45 41.61 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.704 2.269 . . . . 0.0 112.266 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.7 t -64.48 -28.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.112 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.9 ttt-85 -131.17 143.97 51.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.881 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -128.57 143.7 49.36 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.649 0.738 . . . . 0.0 110.806 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.51 -173.04 1.64 Allowed 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.669 2.246 . . . . 0.0 112.377 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.6 m -86.06 41.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -98.58 165.17 11.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -61.06 156.93 16.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.954 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 6.0 tp -46.13 141.81 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.8 m -103.33 147.16 33.75 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.672 0.749 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.78 -19.01 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.65 2.233 . . . . 0.0 112.348 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -96.49 -45.3 6.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -55.08 -35.04 64.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.929 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.512 ' CG ' ' N ' ' A' ' 148' ' ' ASP . 14.6 ptt180 -47.83 -48.92 30.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.81 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' CG ' ' A' ' 147' ' ' ARG . 33.1 t70 -61.39 -44.9 96.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -46.69 -51.39 16.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.078 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -83.94 43.99 0.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.863 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 42.1 m -130.67 131.96 45.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.1 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.2 p -110.05 149.56 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.1 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.516 ' CE1' ' HB ' ' A' ' 193' ' ' ILE . 14.8 t80 -110.66 124.1 51.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.414 ' C ' ' HG3' ' A' ' 155' ' ' MET . 41.9 m -113.79 161.16 17.89 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.414 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 33.9 mtm -155.03 179.52 9.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.858 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.435 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.1 tt0 55.98 46.07 22.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.915 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.721 HD22 HD13 ' A' ' 161' ' ' ILE . 62.5 mt -79.06 159.56 27.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.0 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.491 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -69.43 174.18 5.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.168 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.82 -38.26 38.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.132 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.3 tpt180 -118.39 50.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.721 HD13 HD22 ' A' ' 157' ' ' LEU . 14.7 tt -89.96 156.8 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.04 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.4 mtm105 -131.51 155.06 81.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.66 0.743 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.02 -47.2 14.79 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.658 2.239 . . . . 0.0 112.327 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -52.92 -53.92 42.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 165' ' ' ASP . 0.7 OUTLIER -39.73 -45.73 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.931 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.4 mt -76.89 -46.84 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.883 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -45.1 -65.61 0.51 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -59.19 -46.31 88.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.812 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -54.17 -28.77 42.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.902 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.42 -8.56 32.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.848 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -70.24 -5.9 30.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -78.21 -23.6 47.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.117 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -113.5 -31.86 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.166 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.48 158.57 31.52 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.521 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -78.29 136.44 37.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.821 0.343 . . . . 0.0 110.918 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.406 HG11 ' CG2' ' A' ' 179' ' ' VAL . 65.8 t -97.9 140.74 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.126 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.73 -36.26 6.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.451 ' CG ' ' OE1' ' A' ' 197' ' ' GLU . 0.5 OUTLIER -151.49 152.34 32.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.406 ' CG2' HG11 ' A' ' 176' ' ' VAL . 99.3 t -141.19 109.3 2.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -96.53 106.71 19.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.837 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 83.3 mt -96.05 131.42 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.18 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.7 mm -96.3 120.78 46.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.186 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 5.0 t -111.56 -32.16 6.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.94 117.82 5.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.883 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -61.62 110.74 1.58 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 35.6 m-20 -92.87 -46.47 7.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 70.1 m -118.54 147.42 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.88 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -39.02 -55.62 1.55 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -44.77 123.8 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.878 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 17.0 t -77.95 83.49 4.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.878 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -124.92 153.01 43.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.905 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -117.86 104.85 1.18 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.457 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.516 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 29.0 pt -98.71 143.47 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 111.118 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.641 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -141.92 157.88 44.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -122.18 134.85 54.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.85 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.556 ' O ' HG12 ' A' ' 152' ' ' VAL . 60.6 t -131.08 128.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.112 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . 0.451 ' OE1' ' CG ' ' A' ' 178' ' ' ASP . 41.5 mt-10 -94.84 129.99 41.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.855 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -103.08 159.66 15.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.842 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.0 p -58.58 -32.21 68.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.879 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -148.01 164.91 32.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.0 tt -78.53 -20.72 13.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.421 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.1 mm-40 -73.53 -12.35 60.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.867 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 38.0 t -92.42 -14.41 28.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.888 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.5 t -63.8 -43.32 76.04 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.632 0.73 . . . . 0.0 111.092 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.7 Cg_exo -47.92 -47.96 17.5 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.697 2.265 . . . . 0.0 112.325 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.1 mt -62.5 -45.0 95.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.883 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.5 -43.2 83.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.7 mt -52.21 -47.53 44.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.187 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -55.47 -43.99 85.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.507 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.58 HD22 ' NE2' ' A' ' 213' ' ' GLN . 86.6 mt -40.32 -28.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.428 ' C ' ' O ' ' A' ' 210' ' ' LEU . 53.2 m -35.52 102.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.183 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 117.64 21.12 4.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.512 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.58 ' NE2' HD22 ' A' ' 210' ' ' LEU . 17.9 mt-30 -98.28 110.03 22.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.338 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.6 mtt180 -46.75 107.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 22.4 tp -116.24 108.51 16.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.944 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.0 mt 66.35 27.37 10.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 95.42 -15.52 63.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.24 118.99 25.07 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.616 0.722 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.07 152.27 5.11 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.284 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.8 tt -115.5 149.29 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.061 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.435 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.3 mm -108.87 141.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.143 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -138.03 127.33 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.178 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -150.55 151.3 32.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -60.34 113.63 2.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.076 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 10.4 p -56.41 -32.18 64.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.842 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 229' ' ' LYS . 15.0 pt20 -70.74 -41.39 71.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -42.7 -55.5 3.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -62.86 -21.9 66.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.912 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.431 ' N ' ' O ' ' A' ' 226' ' ' GLN . 25.7 tptp -79.89 -62.35 1.71 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -38.74 -39.9 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.33 -58.27 8.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.825 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.0 tt -41.5 -50.84 3.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.903 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 68.5 m -74.99 160.85 30.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -61.09 157.62 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.52 -27.28 3.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.656 2.238 . . . . 0.0 112.335 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 6.0 m -80.36 174.6 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.816 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 7.9 t -43.14 159.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.843 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.239 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.472 179.981 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 83.0 p -139.23 128.98 24.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.849 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.1 m -43.07 112.91 0.42 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -132.4 -55.12 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.455 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.6 t -92.43 -48.59 6.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.906 0.384 . . . . 0.0 110.816 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 58.3 m 43.31 42.49 3.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.846 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 135.07 110.15 1.08 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.509 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.5 mmmm -53.68 141.92 24.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.782 0.325 . . . . 0.0 110.864 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.1 m -55.74 143.52 59.55 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.701 0.762 . . . . 0.0 110.862 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.17 110.01 2.8 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.658 2.239 . . . . 0.0 112.342 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 82.9 t -125.27 105.97 15.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.155 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 25.4 mtt85 -138.6 111.23 7.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -136.11 138.17 26.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.595 0.712 . . . . 0.0 110.938 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -79.43 172.85 13.93 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.713 2.275 . . . . 0.0 112.372 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.8 m -79.72 167.58 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.168 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -161.67 122.64 2.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.795 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -59.86 164.85 3.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.19 94.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 15.4 m -100.13 158.72 31.49 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.672 0.748 . . . . 0.0 110.818 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.04 -19.42 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 0.0 112.362 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 58.2 mt-10 -89.61 -39.55 13.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -59.86 -35.73 75.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -50.65 -48.96 58.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.869 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -57.63 -53.67 55.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.45 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -40.01 -44.48 1.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.098 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.448 ' NH2' ' O ' ' A' ' 199' ' ' CYS . 2.5 mtp-105 -83.35 37.7 0.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m -133.28 141.62 48.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.441 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.6 p -119.8 146.19 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -98.15 127.76 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.423 ' C ' ' HG3' ' A' ' 155' ' ' MET . 64.7 m -115.54 149.61 37.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 22.9 mtm -149.37 -179.94 7.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.829 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.6 tt0 55.44 50.38 14.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.906 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.675 ' HB3' HG21 ' A' ' 161' ' ' ILE . 79.5 mt -79.24 163.21 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.741 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.67 171.72 13.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.67 -30.5 59.41 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.091 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -126.88 33.67 4.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.741 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.7 tt -71.57 150.88 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.5 mtt-85 -128.83 150.35 74.78 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.576 0.703 . . . . 0.0 110.832 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -45.33 -36.12 12.44 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.701 2.267 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -61.42 -59.62 4.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -38.54 -36.86 0.27 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.859 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.531 HD21 HD11 ' A' ' 161' ' ' ILE . 23.9 mt -80.8 -50.89 9.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.933 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -39.17 -60.83 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.974 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -65.77 -44.98 84.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.597 ' CD2' HD13 ' A' ' 215' ' ' LEU . 23.3 t80 -52.21 -32.55 37.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.883 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -92.64 -16.17 25.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.3 m -66.5 -10.05 40.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.842 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.25 -20.35 60.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.077 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.6 m -117.75 -28.14 2.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.134 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.39 151.84 14.41 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.505 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -62.75 137.11 58.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.78 0.324 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 53.1 t -94.77 126.14 47.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.12 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.406 ' C ' ' HD3' ' A' ' 177' ' ' ARG . 0.0 OUTLIER -87.04 -60.59 1.94 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.899 -179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -138.73 149.5 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 196' ' ' VAL . 60.1 t -136.84 105.15 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.139 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -96.54 104.3 16.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.34 107.89 18.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.094 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 29.1 mm -69.48 106.52 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.124 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 11.8 p -102.96 150.57 23.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.804 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -134.23 178.63 6.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.865 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -92.08 -53.7 4.14 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.819 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -121.95 135.61 54.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -112.43 140.67 46.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -120.93 -59.89 1.7 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.847 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -129.84 -51.2 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 59.9 p -51.53 135.23 28.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.805 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 192' ' ' GLY . 23.4 mmmt -95.88 133.73 39.69 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.94 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 191' ' ' LYS . . . -34.78 111.41 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.454 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.5 pt -97.82 148.83 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.808 0.337 . . . . 0.0 111.119 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -145.29 143.91 30.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.043 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -104.11 147.06 27.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.941 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.547 HG22 HG22 ' A' ' 179' ' ' VAL . 50.9 t -139.64 130.23 31.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.107 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -105.23 124.86 50.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -100.01 155.19 17.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.905 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.448 ' O ' ' NH2' ' A' ' 150' ' ' ARG . 26.7 p -63.21 -24.85 68.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -141.19 152.14 44.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.45 HD12 ' HB1' ' A' ' 149' ' ' ALA . 15.9 tt -76.78 -28.63 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.428 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 13.6 mm100 -67.73 -7.2 25.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.435 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 66.7 m -92.77 -25.49 18.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.87 -43.65 98.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.588 0.708 . . . . 0.0 111.104 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.8 Cg_exo -47.95 -58.63 1.63 Allowed 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.635 2.223 . . . . 0.0 112.411 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.4 mt -52.83 -44.68 66.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -57.68 -38.26 74.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.11 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 93.4 mt -60.24 -44.01 94.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.1 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.89 -33.34 85.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.524 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 211' ' ' THR . 39.0 mt -56.4 -24.9 47.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.912 0.387 . . . . 0.0 110.921 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 210' ' ' LEU . 12.5 m -36.76 118.13 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.194 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.62 26.23 6.25 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.449 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -102.51 110.41 22.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -47.49 104.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 169' ' ' PHE . 29.6 tp -109.57 108.02 18.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 26.3 mt 66.47 25.03 10.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.894 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.85 -16.32 59.68 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.506 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.2 t -123.35 115.72 28.55 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.688 . . . . 0.0 111.116 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.82 149.6 14.1 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.712 2.275 . . . . 0.0 112.356 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.4 tt -113.34 158.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.107 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.452 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.1 mm -119.22 133.49 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 15.8 t -129.87 119.03 46.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.123 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -138.59 156.03 47.83 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -65.57 139.39 58.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 16.7 m -88.57 42.57 1.08 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.883 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.456 ' HG3' ' N ' ' A' ' 227' ' ' ALA . 12.5 pt20 -94.47 -42.04 9.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.973 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.456 ' N ' ' HG3' ' A' ' 226' ' ' GLN . . . -70.71 -55.53 8.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -39.86 -41.67 1.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 21.5 tptt -69.7 -53.97 16.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -47.72 -57.24 5.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -50.78 -42.64 58.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.3 tp -53.83 142.73 23.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 64.2 p -78.17 143.5 37.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 94.68 73.22 1.19 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.438 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.01 -18.61 14.43 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.713 2.275 . . . . 0.0 112.288 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 26.6 t -87.43 134.89 33.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.861 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 15.3 m -73.59 127.29 32.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.9 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.471 179.977 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 N-CA-C 112.451 -0.259 . . . . 0.0 112.451 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.0 m -113.89 163.39 15.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.888 0.375 . . . . 0.0 110.813 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 36.7 t -148.35 143.95 27.21 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.825 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.27 98.23 0.15 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.516 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 t -146.87 120.04 8.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.856 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.7 p -93.17 155.95 17.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.855 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 129.26 109.31 1.39 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.8 mtpt -72.04 151.83 42.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.838 0.352 . . . . 0.0 110.902 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 60.2 m -140.91 141.38 24.09 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.65 0.738 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.23 172.07 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.662 2.242 . . . . 0.0 112.361 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 85.5 t -53.58 116.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.115 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 137' ' ' GLU . 20.8 mtp85 -149.54 173.33 13.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.826 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' C ' ' O ' ' A' ' 136' ' ' ARG . 5.9 mm-40 -37.26 154.73 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.671 0.748 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.11 126.66 8.76 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.599 2.199 . . . . 0.0 112.351 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.0 m -125.92 174.04 10.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.137 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.74 -51.29 61.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -40.94 149.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.881 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.609 HD13 ' N ' ' A' ' 143' ' ' SER . 0.2 OUTLIER -40.15 117.61 0.8 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.609 ' N ' HD13 ' A' ' 142' ' ' LEU . 3.7 p -125.69 160.29 56.86 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.65 0.738 . . . . 0.0 110.844 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.19 -19.36 0.34 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.723 2.282 . . . . 0.0 112.291 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -86.03 -41.24 14.99 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.907 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.22 -39.98 67.23 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -46.84 -42.85 17.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -67.19 -54.98 16.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.922 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.554 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -42.17 -39.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.052 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -87.7 43.99 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 61.9 m -136.9 126.11 24.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.193 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.401 HG21 ' CG1' ' A' ' 222' ' ' VAL . 7.3 p -102.5 149.02 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.139 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.608 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 14.0 t80 -102.48 117.19 34.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 35.4 m -107.74 153.09 23.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 38.0 mtm -151.26 177.3 10.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.896 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.447 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.4 tt0 59.31 50.81 7.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.929 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 166' ' ' LEU . 58.3 mt -95.22 150.18 20.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.922 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -62.35 168.63 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.82 23.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.176 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -98.28 42.01 1.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.865 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.1 tt -88.04 157.95 3.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 55.5 mtt180 -127.26 143.65 47.9 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.626 0.727 . . . . 0.0 110.918 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.95 -29.49 8.46 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.759 2.306 . . . . 0.0 112.288 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 165' ' ' ASP . 18.7 mmt85 -66.47 -58.45 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.48 ' OD2' HD11 ' A' ' 216' ' ' LEU . 43.3 m-20 -34.99 -45.39 0.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 157' ' ' LEU . 29.4 mt -68.79 -46.26 69.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.474 ' HA ' HG21 ' A' ' 176' ' ' VAL . 29.9 mt-10 -47.11 -68.6 0.18 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.952 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -56.54 -50.26 72.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.65 ' CE2' HG21 ' A' ' 220' ' ' ILE . 22.1 t80 -49.39 -31.64 9.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.524 ' CE2' HG21 ' A' ' 196' ' ' VAL . 27.1 m-85 -95.87 -11.54 26.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.1 t -66.51 -5.61 11.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.84 -20.16 53.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.127 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 m -121.01 -30.74 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.57 153.72 24.15 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.461 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -77.0 134.23 38.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 110.877 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 167' ' ' GLU . 88.0 t -94.29 128.21 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.2 ptt85 -96.22 -41.27 8.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.808 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -146.6 154.78 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.459 ' CG2' HG11 ' A' ' 176' ' ' VAL . 25.4 t -143.76 107.29 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.083 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -92.87 105.08 17.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.899 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 95.0 mt -96.72 123.08 48.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.169 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 38.5 mm -79.96 119.04 28.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.181 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 24.0 t -127.38 80.94 1.99 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.443 ' OD2' ' NH1' ' A' ' 185' ' ' ARG . 24.8 t0 -126.99 -59.18 1.27 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.824 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.443 ' NH1' ' OD2' ' A' ' 184' ' ' ASP . 0.7 OUTLIER -110.79 39.52 2.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.859 -179.846 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -50.69 -27.07 6.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 50.0 m -101.98 -60.32 1.55 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 8.0 tpt85 -43.74 -31.07 0.73 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.862 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.5 mmt180 -109.6 -10.65 14.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.864 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 3.0 m 46.95 36.85 4.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.83 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 18.7 mmmt -134.01 -177.88 4.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.94 113.04 0.55 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.501 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 41.4 pt -118.4 141.6 37.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.821 0.343 . . . . 0.0 111.126 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.25 157.65 43.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.072 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.608 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 98.8 m-85 -114.64 125.44 53.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 170' ' ' PHE . 82.6 t -109.46 122.66 64.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.103 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -94.11 106.37 18.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.915 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -78.29 166.25 22.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 45.9 t -71.73 -35.75 70.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.884 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -133.93 165.78 24.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.904 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.554 HD12 ' HB1' ' A' ' 149' ' ' ALA . 20.8 tt -84.65 -24.48 7.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -75.06 -9.76 58.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 -11.89 27.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.6 t -64.73 -43.75 70.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.642 0.734 . . . . 0.0 111.141 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.4 Cg_exo -48.02 -54.2 5.56 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.607 2.205 . . . . 0.0 112.326 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 96.9 mt -57.64 -33.37 68.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.9 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.428 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -69.92 -34.85 74.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.114 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.17 -38.63 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 -40.32 98.72 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.522 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.467 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 95.7 mt -42.26 -32.17 0.47 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.894 0.378 . . . . 0.0 110.902 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 210' ' ' LEU . 57.3 m -35.79 98.18 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.121 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 126.29 7.42 5.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.467 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.493 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -90.83 116.73 28.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 0.0 110.922 -179.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -53.11 108.71 0.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.843 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -115.32 117.08 29.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.985 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.48 HD11 ' OD2' ' A' ' 165' ' ' ASP . 46.6 mt 61.64 24.96 14.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.933 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.23 -29.23 12.94 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 87.2 t -117.64 124.98 28.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.565 0.698 . . . . 0.0 111.139 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.32 153.84 6.65 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.728 2.285 . . . . 0.0 112.356 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.65 HG21 ' CE2' ' A' ' 169' ' ' PHE . 14.1 tt -116.48 154.28 18.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.447 HG12 ' CB ' ' A' ' 156' ' ' GLN . 8.5 mm -110.12 142.35 22.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.08 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.428 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.5 t -142.82 118.39 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.15 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -149.47 148.9 29.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -45.78 125.06 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.08 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.408 ' CB ' ' HB2' ' A' ' 153' ' ' PHE . 23.2 t -76.65 50.17 0.67 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.839 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -85.86 43.61 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -107.75 -36.46 6.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.148 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -65.01 -44.93 87.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.71 -40.79 61.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.938 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -61.54 -48.09 82.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' A' ' 232' ' ' LEU . 23.8 ttm180 -60.04 -52.11 66.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -36.0 -54.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.944 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.88 -43.75 71.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 149.64 145.8 4.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.18 42.1 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.686 2.257 . . . . 0.0 112.335 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.4 t -56.03 123.51 14.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.0 p -42.83 -45.89 5.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.851 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.97 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 p -140.3 148.46 41.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.948 0.404 . . . . 0.0 110.872 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.3 m -132.12 109.11 9.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.822 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 94.51 175.16 38.69 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.456 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 49.7 m -93.9 -55.18 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.401 . . . . 0.0 110.839 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 19.2 m -73.33 152.89 40.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.864 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.27 -135.31 2.97 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.503 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.08 124.17 19.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.764 0.316 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.2 p -128.71 94.42 34.91 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.626 0.727 . . . . 0.0 110.92 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -43.73 124.33 4.39 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.637 2.224 . . . . 0.0 112.389 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 92.7 t -75.61 150.04 6.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.8 171.72 19.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.995 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.38 155.68 51.36 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.674 0.75 . . . . 0.0 110.84 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -45.22 122.38 4.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.682 2.254 . . . . 0.0 112.248 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.9 m -110.73 178.65 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.107 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -90.96 105.16 17.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.917 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 142' ' ' LEU . 31.7 m-20 -171.99 173.57 4.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.854 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.52 HD21 ' NH2' ' A' ' 150' ' ' ARG . 1.3 tm? -34.74 115.44 0.27 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.945 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 95.4 p -82.33 147.25 56.21 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.649 0.738 . . . . 0.0 110.848 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -48.88 -16.05 0.72 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.723 2.282 . . . . 0.0 112.394 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.41 -44.39 13.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -55.18 -42.31 73.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -58.72 -41.32 86.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -55.94 -48.61 75.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.42 -53.57 13.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.52 ' NH2' HD21 ' A' ' 142' ' ' LEU . 46.2 mtm180 -82.5 46.8 1.09 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.849 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 74.3 m -140.61 138.6 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.131 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 7.6 p -114.19 152.42 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.096 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.7 t80 -109.01 122.58 47.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.872 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 60.9 m -111.32 152.37 27.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.464 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.8 mtm -147.22 175.5 10.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.863 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.424 ' CB ' HG12 ' A' ' 221' ' ' ILE . 3.1 tt0 56.52 54.37 7.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.539 HD22 HD13 ' A' ' 161' ' ' ILE . 87.3 mt -91.96 156.91 17.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.889 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -74.28 169.56 17.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.134 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -78.78 -44.49 23.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.098 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 19.0 mtm105 -98.57 46.67 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.84 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.539 HD13 HD22 ' A' ' 157' ' ' LEU . 17.9 tt -91.71 148.86 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -121.2 143.16 36.61 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-O 121.597 0.713 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -46.01 -30.51 7.34 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.656 2.237 . . . . 0.0 112.377 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.442 ' O ' ' C ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -68.43 -55.83 10.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 164' ' ' ARG . 2.1 m-20 -35.23 -44.54 0.27 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.859 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.41 HD12 HG11 ' A' ' 179' ' ' VAL . 26.7 mt -71.69 -52.56 17.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.9 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -38.5 -68.37 0.16 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.964 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 171' ' ' SER . 0.8 OUTLIER -56.9 -56.13 25.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.833 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.436 ' CE2' HG21 ' A' ' 220' ' ' ILE . 38.7 t80 -44.17 -29.74 0.67 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.619 ' CE2' HG21 ' A' ' 196' ' ' VAL . 23.8 m-85 -95.34 -21.8 18.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.899 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.464 ' N ' ' O ' ' A' ' 168' ' ' ASP . 4.2 t -58.67 -14.16 7.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -67.84 -29.47 68.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.104 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.1 m -110.08 -30.9 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.204 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -169.53 150.99 16.21 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -68.08 138.13 55.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.819 0.342 . . . . 0.0 110.971 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 50.1 t -100.05 134.66 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.087 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttt180 -92.77 -56.98 2.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.933 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -136.8 161.21 36.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.41 HG11 HD12 ' A' ' 166' ' ' LEU . 99.0 t -140.86 106.58 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -93.19 103.95 16.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -94.1 119.99 42.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.115 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.448 ' CG1' HG13 ' A' ' 193' ' ' ILE . 14.9 mm -67.99 145.96 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.15 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.1 t 75.02 40.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -104.9 -32.22 8.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 186' ' ' ASN . 0.3 OUTLIER -116.57 77.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.925 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 185' ' ' ARG . 7.0 p-10 37.81 40.01 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 3.3 m -94.85 166.27 12.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -38.59 155.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -109.41 132.96 53.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 191' ' ' LYS . 9.1 t -172.82 176.35 3.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.827 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.611 ' O ' HG23 ' A' ' 193' ' ' ILE . 0.0 OUTLIER -35.38 126.4 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.836 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -51.77 89.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.611 HG23 ' O ' ' A' ' 191' ' ' LYS . 24.6 pt -111.5 146.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.814 0.34 . . . . 0.0 111.14 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.434 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -153.8 153.76 32.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.52 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 96.0 m-85 -109.04 135.34 50.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.921 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.619 HG21 ' CE2' ' A' ' 170' ' ' PHE . 87.2 t -118.88 133.45 65.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.19 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -97.89 112.81 24.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.463 ' HE2' HG11 ' A' ' 152' ' ' VAL . 39.1 m-85 -89.0 162.13 16.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 10.9 t -64.87 -43.38 93.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.892 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -137.04 162.45 33.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 18.8 tt -73.51 -22.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.069 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -74.09 -6.46 47.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 66.1 m -97.83 -18.04 18.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.2 t -61.68 -43.49 88.25 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.646 0.736 . . . . 0.0 111.176 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.2 Cg_exo -48.02 -55.28 4.17 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.9 mt -58.2 -35.7 72.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.968 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -67.5 -34.89 78.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.079 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 71.9 mt -62.94 -40.89 90.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.081 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.27 -33.87 87.4 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.502 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.474 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.4 mt -50.42 -27.6 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.888 0.375 . . . . 0.0 110.967 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 19.8 m -38.01 99.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.195 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 125.38 9.88 4.81 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.459 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.486 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.04 117.91 29.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.721 0.296 . . . . 0.0 110.977 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.6 mtt180 -54.51 109.9 0.56 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.82 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -113.21 112.73 24.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.963 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.1 mt 61.39 25.4 15.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.908 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.0 -30.63 9.84 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.465 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -114.74 121.34 35.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.712 0.768 . . . . 0.0 111.074 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -50.76 154.15 7.22 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 0.0 112.415 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.2 tt -116.77 152.73 18.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.129 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.424 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.3 mm -109.63 148.72 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.184 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 22.5 t -146.16 126.33 6.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.097 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -149.63 151.21 33.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.906 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.09 107.53 0.55 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.111 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.2 t -49.37 -36.93 23.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -94.7 41.0 1.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.923 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.407 ' HB1' ' NH1' ' A' ' 231' ' ' ARG . . . -67.15 -45.5 76.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.009 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.503 ' OE2' HD13 ' A' ' 232' ' ' LEU . 2.4 tm-20 -58.46 -56.53 20.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -51.29 -57.83 7.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -56.55 -41.66 77.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.407 ' NH1' ' HB1' ' A' ' 227' ' ' ALA . 42.5 mtt85 -92.31 56.68 2.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.503 HD13 ' OE2' ' A' ' 228' ' ' GLU . 15.0 tp -129.41 -49.21 1.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.948 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 p -101.03 135.61 42.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -60.88 145.2 48.19 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.515 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -78.35 98.78 1.22 Allowed 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.676 2.251 . . . . 0.0 112.335 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 1.7 t -59.31 106.01 0.4 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 13.3 m -128.02 -55.99 1.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.42 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -121.62 109.87 15.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.881 0.372 . . . . 0.0 110.878 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.4 t -136.4 130.34 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.452 ' O ' ' C ' ' A' ' 129' ' ' SER . . . 123.51 -92.87 0.46 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.504 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 128' ' ' GLY . 69.8 m 34.36 52.14 0.5 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.945 0.402 . . . . 0.0 110.817 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 18.7 m -119.51 42.9 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.81 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 132' ' ' LYS . . . 119.78 -107.35 1.33 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.49 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 131' ' ' GLY . 14.2 ptpt 34.42 45.39 0.13 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.799 0.333 . . . . 0.0 110.873 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 53.8 p -99.65 139.11 20.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.599 0.714 . . . . 0.0 110.906 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -79.39 137.92 13.56 Favored 'Trans proline' 0 N--CA 1.466 -0.118 0 C-N-CA 122.738 2.292 . . . . 0.0 112.366 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.2 m -87.26 173.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.5 mtt180 -48.56 114.2 0.92 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -136.84 148.79 64.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.651 0.738 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.18 176.1 10.52 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.711 2.274 . . . . 0.0 112.306 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.9 35.9 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.133 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.35 -55.41 5.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -106.71 156.25 18.82 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -69.83 167.98 16.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -164.89 160.9 15.13 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.705 0.764 . . . . 0.0 110.877 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.4 -17.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.325 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -106.11 -49.43 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.88 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -57.65 -38.49 75.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.864 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -46.23 -44.83 16.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.859 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -69.44 -47.77 63.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -41.95 -46.65 4.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.056 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -82.29 39.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.814 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 49.5 m -137.2 120.9 17.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.144 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.812 HG12 ' O ' ' A' ' 196' ' ' VAL . 11.4 p -99.04 148.86 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -106.04 141.58 37.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.424 ' C ' ' HG3' ' A' ' 155' ' ' MET . 82.0 m -133.34 150.7 51.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.424 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 32.3 mtm -148.76 -179.44 6.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.9 tt0 61.13 46.5 8.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.878 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.573 HD11 ' CB ' ' A' ' 194' ' ' ALA . 70.1 mt -86.3 154.25 21.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.969 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -70.21 171.87 9.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.047 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.87 -43.29 36.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.121 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.34 51.63 0.74 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.937 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.469 HD13 HD22 ' A' ' 157' ' ' LEU . 15.7 tt -87.37 147.8 5.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.202 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 83.3 mtm180 -117.97 144.34 34.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.614 0.721 . . . . 0.0 110.876 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -40.65 19.51 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.625 2.217 . . . . 0.0 112.379 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 165' ' ' ASP . 26.4 mmt180 -54.97 -57.81 10.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 164' ' ' ARG . 14.2 m-20 -35.52 -47.0 0.43 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 73.6 mt -73.17 -47.6 42.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -43.82 -62.54 1.08 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -65.45 -48.89 71.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.423 ' CE2' HG21 ' A' ' 220' ' ' ILE . 17.4 t80 -47.05 -35.78 7.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.867 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.625 ' CE2' HG21 ' A' ' 196' ' ' VAL . 38.0 m-85 -91.98 -15.66 27.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 36.7 t -65.82 -6.53 12.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.862 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.25 -20.26 55.42 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.5 m -122.9 -32.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.79 154.85 25.95 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.461 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.62 139.75 42.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.857 0.36 . . . . 0.0 110.91 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.44 HG11 ' CG2' ' A' ' 179' ' ' VAL . 87.0 t -95.61 127.73 47.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 20.3 tpt85 -92.48 -49.44 6.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -142.69 145.7 33.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.822 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.44 ' CG2' HG11 ' A' ' 176' ' ' VAL . 93.2 t -127.76 115.4 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.123 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -103.0 108.56 19.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.67 112.67 38.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.9 mm -80.83 111.69 17.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.8 t -106.35 77.42 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -154.85 164.87 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -119.49 117.97 29.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.886 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -133.32 -43.04 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 42.0 m -84.55 177.96 7.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.881 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 tpt85 -82.14 -61.04 2.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -115.64 109.5 17.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.816 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.7 m -169.28 130.39 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 28.4 mmtm -75.61 -51.39 12.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.905 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 164.3 129.66 1.06 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.49 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.4 pt -96.3 140.75 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.789 0.328 . . . . 0.0 111.13 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.573 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -141.73 140.0 33.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.127 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -101.38 127.15 48.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.882 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.812 ' O ' HG12 ' A' ' 152' ' ' VAL . 78.8 t -116.56 119.38 61.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.132 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -91.59 115.59 28.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.653 ' HE2' HG11 ' A' ' 152' ' ' VAL . 38.4 m-85 -90.07 155.49 19.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.88 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.8 m -63.23 -39.97 96.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -126.77 165.05 20.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.6 tt -84.4 -29.5 7.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -71.8 -7.03 45.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.964 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -95.37 -17.38 21.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.833 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -63.07 -43.47 81.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.625 0.726 . . . . 0.0 111.175 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.3 Cg_exo -47.98 -57.31 2.41 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -54.97 -41.13 70.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.932 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.14 76.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.5 mt -64.54 -38.95 83.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.11 -38.38 96.03 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.476 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 88.3 mt -45.01 -28.36 0.67 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.948 0.404 . . . . 0.0 110.948 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 210' ' ' LEU . 41.7 m -35.41 107.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 119.29 5.75 11.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.47 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.506 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -84.51 119.54 25.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.908 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -59.49 100.17 0.07 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.938 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.7 tp -101.46 112.26 24.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 39.9 mt 61.83 25.27 15.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.11 -23.14 36.55 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.464 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -116.68 117.99 37.28 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.635 0.731 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -50.69 149.6 13.67 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.678 2.252 . . . . 0.0 112.358 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.47 HG12 ' N ' ' A' ' 221' ' ' ILE . 13.5 tt -113.49 159.49 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.115 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' N ' HG12 ' A' ' 220' ' ' ILE . 3.6 mm -118.65 148.71 21.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.142 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 21.7 t -147.0 138.72 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.102 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.419 ' OE1' HG22 ' A' ' 221' ' ' ILE . 12.9 mp0 -152.67 -177.75 6.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.916 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -89.84 115.82 27.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.092 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -75.71 57.82 1.03 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -100.55 35.11 2.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -95.53 -40.69 9.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.111 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -66.32 -47.52 73.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 13.6 pttt -45.88 -22.97 0.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.895 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -93.24 -40.21 10.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.921 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -108.14 62.45 0.61 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 9.0 tp -138.97 116.33 11.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.946 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.1 t -51.37 132.42 29.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.862 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 165.41 95.83 0.1 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.6 145.71 33.48 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.719 2.279 . . . . 0.0 112.404 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 27.9 p -111.37 141.72 44.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 23.3 t -88.22 -45.3 10.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.49 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 36.4 p -53.94 170.96 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.92 0.391 . . . . 0.0 110.888 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 8.0 t 61.66 45.22 8.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 128.91 123.36 2.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.45 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.2 m -107.91 157.72 17.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 0.0 110.874 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.2 t -121.24 112.26 18.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 130.16 43.73 0.19 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -111.76 98.1 7.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.755 0.312 . . . . 0.0 110.919 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 12.4 t -107.33 93.41 9.61 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.668 0.747 . . . . 0.0 110.843 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.18 142.9 27.88 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 0.0 112.349 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.1 p -147.27 144.5 19.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.451 ' CZ ' ' HB3' ' A' ' 136' ' ' ARG . 4.6 ptp180 -121.62 43.02 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.807 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.21 141.81 10.24 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.63 0.729 . . . . 0.0 110.889 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -79.27 154.3 24.83 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.65 2.233 . . . . 0.0 112.374 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.2 m -124.79 145.56 31.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.201 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.69 -57.74 3.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.414 ' O ' ' C ' ' A' ' 142' ' ' LEU . 39.6 p-10 -126.15 147.82 49.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 141' ' ' ASN . 13.4 mt -35.83 131.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.947 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 18.4 p -76.44 155.53 83.73 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.679 0.752 . . . . 0.0 110.855 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.72 -40.6 19.18 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.664 2.243 . . . . 0.0 112.299 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -74.73 -53.79 8.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.846 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -49.37 -42.13 41.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.5 mtp85 -58.05 -66.34 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.872 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -40.71 -47.19 2.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.595 ' HB1' ' CD1' ' A' ' 201' ' ' ILE . . . -45.43 -62.66 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 3.5 mtp-105 -43.83 -25.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.7 m -96.0 133.9 39.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.128 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.56 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.2 p -105.04 154.91 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.023 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -111.88 121.48 45.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.2 m -108.43 157.07 18.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.757 ' HG2' HG22 ' A' ' 193' ' ' ILE . 63.6 mtm -151.6 171.74 17.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.872 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.491 ' NE2' HD11 ' A' ' 221' ' ' ILE . 5.6 tt0 65.62 53.89 1.16 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 161' ' ' ILE . 66.6 mt -91.63 152.23 20.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.979 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -71.63 179.57 3.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.053 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.47 -33.65 18.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.05 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.9 mtt180 -113.93 46.54 1.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.88 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.748 HD13 HD22 ' A' ' 157' ' ' LEU . 11.8 tt -91.76 150.03 3.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.108 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -125.37 148.76 62.22 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.497 0.665 . . . . 0.0 110.935 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.6 -40.4 18.37 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.35 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 tpt85 -54.42 -52.93 60.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.817 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -41.22 -47.79 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.822 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.0 mt -72.34 -41.5 66.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -47.11 -65.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -61.14 -47.73 84.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.475 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 6.8 t80 -52.34 -33.4 42.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.406 ' CE2' HG21 ' A' ' 196' ' ' VAL . 35.3 m-85 -96.9 -14.75 21.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.916 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.6 t -67.21 -5.62 14.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.2 -26.93 38.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.136 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.9 m -110.47 -33.75 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -163.81 150.08 18.14 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -70.6 135.68 48.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.824 0.345 . . . . 0.0 110.831 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.472 HG11 ' CG2' ' A' ' 179' ' ' VAL . 93.1 t -95.72 131.15 43.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.132 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -103.94 -42.47 5.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -136.68 143.79 43.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.472 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.1 t -134.25 110.62 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.107 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 30.3 mtt85 -102.33 113.42 26.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 74.5 mt -110.55 115.5 49.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 9.4 mm -78.52 108.75 12.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.129 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.6 t -94.01 74.24 4.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.898 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -149.25 151.44 34.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -153.76 138.0 16.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.852 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -90.09 -42.21 11.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 1.7 t -127.35 165.0 20.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -49.16 -62.54 1.48 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 13.5 mtp85 -80.56 90.21 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.856 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 57.9 m -134.58 164.79 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -109.96 141.21 43.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.937 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -92.28 120.19 6.03 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.521 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.757 HG22 ' HG2' ' A' ' 155' ' ' MET . 32.7 pt -96.89 146.59 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 0.0 111.156 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.607 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -150.9 141.88 22.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.107 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -101.34 133.37 46.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.932 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.548 ' O ' HG12 ' A' ' 152' ' ' VAL . 92.3 t -120.85 119.77 60.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.138 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.96 111.97 20.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.56 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.37 150.09 22.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.828 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.4 p -52.26 -36.06 51.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.844 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -145.74 176.94 9.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.595 ' CD1' ' HB1' ' A' ' 149' ' ' ALA . 7.2 tt -87.59 -29.28 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.089 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -65.24 -7.33 12.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.936 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 45.2 t -97.26 -17.2 19.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.82 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.616 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -61.02 -43.35 90.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.612 0.72 . . . . 0.0 111.144 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 63.1 Cg_exo -47.93 -54.47 5.15 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.667 2.245 . . . . 0.0 112.392 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.2 mt -57.33 -45.65 84.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -55.99 -43.63 77.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.079 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 90.9 mt -56.67 -40.87 72.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.125 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.79 -40.48 98.86 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.514 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.552 HD22 ' NE2' ' A' ' 213' ' ' GLN . 80.0 mt -55.3 -26.3 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.875 0.369 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' ' 221' ' ' ILE . 93.3 m -35.68 104.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.7 26.64 2.53 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.51 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.552 ' NE2' HD22 ' A' ' 210' ' ' LEU . 44.8 mt-30 -101.71 106.07 17.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.836 0.351 . . . . 0.0 110.947 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -41.47 104.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.883 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.475 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.2 tp -110.06 109.99 20.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.6 mt 63.21 26.44 15.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.43 -25.37 28.56 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.476 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.6 t -115.24 118.31 40.1 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.622 0.725 . . . . 0.0 111.143 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -50.02 150.53 9.98 Favored 'Trans proline' 0 N--CA 1.465 -0.158 0 C-N-CA 122.716 2.277 . . . . 0.0 112.322 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.0 tt -110.98 149.44 13.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.519 ' HA ' HG23 ' A' ' 211' ' ' THR . 5.2 mm -112.21 142.66 23.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.105 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 60.9 t -141.07 124.82 16.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.137 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -148.02 148.25 30.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -54.61 121.0 7.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.108 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.6 t -61.93 -39.92 93.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.42 -1.39 15.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.926 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -101.48 9.27 41.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.143 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -109.5 -35.84 6.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 230' ' ' ASN . 14.3 mmmt -87.66 -46.93 9.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 229' ' ' LYS . 11.3 p-10 -34.72 -48.32 0.37 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 40.8 ttt-85 -64.08 -62.01 1.9 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.888 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -41.07 121.5 1.57 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.94 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.9 t -84.49 101.65 12.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.842 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -99.44 162.0 19.76 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.508 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.24 97.09 1.12 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.683 2.256 . . . . 0.0 112.353 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 7.8 t -52.01 108.52 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.903 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 77.8 p -100.24 139.63 35.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.842 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.487 -179.977 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.216 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 62.0 p -112.32 161.33 16.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.858 0.361 . . . . 0.0 110.844 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.2 m -102.95 138.85 39.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 109.63 177.51 21.21 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 t -147.67 159.09 44.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.939 0.399 . . . . 0.0 110.771 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.4 m -143.89 138.89 28.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -50.84 159.99 1.64 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.549 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -109.26 86.97 2.39 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.742 0.306 . . . . 0.0 110.837 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.612 ' O ' HG13 ' A' ' 135' ' ' VAL . 32.9 m -151.76 145.18 17.52 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.657 0.741 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.57 109.24 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.665 2.243 . . . . 0.0 112.37 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 133' ' ' SER . 21.4 m -120.24 163.66 17.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.091 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -100.85 104.92 16.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.904 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -121.99 156.17 59.95 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.646 0.736 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.26 -168.54 0.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.725 2.283 . . . . 0.0 112.374 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.598 ' O ' HG23 ' A' ' 139' ' ' VAL . 21.5 m -80.94 52.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.135 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.3 p-10 -119.08 87.4 2.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.859 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -165.68 165.67 18.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.412 HD23 ' CG ' ' A' ' 147' ' ' ARG . 8.4 tp -64.06 149.53 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.848 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 58.0 m -67.67 143.58 96.89 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.636 0.731 . . . . 0.0 110.9 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.98 -40.76 25.95 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.268 . . . . 0.0 112.34 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -74.17 -52.32 12.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -42.36 -45.94 4.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.933 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.412 ' CG ' HD23 ' A' ' 142' ' ' LEU . 12.3 mtp180 -47.5 -58.28 4.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.27 -49.5 73.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.13 -43.77 21.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.6 mtt-85 -83.97 38.73 0.66 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.919 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 95.7 m -139.48 138.83 36.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.112 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.6 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.75 145.11 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 10.8 t80 -103.23 120.2 40.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.894 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.492 ' HG ' ' C ' ' A' ' 194' ' ' ALA . 0.6 OUTLIER -109.7 144.19 38.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.866 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.423 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 12.4 mtm -144.46 178.29 8.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.862 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.466 ' OE1' HD11 ' A' ' 221' ' ' ILE . 3.0 tt0 57.0 51.88 9.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.46 HD22 HD21 ' A' ' 166' ' ' LEU . 28.4 mt -102.6 129.49 49.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.12 169.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.068 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.3 -35.91 40.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.122 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -99.45 45.43 0.99 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.833 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 16.8 tt -93.51 148.32 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 18.5 mmt85 -120.71 147.4 45.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.601 0.715 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.66 -41.98 19.07 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.668 2.245 . . . . 0.0 112.355 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 -56.32 -51.68 67.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.855 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -39.59 -44.93 1.54 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.851 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.46 HD21 HD22 ' A' ' 157' ' ' LEU . 68.1 mt -76.84 -48.41 18.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.909 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -40.82 -68.55 0.17 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.65 -54.94 38.03 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -47.83 -29.99 3.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -96.14 -20.57 18.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.801 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 19.3 t -65.57 -7.01 12.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.831 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.38 -23.68 57.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.3 m -112.96 -29.65 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.108 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -171.98 156.49 25.75 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.485 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 135.53 46.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.894 0.378 . . . . 0.0 110.891 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.5 t -96.05 128.16 47.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.15 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.8 tpm_? -82.76 -56.8 3.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -141.86 154.15 44.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 196' ' ' VAL . 76.9 t -133.93 121.35 38.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.077 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -110.13 107.41 17.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 68.6 mt -96.67 121.74 47.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.095 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 47.2 mm -78.25 104.53 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.144 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.3 t -99.63 44.11 1.03 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.76 144.57 30.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.914 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -111.54 41.81 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -47.79 -49.88 27.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.873 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 4.0 m -102.24 160.11 14.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -82.36 44.15 0.86 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.848 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -114.2 170.72 8.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.838 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.0 t -109.69 21.73 16.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.443 ' HE3' ' N ' ' A' ' 191' ' ' LYS . 0.3 OUTLIER -73.34 170.21 15.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -154.54 98.45 0.18 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.477 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 33.3 pt -94.09 148.05 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.823 0.344 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.492 ' C ' ' HG ' ' A' ' 154' ' ' CYS . . . -150.77 170.6 18.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.128 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.525 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 97.2 m-85 -129.33 137.23 50.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.6 ' O ' HG12 ' A' ' 152' ' ' VAL . 94.2 t -130.63 127.01 61.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -93.73 123.9 37.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.83 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.529 ' CE2' HG11 ' A' ' 152' ' ' VAL . 36.9 m-85 -94.66 162.56 13.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.878 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 21.1 p -64.42 -30.33 71.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.883 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -147.23 174.96 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 10.6 tt -84.89 -35.9 10.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.174 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -63.99 -6.71 6.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.938 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.6 t -95.18 -17.42 21.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.861 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.64 -43.37 83.55 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.62 0.724 . . . . 0.0 111.154 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.6 Cg_exo -47.99 -56.88 2.71 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.65 2.233 . . . . 0.0 112.358 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 86.7 mt -54.56 -49.03 71.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -52.52 -39.92 61.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.095 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 95.2 mt -58.57 -46.02 90.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.39 -43.5 84.93 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.511 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 211' ' ' THR . 97.5 mt -43.0 -28.18 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.867 0.365 . . . . 0.0 110.869 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.432 ' C ' ' O ' ' A' ' 210' ' ' LEU . 86.7 m -35.65 120.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 105.22 26.45 6.27 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -105.5 111.79 24.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.325 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -50.01 105.28 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.899 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.1 tp -112.09 112.47 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 28.2 mt 62.78 25.24 14.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.54 -27.55 19.78 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.508 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 92.3 t -117.36 121.07 32.63 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.633 0.73 . . . . 0.0 111.143 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -50.64 148.44 15.66 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.657 2.238 . . . . 0.0 112.37 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.445 HG12 ' N ' ' A' ' 221' ' ' ILE . 11.9 tt -106.79 154.19 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.083 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.466 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.5 mm -112.92 140.61 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.117 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.429 ' CG1' HG21 ' A' ' 152' ' ' VAL . 10.4 t -138.69 125.25 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 61.7 mt-30 -147.53 163.04 37.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -68.33 130.51 43.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.135 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.1 t -89.6 53.1 2.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.817 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.427 ' O ' ' CB ' ' A' ' 230' ' ' ASN . 21.3 pt20 -129.94 33.99 4.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -106.49 -57.62 2.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.093 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.14 -57.06 14.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -63.3 -49.65 73.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 226' ' ' GLN . 25.2 t-20 -48.13 -55.96 9.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.952 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.446 ' NE ' ' HA ' ' A' ' 231' ' ' ARG . 2.2 tpm_? -63.77 -60.58 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 5.5 tp -41.69 -46.0 3.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.931 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -148.35 137.44 21.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.885 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -116.13 176.29 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.507 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.03 -179.8 5.77 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.7 2.266 . . . . 0.0 112.369 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 17.0 t -167.08 151.09 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 43.3 t -61.36 109.67 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.846 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.435 179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 66.3 m -114.49 165.66 12.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.895 0.379 . . . . 0.0 110.855 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.7 t -121.75 -53.65 1.97 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -174.08 -113.82 0.33 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.535 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 38.4 m 57.05 42.7 25.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.907 0.384 . . . . 0.0 110.898 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 p -51.46 142.49 13.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.824 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -68.77 159.85 52.28 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 21.6 mmtp -74.76 168.31 20.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.331 . . . . 0.0 110.897 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 91.9 p -72.97 143.41 84.06 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.673 0.749 . . . . 0.0 110.891 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.74 86.06 1.75 Allowed 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.729 2.286 . . . . 0.0 112.33 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 35.3 m -76.22 165.4 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.082 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 17.6 ptt180 -96.41 140.76 30.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 29.9 mp0 -106.48 142.29 24.6 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.62 0.724 . . . . 0.0 110.853 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -47.04 153.09 1.6 Allowed 'Trans proline' 0 N--CA 1.465 -0.16 0 C-N-CA 122.697 2.264 . . . . 0.0 112.293 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -51.28 148.49 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.18 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -173.35 165.98 4.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.885 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -53.47 179.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 146' ' ' GLU . 4.7 tp -39.18 107.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.812 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 9.2 m -68.7 144.17 95.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.697 0.761 . . . . 0.0 110.867 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.63 -22.34 1.11 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.344 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -88.76 -32.2 18.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.965 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.572 ' HB3' HD12 ' A' ' 142' ' ' LEU . 22.5 mt-10 -65.7 -35.86 81.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -59.32 -34.96 72.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.918 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 151' ' ' THR . 4.9 t0 -65.14 -49.89 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.908 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -42.4 -39.93 2.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.1 mtt-85 -91.61 37.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.406 ' N ' ' O ' ' A' ' 148' ' ' ASP . 76.9 m -137.92 135.01 35.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.451 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.3 p -110.76 152.92 12.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -105.43 133.8 49.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 81.9 m -121.34 143.6 49.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 22.0 mtm -144.51 177.4 8.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.45 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.6 tt0 58.63 51.99 7.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.975 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.603 HD22 HD13 ' A' ' 161' ' ' ILE . 49.4 mt -82.28 162.55 22.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.908 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.63 174.91 11.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.124 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.69 -33.76 27.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 18.2 ttp180 -115.86 41.99 2.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.862 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.603 HD13 HD22 ' A' ' 157' ' ' LEU . 13.4 tt -86.16 158.2 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.191 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.401 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 13.9 mtt85 -136.66 146.72 56.63 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.665 0.745 . . . . 0.0 110.863 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -45.47 -33.11 8.83 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.647 2.232 . . . . 0.0 112.346 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 9.3 mmt85 -66.6 -42.62 86.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -50.95 -34.88 30.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 62.1 mt -80.54 -50.64 9.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.863 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.686 ' HA ' HG21 ' A' ' 176' ' ' VAL . 21.5 mt-10 -38.83 -66.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.942 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.51 -52.2 65.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.854 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.718 ' CD2' HD13 ' A' ' 215' ' ' LEU . 7.0 t80 -47.76 -27.59 2.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.926 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 196' ' ' VAL . 17.0 m-85 -96.96 -18.6 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 23.2 t -59.88 -12.18 7.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.825 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.19 -27.29 63.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.127 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.3 m -109.58 -32.98 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.138 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.24 161.0 32.65 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.505 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.68 138.44 48.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.811 0.338 . . . . 0.0 110.914 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 167' ' ' GLU . 72.8 t -90.79 125.38 43.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.111 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -88.03 -50.01 6.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.813 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -149.92 151.12 32.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.867 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 46.4 t -137.95 114.87 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.2 mtm180 -106.77 106.39 16.89 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 90.6 mt -96.78 115.29 35.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 41.2 mm -74.35 114.43 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 t -125.74 119.35 27.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -129.7 -48.0 1.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.881 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 20.6 mmt-85 -106.46 116.17 31.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.847 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -87.79 97.22 10.79 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 57.0 m -140.54 158.3 44.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.896 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -84.49 156.96 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.812 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 42.68 47.75 4.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.862 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.7 t -119.63 147.97 43.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -71.4 176.08 4.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.871 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -173.96 151.82 13.81 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.485 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.9 pt -114.14 143.79 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.888 0.375 . . . . 0.0 111.097 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -148.13 152.14 36.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.062 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -109.32 148.39 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 170' ' ' PHE . 91.7 t -139.2 133.96 40.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.135 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -106.81 119.29 38.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.85 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -94.31 154.17 17.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.889 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -48.03 -43.17 29.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -136.27 175.24 9.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.879 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 14.5 tt -84.2 -30.0 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -66.11 -6.44 13.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 12.0 m -95.39 -21.75 18.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -57.93 -43.51 98.61 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.655 0.74 . . . . 0.0 111.192 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.99 -55.59 3.88 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.655 2.237 . . . . 0.0 112.331 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 41.4 mt -56.08 -43.28 77.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -60.18 -36.46 77.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 57.5 mt -59.1 -47.19 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.157 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.79 -42.32 91.58 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.5 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 211' ' ' THR . 31.5 mt -43.19 -24.72 0.09 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.905 0.383 . . . . 0.0 110.967 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 18.7 m -36.39 110.2 0.11 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 109.86 19.37 8.22 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.508 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.55 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 42.2 mt-30 -92.01 110.96 22.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.788 0.328 . . . . 0.0 110.973 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 29.3 mtm180 -50.21 105.42 0.09 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.867 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.718 HD13 ' CD2' ' A' ' 169' ' ' PHE . 15.7 tp -105.77 104.56 14.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.921 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 37.1 mt 64.06 25.01 13.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.946 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 103.48 -24.53 29.71 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.488 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 95.2 t -113.23 114.21 48.43 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.634 0.731 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.38 148.53 14.49 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.662 2.242 . . . . 0.0 112.352 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 20.0 tt -113.68 153.32 15.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.128 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.45 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.7 mm -112.5 137.74 44.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.122 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 16.8 t -134.84 115.92 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.139 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -133.63 167.83 19.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.879 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -72.92 109.5 6.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.088 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' GLN . 1.7 t -62.6 -55.61 25.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 225' ' ' SER . 21.0 pt20 -36.62 -44.5 0.46 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.889 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.96 49.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.135 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -41.69 -56.66 2.56 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.856 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.447 ' O ' ' C ' ' A' ' 230' ' ' ASN . 0.0 OUTLIER -56.72 -71.06 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.879 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.447 ' C ' ' O ' ' A' ' 229' ' ' LYS . 5.3 t-20 -34.28 -58.15 0.47 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.84 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 232' ' ' LEU . 31.5 mmt180 -56.65 -60.16 3.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.951 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 231' ' ' ARG . 0.5 OUTLIER -36.54 125.15 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.903 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 95.8 p -77.72 130.87 37.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -117.69 79.98 0.3 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.485 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.17 112.15 3.34 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.678 2.252 . . . . 0.0 112.337 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 39.7 t -174.42 128.33 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.7 p -93.18 127.21 38.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.86 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.537 -179.952 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.372 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.4 m -109.94 113.45 26.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.908 0.385 . . . . 0.0 110.909 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.5 t -140.05 113.08 8.21 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.783 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -154.56 115.43 0.67 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.494 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 59.6 p -117.9 166.69 12.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.858 0.361 . . . . 0.0 110.887 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.9 t -123.23 139.59 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 177.5 167.22 35.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.425 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -127.81 177.69 6.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.811 0.339 . . . . 0.0 110.869 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.1 m -109.59 91.41 10.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.694 0.759 . . . . 0.0 110.874 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.09 119.62 5.41 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.707 2.271 . . . . 0.0 112.328 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.6 m -51.74 158.7 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.146 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 37.6 mtp85 -118.46 158.38 25.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -107.89 152.68 41.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.653 0.74 . . . . 0.0 110.875 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.94 150.02 29.66 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.721 2.28 . . . . 0.0 112.359 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -126.78 174.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -59.23 -41.99 90.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 142' ' ' LEU . 30.4 t30 -40.54 155.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.479 HD11 ' HB3' ' A' ' 146' ' ' GLU . 14.4 tp -35.58 136.59 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.923 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 m -68.42 161.7 67.6 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.652 0.739 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.67 -27.17 18.72 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.686 2.257 . . . . 0.0 112.305 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -80.44 -38.89 29.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.479 ' HB3' HD11 ' A' ' 142' ' ' LEU . 20.6 mt-10 -51.72 -29.74 19.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.924 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.463 ' HG3' ' CD2' ' A' ' 142' ' ' LEU . 47.6 mtt180 -78.73 -41.57 30.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.838 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.446 ' OD1' ' N ' ' A' ' 149' ' ' ALA . 0.2 OUTLIER -61.8 -47.89 83.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.887 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.833 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -45.45 -36.4 4.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.0 mtt180 -95.95 48.27 1.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.814 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 63.3 m -143.23 134.08 25.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.156 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.478 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 8.1 p -108.27 148.98 11.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.126 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -106.83 120.78 42.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 47.2 m -105.79 146.27 30.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.804 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 19.7 mtm -143.28 -179.3 6.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.463 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.7 tt0 53.52 51.54 15.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.896 HD22 HD13 ' A' ' 161' ' ' ILE . 99.1 mt -81.5 156.96 25.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.72 172.05 9.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.142 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.48 -35.07 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.053 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 60.7 mtt-85 -124.37 42.36 3.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.826 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.896 HD13 HD22 ' A' ' 157' ' ' LEU . 15.9 tt -74.3 164.19 3.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.488 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 44.0 mtt-85 -128.12 158.71 70.15 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.573 0.702 . . . . 0.0 110.895 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.487 ' CA ' HD11 ' A' ' 181' ' ' ILE . 56.6 Cg_endo -71.06 -9.4 25.53 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.654 2.236 . . . . 0.0 112.303 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -90.47 -41.84 11.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -49.64 -36.48 24.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.902 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 38.8 mt -77.12 -40.3 46.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.903 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -48.46 -68.46 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -57.13 -40.17 76.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 220' ' ' ILE . 24.3 t80 -61.38 -30.7 70.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.782 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -94.72 -16.12 23.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 48.3 t -67.48 -4.04 10.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.832 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.19 -17.68 51.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.141 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.9 m -125.08 -27.92 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.123 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -167.34 154.49 24.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.552 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -77.83 137.77 38.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.856 0.36 . . . . 0.0 110.8 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 196' ' ' VAL . 69.6 t -93.67 138.94 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.161 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -99.38 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.844 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -152.88 145.87 24.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.802 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 46.5 t -126.75 120.35 55.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -109.48 104.38 13.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.842 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.487 HD11 ' CA ' ' A' ' 163' ' ' PRO . 45.3 mt -93.37 103.44 14.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.134 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 37.8 mm -67.89 112.12 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.11 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.3 m -136.08 130.65 33.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.45 108.08 10.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.873 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 17.6 ttm105 -64.6 99.31 0.31 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.877 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -159.4 170.53 21.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 11.0 t -93.04 40.75 1.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.858 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 73.8 mtt-85 -113.26 128.63 56.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -79.66 111.81 16.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 96.5 p -152.79 169.03 23.78 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.857 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.84 174.93 9.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.28 118.65 4.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.54 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 46.8 pt -109.61 142.96 20.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.906 0.384 . . . . 0.0 111.052 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.82 143.29 28.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.042 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -103.85 143.19 33.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.504 HG13 HG13 ' A' ' 176' ' ' VAL . 78.9 t -131.6 122.18 49.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -87.13 124.34 33.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.44 ' HE2' HG11 ' A' ' 152' ' ' VAL . 31.4 m-85 -104.51 153.89 20.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 4.1 t -56.88 -44.71 82.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.856 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -130.93 168.91 16.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.902 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.833 HD12 ' HB1' ' A' ' 149' ' ' ALA . 20.1 tt -87.34 -28.07 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.125 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.417 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 68.3 mm-40 -64.59 -9.87 22.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.92 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 14.8 m -93.21 -15.77 25.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.848 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.613 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -63.52 -43.42 78.32 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.667 0.746 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.9 Cg_exo -47.97 -52.02 8.94 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.668 2.245 . . . . 0.0 112.321 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 99.9 mt -60.46 -44.21 96.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.454 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -59.28 -37.56 77.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.094 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 59.1 mt -58.63 -46.06 90.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.12 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -58.96 -39.41 94.1 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.46 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 211' ' ' THR . 19.5 mt -45.77 -30.41 1.63 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.968 0.413 . . . . 0.0 110.927 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.446 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.6 m -34.48 112.11 0.13 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 114.47 19.26 6.25 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.488 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.411 ' NE2' HD22 ' A' ' 210' ' ' LEU . 6.8 mt-30 -98.16 112.0 24.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.0 110.948 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 26.7 mtt85 -49.92 106.84 0.13 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.2 tp -113.33 113.32 25.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.958 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 34.4 mt 62.18 25.85 15.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.864 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.59 -28.11 17.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.465 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.9 t -115.76 121.57 34.02 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.591 0.71 . . . . 0.0 111.213 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.07 154.0 5.91 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.728 2.285 . . . . 0.0 112.379 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 169' ' ' PHE . 18.9 tt -112.91 152.01 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.138 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.463 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.3 mm -111.97 123.76 68.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.078 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 207' ' ' ALA . 4.0 t -121.04 112.74 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.084 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -138.32 143.07 39.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.934 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -43.31 139.3 2.0 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.3 t -98.81 51.94 0.98 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.856 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -121.75 -39.27 2.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.953 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 228' ' ' GLU . . . -46.94 -52.25 15.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.126 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 227' ' ' ALA . 9.3 tp10 -35.79 -45.95 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.887 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 11.5 tppt? -65.2 -50.69 64.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -45.79 -61.68 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.885 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -50.47 -56.16 12.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.853 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.496 HD11 ' O ' ' A' ' 236' ' ' SER . 0.3 OUTLIER -42.46 -59.99 1.67 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.943 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 18.9 t 65.63 48.92 1.86 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 166.68 171.05 32.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.479 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.79 -8.93 18.21 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.693 2.262 . . . . 0.0 112.335 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . 0.496 ' O ' HD11 ' A' ' 232' ' ' LEU . 37.0 t -64.67 113.17 3.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.875 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 8.5 t -76.51 172.38 13.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.841 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.528 -179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 90.2 p -150.23 163.52 38.05 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.913 0.387 . . . . 0.0 110.839 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.6 t -173.15 140.05 0.85 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.855 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -97.07 -127.79 5.71 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.516 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 24.9 p -135.38 133.19 38.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.834 0.349 . . . . 0.0 110.855 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 41.4 t -144.13 126.35 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 133.7 178.93 15.92 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.465 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 19.6 tptt 61.01 54.69 3.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.746 0.308 . . . . 0.0 110.883 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.5 p -86.91 139.17 32.78 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 0.0 110.861 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -47.27 149.66 3.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.672 2.248 . . . . 0.0 112.257 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -95.66 111.57 26.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 38.7 mmt-85 -130.88 168.41 17.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.9 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -43.28 148.86 0.6 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.683 0.754 . . . . 0.0 110.839 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.66 121.49 5.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.674 2.25 . . . . 0.0 112.348 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 31.1 m -85.76 165.12 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.125 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -66.52 -48.83 68.53 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -40.91 144.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.436 ' HA ' HD22 ' A' ' 142' ' ' LEU . 0.7 OUTLIER -58.39 119.81 7.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.949 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 t -95.45 154.6 39.29 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.714 0.768 . . . . 0.0 110.861 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.71 -28.91 7.16 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.65 2.233 . . . . 0.0 112.367 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 69.4 mt-10 -70.27 -55.3 9.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.838 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -42.88 -43.98 4.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 37.5 mtp180 -43.57 -39.81 3.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.887 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -56.06 -56.28 22.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.421 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -40.51 -48.96 2.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.064 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -87.68 48.58 1.66 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.849 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.4 m -144.55 140.77 29.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.146 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.486 HG11 ' HE2' ' A' ' 198' ' ' PHE . 10.9 p -118.66 147.15 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.14 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -98.09 124.36 42.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.876 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.404 ' C ' ' HG3' ' A' ' 155' ' ' MET . 84.8 m -115.01 155.28 27.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.404 ' HG3' ' C ' ' A' ' 154' ' ' CYS . 64.2 mtm -154.03 175.85 12.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.956 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.5 tt0 63.59 54.47 1.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.876 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.417 HD22 HD13 ' A' ' 161' ' ' ILE . 72.0 mt -93.41 148.38 22.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -65.04 176.12 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.02 -43.33 22.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -107.39 46.73 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.87 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.417 HD13 HD22 ' A' ' 157' ' ' LEU . 16.5 tt -86.59 150.71 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.116 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.9 mtp85 -121.06 144.63 39.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.538 0.685 . . . . 0.0 110.936 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.46 -43.85 17.28 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.729 2.286 . . . . 0.0 112.328 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 165' ' ' ASP . 3.6 tmt_? -56.91 -55.28 36.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.425 ' C ' ' O ' ' A' ' 164' ' ' ARG . 7.8 m-20 -36.54 -40.68 0.26 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.929 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 21.0 mt -77.96 -48.19 16.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.627 ' HA ' HG21 ' A' ' 176' ' ' VAL . 23.6 mt-10 -47.53 -68.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.34 -55.39 10.83 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.856 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 44.8 t80 -48.92 -42.89 38.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.884 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.606 ' CE2' HG21 ' A' ' 196' ' ' VAL . 19.0 m-85 -78.56 -20.61 50.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 28.1 t -63.57 -11.26 23.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.831 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.43 -27.79 64.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.079 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 34.6 m -110.74 -32.92 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.37 152.98 22.47 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.477 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -68.71 142.54 54.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.749 0.309 . . . . 0.0 110.885 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG21 ' HA ' ' A' ' 167' ' ' GLU . 90.9 t -98.63 128.71 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -87.51 -53.61 4.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.53 152.79 41.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.93 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 8.0 t -132.54 113.1 20.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.149 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -101.88 109.09 20.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.841 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.3 mt -99.58 104.75 16.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 16.0 mm -69.5 102.9 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.113 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 23.1 t -118.41 99.83 7.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -120.51 -38.47 2.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? 54.24 54.78 9.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.902 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 72.7 m-80 -65.43 -40.9 93.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 56.2 p -109.8 176.52 5.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 16.3 mtt180 -63.41 -53.67 48.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -119.7 101.11 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.821 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.1 t -121.53 169.64 10.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 134.31 38.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -85.66 100.55 2.48 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.483 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 16.8 pt -93.27 145.17 8.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.876 0.369 . . . . 0.0 111.161 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -142.67 168.69 19.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -129.55 128.57 43.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.606 HG21 ' CE2' ' A' ' 170' ' ' PHE . 85.5 t -116.74 121.07 66.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.126 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -94.89 111.24 23.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.486 ' HE2' HG11 ' A' ' 152' ' ' VAL . 49.3 m-85 -85.05 152.05 23.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.881 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 m -60.07 -35.24 74.73 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -135.82 151.33 49.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.421 HD12 ' HB1' ' A' ' 149' ' ' ALA . 20.4 tt -70.93 -27.32 29.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.079 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -69.56 -6.36 30.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.951 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . 0.436 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 14.9 m -95.34 -25.03 16.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.865 -179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.605 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -54.38 -43.72 97.98 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.615 0.721 . . . . 0.0 111.186 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -47.93 -58.7 1.59 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.746 2.298 . . . . 0.0 112.306 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.4 mt -56.86 -31.05 64.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.574 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -72.74 -31.83 65.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.087 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 224' ' ' ALA . 82.5 mt -64.44 -41.78 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.105 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 211' ' ' THR . . . -61.5 -44.42 98.02 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.485 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.484 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 90.3 mt -37.45 -31.74 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.901 0.382 . . . . 0.0 110.868 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.448 ' C ' ' O ' ' A' ' 210' ' ' LEU . 21.3 m -34.45 103.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.117 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.32 9.47 5.5 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.494 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 210' ' ' LEU . 0.0 OUTLIER -90.93 118.99 30.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.852 0.358 . . . . 0.0 110.876 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 66.2 mtt-85 -56.42 109.9 0.69 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 17.6 tp -115.36 115.65 26.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.934 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.0 mt 60.22 25.04 14.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.918 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.21 -32.08 7.93 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.457 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 84.3 t -114.46 124.13 31.18 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.612 0.72 . . . . 0.0 111.164 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -50.02 154.02 5.79 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.676 2.251 . . . . 0.0 112.359 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.424 HG12 ' N ' ' A' ' 221' ' ' ILE . 9.4 tt -111.91 152.04 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.104 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.449 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 7.1 mm -110.47 132.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.111 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.574 HG11 ' O ' ' A' ' 207' ' ' ALA . 12.4 t -133.38 121.53 42.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.123 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -146.67 145.19 29.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.962 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . -51.36 133.63 29.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.184 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 7.6 t -89.35 36.04 0.82 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.837 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -84.35 33.57 0.51 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 230' ' ' ASN . . . -77.12 -57.38 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -43.08 -30.84 0.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 5.8 tttp -67.36 -39.18 85.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.918 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.47 ' OD1' ' C ' ' A' ' 230' ' ' ASN . 0.7 OUTLIER -67.83 -39.19 83.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.431 ' N ' ' OD1' ' A' ' 230' ' ' ASN . 8.5 tpt180 -91.13 44.29 1.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.847 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.2 tp -118.38 -56.51 2.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 28.2 t -88.5 92.0 9.02 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -145.05 169.26 26.8 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.502 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.72 15.02 1.34 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.618 2.212 . . . . 0.0 112.35 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.9 m -53.0 169.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.867 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 9.5 t -149.28 144.14 26.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.877 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.513 -179.982 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.259 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.7 t 54.76 42.43 31.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.79 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.2 p -94.19 -52.0 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.864 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 101.6 160.33 26.9 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.467 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 35.5 p -136.34 153.35 51.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.902 0.382 . . . . 0.0 110.832 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -167.25 133.88 2.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.823 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -141.15 173.65 23.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.505 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 8.3 ptpt -67.82 80.19 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.777 0.322 . . . . 0.0 110.956 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.5 p -173.04 154.25 2.66 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.64 0.733 . . . . 0.0 110.915 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.65 141.93 7.72 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.751 2.301 . . . . 0.0 112.306 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.5 p -157.11 138.34 5.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.126 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -106.85 53.79 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.822 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -122.21 161.16 44.41 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.655 0.741 . . . . 0.0 110.856 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -45.9 120.03 3.25 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.265 . . . . 0.0 112.321 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.7 m -95.14 170.09 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.134 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -137.01 164.91 27.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -148.7 119.13 7.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 9.1 tp -68.13 123.57 21.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.928 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.402 ' OG ' ' HD2' ' A' ' 144' ' ' PRO . 0.4 OUTLIER -86.07 150.12 51.77 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.72 0.771 . . . . 0.0 110.793 -179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 143' ' ' SER . 74.8 Cg_exo -44.93 -20.58 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.727 2.285 . . . . 0.0 112.299 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -90.74 -48.45 7.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -52.1 -37.75 55.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.889 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.8 ptt180 -52.78 -41.26 63.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.845 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -80.65 -43.96 19.59 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 201' ' ' ILE . . . -50.05 -54.26 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 36.9 mtt180 -47.9 -24.56 1.05 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.876 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 15.9 m -91.36 134.28 34.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.164 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.455 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 9.2 p -103.53 151.08 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.128 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.475 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 13.8 t80 -107.04 134.3 50.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.862 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.2 m -119.46 154.9 33.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 44.6 mtm -151.75 174.58 13.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.454 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 60.28 48.46 8.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.918 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.736 HD22 HD13 ' A' ' 161' ' ' ILE . 94.7 mt -77.74 156.67 30.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.891 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.668 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -70.44 173.03 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.098 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.45 -38.05 50.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.094 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -119.7 40.54 3.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.736 HD13 HD22 ' A' ' 157' ' ' LEU . 17.4 tt -76.26 154.45 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.151 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 2.2 mmp_? -129.7 149.06 71.9 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.689 0.757 . . . . 0.0 110.846 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.72 -43.66 18.57 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.64 2.227 . . . . 0.0 112.369 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 165' ' ' ASP . 1.8 mpt_? -53.7 -59.48 4.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 164' ' ' ARG . 4.4 m-20 -36.51 -41.14 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 45.2 mt -74.74 -51.64 13.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.39 -67.7 0.21 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -57.49 -45.19 85.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.832 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -53.03 -32.24 45.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.47 ' CE2' HG21 ' A' ' 196' ' ' VAL . 44.4 m-85 -95.96 -11.0 27.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.881 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 47.6 t -66.85 -4.64 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.85 -23.06 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 m -111.04 -28.56 2.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.174 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 179.04 166.88 35.7 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.483 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -74.99 136.58 41.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.779 0.323 . . . . 0.0 110.943 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.469 HG11 ' CG2' ' A' ' 179' ' ' VAL . 55.7 t -93.17 123.06 45.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.167 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -77.12 -52.86 8.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.916 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -149.53 152.36 35.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.864 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.469 ' CG2' HG11 ' A' ' 176' ' ' VAL . 60.7 t -130.69 103.24 7.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 63.0 mtt180 -93.18 106.25 18.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 93.4 mt -95.39 105.68 17.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 32.2 mm -67.36 104.12 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.16 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 22.9 t -119.41 84.02 2.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.914 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -112.74 171.62 7.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 14.7 ttt85 -90.44 98.8 11.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.941 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 187' ' ' SER . 17.4 m-20 -114.37 176.11 5.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 188' ' ' ARG . 14.2 t -37.99 155.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 187' ' ' SER . 10.6 mtt85 -36.16 -56.26 0.76 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -82.83 116.5 22.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.851 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 12.8 m -154.03 130.93 10.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 30.7 mmtt -83.45 -73.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.896 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 129.61 112.01 1.54 Allowed Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.437 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.425 ' HB ' ' CE1' ' A' ' 153' ' ' PHE . 46.0 pt -95.76 144.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.735 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -135.89 163.43 30.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.094 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.475 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 87.5 m-85 -127.15 137.86 53.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.47 HG21 ' CE2' ' A' ' 170' ' ' PHE . 53.4 t -128.04 130.94 69.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -99.95 114.84 28.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -89.78 149.94 22.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.894 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 41.3 t -55.34 -35.83 65.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.855 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -137.25 168.19 20.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.839 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.496 HD11 ' HB1' ' A' ' 149' ' ' ALA . 6.7 tt -85.57 -30.44 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.136 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.42 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 44.8 mt-30 -67.97 -6.85 24.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.931 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 m -93.38 -19.65 21.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -58.71 -43.16 97.52 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.684 0.754 . . . . 0.0 111.15 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.07 -45.37 25.54 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.695 2.263 . . . . 0.0 112.343 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 95.9 mt -67.35 -36.82 82.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.933 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -66.4 -40.87 89.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 224' ' ' ALA . 76.0 mt -55.18 -46.32 77.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -56.71 -42.62 91.36 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.528 HD22 ' NE2' ' A' ' 213' ' ' GLN . 34.1 mt -41.84 -30.48 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.947 0.403 . . . . 0.0 110.947 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.431 ' C ' ' O ' ' A' ' 210' ' ' LEU . 99.7 m -35.72 106.42 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.145 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 120.21 11.24 6.93 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.445 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.528 ' NE2' HD22 ' A' ' 210' ' ' LEU . 9.0 mt-30 -89.87 108.49 19.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.874 0.368 . . . . 0.0 110.86 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -49.31 106.79 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.2 tp -111.45 113.82 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.923 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 46.2 mt 61.73 26.62 16.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.36 -26.94 22.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.1 t -116.44 120.69 34.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.111 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -50.6 151.46 10.46 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.739 2.293 . . . . 0.0 112.304 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 15.7 tt -113.48 144.34 21.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.088 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.454 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.0 mm -100.74 134.27 41.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 3.9 t -130.86 116.35 33.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.098 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -143.5 145.75 32.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.995 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . -60.54 111.43 1.59 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.138 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 44.1 t -42.5 -25.99 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.845 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -99.32 48.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.841 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -83.46 -67.73 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.106 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -51.61 -59.81 3.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 10.3 tttp -43.21 -40.54 3.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -67.22 -55.87 12.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.838 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 53.1 ttt85 -42.09 -61.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.8 tp -42.43 126.66 3.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.956 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 45.8 m -74.52 -52.17 12.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.86 -145.97 47.53 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.508 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.05 121.65 3.76 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.613 2.209 . . . . 0.0 112.434 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 83.9 p -62.71 -47.02 85.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.907 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 2.7 m -78.36 141.34 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.859 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.507 -179.974 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.4 t -140.7 145.48 36.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.3 p -164.8 170.08 15.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.847 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 167.73 71.14 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.541 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.3 t -74.55 159.66 31.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 0.0 110.846 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.4 t -65.51 154.34 38.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.809 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 170.29 85.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.5 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 66.6 mttt -134.51 148.6 50.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.822 0.344 . . . . 0.0 110.858 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.5 p -114.03 82.72 7.2 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.661 0.743 . . . . 0.0 110.872 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -77.28 124.62 7.28 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.633 2.222 . . . . 0.0 112.346 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 30.4 m -80.21 171.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.124 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -151.14 109.23 3.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -112.26 144.92 31.79 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.675 0.75 . . . . 0.0 110.838 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.67 -176.76 3.31 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.692 2.261 . . . . 0.0 112.37 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.7 m -118.37 143.06 30.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.17 160.5 6.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.882 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 -38.23 129.65 1.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.578 HD11 ' HB3' ' A' ' 146' ' ' GLU . 6.5 tp -91.58 149.06 21.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.885 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.441 ' N ' ' HG ' ' A' ' 142' ' ' LEU . 2.2 m -73.52 160.9 81.22 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.724 0.773 . . . . 0.0 110.857 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.42 -18.93 19.89 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.657 2.238 . . . . 0.0 112.354 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -90.12 -19.67 24.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.578 ' HB3' HD11 ' A' ' 142' ' ' LEU . 27.1 mm-40 -85.94 -32.42 21.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.854 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -60.36 -34.42 73.85 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -75.66 -32.01 60.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -61.9 -57.87 10.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.053 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 14.5 mtp85 -46.74 -29.1 1.75 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 36.3 m -89.57 136.37 33.07 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.626 HG11 ' HE2' ' A' ' 198' ' ' PHE . 11.6 p -107.94 154.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.139 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -104.09 134.4 47.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 72.1 m -122.52 149.64 43.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.933 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.527 ' HG2' HG22 ' A' ' 193' ' ' ILE . 34.1 mtm -148.93 169.42 20.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.915 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.442 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.5 tt0 68.51 52.43 0.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.561 HD22 HD13 ' A' ' 161' ' ' ILE . 86.2 mt -86.26 157.86 19.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -72.97 166.24 23.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.064 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.55 -38.63 67.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.89 54.34 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.907 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.561 HD13 HD22 ' A' ' 157' ' ' LEU . 16.3 tt -93.01 162.82 2.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.107 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.445 ' N ' ' CG1' ' A' ' 161' ' ' ILE . 17.3 mtt85 -136.69 146.38 55.11 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.646 0.736 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.19 -25.31 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.72 2.28 . . . . 0.0 112.36 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 165' ' ' ASP . 11.3 tpt85 -72.84 -60.53 2.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.848 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 164' ' ' ARG . 25.3 m-20 -35.67 -36.42 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.5 mt -80.87 -45.61 16.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.846 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' N ' ' O ' ' A' ' 164' ' ' ARG . 56.5 mt-10 -48.34 -66.43 0.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.47 ' CG ' ' N ' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -56.12 -50.77 70.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.795 -179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.546 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 1.5 t80 -50.26 -29.57 9.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.848 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 196' ' ' VAL . 30.3 m-85 -96.58 -17.81 20.18 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.4 p -65.52 -7.78 16.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.835 -179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.36 -29.68 53.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.09 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.8 m -107.04 -31.0 2.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -170.13 161.58 34.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.579 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.0 tptt -75.62 139.39 42.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.887 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 179' ' ' VAL . 82.8 t -97.2 123.29 49.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.091 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -84.23 -44.37 13.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.903 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -153.57 148.4 26.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.86 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.599 ' CG2' HG11 ' A' ' 176' ' ' VAL . 96.7 t -132.6 104.5 7.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.133 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.6 mmm180 -93.14 113.28 25.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 70.7 mt -100.62 111.19 29.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.139 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 23.9 mm -70.08 138.9 21.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.127 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.4 t -158.7 126.18 4.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -74.31 -63.37 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.861 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -148.42 130.15 15.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.878 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -45.44 101.38 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.85 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 27.6 t -165.59 137.2 3.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.842 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 72.6 mtp180 -44.02 133.86 4.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -151.79 169.56 21.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.858 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 26.1 p -118.46 2.44 11.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 37.7 mmtt -132.01 171.31 13.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 167.0 144.03 3.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.519 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.527 HG22 ' HG2' ' A' ' 155' ' ' MET . 44.4 pt -124.14 141.49 44.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.876 0.37 . . . . 0.0 111.127 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -148.08 155.07 41.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -109.58 137.22 47.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.592 HG21 ' CE2' ' A' ' 170' ' ' PHE . 98.3 t -121.87 126.33 74.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -96.01 115.05 26.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.828 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.626 ' HE2' HG11 ' A' ' 152' ' ' VAL . 34.8 m-85 -90.44 155.04 19.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.938 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 52.7 t -56.8 -38.46 72.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.814 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -139.7 173.71 11.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 15.0 tt -84.82 -29.53 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.169 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -68.49 -6.55 25.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 70.3 m -96.91 -16.56 20.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.909 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -62.4 -43.33 84.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.649 0.737 . . . . 0.0 111.146 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.9 Cg_exo -47.97 -52.19 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.681 2.254 . . . . 0.0 112.312 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 89.9 mt -58.76 -40.2 83.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -65.0 -31.78 73.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.097 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.72 -36.56 77.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.122 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.55 -39.44 90.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.506 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 30.2 mt -50.44 -24.99 3.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.828 0.347 . . . . 0.0 110.925 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.07 102.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.136 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 122.41 15.56 4.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.504 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.546 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 33.0 mt-30 -91.45 109.41 20.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.742 0.306 . . . . 0.0 110.924 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -48.13 103.15 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 21.0 tp -104.07 107.33 18.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 20.1 mt 64.9 25.03 12.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.912 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.84 -22.72 37.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.466 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.6 t -116.66 115.95 39.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.591 0.71 . . . . 0.0 111.179 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.45 153.56 7.31 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.683 2.255 . . . . 0.0 112.328 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.426 HG12 ' N ' ' A' ' 221' ' ' ILE . 18.6 tt -115.35 159.97 14.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.15 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.442 HG12 ' CB ' ' A' ' 156' ' ' GLN . 4.7 mm -118.84 139.94 44.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 207' ' ' ALA . 21.9 t -138.9 131.58 38.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -160.7 147.66 15.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -53.55 121.75 8.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 2.0 t -54.29 -18.14 3.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.408 ' CD ' ' O ' ' A' ' 226' ' ' GLN . 0.0 OUTLIER -94.98 40.66 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.923 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -98.0 -65.47 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.015 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 23.8 mp0 -54.83 -69.92 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.833 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -37.25 -54.24 1.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -48.83 -62.77 1.34 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.874 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.414 ' O ' ' C ' ' A' ' 232' ' ' LEU . 0.2 OUTLIER -61.04 -65.11 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.903 -179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.414 ' C ' ' O ' ' A' ' 231' ' ' ARG . 8.9 tp -37.11 131.2 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.948 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.2 m -66.6 139.27 57.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -107.84 177.63 21.21 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.515 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.91 152.1 31.8 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.692 2.262 . . . . 0.0 112.346 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 2.4 t -78.42 143.5 36.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.86 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 10.1 t -119.08 -55.44 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.438 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.6 t -100.91 -56.55 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 70.0 m -67.55 -50.02 60.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.857 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 105.51 130.19 6.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 47.2 t -95.66 -66.29 0.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.865 0.364 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 22.4 t -108.89 154.05 22.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.829 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 147.33 97.4 0.19 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.534 ' O ' HG13 ' A' ' 135' ' ' VAL . 44.1 tttp -124.71 3.49 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.601 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -54.22 -44.91 99.2 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.657 0.741 . . . . 0.0 110.801 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 133' ' ' SER . 61.1 Cg_endo -80.42 92.87 1.06 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.653 2.236 . . . . 0.0 112.364 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 132' ' ' LYS . 29.0 m -117.63 -24.63 3.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.099 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -167.86 169.11 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -128.35 140.33 38.06 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.672 0.749 . . . . 0.0 110.935 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.86 163.4 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.643 2.229 . . . . 0.0 112.357 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.3 m -91.36 37.85 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.143 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -78.2 157.46 29.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.835 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -41.83 149.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.443 HD13 ' N ' ' A' ' 143' ' ' SER . 0.7 OUTLIER -45.54 120.07 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.948 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' HD13 ' A' ' 142' ' ' LEU . 19.8 m -110.87 155.03 43.04 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.682 0.753 . . . . 0.0 110.84 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.85 -19.13 0.68 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.745 2.297 . . . . 0.0 112.305 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -87.28 -33.62 19.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.844 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.64 -29.51 70.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.955 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -59.98 -45.02 94.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.857 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -64.32 -38.37 90.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -54.25 -60.12 3.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.048 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.474 ' CZ ' ' HB2' ' A' ' 150' ' ' ARG . 20.7 mtm105 -49.44 -22.99 1.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 24.4 m -96.79 138.5 34.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.08 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.631 HG12 ' O ' ' A' ' 196' ' ' VAL . 9.9 p -111.93 150.95 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD1' ' CE1' ' A' ' 195' ' ' TYR . 6.0 t80 -106.48 133.06 51.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 21.2 m -121.71 159.83 25.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.471 ' HG2' HG22 ' A' ' 193' ' ' ILE . 37.9 mtm -153.4 175.32 13.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.873 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.449 ' CB ' HG12 ' A' ' 221' ' ' ILE . 6.0 tt0 63.21 53.16 2.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.883 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 194' ' ' ALA . 29.5 mt -93.66 142.02 27.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.86 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.77 175.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.61 -46.81 13.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.087 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 44.0 ttp180 -103.43 48.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.819 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.418 HD12 HD12 ' A' ' 216' ' ' LEU . 10.1 tt -90.27 155.62 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.187 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -129.16 147.55 65.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.5 0.667 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.47 -47.35 13.26 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.652 2.235 . . . . 0.0 112.364 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -46.96 -58.23 4.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.584 ' OD2' HD21 ' A' ' 216' ' ' LEU . 3.5 m-20 -37.55 -55.09 1.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.88 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 18.3 mt -64.3 -47.16 80.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -46.45 -66.33 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -59.96 -43.19 95.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.499 ' CE2' HG21 ' A' ' 220' ' ' ILE . 30.1 t80 -54.81 -35.65 64.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.908 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.6 m-85 -92.64 -12.64 31.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 8.5 t -65.98 -7.22 15.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.49 -23.84 58.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 8.6 m -113.03 -28.95 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.064 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -172.82 154.45 20.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 28.5 tptt -71.29 139.51 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.326 . . . . 0.0 110.903 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.408 HG11 ' CG2' ' A' ' 179' ' ' VAL . 98.8 t -98.51 136.12 30.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.18 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 11.6 ttt85 -93.8 -50.94 5.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.949 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -142.18 157.27 45.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.83 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.408 ' CG2' HG11 ' A' ' 176' ' ' VAL . 84.5 t -142.92 108.03 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.178 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 4.2 tpt85 -95.95 112.54 24.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.8 mt -100.65 107.95 22.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 36.3 mm -72.18 121.05 21.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.138 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 48.1 t -116.06 90.11 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -97.34 160.38 14.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.853 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -53.73 115.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.8 m-20 -49.42 128.38 17.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.865 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 16.6 m -132.2 166.75 21.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.911 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 57.8 mtt180 -46.19 -53.02 11.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.828 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -114.4 92.62 4.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.893 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.3 t -146.34 157.23 43.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.456 ' O ' HG23 ' A' ' 193' ' ' ILE . 39.6 mmtm -141.35 124.53 16.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -59.59 105.39 0.73 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.471 HG22 ' HG2' ' A' ' 155' ' ' MET . 36.4 pt -101.28 148.46 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.832 0.348 . . . . 0.0 111.068 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.412 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.25 166.85 29.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.132 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.474 ' CE1' ' CD1' ' A' ' 153' ' ' PHE . 88.6 m-85 -122.63 127.92 49.99 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.631 ' O ' HG12 ' A' ' 152' ' ' VAL . 23.6 t -117.38 123.23 71.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.118 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.04 133.68 35.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.52 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.8 m-85 -109.86 157.33 19.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.884 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 28.8 p -60.57 -40.09 90.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 -135.82 163.25 30.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 14.8 tt -74.23 -29.25 24.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.198 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.423 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 41.6 mt-30 -69.44 -5.95 27.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 51.7 m -94.12 -18.17 22.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.86 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.612 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -64.18 -43.32 73.26 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.64 0.733 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.6 Cg_exo -47.96 -53.38 6.71 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.681 2.254 . . . . 0.0 112.387 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.77 -34.29 71.26 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.935 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -68.29 -34.85 76.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.022 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 224' ' ' ALA . 71.5 mt -63.01 -40.5 89.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.118 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -62.34 -35.93 92.35 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.491 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.475 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 84.6 mt -49.97 -28.24 6.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.872 0.368 . . . . 0.0 110.887 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 210' ' ' LEU . 98.0 m -36.93 98.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.136 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 124.99 7.9 5.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.501 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.501 ' OE1' ' N ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -88.68 119.24 28.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.757 0.313 . . . . 0.0 110.898 -179.861 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.79 108.14 0.42 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.915 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.0 tp -116.36 118.22 32.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.584 HD21 ' OD2' ' A' ' 165' ' ' ASP . 52.3 mt 61.37 25.61 15.54 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.939 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.92 -29.04 13.33 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.523 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 89.4 t -117.91 126.88 26.99 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.578 0.704 . . . . 0.0 111.136 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.07 153.96 3.76 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.736 2.291 . . . . 0.0 112.292 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.499 HG21 ' CE2' ' A' ' 169' ' ' PHE . 16.1 tt -114.39 151.06 16.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.151 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.449 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.8 mm -109.94 139.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.8 t -137.58 134.6 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.129 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -157.56 142.88 17.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.919 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 208' ' ' ILE . . . -59.68 118.37 6.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.135 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 21.2 t -57.23 -44.89 84.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.889 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -50.46 -40.55 51.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.405 ' HA ' ' OD1' ' A' ' 230' ' ' ASN . . . -41.44 -62.87 0.79 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -38.45 -39.56 0.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.946 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 2.7 tppp? -61.59 -70.28 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.533 ' H ' ' ND2' ' A' ' 230' ' ' ASN . 0.2 OUTLIER -49.29 -51.23 35.18 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.948 179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -75.96 58.91 1.22 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.847 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 10.0 tt -144.81 142.66 30.14 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.972 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.2 p -68.93 90.62 0.44 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.816 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -131.0 89.58 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.456 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.57 -43.59 17.96 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.754 2.303 . . . . 0.0 112.37 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 75.7 m -120.11 158.0 27.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.794 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 99.5 p -113.13 119.68 38.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.803 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.439 179.954 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.6 t -68.79 95.56 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.906 0.384 . . . . 0.0 110.894 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 15.2 m -92.39 99.08 11.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.864 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 168.15 160.29 15.56 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.468 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 26.0 m -162.65 160.5 25.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.903 0.382 . . . . 0.0 110.776 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.42 162.99 13.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.844 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -59.8 -172.14 0.59 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.498 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -150.92 122.07 7.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.827 0.346 . . . . 0.0 110.934 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.2 t -120.37 143.53 36.14 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.648 0.737 . . . . 0.0 110.86 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -77.71 57.7 6.13 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.677 2.251 . . . . 0.0 112.333 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 33.4 m -91.89 178.54 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.118 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.419 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 0.9 OUTLIER -127.9 138.81 52.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 -179.9 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -71.17 151.99 94.6 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.647 0.737 . . . . 0.0 110.936 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.95 173.64 0.02 OUTLIER 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.679 2.253 . . . . 0.0 112.358 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.416 ' O ' HG23 ' A' ' 139' ' ' VAL . 33.9 m -116.7 45.87 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.12 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 141' ' ' ASN . 1.0 OUTLIER -128.01 175.76 8.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 140' ' ' ASP . 6.6 m120 -36.96 151.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.762 ' C ' HD12 ' A' ' 142' ' ' LEU . 0.3 OUTLIER -70.98 131.65 44.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 146' ' ' GLU . 3.4 m -89.88 157.85 45.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.66 0.743 . . . . 0.0 110.859 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -46.25 -22.59 1.61 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.715 2.277 . . . . 0.0 112.369 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -91.54 -27.08 18.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 143' ' ' SER . 38.8 mt-10 -75.17 -28.58 60.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.832 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -57.99 -35.7 71.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -61.39 -44.52 97.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -47.87 -37.32 13.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.119 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 45.5 mtt85 -89.88 42.5 1.1 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.838 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 77.4 m -128.23 127.75 43.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 4.7 p -103.62 157.9 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -113.46 127.11 55.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.886 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 82.6 m -114.63 149.33 36.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.917 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.813 ' HG2' HG22 ' A' ' 193' ' ' ILE . 60.6 mtm -144.34 177.8 8.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.451 ' CB ' HG12 ' A' ' 221' ' ' ILE . 5.9 tt0 56.77 47.69 17.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.656 HD22 HD13 ' A' ' 161' ' ' ILE . 93.4 mt -79.54 154.44 28.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.898 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.418 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -74.53 169.63 17.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.042 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.37 31.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.12 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -114.34 38.0 3.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.935 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.656 HD13 HD22 ' A' ' 157' ' ' LEU . 14.5 tt -88.56 155.14 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 56.9 mtt85 -131.54 147.43 66.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.643 0.735 . . . . 0.0 110.839 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -25.87 2.4 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.73 2.287 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.5 tpt85 -73.05 -52.89 12.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -40.77 -37.26 0.73 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 68.1 mt -79.46 -41.94 26.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -50.09 -67.16 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -58.94 -48.14 82.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' CZ ' ' NE2' ' A' ' 213' ' ' GLN . 81.8 t80 -54.37 -29.84 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -96.54 -12.35 24.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.839 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 5.9 p -71.63 -5.13 31.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -79.09 -22.09 45.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.1 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -116.79 -32.18 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.118 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -166.19 159.0 32.16 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.442 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -76.54 133.06 39.84 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.908 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.525 HG11 ' CG2' ' A' ' 179' ' ' VAL . 39.4 t -91.54 121.71 42.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.152 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -80.7 -60.9 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -135.4 145.8 47.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.525 ' CG2' HG11 ' A' ' 176' ' ' VAL . 42.9 t -126.69 104.5 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -102.42 104.95 15.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 63.3 mt -91.39 119.55 38.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.116 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 7.0 mm -94.37 130.49 43.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.174 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 29.9 t -113.0 44.95 1.42 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.782 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -112.11 86.71 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.832 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 24.4 ttm180 -91.51 95.32 9.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.828 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -112.74 88.88 2.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.891 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 38.6 m 58.58 40.39 23.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.823 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.6 ttm-85 -104.81 138.13 41.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.87 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -67.41 -44.71 78.14 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.4 p -60.48 163.12 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -83.21 -53.88 5.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -147.72 142.41 10.13 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.505 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.813 HG22 ' HG2' ' A' ' 155' ' ' MET . 22.4 pt -117.04 144.33 25.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.76 0.315 . . . . 0.0 111.169 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.58 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -151.86 152.25 32.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.066 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.77 145.7 34.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 48.0 t -135.58 114.06 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.125 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 25.7 tt0 -86.88 116.85 25.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -92.55 162.63 14.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.924 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 6.7 m -78.15 -16.14 58.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.931 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -145.67 148.91 33.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.844 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.429 HD11 HE22 ' A' ' 226' ' ' GLN . 13.3 tt -81.87 -23.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -73.52 -6.49 46.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.933 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 15.8 m -95.91 -16.83 21.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.614 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -62.69 -43.22 82.88 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.645 0.736 . . . . 0.0 111.135 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.614 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.1 Cg_exo -47.91 -49.47 13.74 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.64 2.227 . . . . 0.0 112.355 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 91.8 mt -62.04 -38.91 90.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.897 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -35.7 81.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 64.5 mt -59.11 -47.45 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.187 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -57.63 -32.7 65.52 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.52 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.603 HD22 ' NE2' ' A' ' 213' ' ' GLN . 24.7 mt -52.07 -28.17 16.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.872 0.368 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 210' ' ' LEU . 76.3 m -35.86 105.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.158 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.59 14.07 6.47 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.462 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.603 ' NE2' HD22 ' A' ' 210' ' ' LEU . 6.1 mt-30 -91.68 116.59 29.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.926 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 41.2 mtt180 -57.79 106.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.4 tp -112.34 112.49 24.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.948 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.8 mt 64.08 25.87 13.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 98.55 -20.93 48.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.533 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 88.1 t -120.96 119.29 29.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.659 0.742 . . . . 0.0 111.088 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -50.72 152.63 9.23 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.66 2.24 . . . . 0.0 112.379 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 11.6 tt -113.88 144.17 22.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.163 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.451 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.5 mm -103.25 133.17 47.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 2.6 t -128.94 128.63 67.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.181 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -151.91 150.52 30.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -63.34 115.46 4.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.183 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . 0.464 ' O ' ' N ' ' A' ' 227' ' ' ALA . 5.6 t -63.29 -54.19 41.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.836 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.429 HE22 HD11 ' A' ' 201' ' ' ILE . 0.5 OUTLIER -61.48 76.04 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.881 -179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 225' ' ' SER . . . -125.28 -50.77 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.1 tm-20 -78.67 -61.31 2.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 230' ' ' ASN . 10.6 mmtp -55.07 -57.74 10.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.949 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.406 ' C ' ' O ' ' A' ' 229' ' ' LYS . 57.5 t-20 -37.54 -48.54 1.0 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.85 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -51.05 -58.29 6.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.8 tt -52.41 -53.23 47.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 46.3 t -53.99 134.96 43.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.839 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -178.3 67.75 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.506 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.99 99.15 1.28 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.269 . . . . 0.0 112.354 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 58.2 m -47.76 -44.48 28.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.864 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 93.5 p -135.7 176.34 8.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.827 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.527 -179.945 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 65.3 p 45.18 41.96 6.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.938 0.399 . . . . 0.0 110.941 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.6 t -85.75 134.4 33.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.841 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 145.66 157.25 7.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.455 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 93.1 p -58.3 155.89 10.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 110.833 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 95.9 p -81.65 112.96 19.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.867 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 156.15 121.89 0.73 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.478 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 31.6 mttt -41.71 130.6 3.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.707 0.289 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 89.9 p -132.19 145.27 56.61 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.713 0.768 . . . . 0.0 110.877 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.36 143.61 5.32 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.745 2.297 . . . . 0.0 112.359 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.638 ' O ' HG13 ' A' ' 135' ' ' VAL . 7.1 p -131.19 91.45 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.196 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 18.3 mmm-85 -126.93 161.71 27.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.907 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -160.37 138.83 7.53 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.644 0.735 . . . . 0.0 110.887 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.92 163.2 23.39 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.633 2.222 . . . . 0.0 112.319 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 29.8 m -55.95 142.73 10.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.061 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -172.5 157.97 4.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 142' ' ' LEU . 9.1 t-20 -53.83 160.96 1.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 141' ' ' ASN . 4.4 tp -36.57 128.04 0.82 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.23 149.04 36.14 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.602 0.715 . . . . 0.0 110.894 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -43.37 -35.49 5.67 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.754 2.303 . . . . 0.0 112.324 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -67.76 -53.27 28.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -44.69 -42.86 7.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -44.07 -57.45 3.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.857 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -51.49 -51.99 50.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.964 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.702 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -42.13 -60.47 1.43 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.135 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 8.2 mtp-105 -48.85 -27.95 3.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.887 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 51.3 m -89.06 126.41 35.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.231 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.422 HG12 ' HB ' ' A' ' 196' ' ' VAL . 4.0 p -102.06 158.18 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.153 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CZ ' ' HB ' ' A' ' 193' ' ' ILE . 17.1 t80 -109.27 141.27 41.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 194' ' ' ALA . 58.9 m -126.85 156.66 40.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.839 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 35.8 mtm -152.98 176.48 11.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 58.95 46.96 12.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.926 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.89 HD11 ' HB2' ' A' ' 194' ' ' ALA . 96.1 mt -77.02 168.3 20.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.798 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -79.42 -178.84 6.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.093 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -83.49 -37.6 22.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.127 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.45 37.39 4.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.798 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 13.3 tt -73.22 154.4 7.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.13 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 60.2 mtm180 -128.78 146.58 60.94 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.588 0.709 . . . . 0.0 110.862 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.63 -35.28 12.63 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.73 2.287 . . . . 0.0 112.3 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 21.1 mmt180 -54.94 -51.94 64.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.902 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.432 ' OD2' HD21 ' A' ' 216' ' ' LEU . 9.0 m-20 -48.13 -40.2 22.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 61.5 mt -77.11 -42.9 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.933 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -43.12 -65.3 0.5 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.862 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -65.64 -48.83 70.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.846 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CE2' ' OE1' ' A' ' 213' ' ' GLN . 23.8 t80 -49.25 -30.31 7.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.435 ' CE2' HG21 ' A' ' 196' ' ' VAL . 24.3 m-85 -96.99 -15.46 21.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 27.9 t -68.0 -8.85 40.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.839 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.95 -23.16 55.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 18.9 m -117.37 -33.86 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.09 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.26 151.73 21.12 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.488 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.12 134.13 48.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.895 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 196' ' ' VAL . 86.8 t -90.18 123.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.127 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 35.0 ttt180 -88.7 -61.2 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.893 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -128.51 144.32 51.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.03 104.04 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.142 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.5 ttm-85 -100.49 105.81 17.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 96.3 mt -102.34 105.73 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.8 mm -71.29 128.36 34.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.14 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.2 p -126.55 107.36 10.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.926 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -103.68 97.51 7.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -34.48 77.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -53.09 -46.67 68.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 66.4 m -131.23 103.62 6.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.847 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -86.57 -12.17 49.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.868 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.58 -38.35 89.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.825 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 2.0 m -54.54 177.53 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.878 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 9.9 mptt -99.62 127.59 45.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.896 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -60.05 110.29 2.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.513 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.479 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 48.4 pt -100.0 143.03 14.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.785 0.326 . . . . 0.0 111.179 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.89 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -139.81 158.29 44.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.094 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -124.4 127.53 47.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.975 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.62 HG13 HG13 ' A' ' 176' ' ' VAL . 61.8 t -121.5 120.71 62.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -93.18 111.64 23.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.914 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.0 148.63 25.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 m -56.8 -33.01 66.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -136.21 166.11 24.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.702 HD12 ' HB1' ' A' ' 149' ' ' ALA . 16.4 tt -85.98 -33.08 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.163 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -64.29 -6.49 7.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.887 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 29.1 m -94.65 -19.31 20.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -61.49 -43.23 88.22 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.564 0.697 . . . . 0.0 111.179 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.3 Cg_exo -48.01 -52.96 7.35 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.7 2.267 . . . . 0.0 112.33 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.06 -36.93 83.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.489 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -66.35 -33.99 76.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.8 mt -62.54 -45.84 97.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -55.74 -40.44 79.92 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.537 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 211' ' ' THR . 67.3 mt -44.21 -26.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.86 0.362 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.429 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.3 m -35.61 103.08 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.19 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 116.65 23.58 3.98 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.557 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.553 ' OE1' ' CE2' ' A' ' 169' ' ' PHE . 28.4 mt-30 -100.13 108.9 21.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.784 0.326 . . . . 0.0 110.938 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 59.0 mtt180 -47.93 110.79 0.36 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.539 HD13 ' CD2' ' A' ' 169' ' ' PHE . 16.9 tp -116.52 112.31 21.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.953 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.432 HD21 ' OD2' ' A' ' 165' ' ' ASP . 62.2 mt 62.16 25.32 15.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.908 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.64 -25.47 27.91 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.48 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.0 t -117.29 119.02 35.14 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.673 0.749 . . . . 0.0 111.154 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -51.1 152.03 11.23 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.717 2.278 . . . . 0.0 112.336 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 14.7 tt -111.99 151.61 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.129 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . . . . . . . . . 5.0 mm -112.72 122.43 66.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.489 HG11 ' O ' ' A' ' 207' ' ' ALA . 18.1 t -118.07 128.98 75.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -155.45 150.35 26.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.887 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -57.96 126.35 27.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.186 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.8 t -64.35 -38.47 91.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.897 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -86.03 35.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.918 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -70.21 -44.0 69.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.069 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -63.52 -62.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.815 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.25 -58.55 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.864 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -39.76 -54.7 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -47.07 -57.36 5.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.832 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 12.5 tp -39.83 -61.44 0.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.4 m -39.5 -59.36 1.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.08 145.15 14.15 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.472 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -78.24 106.4 2.14 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.674 2.25 . . . . 0.0 112.356 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 53.7 p -141.98 117.97 10.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 18.7 t -154.66 153.02 30.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.817 -179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.236 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.482 -179.947 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.575 -0.21 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 21.9 m -121.35 176.92 5.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 110.822 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 72.8 m -130.66 140.32 50.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.866 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 118.93 -112.23 2.28 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.445 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 3.9 m 41.27 40.26 1.15 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.86 0.362 . . . . 0.0 110.871 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 98.1 p -109.43 154.63 22.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.821 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -175.56 -167.86 35.18 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.523 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 23.7 tttm -83.46 144.82 29.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.743 0.306 . . . . 0.0 110.939 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 81.1 p -110.44 105.15 56.95 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.645 0.736 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -43.83 119.82 2.08 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.727 2.285 . . . . 0.0 112.339 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.3 t -44.61 125.14 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -151.56 152.37 32.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.867 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -41.25 144.55 0.68 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.672 0.748 . . . . 0.0 110.838 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.73 150.14 1.71 Allowed 'Trans proline' 0 N--CA 1.465 -0.165 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -103.22 166.68 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.069 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.6 -51.31 7.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.865 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -64.6 169.93 4.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.824 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.436 HD22 ' HB3' ' A' ' 146' ' ' GLU . 18.0 mt -54.05 177.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 51.5 p -126.83 151.15 73.28 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.666 0.746 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.97 -18.81 0.43 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.656 2.237 . . . . 0.0 112.291 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -93.73 -57.64 2.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.436 ' HB3' HD22 ' A' ' 142' ' ' LEU . 39.2 mm-40 -45.09 -42.81 9.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -50.19 -39.57 44.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.925 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -75.12 -50.33 16.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -46.96 -46.41 21.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.9 mtp-105 -83.67 38.48 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.901 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 93.2 m -137.36 122.02 18.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.148 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.555 HG12 ' O ' ' A' ' 196' ' ' VAL . 13.0 p -99.04 146.48 8.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 10.6 t80 -101.22 126.91 47.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.879 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 83.7 m -116.78 150.7 37.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 42.7 mtm -149.75 178.05 9.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.865 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.482 ' NE2' ' O ' ' A' ' 219' ' ' PRO . 4.5 tt0 58.54 52.68 6.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.964 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.431 HD22 HD13 ' A' ' 161' ' ' ILE . 60.9 mt -92.31 137.12 32.63 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -55.26 177.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.89 -42.65 13.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.077 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 53.9 mtm-85 -97.81 39.97 1.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.908 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.431 HD13 HD22 ' A' ' 157' ' ' LEU . 19.5 tt -85.05 158.44 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.17 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -135.63 147.13 60.22 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.566 0.698 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -45.06 -33.99 8.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.237 . . . . 0.0 112.423 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -66.79 -49.63 65.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.508 ' OD2' HD11 ' A' ' 216' ' ' LEU . 72.0 m-20 -41.39 -36.69 0.88 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 23.4 mt -83.79 -39.99 19.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.916 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -51.24 -64.83 0.68 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -53.65 55.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' CE2' HG21 ' A' ' 220' ' ' ILE . 29.0 t80 -45.42 -46.04 13.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.864 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.605 ' CE2' HG21 ' A' ' 196' ' ' VAL . 21.4 m-85 -80.03 -19.93 46.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.918 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.4 t -63.39 -7.73 7.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.834 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.12 -24.01 60.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 20.0 m -117.05 -31.74 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -164.27 150.62 19.13 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.463 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.5 133.93 47.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 0.0 110.921 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.452 HG11 ' CG2' ' A' ' 179' ' ' VAL . 54.9 t -90.3 132.18 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.15 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 19.0 tpt180 -97.11 -52.87 3.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -134.38 145.67 49.17 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.851 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.452 ' CG2' HG11 ' A' ' 176' ' ' VAL . 94.4 t -130.76 108.49 15.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.138 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -96.47 111.01 23.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.9 mt -107.95 106.32 20.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.21 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 19.3 mm -73.66 111.72 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.18 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 35.5 t -105.83 39.8 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.824 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -83.58 99.08 9.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.4 ttm-85 -39.91 136.67 1.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.84 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -116.02 175.67 5.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 22.3 t -127.36 -54.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.818 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -100.22 -46.44 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.817 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -96.53 74.78 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.872 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 39.0 t -80.61 112.86 18.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.856 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -175.0 108.86 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -66.56 102.58 0.76 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 17.9 pt -93.64 147.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.903 0.382 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.421 ' HB3' HD11 ' A' ' 157' ' ' LEU . . . -151.19 154.77 37.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.128 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.478 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 77.5 m-85 -116.82 139.34 50.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.882 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.605 HG21 ' CE2' ' A' ' 170' ' ' PHE . 99.0 t -120.82 128.09 76.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.146 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -96.81 104.37 16.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -79.42 157.17 27.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.902 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 11.5 t -58.89 -37.44 76.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.934 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -140.38 167.19 22.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.85 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.402 ' O ' ' HD3' ' A' ' 205' ' ' PRO . 18.7 tt -77.42 -33.63 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.087 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -64.94 -6.1 7.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.944 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 16.1 m -95.85 -20.26 18.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.8 t -59.85 -43.47 94.91 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.606 0.717 . . . . 0.0 111.129 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.97 -59.85 1.09 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.716 2.278 . . . . 0.0 112.353 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 92.6 mt -51.6 -45.67 63.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.59 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -58.13 -30.4 66.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 84.5 mt -71.48 -44.65 70.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.133 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -59.94 -30.84 70.68 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.51 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.473 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 80.9 mt -58.9 -17.83 27.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.922 0.392 . . . . 0.0 110.898 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 51.9 m -38.34 114.0 0.33 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.105 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.401 ' C ' ' OE1' ' A' ' 213' ' ' GLN . . . 113.33 15.55 8.88 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.513 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.5 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.36 115.12 27.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.803 0.335 . . . . 0.0 110.962 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 -55.42 110.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 15.7 tp -114.58 113.16 24.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.508 HD11 ' OD2' ' A' ' 165' ' ' ASP . 33.5 mt 61.56 25.02 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.923 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 104.12 -30.14 10.74 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.501 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.97 122.17 32.84 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.705 0.764 . . . . 0.0 111.093 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . 0.482 ' O ' ' NE2' ' A' ' 156' ' ' GLN . 74.5 Cg_exo -50.44 152.52 8.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.638 2.225 . . . . 0.0 112.381 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.424 HG21 ' CE2' ' A' ' 169' ' ' PHE . 20.1 tt -108.06 154.17 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.418 HG12 ' CB ' ' A' ' 156' ' ' GLN . 7.4 mm -110.96 124.2 67.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.135 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.59 HG11 ' O ' ' A' ' 207' ' ' ALA . 16.7 t -122.17 125.11 72.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.082 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -156.0 152.7 28.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.933 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -59.33 129.69 43.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.093 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 11.6 t -74.61 -44.7 49.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -56.83 -26.61 58.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.827 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -56.6 -44.72 81.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.071 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -56.05 -47.32 78.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.96 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 230' ' ' ASN . 6.8 mmpt? -66.01 -62.1 1.68 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 229' ' ' LYS . 4.4 m120 -34.39 -39.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -104.3 75.8 1.28 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.91 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -162.59 116.6 1.75 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.95 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.3 t -135.87 113.55 10.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.805 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 176.25 145.33 5.54 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.475 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -78.51 -15.94 13.63 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.708 2.272 . . . . 0.0 112.365 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 79.4 p -64.0 149.27 47.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 32.3 t -124.59 41.98 3.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.835 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.488 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.367 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 59.7 p -83.75 136.15 34.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.858 0.361 . . . . 0.0 110.842 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.1 m -165.05 152.1 10.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -121.94 145.4 16.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.46 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 62.5 p -42.75 136.54 2.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 0.0 110.853 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 66.2 m -100.6 92.13 4.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.885 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -80.04 -83.39 0.7 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.437 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.08 108.05 16.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 110.884 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.6 m -152.08 144.13 16.46 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.685 0.755 . . . . 0.0 110.843 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.57 146.94 21.91 Favored 'Trans proline' 0 C--O 1.231 0.127 0 C-N-CA 122.714 2.276 . . . . 0.0 112.334 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.9 t -138.7 106.41 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.63 153.06 21.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.875 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -93.52 155.1 41.05 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.709 0.766 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.08 155.4 38.02 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.709 2.272 . . . . 0.0 112.308 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.465 ' O ' HG23 ' A' ' 139' ' ' VAL . 33.7 m -119.61 49.92 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.121 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -150.79 144.71 25.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.856 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -82.32 166.36 19.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.863 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 147' ' ' ARG . 5.8 tp -89.31 147.7 23.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 11.3 p -75.32 153.82 86.06 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.672 0.749 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.0 -17.89 36.2 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.255 . . . . 0.0 112.359 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -90.47 -25.2 20.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.772 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -71.44 -38.92 71.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.938 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.551 ' HG3' HD23 ' A' ' 142' ' ' LEU . 72.0 mtm180 -49.05 -44.26 41.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.932 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -50.1 -47.94 53.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -52.35 -28.26 18.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.103 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.423 ' HB2' ' NH1' ' A' ' 150' ' ' ARG . 9.1 mtp-105 -90.19 34.94 0.86 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.6 m -123.47 127.08 47.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.169 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 196' ' ' VAL . 4.1 p -102.95 151.95 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.624 ' CD1' ' CE2' ' A' ' 195' ' ' TYR . 9.7 t80 -109.09 137.12 47.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.912 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 25.2 m -126.62 152.64 46.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . 0.427 ' CE ' ' OE1' ' A' ' 223' ' ' GLN . 42.8 mtm -152.5 172.85 15.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.414 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.4 tt0 65.38 41.51 4.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.519 HD11 ' CB ' ' A' ' 194' ' ' ALA . 62.1 mt -76.49 161.36 28.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -81.49 171.15 15.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.068 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.35 -29.03 42.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.2 mtp85 -114.73 42.92 2.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.872 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 19.2 tt -91.36 148.35 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.142 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 -127.6 149.35 70.0 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.593 0.711 . . . . 0.0 110.892 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.65 -35.6 13.15 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.679 2.252 . . . . 0.0 112.377 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 20.9 mmt-85 -61.78 -53.12 60.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.955 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -41.95 -48.28 4.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -69.05 -49.3 58.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.938 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 176' ' ' VAL . 38.3 mt-10 -43.13 -69.06 0.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.797 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -58.83 -48.29 81.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.856 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.575 ' CD1' HD13 ' A' ' 215' ' ' LEU . 36.2 t80 -51.57 -31.16 23.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -94.95 -10.41 31.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.878 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 16.6 t -69.92 -4.39 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.867 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -77.95 -21.55 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.116 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.9 m -114.31 -28.18 2.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.165 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.07 154.57 20.9 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 18.8 tttt -69.65 137.08 51.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.824 0.345 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.507 HG21 ' HA ' ' A' ' 167' ' ' GLU . 81.1 t -93.51 136.2 25.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.158 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.0 tpp85 -101.06 -54.28 2.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.932 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -137.12 148.64 46.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.527 HG13 HG22 ' A' ' 196' ' ' VAL . 2.9 t -131.89 121.89 48.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.163 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -115.1 104.21 11.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.868 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 82.8 mt -96.61 115.59 36.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.114 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 14.0 mm -76.18 119.73 24.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.138 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 56.1 p -113.57 121.28 43.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -116.81 125.78 52.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -89.13 140.22 29.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.802 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 43.15 50.37 5.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.841 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 62.4 p -91.0 143.6 26.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.816 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.44 ' O ' ' C ' ' A' ' 189' ' ' ARG . 3.3 mpt_? -63.33 170.74 2.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.79 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' A' ' 188' ' ' ARG . 49.8 ttt180 -35.41 99.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.908 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 1.4 t -159.42 172.36 18.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.893 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -117.03 163.16 16.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -81.71 117.48 4.42 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.51 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.441 ' HB ' ' CZ ' ' A' ' 153' ' ' PHE . 17.4 pt -101.9 144.17 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.906 0.384 . . . . 0.0 111.112 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.519 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -145.92 145.95 30.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.023 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.624 ' CE2' ' CD1' ' A' ' 153' ' ' PHE . 88.4 m-85 -110.98 139.02 46.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.944 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.622 ' O ' HG12 ' A' ' 152' ' ' VAL . 90.9 t -128.04 128.29 68.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.148 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.47 127.42 36.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.923 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -105.39 150.59 25.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 49.1 t -48.07 -42.29 28.29 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -139.47 173.5 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.879 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.481 HD12 ' HB1' ' A' ' 149' ' ' ALA . 19.4 tt -86.08 -25.64 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.159 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.55 -10.6 58.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.951 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 18.1 m -95.2 -13.65 24.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.857 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.621 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -64.04 -43.44 74.69 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.647 0.737 . . . . 0.0 111.191 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 66.6 Cg_exo -48.02 -47.52 18.96 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.701 2.268 . . . . 0.0 112.29 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 79.2 mt -62.36 -40.2 95.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.858 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -64.05 -40.24 95.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.128 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 92.3 mt -55.39 -44.18 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.16 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -60.16 -41.06 98.0 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.504 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.443 HD22 ' NE2' ' A' ' 213' ' ' GLN . 44.9 mt -44.54 -27.86 0.52 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.941 0.4 . . . . 0.0 110.973 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.419 ' C ' ' O ' ' A' ' 210' ' ' LEU . 49.0 m -36.74 116.25 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 108.3 13.03 20.37 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.583 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.443 ' NE2' HD22 ' A' ' 210' ' ' LEU . 8.7 mt-30 -92.19 114.37 26.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.789 0.328 . . . . 0.0 110.903 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 33.2 mtt180 -48.81 109.52 0.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.575 HD13 ' CD1' ' A' ' 169' ' ' PHE . 16.6 tp -115.39 113.18 23.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 42.2 mt 62.36 25.12 14.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 101.66 -26.97 22.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.482 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 90.8 t -116.52 122.24 32.11 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.657 0.741 . . . . 0.0 111.139 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -49.1 153.73 3.98 Favored 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.727 2.285 . . . . 0.0 112.291 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.1 tt -118.83 153.87 21.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.414 HG12 ' CB ' ' A' ' 156' ' ' GLN . 5.1 mm -114.18 143.09 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.106 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.443 ' N ' HE21 ' A' ' 223' ' ' GLN . 67.7 t -140.14 120.19 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.185 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . 0.443 HE21 ' N ' ' A' ' 222' ' ' VAL . 0.3 OUTLIER -132.52 166.98 20.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.928 179.993 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -82.56 107.32 15.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.059 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 1.4 t -57.48 -38.6 74.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.862 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -45.11 -42.39 8.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.861 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -41.9 -45.17 3.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.139 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 232' ' ' LEU . 30.5 tp10 -57.02 -38.03 72.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 19.6 ttmt -72.93 -18.22 61.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -92.02 -17.96 24.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -127.91 9.42 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 233' ' ' SER . 1.1 pt? -47.26 -20.68 0.21 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.88 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.629 ' N ' HD23 ' A' ' 232' ' ' LEU . 8.8 m -140.34 118.95 12.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.819 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -153.35 -94.93 0.11 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.487 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -77.31 148.04 26.45 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.622 2.215 . . . . 0.0 112.352 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 3.5 m -117.87 -51.3 2.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 47.2 t -39.8 116.57 0.65 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.915 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.398 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.51 -179.988 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.3 m -151.26 162.47 40.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.884 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 74.3 m -153.27 158.47 41.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -130.49 144.7 16.05 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.438 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 5.0 t -78.25 118.29 20.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 110.806 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -171.92 141.4 1.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.885 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -67.29 98.1 0.42 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.486 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -172.09 133.99 0.72 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.806 0.336 . . . . 0.0 110.889 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 8.9 t -54.38 108.77 1.23 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.636 0.732 . . . . 0.0 110.887 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -44.64 163.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.645 2.23 . . . . 0.0 112.353 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 5.4 t -81.7 -17.32 11.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.171 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -126.68 175.37 8.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.828 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.415 ' C ' ' O ' ' A' ' 136' ' ' ARG . 1.0 OUTLIER -36.01 141.84 0.32 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.632 0.73 . . . . 0.0 110.911 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -79.06 -172.81 1.64 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.711 2.274 . . . . 0.0 112.321 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.0 m -61.7 145.63 12.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.416 ' O ' ' C ' ' A' ' 141' ' ' ASN . 0.5 OUTLIER -153.59 175.85 12.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.805 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 140' ' ' ASP . 16.9 t-20 -36.83 111.41 0.15 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 7.1 tp -51.16 149.13 3.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.3 m -79.9 161.33 66.46 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.822 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.09 -20.09 17.03 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.374 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -88.08 -20.06 26.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.883 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -75.87 -36.67 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -50.26 -26.76 5.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.921 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -72.73 -47.13 49.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -42.77 -44.81 4.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -83.04 42.96 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.877 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 86.6 m -142.51 128.28 19.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.133 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.3 p -104.43 149.5 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.191 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -100.29 125.94 46.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.964 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.7 m -116.2 154.09 30.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 36.2 mtm -153.58 178.09 10.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.418 ' OE1' HD11 ' A' ' 221' ' ' ILE . 4.7 tt0 59.97 51.46 5.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.854 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.698 HD22 HD13 ' A' ' 161' ' ' ILE . 82.0 mt -89.19 142.54 27.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.883 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -52.89 -175.59 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.097 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -87.72 -43.38 11.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.102 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -109.68 32.84 4.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.868 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.698 HD13 HD22 ' A' ' 157' ' ' LEU . 18.5 tt -67.76 153.39 8.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 38.7 mmm-85 -127.0 146.89 59.34 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.589 0.709 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.44 -48.63 11.49 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.64 2.226 . . . . 0.0 112.348 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.3 mmt85 -47.44 -56.88 6.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -37.94 -55.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 89.8 mt -60.35 -44.43 95.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -53.4 -68.55 0.16 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.921 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.78 -45.07 70.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.669 ' CE2' HG21 ' A' ' 220' ' ' ILE . 16.5 t80 -55.24 -42.31 73.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.438 ' CE2' HG21 ' A' ' 196' ' ' VAL . 37.1 m-85 -83.83 -19.26 35.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 15.8 t -58.41 -11.71 3.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.838 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -69.3 -26.32 64.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.113 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.98 -30.97 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -174.17 156.31 23.22 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.478 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.421 ' HA ' ' CE ' ' A' ' 175' ' ' LYS . 0.0 OUTLIER -70.24 133.49 47.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 110.879 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 54.7 t -88.27 132.55 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.124 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -86.1 -56.43 3.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.84 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 179' ' ' VAL . 9.7 t70 -137.59 159.08 42.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.874 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.479 ' N ' ' OD1' ' A' ' 178' ' ' ASP . 21.2 t -138.73 119.63 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.101 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -110.8 117.45 33.45 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 67.6 mt -112.78 113.94 45.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 4.7 mm -78.74 104.89 7.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 43.0 t -102.62 95.89 6.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.855 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -159.83 141.67 13.05 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -110.19 96.89 6.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.846 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -82.43 -49.81 9.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . 0.444 ' O ' ' C ' ' A' ' 188' ' ' ARG . 68.3 p -131.07 127.8 38.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 187' ' ' SER . 15.0 ptm180 -34.46 133.19 0.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.885 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 15.0 ttm180 69.58 44.0 0.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 47.0 t -84.8 167.41 16.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.814 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.58 165.08 11.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.07 107.74 2.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.515 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 34.6 pt -96.04 148.15 5.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.89 0.376 . . . . 0.0 111.109 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.4 ' CB ' HD11 ' A' ' 157' ' ' LEU . . . -149.86 168.0 24.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.065 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -131.22 133.08 45.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 152' ' ' VAL . 50.2 t -118.77 120.2 63.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.117 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.17 104.37 16.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -78.78 159.77 27.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.6 t -61.79 -33.31 73.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.958 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -140.06 152.36 46.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.53 HD12 ' HB1' ' A' ' 149' ' ' ALA . 17.5 tt -68.85 -31.68 51.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.18 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . 0.41 ' C ' ' HD2' ' A' ' 205' ' ' PRO . 27.4 mt-30 -64.33 -10.33 23.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 4.8 t -92.83 -18.07 23.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.901 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.615 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.7 t -60.28 -43.24 92.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.595 0.712 . . . . 0.0 111.129 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 65.5 Cg_exo -48.01 -52.13 8.77 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.632 2.222 . . . . 0.0 112.328 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.85 -37.93 83.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.927 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . 0.605 ' O ' HG11 ' A' ' 222' ' ' VAL . . . -64.95 -32.57 74.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.084 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 68.0 mt -64.7 -43.33 96.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.36 -42.0 99.66 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.424 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.482 ' HA ' ' NE2' ' A' ' 213' ' ' GLN . 77.1 mt -41.23 -28.72 0.11 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 75.8 m -36.85 107.2 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.103 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.86 11.59 7.62 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.457 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.495 ' OE1' ' CA ' ' A' ' 213' ' ' GLN . 0.0 OUTLIER -91.25 119.13 31.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.959 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -56.5 108.34 0.47 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 14.8 tp -113.14 112.97 24.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 35.9 mt 61.18 26.51 16.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 102.19 -30.24 10.82 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.541 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 98.8 t -114.46 121.71 35.54 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.529 0.681 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.05 153.87 6.03 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.625 2.217 . . . . 0.0 112.327 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.669 HG21 ' CE2' ' A' ' 169' ' ' PHE . 19.8 tt -112.08 153.23 13.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.418 HD11 ' OE1' ' A' ' 156' ' ' GLN . 5.9 mm -112.38 132.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.173 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . 0.605 HG11 ' O ' ' A' ' 207' ' ' ALA . 11.7 t -131.97 120.61 44.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -151.36 142.37 23.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.916 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -48.84 133.41 17.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.103 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 42.4 t -74.24 -43.42 57.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -91.3 44.41 1.19 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.909 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -73.13 -39.74 65.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.099 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -81.25 -42.62 20.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 18.1 mmtm -59.66 -56.52 20.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.915 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -42.54 -41.47 3.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 25.2 ttp85 -106.83 77.94 1.21 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.881 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 232' ' ' LEU . 0.5 OUTLIER -157.35 110.02 2.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.915 -179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.9 t -128.49 131.85 48.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.847 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 146.05 82.62 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.24 38.46 0.7 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.73 2.287 . . . . 0.0 112.402 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 76.6 p -167.27 138.48 3.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.827 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 53.6 p -59.17 118.04 5.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.812 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.463 179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 8.9 t -86.05 167.28 15.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 42.7 t -99.2 -43.95 6.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.881 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 130.41 169.85 12.58 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.1 m -135.92 152.11 50.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 0.0 110.855 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 83.1 p -173.72 164.46 4.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.861 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -115.41 73.01 0.25 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.464 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -172.68 170.37 4.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.795 0.331 . . . . 0.0 110.872 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.4 m -123.62 87.52 52.28 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.623 0.725 . . . . 0.0 110.887 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.98 170.92 18.89 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.368 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 p -61.89 129.48 24.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.6 ttp85 -164.24 160.57 21.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -43.33 143.25 1.47 Allowed Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.669 0.747 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -46.33 112.24 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.643 2.228 . . . . 0.0 112.341 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.5 m -81.39 139.82 17.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.092 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 26.2 m-20 -138.22 148.17 44.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -135.48 144.52 46.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.888 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.677 HD13 ' H ' ' A' ' 142' ' ' LEU . 0.0 OUTLIER -49.16 178.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.001 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 60.0 p -85.11 149.83 53.73 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.665 0.745 . . . . 0.0 110.87 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -44.89 -34.2 8.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.664 2.242 . . . . 0.0 112.348 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 146' ' ' GLU . 6.9 pt-20 -72.32 -41.85 66.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.404 ' N ' ' HG3' ' A' ' 145' ' ' GLU . 30.3 mm-40 -55.92 -33.89 65.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 69.4 mtt85 -57.24 -51.28 70.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.833 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -72.63 -26.78 61.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.77 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.467 ' HB1' HD12 ' A' ' 201' ' ' ILE . . . -66.13 -36.77 84.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.446 ' NH1' HD12 ' A' ' 142' ' ' LEU . 48.9 mtt180 -85.92 33.43 0.6 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 7.2 m -125.9 137.38 53.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.152 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 196' ' ' VAL . 12.0 p -116.57 149.14 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.148 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -100.83 137.92 38.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.913 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 91.4 m -127.62 149.82 50.01 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 34.6 mtm -151.84 -179.3 7.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.459 ' CB ' HG12 ' A' ' 221' ' ' ILE . 4.8 tt0 54.67 47.05 23.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 194' ' ' ALA . 72.4 mt -75.81 165.37 25.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.924 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -81.72 175.76 10.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.107 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.87 -34.21 30.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.105 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -118.14 47.99 1.49 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.646 HD13 HD22 ' A' ' 157' ' ' LEU . 14.3 tt -90.3 153.95 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -136.47 152.52 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.55 0.691 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.77 -45.41 16.82 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.663 2.242 . . . . 0.0 112.339 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.96 -48.74 64.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.879 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -47.41 -63.49 1.03 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 35.0 mt -54.94 -45.81 74.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -47.03 -68.37 0.2 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.829 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.66 -43.27 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.879 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.605 ' CD1' HD13 ' A' ' 215' ' ' LEU . 44.4 t80 -54.68 -29.56 53.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . 0.479 ' HB3' ' CZ ' ' A' ' 198' ' ' PHE . 23.0 m-85 -95.29 -12.34 26.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.827 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 13.5 p -67.71 -4.21 11.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.865 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -80.54 -21.36 41.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.066 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.3 m -117.22 -27.56 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.106 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -173.71 159.67 29.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.448 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -74.67 134.98 41.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.5 HG11 ' CG2' ' A' ' 179' ' ' VAL . 80.0 t -95.76 116.48 37.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.102 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -76.05 -43.49 43.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -153.32 158.0 40.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.632 HG13 HG22 ' A' ' 196' ' ' VAL . 86.7 t -137.07 141.45 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.094 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -124.38 120.03 30.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.842 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 61.9 mt -116.68 114.39 45.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.133 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 28.2 mm -78.74 150.45 5.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 71.4 p -157.19 160.4 38.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -150.79 175.37 12.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.868 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -47.65 -53.26 15.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -125.45 107.68 10.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 80.8 p -100.84 41.95 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -102.23 -53.41 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.858 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -80.5 43.18 0.64 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 95.3 p -174.82 171.62 3.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.9 mmtp -104.58 133.96 48.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.931 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -71.94 109.12 2.71 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 35.5 pt -95.09 145.34 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 111.136 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.683 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -146.09 137.01 24.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.049 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -103.4 112.73 25.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.902 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.775 ' O ' HG12 ' A' ' 152' ' ' VAL . 56.2 t -109.54 141.93 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.172 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -118.42 153.21 34.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.479 ' CZ ' ' HB3' ' A' ' 170' ' ' PHE . 63.2 m-85 -123.05 -177.32 3.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.846 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 51.3 m -85.49 -21.73 28.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.9 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.49 144.39 29.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . 0.467 HD12 ' HB1' ' A' ' 149' ' ' ALA . 14.7 tt -70.86 -27.69 31.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 69.9 mm-40 -65.27 -9.61 25.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 6.1 t -94.89 -18.17 21.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.609 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 5.9 t -59.28 -43.56 96.85 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.629 0.728 . . . . 0.0 111.125 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.0 Cg_exo -47.9 -51.59 9.62 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.586 2.191 . . . . 0.0 112.371 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.11 -43.57 95.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.64 -34.36 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.056 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 79.8 mt -64.77 -39.74 86.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.12 -32.88 85.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.571 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.535 HD22 ' NE2' ' A' ' 213' ' ' GLN . 71.2 mt -55.78 -20.47 15.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 110.955 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 210' ' ' LEU . 54.9 m -36.75 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 118.93 14.09 6.26 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.503 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.535 ' NE2' HD22 ' A' ' 210' ' ' LEU . 27.0 mt-30 -88.65 106.29 18.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.829 0.347 . . . . 0.0 110.854 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 42.2 mtm180 -45.9 106.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.893 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.605 HD13 ' CD1' ' A' ' 169' ' ' PHE . 21.2 tp -108.43 107.06 17.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.931 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.2 mt 65.82 27.08 11.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.886 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 97.66 -18.15 57.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.56 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.24 115.21 31.56 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.695 0.759 . . . . 0.0 111.052 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.69 149.79 13.36 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.679 2.253 . . . . 0.0 112.32 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 18.2 tt -115.04 149.74 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.459 HG12 ' CB ' ' A' ' 156' ' ' GLN . 6.0 mm -109.0 125.62 66.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.122 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 17.3 t -120.51 124.2 72.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -143.62 165.79 26.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . . . . . . . . . . . -74.91 124.41 26.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.163 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 90.1 p -75.69 -5.86 47.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.833 -179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -104.43 40.44 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.926 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -96.03 -32.19 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -81.32 -43.35 19.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 4.2 ptmt -60.51 -16.39 36.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.8 m-20 -88.8 -47.7 8.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -89.97 34.96 0.84 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 11.2 tp -116.13 140.39 49.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 90.0 p -69.84 163.39 25.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.82 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 167.81 145.7 4.63 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.01 88.11 1.46 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.711 2.274 . . . . 0.0 112.356 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 7.8 t -123.88 161.64 24.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 30.7 t -85.19 -57.95 2.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.998 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.58 -0.208 . . . . 0.0 112.58 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.9 m -154.57 171.68 19.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.933 0.397 . . . . 0.0 110.837 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.8 p -163.63 152.95 14.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.885 -179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -179.23 138.48 3.53 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.538 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.5 p -145.68 106.85 4.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 77.8 p -118.31 153.92 33.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 114.08 -130.72 9.48 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -147.44 120.11 8.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.78 0.324 . . . . 0.0 110.96 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 14.5 m -145.57 156.74 52.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.705 0.764 . . . . 0.0 110.876 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -77.7 39.83 0.79 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.708 2.272 . . . . 0.0 112.288 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 135' ' ' VAL . 11.4 p -96.7 119.43 44.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.098 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.59 89.25 7.08 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -150.37 153.8 35.14 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.899 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.0 133.27 14.95 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.687 2.258 . . . . 0.0 112.325 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.5 m -84.17 143.34 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -84.8 96.1 9.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.839 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -79.04 160.09 27.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.859 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.71 ' C ' HD12 ' A' ' 142' ' ' LEU . 0.4 OUTLIER -81.6 125.83 31.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.858 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.1 p -82.96 154.35 67.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.73 0.776 . . . . 0.0 110.813 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.4 ' HA ' ' HD2' ' A' ' 147' ' ' ARG . 71.0 Cg_exo -46.2 -20.17 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.634 2.223 . . . . 0.0 112.288 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -83.99 -33.03 24.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.9 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -66.23 -38.57 88.23 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.864 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 148' ' ' ASP . 1.9 ptm180 -58.72 -33.99 70.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.969 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.42 ' N ' ' HG2' ' A' ' 147' ' ' ARG . 6.8 t0 -82.43 -38.51 23.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.91 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -56.86 -41.42 77.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 19.7 mtp180 -86.73 39.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.858 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 27.1 m -133.06 138.52 46.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.084 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 196' ' ' VAL . 10.1 p -113.92 149.3 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.105 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -100.65 120.72 40.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' CYS . . . . . . . . . . . . . 63.4 m -106.29 154.48 20.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.853 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 54.2 mtm -155.54 176.68 12.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.47 ' HB2' ' CG1' ' A' ' 221' ' ' ILE . 5.4 tt0 57.69 52.05 8.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.622 HD11 ' HB2' ' A' ' 194' ' ' ALA . 81.4 mt -81.45 166.78 20.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.938 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.516 ' HB3' ' HB ' ' A' ' 161' ' ' ILE . . . -90.68 174.17 7.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.05 -40.4 27.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.1 mmp_? -108.29 43.67 1.2 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 158' ' ' ALA . 14.4 tt -92.94 153.71 3.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.167 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -134.81 153.92 79.05 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.578 0.704 . . . . 0.0 110.86 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.5 -39.32 17.06 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.608 2.205 . . . . 0.0 112.337 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.45 ' O ' ' C ' ' A' ' 165' ' ' ASP . 12.0 mtt-85 -57.93 -59.74 4.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 164' ' ' ARG . 15.0 m-20 -34.43 -41.94 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.9 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 28.8 mt -78.48 -43.78 26.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.44 ' N ' ' O ' ' A' ' 164' ' ' ARG . 50.6 mt-10 -42.7 -66.43 0.37 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.849 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 171' ' ' SER . 33.4 t70 -62.15 -53.46 55.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.849 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.641 ' CD2' HD13 ' A' ' 215' ' ' LEU . 1.5 t80 -45.46 -30.05 1.29 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -95.25 -20.92 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 168' ' ' ASP . 20.5 t -61.51 -9.49 5.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.78 -29.86 62.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.109 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 7.7 m -111.33 -33.51 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.132 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -162.63 152.5 22.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.483 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 8.5 tppt? -73.72 142.8 46.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.822 0.344 . . . . 0.0 110.922 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.674 HG11 ' CG2' ' A' ' 179' ' ' VAL . 92.0 t -103.18 136.55 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -113.06 -39.07 4.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -141.11 134.58 29.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.674 ' CG2' HG11 ' A' ' 176' ' ' VAL . 59.6 t -134.94 102.89 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.081 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 18.5 mmt-85 -96.04 107.81 20.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 94.4 mt -98.08 117.57 43.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.175 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 26.7 mm -79.59 115.7 22.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.129 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.4 t -125.68 102.04 7.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.46 148.6 27.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.816 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -93.1 -50.2 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.902 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -107.71 96.25 6.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' SER . . . . . . . . . . . . . 99.2 p -144.09 146.05 32.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -72.9 -54.26 9.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.915 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.81 127.14 13.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.828 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 66.7 p -166.07 121.39 1.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 -179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -69.9 -46.34 65.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.914 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 131.18 103.46 0.95 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.485 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 19.4 pt -98.59 144.02 12.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.889 0.376 . . . . 0.0 111.062 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . 0.622 ' HB2' HD11 ' A' ' 157' ' ' LEU . . . -144.96 148.01 33.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.126 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -110.33 135.64 50.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.917 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.496 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.6 t -129.01 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -96.13 103.79 15.7 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.443 ' HE2' HG11 ' A' ' 152' ' ' VAL . 48.3 m-85 -73.85 161.51 30.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.2 m -61.98 -33.55 74.53 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -141.26 170.33 15.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 13.3 tt -84.27 -28.93 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.078 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -68.6 -6.8 27.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' SER . . . . . . . . . . . . . 13.9 t -95.34 -22.26 17.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.917 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.608 ' N ' ' CD ' ' A' ' 205' ' ' PRO . 6.0 t -57.09 -43.72 99.44 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.579 0.704 . . . . 0.0 111.101 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 204' ' ' VAL . 64.5 Cg_exo -47.92 -60.15 0.98 Allowed 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.719 2.279 . . . . 0.0 112.415 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 72.6 mt -52.3 -42.42 63.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.917 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ALA . . . . . . . . . . . . . . . -59.73 -39.76 85.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.12 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 83.5 mt -57.25 -43.68 82.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.133 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.37 -42.8 99.86 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.491 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.454 ' O ' ' C ' ' A' ' 211' ' ' THR . 49.0 mt -42.33 -29.46 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.904 0.383 . . . . 0.0 110.915 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 210' ' ' LEU . 51.5 m -33.97 123.59 0.47 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . 101.24 17.7 21.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.403 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . 0.509 ' OE1' ' CZ ' ' A' ' 169' ' ' PHE . 39.2 mt-30 -93.7 109.82 21.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.812 0.339 . . . . 0.0 110.902 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ARG . . . . . . . . . . . . . 23.5 mtp180 -51.49 99.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.952 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . 0.641 HD13 ' CD2' ' A' ' 169' ' ' PHE . 17.7 tp -101.46 105.63 16.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.956 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 21.1 mt 65.83 25.39 11.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.9 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLY . . . . . . . . . . . . . . . 100.62 -19.75 51.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.471 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.0 114.33 37.21 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.719 0.771 . . . . 0.0 111.058 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -50.6 149.27 13.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.603 2.202 . . . . 0.0 112.361 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 19.8 tt -111.49 156.17 12.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.175 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' CG1' ' HB2' ' A' ' 156' ' ' GLN . 4.6 mm -119.55 135.44 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.055 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.02 122.69 42.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.152 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -145.48 143.13 29.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ALA . . . . . 0.41 ' HB3' HE21 ' A' ' 226' ' ' GLN . . . -43.33 153.45 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.108 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 89.6 p -86.29 51.23 2.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.837 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 224' ' ' ALA . 26.5 pt20 -105.41 44.1 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.925 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -76.95 -58.7 3.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.123 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.425 ' O ' ' C ' ' A' ' 229' ' ' LYS . 1.0 OUTLIER -63.86 -59.79 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.919 -179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 228' ' ' GLU . 19.6 ttmt -36.08 -64.6 0.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -38.82 -55.84 1.45 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.84 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -51.75 -55.03 22.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 6.0 tp -48.64 111.31 0.44 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 m -61.68 125.15 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.897 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . -125.74 88.88 0.37 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.453 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.63 -47.43 13.52 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.636 2.224 . . . . 0.0 112.353 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' SER . . . . . . . . . . . . . 59.9 p -55.59 126.23 24.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 44.5 t -55.94 -51.15 68.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.506 179.961 . . . . . . . . 0 0 . 1 stop_ save_